male reproductive system disease - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

RGD DISEASE ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:	male reproductive system disease	go back to main search page
Accession:	DOID:48	browse the term
Definition:	A reproductive system disease that affects male reproductive organs. (DO)
Synonyms:	exact_synonym:	male genital disease; male genital diseases
	primary_id:	MESH:D005832
	xref:	EFO:0009555; ICD10CM:N50.9; ICD9CM:608.9
For additional species annotation, visit the Alliance of Genome Resources.

show annotations for term's descendants Sort by:
Rat (1984) Mouse (1955) Human (10072) Chinchilla (1777) Bonobo (1926) Dog (1923) Squirrel (1821) Pig (1888) Green Monkey (1889) Naked Mole-rat (1769) All
Genes (1954) Cell Lines (1)

male reproductive system disease

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

androgen receptor

CTD Direct Evidence: marker/mechanism

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

3MC syndrome 2

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

collectin sub-family member 11

ClinVar Annotator: match by term: 3MC syndrome 2
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:2569826 PMID:8933348 PMID:21258343 PMID:25741868 PMID:28301481 More...

NCBI chr12:28,644,171...28,673,458
Ensembl chr12:28,644,172...28,673,376

G

MBL associated serine protease 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:23,261,778...23,340,127
Ensembl chr16:23,268,167...23,339,565

G

solute carrier family 26 (sulfate transporter), member 2

ClinVar Annotator: match by term: OSA syndrome

PMID:7695699 PMID:7923357 PMID:8218237 PMID:8528239 PMID:8571951 More...

NCBI chr18:61,329,926...61,344,668
Ensembl chr18:61,325,991...61,344,684

acquired immunodeficiency syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP-binding cassette, sub-family B member 1A

treatment

DNA:haplotype: :3435T>C((rs1045642), 2677T>G (rs2032582) (human)
DNA:SNP: : rs10276036(human)

RGD

PMID:23372834 PMID:24517233

RGD:39456119, RGD:11098698

NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575

G

Rho GTPase activating protein 44

disease_progression

DNA:SNPs, haplotype:intron, exon: (rs2072255, rs2072254) (human)
DNA:SNP:intron: (rs2072255) (human)

RGD

PMID:28069446 PMID:21107268

RGD:401901288, RGD:401901289

NCBI chr11:64,892,865...65,053,779
Ensembl chr11:64,892,865...65,053,787

G

bone marrow stromal cell antigen 2

DNA:SNPs: :

RGD

NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100

G

C-C motif chemokine ligand 4

DNA:SNP:3' utr:rs1719153 (human)

RGD

NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509

G

C-C motif chemokine receptor 5

ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, delayed progression to

PMID:9742978 PMID:12610055 PMID:12815099 PMID:25741868

NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736

G

CD209d antigen

disease_progression

associated with factor VIII deficiency; DNA:SNP:promoter: g.-139C>T (rs2287886) (human)

RGD

NCBI chr 8:3,921,824...3,928,548
Ensembl chr 8:3,921,824...3,928,555

G

CD40 ligand

treatment

RGD

NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402

G

excision repair cross-complementing rodent repair deficiency, complementation group 2

susceptibility

DNA:polymorphism:exon:p.K751Q(human)

RGD

NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619

G

histocompatibility 2, Q region locus 1

susceptibility

DNA:polymorphism: :HLA-A31

RGD

NCBI chr17:35,539,503...35,547,118
Ensembl chr17:35,539,381...35,544,075

G

indoleamine 2,3-dioxygenase 1

associated with pulmonary tuberculosis;protein:increased expression:blood (human)

RGD

NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025

G

interferon alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893

G

interferon gamma

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, rapid progression to

PMID:9612607 PMID:12854077

NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797

G

insulin-like growth factor 2

protein:decreased expression:plasma

RGD

NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553

G

interleukin 2

CTD Direct Evidence: therapeutic

NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108

G

killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1

severity

DNA:missense mutation:cds: p.I47V (rs643347) (human)

RGD

NCBI chr X:135,418,748...135,435,055
Ensembl chr X:135,418,748...135,435,058

G

natural cytotoxicity triggering receptor 1

protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human)

RGD

NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163

G

natural cytotoxicity triggering receptor 3, pseudogene

protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human)

RGD

NCBI chr17:35,399,512...35,403,785
Ensembl chr17:35,399,511...35,403,638

G

tumor necrosis factor

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

tumor necrosis factor receptor superfamily, member 1a

RGD

NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447

G

tumor necrosis factor receptor superfamily, member 1b

RGD

NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440

G

vitamin D (1,25-dihydroxyvitamin D3) receptor

GAD

NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511

AIDS Dementia Complex

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adrenergic receptor, beta 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030

G

erythropoietin

treatment

RGD

NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504

G

vitamin D binding protein

associated with HIV Infections;protein:increased expression:cerebrospinal fluid:

RGD

NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757

G

interleukin 1 beta

protein:increased expression:neocortex

RGD

NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059

G

insulin receptor

severity

protein:increased expression:cerebrospinal fluid, plasma

RGD

NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617

G

insulin receptor substrate 1

severity

protein:decreased tyrosine phosphorylation:cerebrospinal fluid, leukocyte

RGD

NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137

G

neurofilament, light polypeptide

associated with HIV Seropositivity;protein:increased expression:plasma, CSF (human)
protein:increased expression:CSF (human)

RGD

PMID:30105502 PMID:27400930

RGD:127284876, RGD:127284885

NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544

G

neuropeptide Y

severity

protein:increased expression:cerebrospinal fluid

RGD

NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487

G

opioid receptor, mu 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198

G

platelet derived growth factor, B polypeptide

RGD

NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178

G

solute carrier family 6 (neurotransmitter transporter, serotonin), member 4

RGD

NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166

AIDS-Associated Nephropathy

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

angiotensin II receptor, type 1a

RGD

NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850

G

angiotensin II receptor, type 2

RGD

NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403

G

epidermal growth factor

RGD

NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965

G

haptoglobin

protein:increased expression:urine

RGD

NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804

G

mechanistic target of rapamycin kinase

RGD

PMID:23678040 PMID:23678040

RGD:7245474, RGD:7245474

NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140

G

myosin, heavy polypeptide 9, non-muscle

protein:decreased expression:glomerulus

RGD

NCBI chr15:77,644,788...77,726,315
Ensembl chr15:77,644,787...77,726,375

G

notch 4

protein: increased expression: kidney

RGD

PMID:20706108 PMID:20706108

RGD:6480788, RGD:6480788

NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477

G

nephrosis 1, nephrin

treatment

RGD

PMID:19188342 PMID:17229913

RGD:38596324, RGD:38599164

NCBI chr 7:30,157,259...30,188,048
Ensembl chr 7:30,157,740...30,186,648

AIDS-Related Complex

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

killer cell lectin-like receptor subfamily K, member 1

treatment

RGD

NCBI chr 6:129,587,286...129,600,863
Ensembl chr 6:129,587,286...129,600,827

AIDS-Related Kaposi Sarcoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

B cell leukemia/lymphoma 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

AIDS-Related Opportunistic Infections

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

CD4 antigen

CTD Direct Evidence: marker/mechanism

NCBI chr 6:124,841,656...124,865,210
Ensembl chr 6:124,841,655...124,865,184

G

tumor necrosis factor receptor superfamily, member 8

CTD Direct Evidence: marker/mechanism

NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734

Alazami-Yuan Syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adaptor-related protein complex AP-4, mu 1

ClinVar Annotator: match by term: Alazami-Yuan syndrome

PMID:25741868 PMID:28492532

NCBI chr 5:138,170,283...138,178,691
Ensembl chr 5:138,170,264...138,178,691

G

La ribonucleoprotein 7, transcriptional regulator

ClinVar Annotator: match by term: Alazami-Yuan syndrome

PMID:25741868 PMID:26374271 PMID:29619239 PMID:30006060 PMID:30426380 More...

NCBI chr 3:127,330,363...127,346,998
Ensembl chr 3:127,330,363...127,346,998

G

TATA-box binding protein associated factor 6

ClinVar Annotator: match by term: Alazami-Yuan syndrome
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:11295558 PMID:25558065 PMID:25574841 PMID:25741868 PMID:25741913 More...

NCBI chr 5:138,176,879...138,185,713
Ensembl chr 5:138,176,879...138,185,713

Anal Atresia, Hypospadias, and Penoscrotal Inversion

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP-binding cassette, sub-family C member 4

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631

G

abhydrolase domain containing 13

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:10,027,717...10,042,155
Ensembl chr 8:10,027,707...10,042,155

G

ankyrin repeat domain 10

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:11,661,581...11,694,617
Ensembl chr 8:11,661,583...11,685,757

G

arginine and glutamate rich 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:8,716,307...8,741,818
Ensembl chr 8:8,715,075...8,740,521

G

basic, immunoglobulin-like variable motif containing

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 1:44,158,032...44,183,931
Ensembl chr 1:44,158,117...44,183,930

G

cysteinyl-tRNA synthetase 2, mitochondrial

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:11,564,017...11,600,781
Ensembl chr 8:11,563,977...11,600,783

G

coiled-coil domain containing 168

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 1:44,095,031...44,118,906
Ensembl chr 1:44,095,032...44,118,906

G

claudin 10

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:119,025,283...119,111,937
Ensembl chr14:119,025,320...119,112,901

G

citrate lyase beta like

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:122,408,289...122,639,646
Ensembl chr14:122,419,116...122,639,646

G

collagen, type IV, alpha 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826

G

collagen, type IV, alpha 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:11,362,878...11,499,287
Ensembl chr 8:11,362,805...11,499,287

G

dopachrome tautomerase

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:118,250,202...118,289,658
Ensembl chr14:118,250,202...118,289,656

G

DnaJ heat shock protein family (Hsp40) member C3

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:119,175,371...119,219,114
Ensembl chr14:119,175,388...119,219,109

G

dedicator of cytokinesis 9

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:121,772,026...122,038,465
Ensembl chr14:121,779,458...122,035,249

G

DAZ interacting protein 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:119,112,927...119,162,947
Ensembl chr14:119,112,932...119,162,872

G

ephrin B2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:8,667,235...8,711,242
Ensembl chr 8:8,667,434...8,711,242

G

excision repair cross-complementing rodent repair deficiency, complementation group 5

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 1:44,184,084...44,220,399
Ensembl chr 1:44,186,904...44,220,420

G

FERM, ARH/RhoGEF and pleckstrin domain protein 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:121,272,563...121,521,156
Ensembl chr14:121,272,612...121,521,156

G

fibroblast growth factor 14

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:124,211,257...124,915,098
Ensembl chr14:124,215,319...124,914,539

G

gamma-glutamylamine cyclotransferase

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:123,128,272...123,151,173
Ensembl chr14:123,053,635...123,151,169

G

glypican 6

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:117,162,332...118,216,941
Ensembl chr14:117,162,727...118,213,956

G

G protein-coupled receptor 18

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:122,148,846...122,153,300
Ensembl chr14:122,148,665...122,153,193

G

G protein-coupled receptor 180

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:118,374,513...118,401,644
Ensembl chr14:118,374,570...118,400,673

G

G protein-coupled receptor 183

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:122,189,743...122,202,605
Ensembl chr14:122,189,963...122,202,607

G

heparan sulfate 6-O-sulfotransferase 3

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:119,374,902...120,226,864
Ensembl chr14:119,375,753...120,107,227

G

inhibitor of growth family, member 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:11,605,762...11,613,251
Ensembl chr 8:11,605,571...11,613,251

G

importin 5

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:121,134,271...121,185,451
Ensembl chr14:121,148,636...121,185,411

G

insulin receptor substrate 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458

G

integrin, beta-like 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:123,897,331...124,215,173
Ensembl chr14:123,897,383...124,213,030

G

ligase IV, DNA, ATP-dependent

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:10,020,020...10,027,680
Ensembl chr 8:10,019,049...10,027,686

G

muscleblind like splicing factor 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:120,513,077...120,669,110
Ensembl chr14:120,513,081...120,669,109

G

methyltransferase 21C, AARS1 lysine

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 1:44,048,559...44,081,745
Ensembl chr 1:44,048,568...44,059,194

G

myosin XVI

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:10,203,911...10,684,742
Ensembl chr 8:10,203,911...10,684,742

G

sodium leak channel, non-selective

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:123,514,046...123,864,846
Ensembl chr14:123,514,046...123,864,556

G

NALCN channel auxiliary factor 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:9,256,006...9,823,329
Ensembl chr 8:9,255,902...9,821,161

G

NAD(P)HX dehydratase

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:11,547,506...11,563,287
Ensembl chr 8:11,547,506...11,564,960

G

oxoglutarate (alpha-ketoglutarate) receptor 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:120,256,997...120,279,847
Ensembl chr14:120,256,997...120,279,847

G

propionyl-Coenzyme A carboxylase, alpha polypeptide

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:122,721,822...123,127,372
Ensembl chr14:122,771,736...123,128,512

G

protein O-glucosyltransferase 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 1:44,143,060...44,158,844
Ensembl chr 1:44,145,706...44,157,968

G

RAB20, member RAS oncogene family

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:11,503,390...11,528,640
Ensembl chr 8:11,503,518...11,528,710

G

RAS related protein 2a

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:120,715,873...120,744,606
Ensembl chr14:120,715,856...120,744,606

G

solute carrier family 10, member 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:5,133,219...5,155,287
Ensembl chr 8:5,133,219...5,155,351

G

solute carrier family 15 (oligopeptide transporter), member 1

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:121,697,033...121,742,666
Ensembl chr14:121,697,033...121,742,664

G

SRY (sex determining region Y)-box 21

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:118,470,645...118,474,442
Ensembl chr14:118,470,644...118,474,442

G

serine/threonine kinase 24

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:121,521,599...121,618,269
Ensembl chr14:121,523,755...121,617,423

G

testis expressed 30

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 1:44,125,773...44,141,650
Ensembl chr 1:44,125,773...44,141,601

G

TDP-glucose 4,6-dehydratase

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:118,349,323...118,370,177
Ensembl chr14:118,349,323...118,370,167

G

transmembrane 9 superfamily member 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:122,342,290...122,397,015
Ensembl chr14:122,344,450...122,397,016

G

transmembrane and tetratricopeptide repeat containing 4

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:123,156,383...123,220,697
Ensembl chr14:123,156,383...123,221,447

G

tumor necrosis factor (ligand) superfamily, member 13b

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 8:10,056,637...10,086,000
Ensembl chr 8:10,056,467...10,089,072

G

tripeptidyl peptidase II

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr 1:43,973,130...44,042,160
Ensembl chr 1:43,972,807...44,042,160

G

ubiquitin associated domain containing 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:122,115,970...122,258,447
Ensembl chr14:122,116,032...122,258,446

G

UDP-glucose glycoprotein glucosyltransferase 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:119,219,177...119,337,208
Ensembl chr14:119,222,451...119,336,842

G

zinc finger protein of the cerebellum 2

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:122,712,796...122,717,740
Ensembl chr14:122,712,847...122,717,264

G

zinc finger protein of the cerebellum 5

ClinVar Annotator: match by term: Anal atresia, hypospadias, and penoscrotal inversion

NCBI chr14:122,696,572...122,703,127
Ensembl chr14:122,694,207...122,703,089

anogenital venereal wart

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-C motif chemokine ligand 20

protein:decreased expression:skin

RGD

NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888

G

CD8 subunit alpha

mRNA:decreased expression:zone of skin (human)

NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157

G

cytotoxic T-lymphocyte-associated protein 4

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991

G

forkhead box P3

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484

G

interferon alpha 16

treatment

RGD

NCBI chr 4:88,594,524...88,595,093
Ensembl chr 4:88,594,152...88,595,161

G

interferon alpha 6

treatment

NCBI chr 4:88,745,627...88,746,269
Ensembl chr 4:88,745,653...88,746,222

G

interleukin 10

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

interleukin 12b

treatment

protein:decreased expression:peripheral blood mononuclear cells (human)

RGD

PMID:16114559 PMID:23754510

RGD:7829774, RGD:40400714

NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860

G

interleukin 2

protein:decreased expression:peripheral blood mononuclear cells (human)

RGD

NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108

G

interleukin 21

protein:decreased expression:blood serum (human)

RGD

NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785

G

interleukin 4

treatment

protein:increased expression:peripheral blood mononuclear cells (human)

RGD

PMID:16114559 PMID:23754510

RGD:7829774, RGD:40400714

NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496

G

interleukin 6

protein:decreased expression:peripheral blood mononuclear cells (human)

RGD

NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979

G

killer cell lectin-like receptor subfamily K, member 1

mRNA,protein:decreased expression:multiple (human)

RGD

NCBI chr 6:129,587,286...129,600,863
Ensembl chr 6:129,587,286...129,600,827

G

mitogen-activated protein kinase 8

treatment

mRNA:increased expression:zone of skin (human)

NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115

G

myeloid differentiation primary response gene 88

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477

G

natural cytotoxicity triggering receptor 1

mRNA,protein:decreased expression:multiple (human)

RGD

NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163

G

programmed cell death 1

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278

G

protein tyrosine phosphatase, non-receptor type 11

protein:increased expression:foreskin

RGD

NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460

G

protein tyrosine phosphatase, non-receptor type 6

protein:increased expression:foreskin

RGD

NCBI chr 6:124,697,670...124,715,672
Ensembl chr 6:124,697,670...124,715,677

G

serine (or cysteine) peptidase inhibitor, clade F, member 1

disease_progression

mRNA, protein:decreased expression:skin of body (human)

RGD

NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527

G

transforming growth factor, beta 1

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502

G

toll-like receptor 2

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074

G

toll-like receptor 3

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117

G

toll-like receptor 4

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521

G

toll-like receptor 7

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr X:166,086,376...166,113,570
Ensembl chr X:166,087,925...166,113,554

G

toll-like receptor 8

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr X:166,024,119...166,047,325
Ensembl chr X:166,025,692...166,047,325

G

toll-like receptor 9

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082

G

tumor necrosis factor

protein:increased expression:peripheral blood mononuclear cells (human)

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

tumor necrosis factor receptor superfamily, member 18

mRNA,protein:increased expression:multiple (human)

RGD

NCBI chr 4:156,110,779...156,113,351
Ensembl chr 4:156,110,621...156,113,352

Asthenozoospermia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BSCL2 lipid droplet biogenesis associated, seipin

CTD Direct Evidence: marker/mechanism

NCBI chr19:8,814,831...8,826,047
Ensembl chr19:8,814,831...8,826,047

G

cilia and flagella associated protein 251

ClinVar Annotator: match by term: asthenozoospermia

NCBI chr 5:123,390,196...123,465,547
Ensembl chr 5:123,390,165...123,465,547

G

glutathione S-transferase, theta 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418

G

plasminogen activator, urokinase

mRNA, protein:decreased expression:testes, epididymis (rat)
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:18998460 PMID:18998460

NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453

atrophy of testis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BCL2-like 2

RGD

NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691

G

breast cancer 2, early onset

RGD

NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794

autosomal recessive congenital bilateral absence of vas deferens

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adhesion G protein-coupled receptor G2

ClinVar Annotator: match by term: Congenital bilateral aplasia of vas deferens from CFTR mutation

PMID:25741868 PMID:27476656

NCBI chr X:159,173,315...159,281,072
Ensembl chr X:159,173,686...159,281,066

G

cystic fibrosis transmembrane conductance regulator

ClinVar Annotator: match by term: Congenital bilateral aplasia of vas deferens from CFTR mutation

PMID:754013 PMID:1282016 PMID:1283148 PMID:1283149 PMID:1284466 More...

NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767

G

Cftr promoter region

ClinVar Annotator: match by term: Congenital bilateral aplasia of vas deferens from CFTR mutation

PMID:25741868 PMID:28492532

NCBI chr 6:18,169,701...18,171,127

Autosomal Recessive Syndrome of Syndactyly, Undescended Testes and Central Nervous System Defects

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

fibulin 1

ClinVar Annotator: match by term: Autosomal recessive syndrome of syndactyly, undescended testes and central nervous system defects

NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736

azoospermia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 4930447C04 gene

ClinVar Annotator: match by term: Azoospermia

NCBI chr12:72,926,967...72,964,742
Ensembl chr12:72,927,883...72,987,548

G

albumin

CTD Direct Evidence: therapeutic

NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461

G

B cell leukemia/lymphoma 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

BCL2-like 2

RGD

NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691

G

bromodomain, testis-specific

susceptibility

protein:decreased expression:testis:
DNA:SNP: :rs3088232(human)

RGD

PMID:22035730 PMID:22016351

RGD:9586359, RGD:9586360

NCBI chr 5:107,478,982...107,534,927
Ensembl chr 5:107,479,025...107,534,924

G

BSCL2 lipid droplet biogenesis associated, seipin

RGD

NCBI chr19:8,814,831...8,826,047
Ensembl chr19:8,814,831...8,826,047

G

cystic fibrosis transmembrane conductance regulator

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Obstructive azoospermia

PMID:1283148 PMID:1284534 PMID:1284535 PMID:1284639 PMID:1370875 More...

NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767

G

DEAD box helicase 25

ClinVar Annotator: match by term: Azoospermia

NCBI chr 9:35,453,144...35,469,766
Ensembl chr 9:35,447,943...35,469,824

G

DNA meiotic recombinase 1

ClinVar Annotator: match by term: Azoospermia

NCBI chr15:79,445,698...79,489,362
Ensembl chr15:79,445,698...79,489,310

G

endothelial PAS domain protein 1

RGD

NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838

G

excision repair cross-complementing rodent repair deficiency, complementation group 1

susceptibility

DNA:snp:3' utr:c.8092C>A (human)

RGD

NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449

G

fumarylacetoacetate hydrolase domain containing 1

ClinVar Annotator: match by term: Azoospermia

NCBI chr17:25,067,866...25,069,276
Ensembl chr17:25,067,866...25,069,338

G

Fanconi anemia, complementation group M

ClinVar Annotator: match by term: Azoospermia

PMID:17289582 PMID:18174376 PMID:19379763 PMID:23409019 PMID:23932590 More...

NCBI chr12:65,120,884...65,178,616
Ensembl chr12:65,122,377...65,178,832

G

golgi associated PDZ and coiled-coil motif containing

OMIM:102530 | OMIM:108420 | OMIM:243060 | OMIM:258150 | OMIM:270960 | OMIM:309120 | OMIM:415000 | OMIM:606766 | OMIM:612997 | OMIM:613957 | OMIM:613958 | OMIM:614822 | OMIM:615081 | OMIM:615413 | OMIM:615841 | OMIM:615842

NCBI chr10:52,213,120...52,258,220
Ensembl chr10:52,211,946...52,258,220

G

HEN1 methyltransferase homolog 1 (Arabidopsis)

ClinVar Annotator: match by term: Azoospermia

NCBI chr 3:108,846,770...108,887,201
Ensembl chr 3:108,847,375...108,868,090

G

HFM1, ATP-dependent DNA helicase homolog

ClinVar Annotator: match by term: Azoospermia

NCBI chr 5:106,988,059...107,074,427
Ensembl chr 5:106,988,058...107,074,187

G

hydroxysteroid (17-beta) dehydrogenase 10

mRNA:increased expression:testis

RGD

NCBI chr X:150,784,892...150,787,438
Ensembl chr X:150,784,841...150,787,438

G

KASH domain containing 5

ClinVar Annotator: match by term: Azoospermia

NCBI chr 7:44,833,043...44,854,344
Ensembl chr 7:44,833,048...44,854,316

G

minichromosome maintenance 8 homologous recombination repair factor

ClinVar Annotator: match by term: Azoospermia

NCBI chr 2:132,658,061...132,686,117
Ensembl chr 2:132,658,061...132,686,117

G

minichromosome maintenance domain containing 2

ClinVar Annotator: match by term: Azoospermia

NCBI chr 1:9,978,863...10,011,179
Ensembl chr 1:9,978,863...10,012,310

G

meiosis specific with OB domains

ClinVar Annotator: match by term: Azoospermia

NCBI chr17:25,023,275...25,058,762
Ensembl chr17:25,023,263...25,058,762

G

Mov10 like RISC complex RNA helicase 1

ClinVar Annotator: match by term: Azoospermia

NCBI chr15:88,867,094...88,939,355
Ensembl chr15:88,867,112...88,939,355

G

mutS homolog 5

ClinVar Annotator: match by term: Azoospermia

NCBI chr17:35,247,581...35,267,842
Ensembl chr17:35,247,581...35,265,721

G

pyruvate dehydrogenase E1 alpha 2

ClinVar Annotator: match by term: Azoospermia

PMID:29581481 PMID:35172124

NCBI chr 3:140,915,765...140,918,116
Ensembl chr 3:140,915,765...140,918,116

G

REC8 meiotic recombination protein

ClinVar Annotator: match by term: Azoospermia

NCBI chr14:55,855,459...55,862,852
Ensembl chr14:55,855,494...55,862,852

G

synaptonemal complex protein 3

CTD Direct Evidence: marker/mechanism
OMIM:102530 | OMIM:108420 | OMIM:243060 | OMIM:258150 | OMIM:270960 | OMIM:309120 | OMIM:415000 | OMIM:606766 | OMIM:612997 | OMIM:613957 | OMIM:613958 | OMIM:614822 | OMIM:615081 | OMIM:615413 | OMIM:615841 | OMIM:615842

NCBI chr10:88,295,449...88,309,098
Ensembl chr10:88,295,431...88,309,098

G

tudor domain containing 9

ClinVar Annotator: match by term: Azoospermia

NCBI chr12:111,937,922...112,035,288
Ensembl chr12:111,937,993...112,035,288

G

tudor and KH domain containing protein

ClinVar Annotator: match by term: Azoospermia

NCBI chr 3:94,320,551...94,342,161
Ensembl chr 3:94,320,580...94,341,975

G

telomere repeat binding bouquet formation protein 1

ClinVar Annotator: match by term: Azoospermia

NCBI chr 8:105,173,350...105,236,692
Ensembl chr 8:105,173,351...105,236,542

AZOOSPERMIA, OBSTRUCTIVE, WITH NEPHROLITHIASIS

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

claudin 2

ClinVar Annotator: match by term: Azoospermia, obstructive, with nephrolithiasis

NCBI chr X:138,701,552...138,712,135
Ensembl chr X:138,701,577...138,712,135

bowenoid papulosis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

baculoviral IAP repeat-containing 2

mRNA:increased expression:perianal skin (human)

RGD

NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065

G

baculoviral IAP repeat-containing 3

mRNA:increased expression:perianal skin (human)

RGD

NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187

castration-resistant prostate carcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aldo-keto reductase family 1, member C18

mRNA,protein:increased expression:epithelial cell:
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25555457 PMID:23196782

NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653

G

androgen receptor

CTD Direct Evidence: marker/mechanism

PMID:18985049 PMID:24740322 PMID:28500234 PMID:28757136

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

anti-silencing function 1B histone chaperone

CTD Direct Evidence: marker/mechanism

NCBI chr 8:84,682,323...84,696,824
Ensembl chr 8:84,682,136...84,696,826

G

cyclin E2

treatment

RGD

NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779

G

CD46 antigen, complement regulatory protein

CTD Direct Evidence: marker/mechanism

NCBI chr 1:194,721,279...194,781,149
Ensembl chr 1:194,719,134...194,774,557

G

centromere protein K

CTD Direct Evidence: marker/mechanism

NCBI chr13:104,365,474...104,386,130
Ensembl chr13:104,365,119...104,388,900

G

chromodomain helicase DNA binding protein 1

DNA:mutations: :

RGD

NCBI chr17:15,925,229...15,992,874
Ensembl chr17:15,925,229...15,992,872

G

lysine (K)-specific demethylase 1A

CTD Direct Evidence: marker/mechanism

NCBI chr 4:136,277,844...136,330,127
Ensembl chr 4:136,277,851...136,330,034

G

NUF2, NDC80 kinetochore complex component

treatment

RGD

NCBI chr 1:169,325,503...169,359,033
Ensembl chr 1:169,325,503...169,359,033

G

signal transducer and activator of transcription 5A

disease_progression
treatment

DNA:CNV: :prostate (human)

RGD

PMID:23660011 PMID:23660011

RGD:151667415, RGD:151667415

NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995

G

tripartite motif-containing 24

CTD Direct Evidence: marker/mechanism

NCBI chr 6:37,846,816...37,945,380
Ensembl chr 6:37,847,746...37,943,231

G

zinc finger protein 217

CTD Direct Evidence: marker/mechanism

NCBI chr 2:169,950,563...169,993,598
Ensembl chr 2:169,950,563...169,990,023

G

zinc finger protein 367

CTD Direct Evidence: marker/mechanism

NCBI chr13:64,280,836...64,301,013
Ensembl chr13:64,280,832...64,301,016

chlamydia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-C motif chemokine receptor 5

RGD

NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736

G

CD40 antigen

RGD

NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868

G

forkhead box P3

treatment

RGD

NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484

G

intercellular adhesion molecule 1

mRNA:increased expression:lung (mouse)

RGD

NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113

G

indoleamine 2,3-dioxygenase 1

treatment

mRNA:increased expression:lung (mouse)

RGD

PMID:30832593 PMID:31249813

RGD:38455984, RGD:39938856

NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025

G

interferon gamma

CTD Direct Evidence: marker/mechanism

NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797

G

interleukin 13

RGD

NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529

G

interleukin 17A

associated with Bronchial Hyprractivity; mRNA:increased expression:lung

RGD

PMID:20228193 PMID:19812198

RGD:4888528, RGD:4889101

NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720

G

microRNA 21a

associated with asthma;RNA:increased expression:lung

RGD

NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984

G

transforming growth factor, beta 1

treatment

RGD

NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502

G

tumor necrosis factor

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

Chlamydia pneumonia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

CD274 antigen

mRNA:increased expression:lung

RGD

NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495

G

programmed cell death 1

mRNA:increased expression:lung

RGD

NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta

severity

RGD

NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028

congenital bilateral absence of vas deferens

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adhesion G protein-coupled receptor G2

CTD Direct Evidence: marker/mechanism

NCBI chr X:159,173,315...159,281,072
Ensembl chr X:159,173,686...159,281,066

G

cystic fibrosis transmembrane conductance regulator

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Congenital bilateral absence of the vas deferens | ClinVar Annotator: match by term: Congenital bilateral absence of vas deferens
associated with Cystic Fibrosis
DNA:deletion, missense mutations: :multiple
DNA:deletion, nonsense mutations, missense mutations: :multiple

CTD
ClinVar
RGD

PMID:1381723 PMID:2344617 PMID:7506096 PMID:7539342 PMID:7573058 More...

RGD:11566051, RGD:11566040, RGD:11566027

NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767

Coronary Artery Disease, Development of, in HIV

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-C motif chemokine ligand 2

ClinVar Annotator: match by term: Coronary artery disease, development of, in HIV

PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815 More...

NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279

cryptorchidism

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP-binding cassette, sub-family C member 8

ClinVar Annotator: match by term: Bilateral cryptorchidism

PMID:16613899 PMID:16885549 PMID:18025408 PMID:18981553 PMID:21989597 More...

NCBI chr 7:45,753,952...45,829,441
Ensembl chr 7:45,753,947...45,829,457

G

ADAM metallopeptidase with thrombospondin type 1 motif 16

RGD

PMID:24983376 PMID:32037220

RGD:13434925, RGD:38548917

NCBI chr13:70,875,917...70,989,956
Ensembl chr13:70,875,921...70,989,930

G

annexin A5

protein:increased expression: seminiferous tubulle

RGD

NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043

G

androgen receptor

DNA:repeats:exon

RGD

PMID:15472213 PMID:15757859

RGD:1578685, RGD:11576231

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

ATRX, chromatin remodeler

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: undescended testicle

PMID:7697714 PMID:19291773 PMID:24690944 PMID:25741868 PMID:28371217 More...

NCBI chr X:104,841,221...104,972,978
Ensembl chr X:104,841,221...104,973,009

G

BCL2-like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648

G

biotinidase

ClinVar Annotator: match by term: Cryptorchidism

NCBI chr14:31,363,014...31,390,154
Ensembl chr14:31,362,985...31,390,536

G

caspase 3

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:26050606 PMID:29606031

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

Casitas B-lineage lymphoma

CTD Direct Evidence: marker/mechanism

NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346

G

cystic fibrosis transmembrane conductance regulator

mRNA, protein:decreased expression:testis

RGD

NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767

G

cholinergic receptor, muscarinic 3, cardiac

CTD Direct Evidence: marker/mechanism

NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883

G

estrogen receptor 1 (alpha)

mRNA:decreased expression:testis

RGD

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

Fas cell surface death receptor

RGD

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

growth factor, augmenter of liver regeneration

protein:decreased expression:male germ cell:

RGD

NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,130

G

glutathione peroxidase 4

CTD Direct Evidence: marker/mechanism

NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273

G

homeobox D13

DNA:splice-site mutation:exon:180A>G (human)

RGD

NCBI chr 2:74,498,569...74,501,947
Ensembl chr 2:74,498,654...74,501,943

G

heat shock factor 1

protein:increased expression:testis, spermatocyte, nucleus (rat)

RGD

NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113

G

HtrA serine peptidase 2

RGD

NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254

G

insulin-like growth factor I receptor

protein:decreased expression:testis (rat)

RGD

NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416

G

insulin-like 3

idiopathic cryptorchidism, OMIM:219050
ClinVar Annotator: match by term: Bilateral cryptorchidism | ClinVar Annotator: match by term: Cryptorchidism
CTD Direct Evidence: marker/mechanism

ClinVar
MouseDO
CTD
OMIM
RGD

PMID:11095425 PMID:11746019 PMID:12601553 PMID:12970298 PMID:14687758 More...

NCBI chr 8:72,141,896...72,143,221
Ensembl chr 8:72,141,858...72,143,219

G

K(lysine) acetyltransferase 6B

ClinVar Annotator: match by term: Cryptorchidism

NCBI chr14:21,549,284...21,722,546
Ensembl chr14:21,531,502...21,722,546

G

lysine demethylase 5A

mRNA:increased expression:testes (rat)

RGD

NCBI chr 6:120,341,060...120,421,535
Ensembl chr 6:120,341,085...120,421,535

G

KISS1 receptor

ClinVar Annotator: match by term: Bilateral cryptorchidism

PMID:15598687 PMID:28492532 PMID:29452377

NCBI chr10:79,752,786...79,759,922
Ensembl chr10:79,752,805...79,758,107

G

LSM1 homolog, mRNA degradation associated

ClinVar Annotator: match by term: Cryptorchidism

PMID:25741868 PMID:31010896

NCBI chr 8:26,275,326...26,294,003
Ensembl chr 8:26,275,316...26,294,003

G

Mediterranean fever

ClinVar Annotator: match by term: Cryptorchidism | ClinVar Annotator: match by term: undescended testicle

PMID:9288094 PMID:9288758 PMID:9781020 PMID:10364520 PMID:10787449 More...

NCBI chr16:3,524,838...3,536,073
Ensembl chr16:3,525,082...3,535,961

G

MFSD2 lysolipid transporter A, lysophospholipid

ClinVar Annotator: match by term: Cryptorchidism

NCBI chr 4:122,840,643...122,855,844
Ensembl chr 4:122,840,643...122,854,981

G

msh homeobox 1

RGD

NCBI chr 5:37,977,835...37,981,929
Ensembl chr 5:37,977,829...37,981,927

G

nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha

protein:decreased expression:testis

RGD

NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432

G

nerve growth factor

mRNA,protein:decreased expression:testis

RGD

NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329

G

NIPBL cohesin loading factor

ClinVar Annotator: match by term: Cryptorchidism

NCBI chr15:8,319,308...8,494,799
Ensembl chr15:8,320,101...8,473,947

G

procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1

ClinVar Annotator: match by term: Bilateral cryptorchidism

NCBI chr 4:147,994,210...148,021,233
Ensembl chr 4:147,994,210...148,021,224

G

prostaglandin-endoperoxide synthase 2

mRNA, protein:increased expression:testis

RGD

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

RAB3 GTPase activating protein subunit 1

ClinVar Annotator: match by term: Cryptorchidism

NCBI chr 1:127,796,492...127,871,612
Ensembl chr 1:127,796,510...127,871,605

G

v-rel reticuloendotheliosis viral oncogene homolog A (avian)

protein:increased expression:testis

RGD

NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158

G

relaxin/insulin-like family peptide receptor 2

bilateral cryptorchidism, OMIM:219050
ClinVar Annotator: match by term: Bilateral cryptorchidism | ClinVar Annotator: match by term: Cryptorchidism

PMID:12217959 PMID:12970298 PMID:20636340 PMID:25741868 PMID:12217959

NCBI chr 5:149,941,487...150,006,015
Ensembl chr 5:149,942,140...150,005,649

G

SMC hinge domain containing 1

ClinVar Annotator: match by term: Cryptorchidism

PMID:25741868 PMID:28067909

NCBI chr17:71,651,484...71,782,361
Ensembl chr17:71,651,484...71,782,338

G

SRY (sex determining region Y)-box 3

ClinVar Annotator: match by term: undescended testicle

PMID:23757202 PMID:25741868 PMID:28492532

NCBI chr X:59,934,972...59,937,045
Ensembl chr X:59,934,972...59,937,036

G

steroid sulfatase

protein:increased expression:scrotum, testis

RGD

NCBI chr X:168,856,332...169,015,037
Ensembl chr X:168,909,030...169,014,924

G

spectrin repeat containing, nuclear envelope 2

DNA:deletion:exon:

RGD

NCBI chr12:75,865,092...76,157,702
Ensembl chr12:75,864,908...76,157,700

G

SZT2 subunit of KICSTOR complex

ClinVar Annotator: match by term: Cryptorchidism

PMID:25741868 PMID:28492532 PMID:30564332 PMID:30755392 PMID:35773235

NCBI chr 4:118,219,937...118,266,483
Ensembl chr 4:118,219,940...118,266,470

G

transmembrane and coiled-coil domains 1

ClinVar Annotator: match by term: undescended testicle

PMID:25741868 PMID:30755392 PMID:31102500 PMID:32214227

NCBI chr 1:167,136,239...167,161,547
Ensembl chr 1:167,135,947...167,161,547

G

tubulin, alpha 1A

ClinVar Annotator: match by term: Cryptorchidism

PMID:18954413 PMID:24860126 PMID:25741868 PMID:28492532 PMID:30744660 More...

NCBI chr15:98,847,728...98,851,382
Ensembl chr15:98,847,718...98,851,584

CRYPTOZOOSPERMIA

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

meiosis 1 associated protein

ClinVar Annotator: match by term: Cryptozoospermia

PMID:25741868 PMID:32673564

NCBI chr 6:82,923,889...83,007,290
Ensembl chr 6:82,923,883...83,007,290

G

synaptonemal complex protein 2

ClinVar Annotator: match by term: Cryptozoospermia

PMID:25741868 PMID:31866047

NCBI chr 2:177,987,088...178,051,580
Ensembl chr 2:177,987,086...178,049,478

G

tripartite motif-containing 71

ClinVar Annotator: match by term: Cryptozoospermia

NCBI chr 9:114,340,336...114,393,437
Ensembl chr 9:114,336,201...114,393,437

epididymitis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

interleukin 1 beta

RGD

NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059

G

interleukin 6

RGD

NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979

G

tumor necrosis factor

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

Experimental Autoimmune Orchitis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-C motif chemokine ligand 2

protein:increased expression:testis (rat)

RGD

NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279

G

heterogeneous nuclear ribonucleoprotein H1

RGD

NCBI chr11:50,266,084...50,277,355
Ensembl chr11:50,267,817...50,277,355

G

heat shock protein 1 (chaperonin)

RGD

NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402

G

inhibin alpha

protein:decreased expression:serum:

RGD

NCBI chr 1:75,483,872...75,487,010
Ensembl chr 1:75,483,721...75,487,010

Familial Prostate Cancer

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 4930550C14 gene

ClinVar Annotator: match by term: Hereditary prostate cancer

PMID:15928302 PMID:16941484 PMID:17124347 PMID:17910737 PMID:19431188 More...

NCBI chr 9:53,313,814...53,345,726
Ensembl chr 9:53,313,625...53,345,702

G

adhesion G protein-coupled receptor G1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:95,701,321...95,740,836
Ensembl chr 8:95,701,379...95,740,845

G

androgen receptor

ClinVar Annotator: match by term: Prostate cancer susceptibility

PMID:8530589 PMID:10589774 PMID:11103816 PMID:28492532

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

Rho GTPase activating protein 6

CTD Direct Evidence: marker/mechanism

NCBI chr X:167,578,091...168,087,436
Ensembl chr X:167,578,095...168,087,431

G

alpha tubulin acetyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:36,208,487...36,220,971
Ensembl chr17:36,208,487...36,220,967

G

ataxia telangiectasia mutated

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hereditary prostate cancer

PMID:15928302 PMID:16199547 PMID:16941484 PMID:17124347 PMID:17910737 More...

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

beta-1,3-glucuronyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:26,644,813...26,672,646
Ensembl chr 9:26,645,024...26,674,397

G

brain enriched myelin associated protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:170,188,911...170,270,292
Ensembl chr 2:170,188,911...170,269,765

G

B cell leukemia/lymphoma 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

BCL2 like 11

CTD Direct Evidence: marker/mechanism

NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467

G

bridge-like lipid transfer protein family member 3A

CTD Direct Evidence: marker/mechanism

NCBI chr17:28,075,481...28,119,014
Ensembl chr17:28,075,415...28,119,015

G

breast cancer 1, early onset

ClinVar Annotator: match by term: Hereditary prostate cancer

PMID:17319787 PMID:18489799 PMID:20104584 PMID:21203900 PMID:25525159 More...

NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781

G

caspase 8

CTD Direct Evidence: marker/mechanism

NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662

G

cell division cycle associated 7

CTD Direct Evidence: marker/mechanism

NCBI chr 2:72,306,540...72,317,237
Ensembl chr 2:72,306,503...72,317,237

G

cadherin 1

CTD Direct Evidence: marker/mechanism

PMID:14961571 PMID:16189707

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cyclin dependent kinase inhibitor 1B

CTD Direct Evidence: marker/mechanism

NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476

G

chromodomain helicase DNA binding protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,234,099...69,260,325
Ensembl chr11:69,234,099...69,260,232

G

checkpoint kinase 2

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hereditary prostate cancer

PMID:12533788 PMID:21876083 PMID:24713400 PMID:25741868 PMID:26467025 More...

NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011

G

collagen, type XXIII, alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:51,180,508...51,474,752
Ensembl chr11:51,180,747...51,474,745

G

cytochrome P450, family 3, subfamily a, polypeptide 41A

no_association

RGD

NCBI chr 5:145,630,859...145,656,946
Ensembl chr 5:145,630,859...145,656,946

G

DENN domain containing 4B

CTD Direct Evidence: marker/mechanism

NCBI chr 3:90,172,281...90,187,972
Ensembl chr 3:90,172,492...90,187,976

G

DNA methyltransferase 3B

CTD Direct Evidence: marker/mechanism

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

dedicator of cyto-kinesis 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:34,176,815...34,674,732
Ensembl chr11:34,176,815...34,674,719

G

Dppa2 upstream binding RNA

CTD Direct Evidence: marker/mechanism

NCBI chr16:50,547,114...50,553,136
Ensembl chr16:50,530,732...50,553,159

G

EMSY, BRCA2-interacting transcriptional repressor

CTD Direct Evidence: marker/mechanism

NCBI chr 7:98,236,344...98,308,779
Ensembl chr 7:98,236,344...98,305,990

G

fibrosin-like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:110,509,617...110,596,369
Ensembl chr 5:110,509,620...110,596,468

G

predicted gene, 24035

CTD Direct Evidence: marker/mechanism

NCBI chr 8:119,153,232...119,153,338
Ensembl chr 8:119,153,232...119,153,338

G

predicted gene, 26449

CTD Direct Evidence: marker/mechanism

NCBI chr12:14,928,500...14,928,599
Ensembl chr12:14,928,496...14,928,599

G

histocompatibility 2, O region alpha locus

CTD Direct Evidence: marker/mechanism

NCBI chr17:34,311,353...34,314,286
Ensembl chr17:34,311,314...34,314,208

G

HAUS augmin-like complex, subunit 6

CTD Direct Evidence: marker/mechanism

NCBI chr 4:86,497,092...86,530,317
Ensembl chr 4:86,497,092...86,530,292

G

homeobox B13

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Prostate cancer susceptibility

PMID:8756292 PMID:15964834 PMID:17138648 PMID:22236224 PMID:22714738 More...

NCBI chr11:96,085,142...96,087,436
Ensembl chr11:96,085,142...96,088,273

G

inner centromere protein

CTD Direct Evidence: marker/mechanism

NCBI chr19:9,849,659...9,876,853
Ensembl chr19:9,849,660...9,876,915

G

integrin beta 8

CTD Direct Evidence: marker/mechanism

NCBI chr12:119,121,757...119,202,891
Ensembl chr12:119,121,757...119,202,537

G

lysine (K)-specific demethylase 2A

CTD Direct Evidence: marker/mechanism

NCBI chr19:4,366,172...4,448,749
Ensembl chr19:4,364,447...4,448,313

G

kinetochore scaffold 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:118,877,600...118,940,978
Ensembl chr 2:118,877,600...118,935,982

G

La ribonucleoprotein 4B

CTD Direct Evidence: marker/mechanism

NCBI chr13:9,143,643...9,224,487
Ensembl chr13:9,143,917...9,224,487

G

MAD1 mitotic arrest deficient 1-like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:139,994,444...140,307,346
Ensembl chr 5:139,994,444...140,307,307

G

mitogen-activated protein kinase kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913

G

methyl-CpG binding domain protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:70,701,298...70,761,769
Ensembl chr18:70,701,260...70,759,202

G

muscleblind like splicing regulator 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:60,380,209...60,537,171
Ensembl chr 3:60,380,251...60,537,171

G

MDS1 and EVI1 complex locus

CTD Direct Evidence: marker/mechanism

NCBI chr 3:30,005,445...30,563,937
Ensembl chr 3:30,005,445...30,602,157

G

matrix metallopeptidase 14 (membrane-inserted)

CTD Direct Evidence: marker/mechanism

NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821

G

MOB kinase activator 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:141,562,254...141,614,796
Ensembl chr 7:141,562,272...141,614,802

G

mutS homolog 6

ClinVar Annotator: match by term: Hereditary prostate cancer

PMID:18269114 PMID:24362816 PMID:25741868 PMID:28492532

NCBI chr17:88,282,478...88,298,320
Ensembl chr17:88,282,490...88,298,320

G

myosin IXb

CTD Direct Evidence: marker/mechanism

NCBI chr 8:71,725,220...71,813,357
Ensembl chr 8:71,725,358...71,813,357

G

O-acyltransferase like

CTD Direct Evidence: marker/mechanism

NCBI chr18:65,830,441...65,884,695
Ensembl chr18:65,831,339...65,884,672

G

paired box 9

CTD Direct Evidence: marker/mechanism

NCBI chr12:56,738,478...56,759,609
Ensembl chr12:56,738,552...56,759,607

G

Pbx/knotted 1 homeobox 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:36,802,278...37,058,637
Ensembl chr 9:36,802,278...37,058,703

G

POU domain, class 2, transcription factor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:24,790,111...24,879,292
Ensembl chr 7:24,786,769...24,879,151

G

PTPRF interacting protein, binding protein 2 (liprin beta 2)

CTD Direct Evidence: marker/mechanism

NCBI chr 7:107,192,608...107,347,790
Ensembl chr 7:107,194,414...107,347,790

G

Ras association (RalGDS/AF-6) domain family member 3

CTD Direct Evidence: marker/mechanism

NCBI chr10:121,246,255...121,312,220
Ensembl chr10:121,246,255...121,312,252

G

regulatory factor X, 7

CTD Direct Evidence: marker/mechanism

NCBI chr 9:72,439,346...72,530,231
Ensembl chr 9:72,439,522...72,530,111

G

ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)

CTD Direct Evidence: marker/mechanism

NCBI chr 1:153,625,089...153,644,441
Ensembl chr 1:153,625,172...153,639,967

G

ring finger protein 43

CTD Direct Evidence: marker/mechanism

NCBI chr11:87,553,913...87,626,365
Ensembl chr11:87,553,548...87,626,365

G

renalase, FAD-dependent amine oxidase

CTD Direct Evidence: marker/mechanism

NCBI chr19:33,115,140...33,369,695
Ensembl chr19:33,115,147...33,369,665

G

succinyl-CoA glutarate-CoA transferase

CTD Direct Evidence: marker/mechanism

NCBI chr13:17,032,057...17,869,380
Ensembl chr13:17,032,057...17,870,138

G

transcription factor 4

CTD Direct Evidence: marker/mechanism

NCBI chr18:69,476,500...69,821,038
Ensembl chr18:69,476,427...69,822,150

G

transcription factor 7 like 2, T cell specific, HMG box

CTD Direct Evidence: marker/mechanism

NCBI chr19:55,730,227...55,922,091
Ensembl chr19:55,730,252...55,922,086

G

torsin family 1, member A (torsin A)

CTD Direct Evidence: marker/mechanism

NCBI chr 2:30,850,573...30,857,930
Ensembl chr 2:30,850,639...30,857,945

G

teashirt zinc finger family member 1

CTD Direct Evidence: marker/mechanism

NCBI chr18:84,029,752...84,105,833
Ensembl chr18:84,029,752...84,105,831

G

tetratricopeptide repeat domain 28

CTD Direct Evidence: marker/mechanism

NCBI chr 5:111,027,652...111,437,646
Ensembl chr 5:111,027,669...111,437,646

Female Infertility

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adiponectin receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:134,343,116...134,361,089
Ensembl chr 1:134,343,116...134,361,089

G

adiponectin receptor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665

G

alpha fetoprotein

RGD

NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766

G

aryl-hydrocarbon receptor

CTD Direct Evidence: marker/mechanism

NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037

G

androgen receptor

CTD Direct Evidence: marker/mechanism

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

basic helix-loop-helix ARNT like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333

G

basigin

RGD

NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803

G

calcium channel, voltage-dependent, alpha 2/delta subunit 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:107,276,948...107,406,545
Ensembl chr 9:107,276,811...107,406,542

G

cellular communication network factor 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581

G

CD9 antigen

RGD

NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754

G

CCAAT/enhancer binding protein alpha

CTD Direct Evidence: marker/mechanism

NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353

G

CCAAT/enhancer binding protein beta

CTD Direct Evidence: marker/mechanism

NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338

G

cytochrome P450, family 17, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611

G

cytochrome P450, family 19, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394

G

dihydrofolate reductase

CTD Direct Evidence: therapeutic

NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561

G

DNA methyltransferase 3B

CTD Direct Evidence: marker/mechanism

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

estrogen receptor 1 (alpha)

CTD Direct Evidence: marker/mechanism

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

estrogen receptor 2 (beta)

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:23710174 PMID:28520870

NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033

G

Fanconi anemia, complementation group C

RGD

NCBI chr13:63,452,519...63,645,126
Ensembl chr13:63,432,857...63,645,092

G

follicle stimulating hormone beta

CTD Direct Evidence: marker/mechanism

NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001

G

glutathione S-transferase, mu 1

DNA:deletion:: (human)

RGD

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

heat shock protein 90 alpha (cytosolic), class B member 1

RGD

NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197

G

heat shock protein 5

RGD

NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559

G

HtrA serine peptidase 2

RGD

NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254

G

integrin alpha 2

associated with Diabetes Mellitus, Insulin-Dependent; protein:altered expression:natural killer cell (mouse)

RGD

NCBI chr13:114,969,617...115,068,588
Ensembl chr13:114,969,617...115,068,636

G

left-right determination factor 2

RGD

NCBI chr 1:180,720,673...180,726,672
Ensembl chr 1:180,720,673...180,726,668

G

leptin

CTD Direct Evidence: marker/mechanism

NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876

G

leptin receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549

G

luteinizing hormone beta

CTD Direct Evidence: marker/mechanism

NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321

G

leukemia inhibitory factor

CTD Direct Evidence: marker/mechanism

NCBI chr11:4,207,587...4,222,514
Ensembl chr11:4,207,557...4,222,514

G

mitogen-activated protein kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317

G

mitogen-activated protein kinase 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991

G

methylenetetrahydrofolate reductase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008

G

nuclear autoantigenic sperm protein (histone-binding)

RGD

NCBI chr 4:116,458,249...116,488,894
Ensembl chr 4:116,458,249...116,485,138

G

nuclear receptor subfamily 1, group I, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186

G

nuclear receptor subfamily 2, group F, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:70,001,694...70,016,494
Ensembl chr 7:70,001,692...70,016,483

G

nuclear receptor subfamily 5, group A, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186

G

pregnancy-associated plasma protein A

CTD Direct Evidence: marker/mechanism

NCBI chr 4:65,041,993...65,276,776
Ensembl chr 4:65,042,411...65,275,746

G

prolactin

CTD Direct Evidence: marker/mechanism

NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188

G

protein C

RGD

NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623

G

ring finger protein 212B

ClinVar Annotator: match by term: Female infertility

NCBI chr14:55,020,798...55,091,567
Ensembl chr14:55,051,598...55,091,565

G

smoothened, frizzled class receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364

G

STAG3 cohesin complex component

ClinVar Annotator: match by term: Female infertility

NCBI chr 5:138,270,757...138,310,659
Ensembl chr 5:138,278,502...138,310,655

G

transformation related protein 53

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

TSC complex subunit 2

RGD

NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604

Fibrous Sheath Dysplasia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

coiled-coil domain containing 39

ClinVar Annotator: match by term: Fibrous Sheath Dysplasia

NCBI chr 3:33,864,906...33,898,473
Ensembl chr 3:33,866,511...33,898,459

G

tetratricopeptide repeat domain 14

ClinVar Annotator: match by term: Fibrous Sheath Dysplasia

NCBI chr 3:33,853,923...33,869,009
Ensembl chr 3:33,853,981...33,869,009

frontonasal dysplasia 2

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aristaless-like homeobox 4

ClinVar Annotator: match by term: Frontonasal dysplasia 2

PMID:19692347 PMID:22140057 PMID:24668755 PMID:25741868 PMID:28492532

NCBI chr 2:93,472,779...93,511,686
Ensembl chr 2:93,472,729...93,511,684

genital herpes

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-C motif chemokine ligand 5

RGD

NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344

G

interferon (alpha and beta) receptor 1

exacerbates

RGD

NCBI chr16:91,281,016...91,307,411
Ensembl chr16:91,282,126...91,304,329

G

interferon gamma

protein:increased expression:vaginal secretion:

RGD

PMID:10366565 PMID:10366565

RGD:8158034, RGD:8158034

NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797

G

interleukin 21

treatment

RGD

NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785

G

interleukin 3

RNA: increased expression

RGD

NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103

G

interferon regulatory factor 9

exacerbates

RGD

NCBI chr14:55,841,442...55,847,487
Ensembl chr14:55,841,028...55,847,487

G

nuclear factor, erythroid derived 2, like 2

ameliorates

RGD

NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985

G

ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)

severity

RGD

NCBI chr 1:153,625,089...153,644,441
Ensembl chr 1:153,625,172...153,639,967

G

signal transducer and activator of transcription 4

treatment
severity

DNA:SNP:intron:rs7572482 (human)
DNA:SNPs, haplotype: :multiple

RGD

PMID:22718836 PMID:22718836

RGD:8661697, RGD:8661697

NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348

Growth Mental Deficiency Syndrome of Myhre

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

latent transforming growth factor beta binding protein 3

ClinVar Annotator: match by term: Heritable Thoracic Aortic Disease

PMID:25741868 PMID:29625025

NCBI chr19:5,790,928...5,808,564
Ensembl chr19:5,790,932...5,808,560

G

SMAD family member 4

ClinVar Annotator: match by term: Growth mental deficiency syndrome of Myhre | ClinVar Annotator: match by term: Heritable thoracic aortic disease without juvenile polyposis and hereditary hemorrhagic telangiectasia | ClinVar Annotator: match by term: LAPS SYNDROME | ClinVar Annotator: match by term: LARYNGOTRACHEAL STENOSIS, ARTHROPATHY, PROGNATHISM, AND SHORT STATURE | ClinVar Annotator: match by term: Myhre syndrome
ClinVar Annotator: match by term: Growth mental deficiency syndrome of Myhre | ClinVar Annotator: match by term: Heritable thoracic aortic disease without juvenile polyposis and hereditary hemorrhagic telangiectasia | ClinVar Annotator: match by term: LAPS SYNDROME | ClinVar Annotator: match by term: Myhre syndrome
DNA:missense mutations:exon:p.I500T (c.1498A>G), p.I500V, p.I500M (human)
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD
RGD

PMID:7296942 PMID:8898652 PMID:9582123 PMID:9679244 PMID:9811934 More...

NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851

Guttmacher syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

homeobox A13

ClinVar Annotator: match by term: Autosomal dominant preaxial deficiency, postaxial polydactyly, and hypospadias | ClinVar Annotator: match by term: Guttmacher syndrome
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:24239177 PMID:25741868 PMID:28492532

NCBI chr 6:52,235,833...52,237,865
Ensembl chr 6:52,234,674...52,237,788

HIV Encephalitis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

amyloid beta precursor protein

RGD

NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654

G

beta-site APP cleaving enzyme 1

RGD

NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697

G

CD68 antigen

protein:increased expression:brain (human)

RGD

NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979

G

cyclin dependent kinase 5

protein:increased tyrosine phosphorylation:hippocampus

RGD

NCBI chr 5:24,612,595...24,628,737
Ensembl chr 5:24,623,239...24,628,528

G

mitofusin 1

associated with HIV Infections;protein:increased expression:frontal cortex, membrane (human)

RGD

NCBI chr 3:32,583,594...32,633,384
Ensembl chr 3:32,583,614...32,633,388

G

oligodendrocyte transcription factor 2

RGD

NCBI chr16:91,016,745...91,025,567
Ensembl chr16:91,022,345...91,025,565

HIV Seropositivity

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

albumin

CTD Direct Evidence: marker/mechanism

NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461

G

aph1 homolog B, gamma secretase subunit

susceptibility

DNA:SNP:CDS:p.F217L (rs1047552) (human)

RGD

NCBI chr 9:66,682,484...66,704,671
Ensembl chr 9:66,682,484...66,702,772

G

CD209b antigen

susceptibility

DNA:repeats:exon 4
DNA:repeat:

RGD

PMID:25656622 PMID:20217198 PMID:16453266

RGD:11520989, RGD:39938989, RGD:39938979

NCBI chr 8:3,967,655...3,976,841
Ensembl chr 8:3,967,655...3,976,844

G

histocompatibility 2, class II antigen E beta

DNA:polymorphism (human)

RGD

NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648

G

killer cell lectin-like receptor subfamily K, member 1

protein:increased expression:peripheral blood mononuclear cell,natural killer cell (human)

RGD

NCBI chr 6:129,587,286...129,600,863
Ensembl chr 6:129,587,286...129,600,827

G

natural cytotoxicity triggering receptor 1

treatment

protein:decreased expression:peripheral blood mononuclear cell, natural killer cell (human)

RGD

PMID:18724804 PMID:27091211

RGD:40818277, RGD:40818300

NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163

G

neurofilament, light polypeptide

treatment

RGD

NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544

HIV Wasting Syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

interleukin 1 alpha

CTD Direct Evidence: marker/mechanism

NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892

G

interleukin 1 beta

CTD Direct Evidence: marker/mechanism

NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059

G

interleukin 6

CTD Direct Evidence: marker/mechanism

NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979

G

tumor necrosis factor

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

HIV-Associated Lipodystrophy Syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adiponectin, C1Q and collagen domain containing

RGD

NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778

G

adrenergic receptor, beta 3

DNA:missense mutation:cds:p.W64R rs4994 (human)

RGD

NCBI chr 8:27,715,804...27,720,833
Ensembl chr 8:27,715,804...27,740,644

G

interleukin 18

susceptibility

DNA:SNPs, haplotype:promoter:-137G>C (rs187238), -607C>A (rs1946518) (human)

RGD

PMID:20331838 PMID:15353983

RGD:8655915, RGD:8655934

NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140

G

lamin A

CTD Direct Evidence: marker/mechanism

NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263

G

matrix metallopeptidase 1a (interstitial collagenase)

DNA:SNP

RGD

NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857

G

matrix metallopeptidase 1b (interstitial collagenase)

DNA:SNP

NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047

G

zinc metallopeptidase, STE24

CTD Direct Evidence: marker/mechanism

NCBI chr 4:120,916,434...120,955,452
Ensembl chr 4:120,916,434...120,955,438

human immunodeficiency virus infectious disease

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP-binding cassette, sub-family B member 1A

treatment
severity

mRNA:altered expression:brain, heart, kidney (rat)
DNA:SNPs: :4036A>G, 1236C>T (human)

RGD

PMID:24472536 PMID:23133441 PMID:27334660

RGD:11041168, RGD:39456100, RGD:39456096

NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575

G

ATP-binding cassette, sub-family B member 1B

mRNA:decreased expression, increased expression:brain, kidney (rat)

RGD

PMID:16790532 PMID:24472536

RGD:1598562, RGD:11041168

NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315

G

ATP-binding cassette, sub-family E member 1

DNA:mutations:multiple (human)

RGD

NCBI chr 8:80,410,071...80,438,369
Ensembl chr 8:80,410,091...80,438,369

G

adrenergic receptor, beta 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030

G

activation-induced cytidine deaminase

mRNA:increased expression:peripheral blood mononuclear cell (human)

RGD

NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139

G

albumin

CTD Direct Evidence: marker/mechanism

NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461

G

Aly/REF export factor

CTD Direct Evidence: marker/mechanism

NCBI chr11:120,485,330...120,489,342
Ensembl chr11:120,482,947...120,489,191

G

apolipoprotein A-I

CTD Direct Evidence: marker/mechanism

NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764

G

ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3

CTD Direct Evidence: marker/mechanism

NCBI chr18:38,105,676...38,132,583
Ensembl chr18:38,105,681...38,132,022

G

Rho GTPase activating protein 4

CTD Direct Evidence: marker/mechanism

NCBI chr X:72,937,958...72,954,945
Ensembl chr X:72,935,048...72,965,476

G

Rho GDP dissociation inhibitor alpha

CTD Direct Evidence: marker/mechanism

NCBI chr11:120,468,925...120,472,450
Ensembl chr11:120,468,930...120,472,450

G

Rho, GDP dissociation inhibitor beta

CTD Direct Evidence: marker/mechanism

NCBI chr 6:136,900,653...136,918,895
Ensembl chr 6:136,900,653...136,918,897

G

ataxia telangiectasia mutated

protein:decreased expression:T cell (human)

RGD

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

BCL2-associated athanogene 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705

G

BCL2-associated X protein

CTD Direct Evidence: marker/mechanism

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

baculoviral IAP repeat-containing 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065

G

baculoviral IAP repeat-containing 3

CTD Direct Evidence: marker/mechanism

NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187

G

bone marrow stromal cell antigen 2

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, rapid progression to AIDS

NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100

G

complement component 3

RGD

NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136

G

C-C motif chemokine ligand 11

susceptibility

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to
CTD Direct Evidence: marker/mechanism
protein:increased expression:plasma

ClinVar
OMIM
CTD
RGD

PMID:14571188 PMID:27246604

NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781

G

C-C motif chemokine ligand 2

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to
protein:increased expression:plasma
CTD Direct Evidence: marker/mechanism

ClinVar
CTD
RGD

PMID:14571188 PMID:27246604

NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279

G

C-C motif chemokine ligand 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181

G

C-C motif chemokine ligand 4

susceptibility

RGD

NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509

G

C-C motif chemokine ligand 5

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, delayed disease progression with infection by | ClinVar Annotator: match by term: Human immunodeficiency virus type 1, rapid disease progression with infection by
CTD Direct Evidence: marker/mechanism

ClinVar
CTD
OMIM

PMID:10200305 PMID:12114533 PMID:12610055

NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344

G

C-C motif chemokine receptor 2

susceptibility

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to

CTD
OMIM
ClinVar

PMID:9252328 PMID:9662369 PMID:25741868

NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594

G

C-C motif chemokine receptor 3

CTD Direct Evidence: marker/mechanism

NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726

G

C-C motif chemokine receptor 5

protein:decreased expression:blood, T cell (human)
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, increased perinatal transmission of | ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD
RGD

PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 More...

NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736

G

chaperonin containing TCP1 subunit 3

CTD Direct Evidence: marker/mechanism

NCBI chr 3:88,204,442...88,229,073
Ensembl chr 3:88,204,423...88,229,074

G

chaperonin containing TCP1 subunit 5

CTD Direct Evidence: marker/mechanism

NCBI chr15:31,590,946...31,601,992
Ensembl chr15:31,590,946...31,601,950

G

chaperonin containing TCP1 subunit 7

CTD Direct Evidence: marker/mechanism

NCBI chr 6:85,428,487...85,445,459
Ensembl chr 6:85,428,496...85,445,457

G

CD163 antigen

exacerbates
treatment

protein:increased expression:blood plasma (human)

RGD

PMID:23916293 PMID:24594990

RGD:127285682, RGD:149735575

NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486

G

CD274 antigen

RGD

PMID:30161254 PMID:30236481

RGD:41412179, RGD:41412181

NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495

G

CD28 antigen

CTD Direct Evidence: marker/mechanism

NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518

G

CD40 antigen

protein:increased expression:plasmacytoid dendritic cell

RGD

NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868

G

CD40 ligand

RGD

NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402

G

CD68 antigen

disease_progression

associated with opioid use;protein:increased expression:brain (human)

RGD

NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979

G

CD8 subunit alpha

treatment

NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157

G

cell division cycle 42

CTD Direct Evidence: marker/mechanism

NCBI chr 4:137,047,011...137,085,007
Ensembl chr 4:137,047,007...137,085,031

G

cyclin dependent kinase inhibitor 1A

CTD Direct Evidence: marker/mechanism

NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701

G

chloride intracellular channel 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,269,219...35,277,695
Ensembl chr17:35,268,942...35,277,725

G

COP9 signalosome subunit 6

CTD Direct Evidence: marker/mechanism

NCBI chr 5:138,159,364...138,162,246
Ensembl chr 5:138,159,333...138,162,908

G

complement receptor 2

protein:decreased expression:B cell

RGD

NCBI chr 1:194,819,120...194,859,096
Ensembl chr 1:194,819,119...194,859,024

G

C-reactive protein, pentraxin-related

disease_progression

RGD

NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598

G

C-X3-C motif chemokine receptor 1

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945

G

C-X-C motif chemokine ligand 10

protein:increased expression:plasma

RGD

NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748

G

C-X-C motif chemokine ligand 12

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to

OMIM
CTD
ClinVar

PMID:9430590 PMID:25741868

NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328

G

C-X-C motif chemokine ligand 15

associated with pleural tuberculosis;
protein:increased expression:cerebrospinal fluid (human)

RGD

PMID:21303360 PMID:31217522

RGD:36947878, RGD:150521549

NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926

G

C-X-C motif chemokine receptor 1

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to
CTD Direct Evidence: marker/mechanism

ClinVar
CTD
OMIM

NCBI chr 1:74,228,862...74,233,867
Ensembl chr 1:74,230,944...74,233,790

G

cytochrome P450, family 2, subfamily b, polypeptide 10

treatment

DNA:haplotype: :CYP2B6*6(human)
DNA:SNPs: :516G>T,983T>C (human)

RGD

PMID:21862974 PMID:18281305

RGD:11098366, RGD:11097175

NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049

G

DEAD box helicase 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:13,269,308...13,299,175
Ensembl chr12:13,266,974...13,299,214

G

DEAD box helicase 3, X-linked

CTD Direct Evidence: marker/mechanism

NCBI chr X:13,147,261...13,160,222
Ensembl chr X:13,147,209...13,160,291

G

DnaJ heat shock protein family (Hsp40) member C7

CTD Direct Evidence: marker/mechanism

NCBI chr11:100,473,644...100,511,030
Ensembl chr11:100,473,644...100,511,014

G

eukaryotic translation initiation factor 3, subunit B

CTD Direct Evidence: marker/mechanism

NCBI chr 5:140,405,060...140,429,113
Ensembl chr 5:140,405,083...140,429,115

G

eukaryotic translation initiation factor 4A1

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,557,762...69,563,249
Ensembl chr11:69,557,762...69,563,249

G

eukaryotic translation initiation factor 4E binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702

G

eukaryotic translation initiation factor 6

CTD Direct Evidence: marker/mechanism

NCBI chr 2:155,661,757...155,668,845
Ensembl chr 2:155,661,752...155,668,845

G

EMG1 N1-specific pseudouridine methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 6:124,681,344...124,689,118
Ensembl chr 6:124,681,048...124,689,141

G

Eph receptor B2

mRNA:decreased expression:Anterior cingulate

RGD

NCBI chr 4:136,374,850...136,563,637
Ensembl chr 4:136,374,850...136,563,299

G

Fas cell surface death receptor

RGD

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

Fc receptor, IgE, low affinity II, alpha polypeptide

CTD Direct Evidence: marker/mechanism

NCBI chr 8:3,730,280...3,744,174
Ensembl chr 8:3,731,737...3,744,175

G

Fc receptor, IgG, low affinity IV

susceptibility

DNA:polymorphism:exon:p.F158V(rs396991)(human)

RGD

NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330

G

growth arrest and DNA-damage-inducible 45 alpha

CTD Direct Evidence: marker/mechanism

NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441

G

vitamin D binding protein

disease_progression

RGD

NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757

G

GrpE-like 1, mitochondrial

CTD Direct Evidence: marker/mechanism

NCBI chr 5:36,622,529...36,631,421
Ensembl chr 5:36,622,342...36,631,424

G

general transcription factor III A

CTD Direct Evidence: marker/mechanism

NCBI chr 5:146,885,467...146,892,424
Ensembl chr 5:146,885,467...146,892,424

G

histocompatibility 2, class II antigen A, alpha

DNA:polymorphisms (human)

RGD

NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797

G

histocompatibility 2, class II antigen A, beta 1

DNA:polymorphisms: :multiple (human)
DNA:polymorphisms (human)

RGD

PMID:20345872 PMID:18427198

RGD:5147659, RGD:5147817

NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393

G

histocompatibility 2, class II antigen E alpha

RGD

NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618

G

histocompatibility 2, class II antigen E beta

disease_progression
susceptibility

DNA:polymorphism (human)
DNA:polymorphism:cds:HLA-DRB1*08, HLA-B*35, HLA-C*04 (human)
DNA:polymorphisms: :multiple (human)

PMID:28244954 PMID:21257739 PMID:20345872

RGD:40903000, RGD:5147591, RGD:5147659

NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648

G

histocompatibility 2, M region locus 2

susceptibility

CTD Direct Evidence: marker/mechanism
DNA:polymorphism:cds:HLA-DRB1*08, HLA-B*35, HLA-C*04 (human)

PMID:17496894 PMID:28244954

NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443

G

heparin binding growth factor

CTD Direct Evidence: marker/mechanism

NCBI chr 3:87,813,844...87,823,439
Ensembl chr 3:87,813,628...87,823,439

G

haptoglobin

CTD Direct Evidence: marker/mechanism

NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804

G

heat shock protein 90, alpha (cytosolic), class A member 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162

G

heat shock protein 90 alpha (cytosolic), class B member 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197

G

heat shock protein 9

CTD Direct Evidence: marker/mechanism

NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410

G

heat shock protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417

G

heat shock protein 1 (chaperonin)

CTD Direct Evidence: marker/mechanism

NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402

G

heat shock 105kDa/110kDa protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841

G

interferon gamma

CTD Direct Evidence: marker/mechanism

NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797

G

interleukin 10

treatment
susceptibility

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD
RGD

PMID:10202824 PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 More...

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

interleukin 15

protein:decreased expression:plasma

RGD

NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851

G

interleukin 17D

severity

Protein:increased expression:blood plasma (human)

NCBI chr14:57,762,197...57,780,623
Ensembl chr14:57,762,234...57,780,623

G

interleukin 18

treatment

protein:increased expression:serum:
associated with hepatitis C; protein:increased expression:serum:

RGD

PMID:27927859 PMID:27927859

RGD:14696653, RGD:14696653

NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140

G

interleukin 19

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to

PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 More...

NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852

G

interleukin 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108

G

interleukin 21

associated with hepatitis B;protein:decreased expression:blood serum (human)

RGD

NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785

G

interleukin 21 receptor

RGD

NCBI chr 7:125,202,424...125,232,742
Ensembl chr 7:125,202,601...125,232,742

G

interleukin 27

ameliorates

protein:increased expression:blood plasma (human)
associated with hepatitis C;protein:increased expression:blood plasma (human)

RGD

PMID:28338007 PMID:24816922

RGD:126790518, RGD:126790553

NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113

G

interleukin 2 receptor, alpha chain

CTD Direct Evidence: marker/mechanism

NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004

G

interleukin 4 receptor, alpha

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to

PMID:25741868 PMID:28492532

NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646

G

interleukin 6

protein:increased expression:serum

RGD

NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979

G

interleukin enhancer binding factor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:90,383,421...90,395,686
Ensembl chr 3:90,383,433...90,395,686

G

importin 7

CTD Direct Evidence: marker/mechanism

NCBI chr 7:109,617,522...109,655,816
Ensembl chr 7:109,617,481...109,655,816

G

killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1

susceptibility

DNA:deletion:cds

RGD

NCBI chr X:135,418,748...135,435,055
Ensembl chr X:135,418,748...135,435,058

G

lysine (K)-specific methyltransferase 2E

protein:increased expression:peripheral blood, T cell, CD4+ (human)

RGD

NCBI chr 5:23,638,034...23,709,233
Ensembl chr 5:23,639,439...23,709,233

G

karyopherin subunit beta 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:97,050,536...97,078,718
Ensembl chr11:97,050,540...97,078,707

G

lymphocyte protein tyrosine kinase

protein:increased tyrosine phosphorylation:T cell

RGD

NCBI chr 4:129,442,142...129,467,415
Ensembl chr 4:129,442,137...129,467,434

G

leptin receptor

protein:increased phosphorylation:peripheral blood mononuclear cell

RGD

NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549

G

LYN proto-oncogene, Src family tyrosine kinase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:3,676,865...3,791,613
Ensembl chr 4:3,678,115...3,813,122

G

microtubule-associated protein 2

RGD

NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742

G

MYC-associated zinc finger protein (purine-binding transcription factor)

CTD Direct Evidence: marker/mechanism

NCBI chr 7:126,621,306...126,626,177
Ensembl chr 7:126,621,302...126,626,209

G

mannose-binding lectin (protein C) 2

no_association
severity

CTD Direct Evidence: marker/mechanism
DNA:polymorphism:exon:

CTD
RGD

PMID:16960176 PMID:26348711 PMID:19796822

RGD:12910931, RGD:12910857

NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087

G

transformed mouse 3T3 cell double minute 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663

G

antigen identified by monoclonal antibody Ki 67

RGD

NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090

G

multivesicular body subunit 12A

ClinVar Annotator: match by term: Human immunodeficiency virus type 1, rapid progression to AIDS

NCBI chr 8:71,995,552...72,000,670
Ensembl chr 8:71,995,566...72,000,729

G

myosin, heavy polypeptide 9, non-muscle

protein:decreased expression:glomerulus

RGD

NCBI chr15:77,644,788...77,726,315
Ensembl chr15:77,644,787...77,726,375

G

neurofilament, light polypeptide

treatment

RGD

NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544

G

neurofilament, medium polypeptide

protein:increased serine/threonine phosphorylation:brain

RGD

NCBI chr14:68,356,994...68,362,453
Ensembl chr14:68,320,039...68,362,295

G

nucleoporin 88

CTD Direct Evidence: marker/mechanism

NCBI chr11:70,833,884...70,860,799
Ensembl chr11:70,833,884...70,860,799

G

nuclear transport factor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:106,587,165...106,607,034
Ensembl chr 8:106,587,212...106,605,962

G

ornithine decarboxylase, structural 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506

G

8-oxoguanine DNA-glycosylase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029

G

opioid receptor, mu 1

mRNA:increased expression:macrophage

RGD

NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198

G

programmed cell death 1

RGD

NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278

G

phospholipase A2, group IIA (platelets, synovial fluid)

RGD

NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497

G

plasminogen activator, urokinase receptor

disease_progression

protein:increased expression:plasma

RGD

PMID:21384094 PMID:20229356

RGD:6484120, RGD:6484128

NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393

G

peptidylprolyl isomerase A

disease_progression

DNA:SNPs:promotor, intron 1: 1604C>G, 2653A>C (rs8177826, rs3735481) (human)

RGD

NCBI chr11:6,365,867...6,369,817
Ensembl chr11:6,365,443...6,369,817

G

peptidylprolyl isomerase B

CTD Direct Evidence: marker/mechanism

NCBI chr 9:65,967,451...65,973,911
Ensembl chr 9:65,967,504...65,973,905

G

perforin 1 (pore forming protein)

DNA:SNP: :rs885822 (human)

RGD

PMID:20523897 PMID:21157294

RGD:6482808, RGD:6482819

NCBI chr10:61,133,530...61,140,463
Ensembl chr10:61,133,612...61,140,459

G

pre-mRNA processing factor 8

CTD Direct Evidence: marker/mechanism

NCBI chr11:75,377,603...75,400,273
Ensembl chr11:75,377,642...75,400,275

G

proteasome subunit alpha 4

CTD Direct Evidence: marker/mechanism

NCBI chr 9:54,858,074...54,865,316
Ensembl chr 9:54,858,074...54,865,314

G

proteasome subunit alpha 5

CTD Direct Evidence: marker/mechanism

NCBI chr 3:108,164,242...108,187,268
Ensembl chr 3:108,164,242...108,187,290

G

proteasome subunit alpha 6

CTD Direct Evidence: marker/mechanism

NCBI chr12:55,431,007...55,465,244
Ensembl chr12:55,431,007...55,465,239

G

proteasome (prosome, macropain) subunit, beta type 10

CTD Direct Evidence: marker/mechanism

NCBI chr 8:106,662,360...106,665,024
Ensembl chr 8:106,662,367...106,665,076

G

proteasome (prosome, macropain) subunit, beta type 4

CTD Direct Evidence: marker/mechanism

NCBI chr 3:94,791,635...94,794,269
Ensembl chr 3:94,791,404...94,794,272

G

proteasome (prosome, macropain) 26S subunit, ATPase 3

CTD Direct Evidence: marker/mechanism

NCBI chr 2:90,884,361...90,889,783
Ensembl chr 2:90,884,354...90,896,714

G

protease (prosome, macropain) 26S subunit, ATPase 5

CTD Direct Evidence: marker/mechanism

NCBI chr11:106,147,011...106,153,938
Ensembl chr11:106,146,980...106,153,946

G

proteasome (prosome, macropain) 26S subunit, non-ATPase, 13

CTD Direct Evidence: marker/mechanism

NCBI chr 7:140,462,307...140,478,555
Ensembl chr 7:140,461,881...140,478,556

G

proteasome (prosome, macropain) 26S subunit, non-ATPase, 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:98,573,380...98,586,804
Ensembl chr11:98,573,380...98,586,805

G

proteasome (prosome, macropain) 26S subunit, non-ATPase, 6

CTD Direct Evidence: marker/mechanism

NCBI chr14:8,348,818...8,357,578
Ensembl chr14:8,348,779...8,357,589

G

proteasome (prosome, macropain) 26S subunit, non-ATPase, 8

CTD Direct Evidence: marker/mechanism

NCBI chr 7:28,873,612...28,880,098
Ensembl chr 7:28,873,613...28,880,126

G

proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)

CTD Direct Evidence: marker/mechanism

NCBI chr14:55,815,951...55,818,984
Ensembl chr14:55,815,580...55,818,986

G

proteasome (prosome, macropain) activator subunit 2 (PA28 beta)

CTD Direct Evidence: marker/mechanism

NCBI chr14:55,824,897...55,828,558
Ensembl chr14:55,824,898...55,828,570

G

proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki)

CTD Direct Evidence: marker/mechanism

NCBI chr11:101,206,090...101,214,363
Ensembl chr11:101,207,039...101,214,363

G

proteasome (prosome, macropain) activator subunit 4

CTD Direct Evidence: marker/mechanism

NCBI chr11:30,721,753...30,831,150
Ensembl chr11:30,721,726...30,830,361

G

patched 1

CTD Direct Evidence: marker/mechanism

NCBI chr13:63,656,142...63,721,274
Ensembl chr13:63,656,142...63,721,412

G

prostaglandin-endoperoxide synthase 2

mRNA, protein:increased expression:brain

RGD

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

RAB11B, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr17:33,961,458...33,979,460
Ensembl chr17:33,961,458...33,979,504

G

RAB32, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr10:10,420,783...10,433,951
Ensembl chr10:10,420,746...10,434,009

G

RAN, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr 5:129,097,264...129,101,388
Ensembl chr 5:129,097,133...129,101,387

G

RAN binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:18,057,843...18,066,558
Ensembl chr16:18,057,648...18,066,596

G

selectin, platelet

RGD

NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595

G

splicing factor 3a, subunit 3

CTD Direct Evidence: marker/mechanism

NCBI chr 4:124,602,966...124,626,234
Ensembl chr 4:124,608,569...124,626,253

G

splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated)

CTD Direct Evidence: marker/mechanism

NCBI chr 4:126,914,504...126,944,894
Ensembl chr 4:126,915,117...126,930,806

G

sigma non-opioid intracellular receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:41,738,493...41,741,359
Ensembl chr 4:41,738,493...41,756,157

G

sirtuin 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483

G

solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221

G

small nuclear ribonucleoprotein D3

CTD Direct Evidence: marker/mechanism

NCBI chr10:75,353,852...75,371,300
Ensembl chr10:75,353,385...75,373,215

G

suppressor of cytokine signaling 1

mRNA:decreased expression:uterine cervix

RGD

NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400

G

suppressor of cytokine signaling 3

mRNA:decreased expression:uterine cervix

RGD

NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873

G

serum response factor

CTD Direct Evidence: marker/mechanism

NCBI chr17:46,857,764...46,869,194
Ensembl chr17:46,859,255...46,867,101

G

serine and arginine-rich splicing factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:87,937,325...87,944,583
Ensembl chr11:87,938,199...87,944,581

G

serine and arginine-rich splicing factor 9

CTD Direct Evidence: marker/mechanism

NCBI chr 5:115,465,236...115,471,139
Ensembl chr 5:115,465,236...115,471,139

G

stimulator of interferon response cGAMP interactor 1

mRNA:increased expression:multiple tissues (human)

RGD

NCBI chr18:35,866,731...35,873,607
Ensembl chr18:35,866,732...35,873,607

G

TATA-box binding protein associated factor 9

CTD Direct Evidence: marker/mechanism

NCBI chr13:100,787,851...100,792,568
Ensembl chr13:100,788,087...100,792,568
Ensembl chr13:100,788,087...100,792,568

G

toll-like receptor 3

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to

CTD
OMIM
ClinVar

PMID:17872438 PMID:19625408 PMID:20472559 PMID:20855885 PMID:21911422 More...

NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117

G

tumor necrosis factor

protein:increased expression:serum

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

tumor necrosis factor receptor superfamily, member 8

CTD Direct Evidence: marker/mechanism

NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734

G

triggering receptor expressed on myeloid cells 1

mRNA,protein:increased expression:peripheral blood mononuclear cell, macrophage, plasma

RGD

NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952

G

tripartite motif-containing 5

CTD Direct Evidence: therapeutic

NCBI chr 7:103,912,593...103,937,448
Ensembl chr 7:103,912,593...103,937,301

G

U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:31,866,055...31,878,122
Ensembl chr17:31,866,055...31,877,866

G

vitamin D (1,25-dihydroxyvitamin D3) receptor

DNA:SNPs:3' UTR (human)

RGD

NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511

G

YY1 transcription factor

CTD Direct Evidence: marker/mechanism

NCBI chr12:108,758,841...108,786,074
Ensembl chr12:108,758,899...108,786,074

hydrocele

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

polycystin 2, transient receptor potential cation channel

ClinVar Annotator: match by term: Hydrocele

PMID:25741868 PMID:28492532

NCBI chr 5:104,599,379...104,653,685
Ensembl chr 5:104,607,316...104,653,685

hypogonadotropic hypogonadism 24 without anosmia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

follicle stimulating hormone beta

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hypogonadotropic hypogonadism 24 without anosmia

OMIM
CTD
ClinVar

PMID:4344039 PMID:8220432 PMID:9271483 PMID:9280841 PMID:9624193 More...

NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001

hypospadias

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

androgen receptor

mRNA:decreased expression:mucosa of urethra

RGD

PMID:15472213 PMID:23386417

RGD:1578685, RGD:11576230

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

activating transcription factor 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236

G

cytochrome P450, family 1, subfamily a, polypeptide 1

no_association

RGD

PMID:15579657 PMID:21300689

RGD:11576312, RGD:11576313

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

diacylglycerol kinase kappa

CTD Direct Evidence: marker/mechanism

PMID:21113153 PMID:27098078

NCBI chr X:6,691,103...6,814,602
Ensembl chr X:6,690,410...6,814,602

G

estrogen receptor 2 (beta)

susceptibility

DNA:snps, repeat:promoter, 3' utr:rs2987983, rs10483774, g.dupCA (rs1256062) (human)

PMID:17579196 PMID:17579196

RGD:1626506, RGD:1626506

NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033

G

fibroblast growth factor 10

RGD

NCBI chr13:118,851,199...118,928,651
Ensembl chr13:118,806,327...118,928,651

G

fibroblast growth factor 8

RGD

NCBI chr19:45,724,930...45,731,380
Ensembl chr19:45,725,237...45,731,354

G

fibroblast growth factor receptor 2

mRNA:decreased expression:male genital tubercle (rat)

RGD

NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079

G

fascin actin-bundling protein 3

ClinVar Annotator: match by term: Hypospadias

NCBI chr 6:28,427,888...28,438,621
Ensembl chr 6:28,427,788...28,438,621

G

GLI-Kruppel family member GLI3

mRNA:decreased expression:male genital tubercle

RGD

NCBI chr13:15,638,308...15,904,611
Ensembl chr13:15,637,820...15,904,611

G

glutathione S-transferase, mu 1

DNA:deletion, haplotype: : (human)

RGD

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

glutathione S-transferase, theta 1

DNA:deletion, haplotype: : (human)

RGD

NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418

G

Hedgehog-interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635

G

homeobox A13

mRNA:decreased expression:male genital tubercle

RGD

NCBI chr 6:52,235,833...52,237,865
Ensembl chr 6:52,234,674...52,237,788

G

homeobox D13

mRNA:decreased expression:male genital tubercle

RGD

NCBI chr 2:74,498,569...74,501,947
Ensembl chr 2:74,498,654...74,501,943

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

DNA:point mutation:CDS:heterozygous S213T or S284R, result in decreased enzyme activity

RGD

NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110

G

K(lysine) acetyltransferase 6B

ClinVar Annotator: match by term: Hypospadias

NCBI chr14:21,549,284...21,722,546
Ensembl chr14:21,531,502...21,722,546

G

mastermind-like domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr X:70,093,642...70,199,662
Ensembl chr X:70,093,846...70,199,662

G

microRNA 494

RNA:increased expression:urethra

RGD

NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836

G

neural precursor cell expressed, developmentally down-regulated gene 4-like

protein:decreased expression:urethra

RGD

NCBI chr18:65,017,551...65,350,888
Ensembl chr18:65,020,776...65,350,899

G

nuclear receptor subfamily 5, group A, member 1

ClinVar Annotator: match by term: Hypospadias

NCBI chr 2:38,582,668...38,604,554
Ensembl chr 2:38,582,668...38,604,554

G

phosphofurin acidic cluster sorting protein 1

ClinVar Annotator: match by term: Hypospadias

NCBI chr19:5,183,714...5,323,138
Ensembl chr19:5,183,186...5,323,147

G

pro-platelet basic protein

protein:increased expression:blood

RGD

NCBI chr 5:90,916,377...90,917,922
Ensembl chr 5:90,916,377...90,917,922

G

staphylococcal nuclease and tudor domain containing 1

ClinVar Annotator: match by term: Hypospadias

NCBI chr 6:28,480,332...28,935,161
Ensembl chr 6:28,475,138...28,935,161

G

steroid 5 alpha-reductase 2

susceptibility

protein:missense mutations:cds:p.R227Q, p.F186L (human)

RGD

NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911

G

wingless-type MMTV integration site family, member 11

ClinVar Annotator: match by term: Hypospadias

NCBI chr 7:98,484,293...98,503,954
Ensembl chr 7:98,484,319...98,504,402

G

wingless-type MMTV integration site family, member 8A

ClinVar Annotator: match by term: Hypospadias

NCBI chr18:34,675,380...34,681,114
Ensembl chr18:34,675,366...34,681,326

Hypospadias 1, X-Linked

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

androgen receptor

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hypospadias 1, X-linked

CTD
OMIM
ClinVar

PMID:2594783 PMID:7981687 PMID:8033918 PMID:8097257 PMID:8683794 More...

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

Hypospadias 2, X-Linked

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

mastermind-like domain containing 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hypospadias 2, X-linked

OMIM
CTD
ClinVar

PMID:17086185 PMID:20347055 PMID:25741868 PMID:28492532 PMID:32690052 More...

NCBI chr X:70,093,642...70,199,662
Ensembl chr X:70,093,846...70,199,662

IGSF1 deficiency syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aminopeptidase O

ClinVar Annotator: match by term: X-linked central congenital hypothyroidism with late-onset testicular enlargement

NCBI chr13:63,112,707...63,473,910
Ensembl chr13:63,112,707...63,473,910

G

Fanconi anemia, complementation group B

ClinVar Annotator: match by term: X-linked central congenital hypothyroidism with late-onset testicular enlargement

PMID:24033266 PMID:25741868 PMID:28492532

NCBI chr X:163,763,678...163,780,266
Ensembl chr X:163,763,588...163,780,268

G

Fanconi anemia, complementation group C

ClinVar Annotator: match by term: X-linked central congenital hypothyroidism with late-onset testicular enlargement

NCBI chr13:63,452,519...63,645,126
Ensembl chr13:63,432,857...63,645,092

G

immunoglobulin superfamily, member 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: X-linked central congenital hypothyroidism with late-onset testicular enlargement
OMIM:300888

OMIM
CTD
ClinVar
MouseDO

PMID:23143598 PMID:23966245 PMID:25741868 PMID:27310681 PMID:28492532 More...

NCBI chr X:48,871,413...48,886,798
Ensembl chr X:48,871,413...48,886,626

impotence

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

advanced glycosylation end product-specific receptor

treatment

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910

G

angiotensinogen

treatment

RGD

NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445

G

thymoma viral proto-oncogene 1

treatment

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318

G

BCL2-associated agonist of cell death

treatment

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267

G

BCL2-associated X protein

treatment

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

B cell leukemia/lymphoma 2

treatment

CTD Direct Evidence: marker/mechanism
associated with Diabetes Mellitus, Experimental

CTD
RGD

PMID:12394778 PMID:12394778 PMID:21235725

RGD:1579980, RGD:10053666

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

BCL2-like 1

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:12394778 PMID:12394778

NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648

G

caspase 3

treatment

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

cyclin D1

mRNA:decreased expression:penis erectile tissue

RGD

NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662

G

cyclin D2

associated with Diabetes Mellitus, Experimental;mRNA:decreased expression:penis

RGD

NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156

G

cofilin 1, non-muscle

treatment

protein:increased phosphorylation:corpus cavernosum penis (rat)

RGD

PMID:25923835 PMID:25444982

RGD:11568706, RGD:11570410

NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229

G

cannabinoid receptor 1

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831

G

dynein light chain LC8-type 1

treatment

RGD

NCBI chr 5:115,435,129...115,438,995
Ensembl chr 5:115,435,169...115,439,058

G

endothelin 1

protein:increased expression:plasma
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:12002441 PMID:17420087

NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466

G

endothelin receptor type A

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:18823320 PMID:17420087

NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093

G

fatty acid binding protein 4, adipocyte

associated with hypercholesterolemia;mRNA:increased expression:penis erectile tissue

RGD

NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636

G

fibroblast growth factor 2

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257

G

gap junction protein, alpha 1

mRNA, protein:decreased expression:corpus cavernosum penis

RGD

NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609

G

glutamate receptor ionotropic, NMDA3A

CTD Direct Evidence: marker/mechanism

NCBI chr 4:49,661,611...49,846,023
Ensembl chr 4:49,661,611...49,845,744

G

G protein-coupled receptor kinase 2

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250

G

histone deacetylase 3

protein:increased expression:penis:

RGD

NCBI chr18:38,070,024...38,088,073
Ensembl chr18:38,068,897...38,088,069

G

histone deacetylase 4

protein:increased expression:penis:

RGD

NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421

G

insulin-like growth factor binding protein 3

treatment

mRNA, protein:increased expression:penis

RGD

PMID:24576658 PMID:21595839

RGD:10402763, RGD:10402765

NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923

G

interleukin 6

treatment

associated with Diabetes Mellitus, Type 2

RGD

PMID:21492407 PMID:24467772

RGD:10402827, RGD:9495931

NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979

G

kinase insert domain protein receptor

RGD

NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118

G

melanoma cell adhesion molecule

protein:decreased expression:penis erectile tissue

RGD

NCBI chr 9:44,045,958...44,054,024
Ensembl chr 9:44,045,766...44,054,024

G

nitric oxide synthase 1, neuronal

treatment

associated with Diabetes Mellitus, Experimental
associated with Urethral Obstruction;protein:decreased expression:penis erectile tissue

RGD

PMID:23698784 PMID:23522997 PMID:23535456

RGD:7244246, RGD:7257657, RGD:7257656

NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905

G

nitric oxide synthase 2, inducible

associated with Diabetes Mellitus, Experimental;protein:increased expression:penis

RGD

NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080

G

nitric oxide synthase 3, endothelial cell

treatment

associated with Cocaine-Related Disorders;protein:decreased expression:penis
CTD Direct Evidence: marker/mechanism|therapeutic
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:decreased expression, decreased activity

CTD
RGD

PMID:12002441 PMID:17071732 PMID:17420087 PMID:29260891 PMID:20807325

RGD:2292142, RGD:13504711, RGD:4891999

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

purinergic receptor P2Y, G-protein coupled 1

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr 3:60,910,206...60,916,403
Ensembl chr 3:60,910,216...60,916,403

G

purinergic receptor P2Y, G-protein coupled 2

associated with Diabetes Mellitus, Experimental

RGD

NCBI chr 7:100,645,775...100,661,260
Ensembl chr 7:100,645,775...100,662,073

G

phosphodiesterase 5A, cGMP-specific

associated with Hypercholesterolemia
associated with Diabetes Mellitus, Experimental

RGD

PMID:15667904 PMID:15920460 PMID:15578039

RGD:2314520, RGD:2314519, RGD:2314521

NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023

G

protein kinase, cGMP-dependent, type I

associated with Diabetes Mellitus, Experimental;protein:decreased expression:penis erectile tissue

RGD

NCBI chr19:30,541,887...31,742,675
Ensembl chr19:30,541,889...31,742,433

G

prolactin

CTD Direct Evidence: marker/mechanism

PMID:387166 PMID:4001434 PMID:7878608 PMID:8845563 PMID:15829128

NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188

G

sex hormone binding globulin

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731

G

sirtuin 1

treatment

associated with Diabetes Mellitus, Type 2

RGD

NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483

G

transforming growth factor, beta 1

associated with Diabetes Mellitus, Experimental;protein:increased expression:penis

RGD

PMID:18778311 PMID:27051243

RGD:2306738, RGD:14995446

NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502

G

thrombomodulin

associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:plasma

RGD

NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108

G

tumor necrosis factor

treatment

associated with Diabetes Mellitus, Type 2

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

vascular endothelial growth factor A

CTD Direct Evidence: marker/mechanism

NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295

G

vasoactive intestinal polypeptide

CTD Direct Evidence: therapeutic

NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617

G

X-ray repair complementing defective repair in Chinese hamster cells 1

susceptibility

associated with Prostatic Neoplasms;DNA:polymorphism: :p.R280H

RGD

NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865

infertility

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

a disintegrin and metallopeptidase domain 7

RGD

NCBI chr14:68,734,785...68,771,138
Ensembl chr14:68,734,785...68,771,190

G

ataxia telangiectasia mutated

DNA:deletion:exon:

RGD

PMID:27895165 PMID:28007901

RGD:12879393, RGD:12879399

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

breast cancer 2, early onset

RGD

NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794

G

cation channel, sperm associated 2

ClinVar Annotator: match by term: Infertility

NCBI chr 2:121,222,109...121,245,082
Ensembl chr 2:121,223,112...121,244,273

G

coiled-coil domain containing 103

ClinVar Annotator: match by term: Infertility

PMID:22581229 PMID:23891469 PMID:24033266 PMID:24357714 PMID:25326635 More...

NCBI chr11:102,772,050...102,776,042
Ensembl chr11:102,772,030...102,776,042

G

coiled-coil domain containing 39

ClinVar Annotator: match by term: Infertility

PMID:16199547 PMID:21131972 PMID:22693295 PMID:23255504 PMID:25741868 More...

NCBI chr 3:33,864,906...33,898,473
Ensembl chr 3:33,866,511...33,898,459

G

CDC23 cell division cycle 23

NCBI chr18:34,761,401...34,784,802
Ensembl chr18:34,764,004...34,784,788

G

cyclin dependent kinase inhibitor 1B

RGD

NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476

G

cystic fibrosis transmembrane conductance regulator

ClinVar Annotator: match by term: Infertility

PMID:1284535 PMID:1379210 PMID:1384326 PMID:1977306 PMID:7508183 More...

NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767

G

colony stimulating factor 1 receptor

RGD

NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221

G

dicer 1, ribonuclease type III

RGD

NCBI chr12:104,654,001...104,718,331
Ensembl chr12:104,654,001...104,718,211

G

dynein axonemal assembly factor 11

ClinVar Annotator: match by term: Infertility

PMID:28492532 PMID:30300419

NCBI chr15:66,251,707...66,372,769
Ensembl chr15:66,251,707...66,372,759

G

dynein, axonemal, heavy chain 11

ClinVar Annotator: match by term: Infertility

NCBI chr12:117,841,717...118,162,778
Ensembl chr12:117,841,717...118,162,778

G

dynein, axonemal, heavy chain 5

ClinVar Annotator: match by term: Infertility

PMID:11788826 PMID:16627867 PMID:25741868 PMID:27637300 PMID:28492532 More...

NCBI chr15:28,155,000...28,472,191
Ensembl chr15:28,203,898...28,472,198

G

dynein axonemal intermediate chain 1

ClinVar Annotator: match by term: Infertility

PMID:25741868 PMID:28492532

NCBI chr 4:41,569,731...41,638,158
Ensembl chr 4:41,569,775...41,638,158

G

euchromatic histone lysine N-methyltransferase 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,117,427...35,133,049
Ensembl chr17:35,117,445...35,133,028

G

estrogen receptor 1 (alpha)

RGD

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

Fanconi anemia, complementation group A

associated with Hypogonadism

RGD

NCBI chr 8:123,993,033...124,045,390
Ensembl chr 8:123,995,039...124,045,315

G

fibroblast growth factor receptor 1

ClinVar Annotator: match by term: Infertility

NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734

G

gonadotropin releasing hormone receptor

ClinVar Annotator: match by term: Infertility

PMID:7557974 PMID:9371856 PMID:10022417 PMID:10690855 PMID:10999776 More...

NCBI chr 5:86,328,613...86,345,760
Ensembl chr 5:86,328,613...86,345,760

G

klotho

CTD Direct Evidence: marker/mechanism

NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282

G

leptin receptor

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:15093691 PMID:16284652

NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549

G

nephronophthisis 4 (juvenile) homolog (human)

ClinVar Annotator: match by term: Infertility

PMID:12205563 PMID:12244321 PMID:23559409 PMID:25558065 PMID:25741916 More...

NCBI chr 4:152,561,163...152,647,641
Ensembl chr 4:152,561,163...152,647,640

G

polymerase (RNA) II (DNA directed) polypeptide C

ClinVar Annotator: match by term: Infertility

NCBI chr 8:95,584,078...95,590,870
Ensembl chr 8:95,584,078...95,600,163

G

prokineticin receptor 2

ClinVar Annotator: match by term: Infertility

PMID:16537498 PMID:17054399 PMID:18559922 PMID:18682503 PMID:18723471 More...

NCBI chr 2:132,211,625...132,227,413
Ensembl chr 2:132,179,653...132,227,367

G

prostaglandin E receptor 2 (subtype EP2)

CTD Direct Evidence: marker/mechanism

NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277

G

tachykinin 2

ClinVar Annotator: match by term: Infertility

PMID:25636053 PMID:28492532 PMID:29419413

NCBI chr10:127,560,347...127,567,637
Ensembl chr10:127,560,347...127,567,637

G

transforming growth factor, beta receptor III

ClinVar Annotator: match by term: Infertility

NCBI chr 5:107,254,433...107,437,495
Ensembl chr 5:107,254,436...107,437,495

G

tetratricopeptide repeat domain 19

CTD Direct Evidence: marker/mechanism

NCBI chr11:62,172,256...62,208,611
Ensembl chr11:62,172,299...62,219,277

G

zinc finger SWIM-type containing 7

ClinVar Annotator: match by term: Infertility

NCBI chr11:62,158,050...62,172,221
Ensembl chr11:62,158,050...62,172,201

lepromatous leprosy

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

complement component 3

severity

protein:decreased expression:serum

RGD

NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136

G

CD163 antigen

exacerbates

protein:increased expression:blood serum (human)

RGD

PMID:22851198 PMID:28355218

RGD:39939078, RGD:127345133

NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486

G

complement factor B

severity

RGD

NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494

G

histocompatibility 2, class II antigen A, alpha

susceptibility

DNA:polymorphisms: :HLA-DQA1*03, HLA-DQA1*05 (human)

RGD

NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797

G

interleukin 27

ameliorates

mRNA:decreased expression:skin of body (human)

RGD

NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113

G

mannose-binding lectin (protein C) 2

susceptibility

DNA:SNP:cds:161G>A (human)

RGD

NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087

G

vitamin D (1,25-dihydroxyvitamin D3) receptor

GAD

NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511

leprosy

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

basic leucine zipper transcription factor, ATF-like 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:190,830,611...190,841,140
Ensembl chr 1:190,830,044...190,841,142

G

coiled-coil domain containing 122

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr14:77,274,212...77,349,703
Ensembl chr14:77,274,212...77,349,697

G

coiled-coil domain containing 88B

CTD Direct Evidence: marker/mechanism

NCBI chr19:6,821,991...6,835,586
Ensembl chr19:6,821,991...6,835,579

G

CD8 subunit alpha

exacerbates

mRNA:increased expression:blood (human)

NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157

G

C-X-C motif chemokine ligand 15

severity

DNA:SNP:promoter:g.-353T>A (rs4073) (human)

RGD

NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926

G

histocompatibility 2, class II antigen E beta

susceptibility

DNA:polymorphisms (human)

RGD

PMID:20003324 PMID:19698125

RGD:5147585, RGD:5147788

NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648

G

interleukin 10

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

interleukin 17A

severity

mRNA:decreased expression:epidermis (human)

RGD

NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720

G

interleukin 19

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852

G

interleukin 23 receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 6:67,399,906...67,468,838
Ensembl chr 6:67,399,916...67,468,839

G

laccase domain containing 1

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr14:77,261,640...77,274,344
Ensembl chr14:77,261,640...77,274,344

G

leucine-rich repeat kinase 2

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

PMID:26467025 PMID:28492532

NCBI chr15:91,556,994...91,700,327
Ensembl chr15:91,557,378...91,700,323

G

lymphotoxin A

susceptibility

ClinVar Annotator: match by term: Leprosy, early-onset, susceptibility to
CTD Direct Evidence: marker/mechanism

ClinVar
OMIM
CTD

PMID:15052269 PMID:17353895

NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327

G

mannose receptor, C type 1

ClinVar Annotator: match by term: Susceptibility to leprosy and multibacillary leprosy

NCBI chr 2:14,234,225...14,336,834
Ensembl chr 2:14,234,203...14,336,868

G

nucleotide-binding oligomerization domain containing 2

DNA:polymorphisms: :multiple (human)
ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102

G

presenilin associated, rhomboid-like

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr16:20,098,570...20,121,090
Ensembl chr16:20,098,568...20,121,137

G

PTEN induced putative kinase 1

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618

G

parkin RBR E3 ubiquitin protein ligase

ClinVar Annotator: match by term: LPRS2

PMID:10072423 PMID:11558785 PMID:11889248 PMID:12114481 PMID:12730996 More...

NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248

G

RAB32, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr10:10,420,783...10,433,951
Ensembl chr10:10,420,746...10,434,009

G

receptor (TNFRSF)-interacting serine-threonine kinase 2

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr 4:16,122,740...16,163,674
Ensembl chr 4:16,122,733...16,163,647

G

solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1

susceptibility

DNA:repeat:promoter (human)
CTD Direct Evidence: marker/mechanism
DNA:polymorphisms, haplotype (human)

CTD
RGD

PMID:16597321 PMID:15755200 PMID:10608779

RGD:5684957, RGD:5684972

NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221

G

toll-like receptor 1

susceptibility

DNA:snp:cds:p.I602S (human)
ClinVar Annotator: match by term: LPRS1 | ClinVar Annotator: match by term: Leprosy, susceptibility to, 5
CTD Direct Evidence: marker/mechanism

ClinVar
OMIM
CTD
RGD

PMID:17475868 PMID:17548585 PMID:18461142 PMID:19456232 PMID:23105135 More...

NCBI chr 5:65,082,023...65,090,945
Ensembl chr 5:65,082,022...65,090,906

G

toll-like receptor 2

susceptibility

DNA:polymorphisms:microsatellite,597C>T(human)
ClinVar Annotator: match by term: Leprosy, susceptibility to, 3
CTD Direct Evidence: marker/mechanism

ClinVar
CTD
OMIM
RGD

PMID:11476982 PMID:12646604 PMID:15726416 PMID:19111445 PMID:25741868 More...

NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074

G

toll-like receptor 6

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440

G

tumor necrosis factor

susceptibility

DNA:SNP:promoter:−308G>A (human)

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

tumor necrosis factor (ligand) superfamily, member 15

ClinVar Annotator: match by term: Leprosy, susceptibility to, 1

NCBI chr 4:63,642,837...63,663,296
Ensembl chr 4:63,642,840...63,663,350

G

tumor necrosis factor (ligand) superfamily, member 8

CTD Direct Evidence: marker/mechanism

NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584

Male Genital Neoplasms

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

WT1 transcription factor

RGD

NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961

male infertility

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

angiotensin I converting enzyme

CTD Direct Evidence: marker/mechanism

PMID:8642790 PMID:12075344

NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790

G

actin-like 7a

RGD

NCBI chr 4:56,743,422...56,744,925
Ensembl chr 4:56,743,413...56,744,925

G

ADAM metallopeptidase with thrombospondin type 1 motif 16

RGD

PMID:24983376 PMID:32037220

RGD:13434925, RGD:38548917

NCBI chr13:70,875,917...70,989,956
Ensembl chr13:70,875,921...70,989,930

G

adenylate cyclase 10

ClinVar Annotator: match by term: Male infertility

NCBI chr 1:165,309,114...165,404,347
Ensembl chr 1:165,312,752...165,404,343

G

aryl-hydrocarbon receptor

CTD Direct Evidence: marker/mechanism

NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037

G

A kinase anchor protein 4

RGD

NCBI chr X:6,933,754...6,944,848
Ensembl chr X:6,933,758...6,944,848

G

aldehyde dehydrogenase 2, mitochondrial

CTD Direct Evidence: marker/mechanism

NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887

G

androgen receptor

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Male infertility

PMID:1307250 PMID:1430233 PMID:7581399 PMID:7671849 PMID:8097257 More...

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

ADP-ribosylation factor-like 2 binding protein

NCBI chr 8:95,393,228...95,401,085
Ensembl chr 8:95,393,228...95,401,053

G

armadillo repeat containing 2

NCBI chr10:41,784,284...41,894,383
Ensembl chr10:41,790,986...41,894,438

G

aurora kinase C

CTD Direct Evidence: marker/mechanism

NCBI chr 7:6,998,346...7,006,090
Ensembl chr 7:6,998,299...7,006,090

G

BCL2-associated X protein

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:24723216 PMID:7569956

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

B cell leukemia/lymphoma 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

bromodomain and WD repeat domain containing 1

ClinVar Annotator: match by term: Male infertility

NCBI chr16:95,793,289...95,883,905
Ensembl chr16:95,793,292...95,883,726

G

BSCL2 lipid droplet biogenesis associated, seipin

NCBI chr19:8,814,831...8,826,047
Ensembl chr19:8,814,831...8,826,047

G

calcium binding tyrosine phosphorylation regulated

NCBI chr18:12,874,141...12,888,203
Ensembl chr18:12,873,379...12,888,317

G

calcium/calmodulin-dependent protein kinase IV

RGD

NCBI chr18:33,067,995...33,328,820
Ensembl chr18:33,067,984...33,324,281

G

capping actin protein of muscle Z-line subunit alpha 3

mRNA:decreased expression:semen
DNA:missense mutation: :p.M44K (human)

RGD

PMID:27114798 PMID:19341723

RGD:18899565, RGD:19165126

NCBI chr 6:139,987,283...139,988,563
Ensembl chr 6:139,986,978...139,988,504

G

cation channel, sperm associated 1

ClinVar Annotator: match by term: Male infertility

NCBI chr19:5,385,643...5,394,309
Ensembl chr19:5,385,769...5,394,308

G

cation channel, sperm associated 2

ClinVar Annotator: match by term: Male infertility

NCBI chr 2:121,222,109...121,245,082
Ensembl chr 2:121,223,112...121,244,273

G

Casitas B-lineage lymphoma

CTD Direct Evidence: marker/mechanism

NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346

G

coiled-coil domain containing 146

NCBI chr 5:21,496,749...21,629,675
Ensembl chr 5:21,497,959...21,629,675

G

coiled-coil domain containing 40

ClinVar Annotator: match by term: Male infertility

PMID:24033266 PMID:25741868 PMID:28492532

NCBI chr11:119,119,328...119,156,074
Ensembl chr11:119,119,398...119,156,064

G

CDC14 cell division cycle 14A

CTD Direct Evidence: marker/mechanism

NCBI chr 3:116,066,202...116,222,390
Ensembl chr 3:116,066,202...116,222,394

G

cilia and flagella associated protein 47

NCBI chr X:78,310,164...78,560,957
Ensembl chr X:78,310,165...78,560,891

G

cilia and flagella associated protein 57

NCBI chr 4:118,411,747...118,477,982
Ensembl chr 4:118,411,748...118,477,974

G

cystic fibrosis transmembrane conductance regulator

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Male infertility

PMID:7586569 PMID:7739684 PMID:9804160 PMID:11180668 PMID:11547256 More...

NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767

G

claudin 2

ClinVar Annotator: match by term: Male infertility

NCBI chr X:138,701,552...138,712,135
Ensembl chr X:138,701,577...138,712,135

G

CCR4-NOT transcription complex, subunit 7

mRNA:increased expression:testis

RGD

NCBI chr 8:40,945,579...40,968,888
Ensembl chr 8:40,945,581...40,968,888

G

casein kinase 2, alpha prime polypeptide

NCBI chr 8:96,172,724...96,215,505
Ensembl chr 8:96,172,724...96,216,667

G

cystatin 8 (cystatin-related epididymal spermatogenic)

CTD Direct Evidence: marker/mechanism

NCBI chr 2:148,640,759...148,647,516
Ensembl chr 2:148,640,705...148,647,515

G

cytochrome P450, family 17, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611

G

cytochrome P450, family 1, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

DDB1 and CUL4 associated factor 6

ClinVar Annotator: match by term: Male infertility

NCBI chr 1:165,157,069...165,288,475
Ensembl chr 1:165,156,267...165,288,044

G

dynein axonemal assembly factor 4

CTD Direct Evidence: marker/mechanism

NCBI chr 9:72,863,574...72,880,971
Ensembl chr 9:72,866,067...72,880,346

G

dynein, axonemal assembly factor 5

NCBI chr 5:139,135,888...139,172,265
Ensembl chr 5:139,135,978...139,172,265

G

dynein, axonemal, heavy chain 10

ClinVar Annotator: match by term: Male infertility

NCBI chr 5:124,802,149...124,911,372
Ensembl chr 5:124,802,149...124,911,372

G

dynein, axonemal, heavy chain 11

ClinVar Annotator: match by term: Male infertility

PMID:22184204 PMID:25741868

NCBI chr12:117,841,717...118,162,778
Ensembl chr12:117,841,717...118,162,778

G

dynein, axonemal, heavy chain 5

ClinVar Annotator: match by term: Male infertility

PMID:11788826 PMID:16627867 PMID:19357118 PMID:25741868 PMID:28492532 More...

NCBI chr15:28,155,000...28,472,191
Ensembl chr15:28,203,898...28,472,198

G

dynein axonemal intermediate chain 1

ClinVar Annotator: match by term: Male infertility

PMID:25741868 PMID:28492532

NCBI chr 4:41,569,731...41,638,158
Ensembl chr 4:41,569,775...41,638,158

G

drosha, ribonuclease type III

CTD Direct Evidence: marker/mechanism

NCBI chr15:12,824,893...12,935,377
Ensembl chr15:12,824,901...12,935,377

G

ELOVL fatty acid elongase 2

CTD Direct Evidence: marker/mechanism

NCBI chr13:41,335,858...41,373,879
Ensembl chr13:41,335,857...41,373,881

G

enolase 1, alpha non-neuron

CTD Direct Evidence: marker/mechanism

NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336

G

enolase 4

CTD Direct Evidence: marker/mechanism

NCBI chr19:58,922,490...58,959,853
Ensembl chr19:58,931,857...58,959,853

G

estrogen receptor 1 (alpha)

CTD Direct Evidence: marker/mechanism

PMID:20833731 PMID:23213263

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

Fas cell surface death receptor

protein:increased expression:testis (rat)

RGD

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

FK506 binding protein 6

DNA:deletion:exon (rat)
ClinVar Annotator: match by term: Male infertility

PMID:25741868 PMID:36150389 PMID:12764197 PMID:12764197

RGD:1582485, RGD:1582485

NCBI chr 5:135,320,558...135,380,662
Ensembl chr 5:135,320,558...135,378,898

G

forkhead box K2

CTD Direct Evidence: marker/mechanism

NCBI chr11:121,150,805...121,200,726
Ensembl chr11:121,150,816...121,200,722

G

follicle stimulating hormone beta

CTD Direct Evidence: marker/mechanism

NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001

G

UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5

ClinVar Annotator: match by term: Male infertility

NCBI chr 5:25,386,438...25,425,295
Ensembl chr 5:25,386,458...25,425,295

G

G protein subunit alpha transducin 3

CTD Direct Evidence: marker/mechanism

NCBI chr 5:18,167,568...18,224,666
Ensembl chr 5:18,167,547...18,224,832

G

gonadotropin releasing hormone 1

CTD Direct Evidence: therapeutic

NCBI chr14:67,982,717...67,986,889
Ensembl chr14:67,982,630...67,986,888

G

glutathione peroxidase 3

treatment

RGD

NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203

G

glutathione peroxidase 4

CTD Direct Evidence: marker/mechanism

PMID:19417079 PMID:19744930

NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273

G

HORMA domain containing 1

ClinVar Annotator: match by term: Male infertility

NCBI chr 3:95,466,988...95,495,174
Ensembl chr 3:95,466,988...95,494,982

G

homeobox D11

CTD Direct Evidence: marker/mechanism

NCBI chr 2:74,509,902...74,517,360
Ensembl chr 2:74,509,901...74,517,360

G

KIT proto-oncogene receptor tyrosine kinase

RGD

NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382

G

kallikrein related-peptidase 14

ClinVar Annotator: match by term: Male infertility

NCBI chr 7:43,330,305...43,344,960
Ensembl chr 7:43,339,842...43,344,960

G

kallikrein related-peptidase 4 (prostase, enamel matrix, prostate)

ClinVar Annotator: match by term: Male infertility

NCBI chr 7:43,530,584...43,535,228
Ensembl chr 7:43,530,584...43,535,228

G

lysine (K)-specific methyltransferase 2D

CTD Direct Evidence: marker/mechanism

NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085

G

lactate dehydrogenase C

CTD Direct Evidence: marker/mechanism

PMID:21565994 PMID:23486916

NCBI chr 7:46,510,687...46,527,571
Ensembl chr 7:46,510,627...46,527,566

G

luteinizing hormone beta

CTD Direct Evidence: marker/mechanism

PMID:387166 PMID:10739843 PMID:15602022

NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321

G

luteinizing hormone/choriogonadotropin receptor

CTD Direct Evidence: marker/mechanism

NCBI chr17:89,023,812...89,099,487
Ensembl chr17:89,023,909...89,099,418

G

transformed mouse 3T3 cell double minute 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663

G

methylenetetrahydrofolate reductase

susceptibility

CTD Direct Evidence: marker/mechanism
:DNA:polymorphism: :677C>T(human)

CTD
RGD

PMID:16861746 PMID:16247718

NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008

G

5-methyltetrahydrofolate-homocysteine methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999

G

5-methyltetrahydrofolate-homocysteine methyltransferase reductase

CTD Direct Evidence: marker/mechanism

NCBI chr13:68,708,897...68,730,273
Ensembl chr13:68,708,899...68,730,268

G

myosin VI

ClinVar Annotator: match by term: Male infertility

PMID:9536098 PMID:17576681 PMID:24033266 PMID:25741868 PMID:28492532 More...

NCBI chr 9:80,072,262...80,219,011
Ensembl chr 9:80,072,313...80,219,011

G

nanos C2HC-type zinc finger 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:18,721,449...18,722,887
Ensembl chr 7:18,721,325...18,722,887

G

nitric oxide synthase 3, endothelial cell

CTD Direct Evidence: marker/mechanism

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

nuclear receptor subfamily 1, group H, member 4

CTD Direct Evidence: marker/mechanism

NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447

G

nuclear receptor subfamily 5, group A, member 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Male infertility

PMID:17940071 PMID:20887963 PMID:25741868 PMID:25989977 PMID:28492532 More...

NCBI chr 2:38,582,668...38,604,554
Ensembl chr 2:38,582,668...38,604,554

G

NOL1/NOP2/Sun domain family, member 7

CTD Direct Evidence: marker/mechanism

NCBI chr 5:66,417,181...66,457,544
Ensembl chr 5:66,417,240...66,455,369

G

outer dynein arm docking complex subunit 2

ClinVar Annotator: match by term: Male infertility

NCBI chr18:7,088,233...7,298,272
Ensembl chr18:7,088,209...7,297,936

G

8-oxoguanine DNA-glycosylase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029

G

polyamine modulated factor 1 binding protein 1

NCBI chr 8:110,104,447...110,269,274
Ensembl chr 8:110,220,659...110,269,272

G

polymerase (DNA directed), gamma

CTD Direct Evidence: marker/mechanism

NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110

G

paraoxonase 1

CTD Direct Evidence: marker/mechanism

PMID:21561808 PMID:22206979

NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946

G

RAD23 homolog B, nucleotide excision repair protein

CTD Direct Evidence: marker/mechanism

NCBI chr 4:55,350,042...55,392,237
Ensembl chr 4:55,350,043...55,392,237

G

RAN binding protein 2

RGD

NCBI chr10:58,282,674...58,329,977
Ensembl chr10:58,282,742...58,330,178

G

ring finger protein 114

mRNA:decreased expression:testes (human)

RGD

NCBI chr 2:167,334,565...167,358,093
Ensembl chr 2:167,334,565...167,358,093

G

retinitis pigmentosa GTPase regulator

RGD

NCBI chr X:10,024,455...10,083,034
Ensembl chr X:9,939,860...10,083,159

G

selenoprotein P

CTD Direct Evidence: marker/mechanism

NCBI chr15:3,300,249...3,309,992
Ensembl chr15:3,298,029...3,309,990

G

SMAD family member 1

protein:decreased expression:spermatogonia, spermatocytes, spermatids

RGD

NCBI chr 8:80,065,024...80,126,057
Ensembl chr 8:80,065,024...80,126,147

G

superoxide dismutase 2, mitochondrial

CTD Direct Evidence: marker/mechanism

NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950

G

SRY (sex determining region Y)-box 30

ClinVar Annotator: match by term: Male infertility

NCBI chr11:45,869,873...45,908,824
Ensembl chr11:45,871,137...45,908,821

G

spermatogenesis associated 16

NCBI chr 3:26,691,769...27,037,398
Ensembl chr 3:26,691,769...27,037,361

G

syntaxin 2

CTD Direct Evidence: marker/mechanism

NCBI chr 5:129,061,621...129,085,664
Ensembl chr 5:129,061,621...129,085,638

G

synaptonemal complex protein 3

ClinVar Annotator: match by term: Male infertility

NCBI chr10:88,295,449...88,309,098
Ensembl chr10:88,295,431...88,309,098

G

taste receptor, type 1, member 3

CTD Direct Evidence: marker/mechanism

NCBI chr 4:155,943,725...155,947,810
Ensembl chr 4:155,943,725...155,947,819

G

t-complex-associated testis expressed 1

NCBI chr17:45,834,360...45,853,605
Ensembl chr17:45,834,360...45,853,606

G

tudor domain containing 7

CTD Direct Evidence: marker/mechanism

NCBI chr 4:45,965,335...46,034,766
Ensembl chr 4:45,965,334...46,034,761

G

transformation related protein 53

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

TSC22 domain family, member 3

CTD Direct Evidence: marker/mechanism

NCBI chr X:139,440,277...139,501,257
Ensembl chr X:139,440,277...139,501,408

G

testis specific gene A8

NCBI chr X:82,530,280...82,531,530
Ensembl chr X:82,530,284...82,531,530

G

thioredoxin domain containing 8

protein:increased expression:sperm (human)

RGD

NCBI chr 4:57,984,029...58,009,126
Ensembl chr 4:57,984,027...58,009,124

G

X-ray repair complementing defective repair in Chinese hamster cells 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865

G

zinc finger, MYND-type containing 15

ClinVar Annotator: match by term: Male infertility

NCBI chr11:70,350,259...70,357,028
Ensembl chr11:70,350,259...70,357,028

male infertility due to acephalic spermatozoa

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

centrobin, centrosomal BRCA2 interacting protein

DNA:insertion:intron 10 (rat)

RGD

NCBI chr11:69,188,735...69,214,720
Ensembl chr11:69,190,313...69,214,601

male infertility due to globozoospermia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

heat shock protein 90, beta (Grp94), member 1

NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373

G

spermatogenesis associated 16

ClinVar Annotator: match by term: Globozoospermia

PMID:17847006 PMID:24265589 PMID:25741868 PMID:28492532 PMID:29065458

NCBI chr 3:26,691,769...27,037,398
Ensembl chr 3:26,691,769...27,037,361

Morbid Obesity and Spermatogenic Failure

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

centrosomal protein 19

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Morbid obesity and spermatogenic failure

OMIM
CTD
ClinVar

PMID:24268657 PMID:25741868 PMID:28492532

NCBI chr16:31,918,618...31,926,875
Ensembl chr16:31,918,618...31,926,887

MORM Syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

inositol polyphosphate-5-phosphatase E

ClinVar Annotator: match by term: INPP5E-related condition | ClinVar Annotator: match by term: MORM syndrome
CTD Direct Evidence: marker/mechanism
DNA:nonsense mutation:exon:p.Q627X (c.1879C>T) (human)

OMIM
ClinVar
CTD
RGD

PMID:9536098 PMID:15786477 PMID:17576681 PMID:19668215 PMID:19668216 More...

NCBI chr 2:26,286,261...26,299,313
Ensembl chr 2:26,286,261...26,299,215

Multibacillary Leprosy

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

gamma-glutamyltransferase 1

protein:increased activity:blood:

RGD

NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034

G

histocompatibility 2, class II antigen E beta

DNA:polymorphism (human)

RGD

NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648

G

solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1

DNA:insertion/deletion:3' utr (human)

RGD

NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221

Neurosyphilis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-X-C motif chemokine ligand 15

treatment

NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926

G

neurofilament, light polypeptide

disease_progression

protein:increased expression:CSF (human)

RGD

NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544

G

triggering receptor expressed on myeloid cells 2

disease_progression

protein:increased expression:CSF (human)

RGD

NCBI chr17:48,653,429...48,659,304
Ensembl chr17:48,653,429...48,661,175

Nonseminomatous Germ Cell Tumor

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Braf transforming gene

ClinVar Annotator: match by term: Germ cell tumor, nonseminomatous

PMID:12068308 PMID:12198537 PMID:12447372 PMID:12460918 PMID:12460919 More...

NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397

oligoasthenoteratozoospermia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ArfGAP with FG repeats 1

NCBI chr 1:82,816,738...82,878,722
Ensembl chr 1:82,817,204...82,878,903

G

coiled-coil domain containing 157

NCBI chr11:4,091,123...4,110,999
Ensembl chr11:4,091,123...4,110,293

G

cilia and flagella associated protein 58

NCBI chr19:47,926,151...48,023,818
Ensembl chr19:47,926,114...48,023,826

G

cilia and flagella associated protein 61

NCBI chr 2:145,776,677...146,056,955
Ensembl chr 2:145,776,704...146,056,959

G

cilia and flagella associated protein 70

NCBI chr14:20,444,258...20,502,332
Ensembl chr14:20,444,261...20,502,294

G

MAX-like protein X

NCBI chr11:100,978,116...100,983,033
Ensembl chr11:100,978,103...100,983,033

G

POC1 centriolar protein B

NCBI chr10:98,942,918...99,033,936
Ensembl chr10:98,942,898...99,033,936

G

protein phosphatase 4, catalytic subunit

NCBI chr 7:126,385,038...126,391,729
Ensembl chr 7:126,385,038...126,391,668

G

spermatogenesis associated 20

NCBI chr11:94,369,730...94,376,136
Ensembl chr11:94,369,730...94,377,005

oligospermia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

branched chain ketoacid dehydrogenase kinase

DNA:missense mutation:cds:G369E (rat)

RGD

NCBI chr 7:127,503,245...127,508,836
Ensembl chr 7:127,503,254...127,509,393

G

bromodomain, testis-specific

susceptibility

DNA:SNP: :rs3088232(human)

RGD

NCBI chr 5:107,478,982...107,534,927
Ensembl chr 5:107,479,025...107,534,924

G

bromodomain and WD repeat domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:95,793,289...95,883,905
Ensembl chr16:95,793,292...95,883,726

G

BSCL2 lipid droplet biogenesis associated, seipin

CTD Direct Evidence: marker/mechanism

NCBI chr19:8,814,831...8,826,047
Ensembl chr19:8,814,831...8,826,047

G

CDC14 cell division cycle 14A

CTD Direct Evidence: marker/mechanism

NCBI chr 3:116,066,202...116,222,390
Ensembl chr 3:116,066,202...116,222,394

G

glycoprotein hormones, alpha subunit

CTD Direct Evidence: therapeutic

NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370

G

dicer 1, ribonuclease type III

CTD Direct Evidence: marker/mechanism

NCBI chr12:104,654,001...104,718,331
Ensembl chr12:104,654,001...104,718,211

G

estrogen receptor 1 (alpha)

CTD Direct Evidence: marker/mechanism

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

family with sequence similarity 83, member F

ClinVar Annotator: match by term: Oligozoospermia

NCBI chr15:80,555,829...80,584,626
Ensembl chr15:80,556,048...80,584,626

G

follicle stimulating hormone beta

CTD Direct Evidence: marker/mechanism

NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001

G

kinesin family member 3B

ClinVar Annotator: match by term: Oligospermia

NCBI chr 2:153,132,028...153,175,310
Ensembl chr 2:153,133,333...153,175,310

G

mutS homolog 4

ClinVar Annotator: match by term: Oligospermia

PMID:25741868 PMID:33448284

NCBI chr 3:153,562,783...153,611,495
Ensembl chr 3:153,562,786...153,611,775

G

nitric oxide synthase 3, endothelial cell

CTD Direct Evidence: marker/mechanism

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

nuclear receptor subfamily 0, group B, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr X:85,235,381...85,239,553
Ensembl chr X:85,235,370...85,239,553

G

piwi-like RNA-mediated gene silencing 4

CTD Direct Evidence: marker/mechanism

NCBI chr 9:14,613,072...14,651,968
Ensembl chr 9:14,607,526...14,652,036

G

poly(A)-specific ribonuclease (PARN)-like domain containing 1

ClinVar Annotator: match by term: Oligospermia

NCBI chr17:13,107,610...13,129,489
Ensembl chr17:13,107,616...13,129,117

G

TBC1 domain family, member 25

ClinVar Annotator: match by term: Oligospermia

NCBI chr X:8,020,709...8,042,420
Ensembl chr X:8,020,711...8,042,420

G

two pore channel 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:120,672,222...120,726,731
Ensembl chr 5:120,672,218...120,726,738

G

YTH domain containing 2

CTD Direct Evidence: therapeutic

NCBI chr18:44,961,521...45,022,782
Ensembl chr18:44,960,813...45,022,791

Oocyte Maturation Defect 1

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

poly(A) binding protein, cytoplasmic 1-like

ClinVar Annotator: match by term: Oocyte maturation defect 1

NCBI chr 2:163,866,685...163,892,458
Ensembl chr 2:163,867,370...163,892,458

G

zona pellucida glycoprotein 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 1 | ClinVar Annotator: match by term: Oocyte maturation defect 1

OMIM
CTD
ClinVar

PMID:24670168 PMID:25741868 PMID:30810869

NCBI chr19:10,891,660...10,897,965
Ensembl chr19:10,891,651...10,897,996

Oocyte Maturation Defect 2

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

protein associated with topoisomerase II homolog 2 (yeast)

ClinVar Annotator: match by term: Oocyte maturation defect 2

PMID:24033266 PMID:25741868 PMID:28965844 PMID:29661911 PMID:32552793

NCBI chr 2:121,950,589...122,016,670
Ensembl chr 2:121,950,589...122,016,670

Oocyte Maturation Defect 3

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

zona pellucida glycoprotein 1

ClinVar Annotator: match by term: Oocyte maturation defect 3

NCBI chr19:10,891,660...10,897,965
Ensembl chr19:10,891,651...10,897,996

G

zona pellucida glycoprotein 3

ClinVar Annotator: match by term: Oocyte maturation defect 3

PMID:25741868 PMID:28886344 PMID:30810869

NCBI chr 5:136,008,959...136,017,478
Ensembl chr 5:136,008,953...136,017,478

Oocyte Maturation Defect 4

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

protein associated with topoisomerase II homolog 2 (yeast)

ClinVar Annotator: match by term: Oocyte maturation defect 4

PMID:24033266 PMID:25741868 PMID:28965844 PMID:28965849 PMID:29661911 More...

NCBI chr 2:121,950,589...122,016,670
Ensembl chr 2:121,950,589...122,016,670

Oocyte Maturation Defect 5

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

WEE1 homolog 2 (S. pombe)

ClinVar Annotator: match by term: Oocyte maturation defect 5

PMID:29606300 PMID:30628060

NCBI chr 6:40,412,180...40,443,749
Ensembl chr 6:40,416,022...40,443,747

Oocyte/Zygote/Embryo Maturation Arrest 10

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

REC114 meiotic recombination protein

ClinVar Annotator: match by term: Oocyte maturation defect 10

NCBI chr 9:58,560,139...58,729,684
Ensembl chr 9:58,560,133...58,651,247

Oocyte/Zygote/Embryo Maturation Arrest 11

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

astacin like metalloendopeptidase

ClinVar Annotator: match by term: Oocyte maturation defect 11

NCBI chr 2:127,180,559...127,199,575
Ensembl chr 2:127,180,559...127,199,571

Oocyte/Zygote/Embryo Maturation Arrest 12

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

F-box protein 43

ClinVar Annotator: match by term: Oocyte maturation defect 12

PMID:34052850 PMID:34595750

NCBI chr15:36,150,206...36,170,086
Ensembl chr15:36,150,206...36,165,030

Oocyte/Zygote/Embryo Maturation Arrest 13

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

zinc finger protein 36, C3H type-like 2

ClinVar Annotator: match by term: Oocyte maturation defect 13

NCBI chr17:84,491,352...84,495,375
Ensembl chr17:84,491,359...84,495,375

Oocyte/Zygote/Embryo Maturation Arrest 14

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cell division cycle 20

ClinVar Annotator: match by term: Oocyte maturation defect 14

PMID:32666501 PMID:33683667 PMID:33898437 PMID:34218387

NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549

Oocyte/Zygote/Embryo Maturation Arrest 15

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

transducin-like enhancer of split 6

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Preimplantation embryonic lethality 1

OMIM
CTD
ClinVar

PMID:25741868 PMID:26537248 PMID:36271123

NCBI chr10:81,426,738...81,437,021
Ensembl chr10:81,426,738...81,436,907

Oocyte/Zygote/Embryo Maturation Arrest 16

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

peptidyl arginine deiminase, type VI

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Preimplantation embryonic lethality 2

OMIM
CTD
ClinVar

PMID:25741868 PMID:27545678 PMID:34987164

NCBI chr 4:140,454,666...140,469,954
Ensembl chr 4:140,454,666...140,469,954

Oocyte/Zygote/Embryo Maturation Arrest 17

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

karyopherin subunit alpha 7

ClinVar Annotator: match by term: Oocyte/zygote/embryo maturation arrest 17

PMID:25741868 PMID:28492532 PMID:29302074 PMID:36647821

NCBI chr 5:144,920,537...144,946,446
Ensembl chr 5:144,920,329...145,020,840

Oocyte/Zygote/Embryo Maturation Arrest 18

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

NLR family, pyrin domain containing 2

ClinVar Annotator: match by term: Oocyte/zygote/embryo maturation arrest 18

NCBI chr 7:5,301,546...5,354,034
Ensembl chr 7:5,301,546...5,354,034

Oocyte/Zygote/Embryo Maturation Arrest 19

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

NLR family, pyrin domain containing 5

ClinVar Annotator: match by term: Oocyte/zygote/embryo maturation arrest 19

PMID:30877238 PMID:35946397

NCBI chr 7:23,085,314...23,141,348
Ensembl chr 7:23,085,314...23,141,347

Oocyte/Zygote/Embryo Maturation Arrest 20

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Moloney sarcoma oncogene

ClinVar Annotator: match by term: Oocyte/zygote/embryo maturation arrest 20

PMID:34779126 PMID:34997960 PMID:35670744 PMID:36403623

NCBI chr 4:3,870,658...3,872,105
Ensembl chr 4:3,870,657...3,872,105

Oocyte/Zygote/Embryo Maturation Arrest 21

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

checkpoint kinase 1

ClinVar Annotator: match by term: Oocyte/zygote/embryo maturation arrest 21

PMID:25741914 PMID:33948904 PMID:33953335

NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361

Oocyte/Zygote/Embryo Maturation Arrest 6

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

zona pellucida glycoprotein 2

ClinVar Annotator: match by term: Oocyte maturation defect 6

PMID:25741868 PMID:28971300 PMID:29895852 PMID:30810869 PMID:35211729

NCBI chr 7:119,725,985...119,744,514
Ensembl chr 7:119,725,995...119,744,514

Oocyte/Zygote/Embryo Maturation Arrest 7

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

pannexin 1

ClinVar Annotator: match by term: Oocyte maturation defect 7

PMID:25741868 PMID:30918116

NCBI chr 9:14,917,081...14,956,774
Ensembl chr 9:14,913,424...14,956,774

Oocyte/Zygote/Embryo Maturation Arrest 8

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BTG anti-proliferation factor 4

ClinVar Annotator: match by term: Oocyte maturation defect 8

PMID:25741868 PMID:32502391 PMID:34647228

NCBI chr 9:51,013,486...51,031,224
Ensembl chr 9:50,972,201...51,031,175

Oocyte/Zygote/Embryo Maturation Arrest 9

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

thyroid hormone receptor interactor 13

ClinVar Annotator: match by term: Oocyte maturation defect 9

PMID:25741868 PMID:32473092

NCBI chr13:74,060,577...74,085,855
Ensembl chr13:74,059,466...74,085,903

Opitz GBBB syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

midline 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: OPITZ-G SYNDROME, TYPE I
OMIM:300000

OMIM
CTD
ClinVar
MouseDO

PMID:9354791 PMID:11030761 PMID:12545276 PMID:15121778 PMID:15558842 More...

NCBI chr X:168,468,178...168,773,692
Ensembl chr X:168,468,195...168,773,794

orchitis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-C motif chemokine ligand 2

protein:increased expression:testicle, fluid (rat)

RGD

NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279

G

C-C motif chemokine ligand 5

NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344

G

C-C motif chemokine receptor 5

severity

RGD

NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736

G

CD86 antigen

protein:increased expression:testis, macrophage (rat)

RGD

NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443

G

interleukin 6 receptor, alpha

protein:increased expression:male germ cell

RGD

NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503

G

platelet/endothelial cell adhesion molecule 1

protein:increased expression:testes, endothelial cells (rat)

RGD

NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454

Paucibacillary Leprosy

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

gamma-glutamyltransferase 1

protein:increased activity:blood:

RGD

NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034

penile benign neoplasm

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cyclin D1

protein:increased expression:nucleus

RGD

NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662

G

prostaglandin E synthase

protein:increased expression:penis, skin

RGD

NCBI chr 2:30,779,483...30,793,309
Ensembl chr 2:30,779,483...30,819,875

G

topoisomerase (DNA) II alpha

severity

RGD

NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015

penile disease

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATRX, chromatin remodeler

CTD Direct Evidence: marker/mechanism

NCBI chr X:104,841,221...104,972,978
Ensembl chr X:104,841,221...104,973,009

G

inositol polyphosphate-5-phosphatase E

CTD Direct Evidence: marker/mechanism

NCBI chr 2:26,286,261...26,299,313
Ensembl chr 2:26,286,261...26,299,215

G

pro-opiomelanocortin-alpha

CTD Direct Evidence: marker/mechanism

PMID:1358647 PMID:2825910 PMID:3033702

NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642

Penile Neoplasms

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Harvey rat sarcoma virus oncogene

CTD Direct Evidence: marker/mechanism

NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918

G

Kirsten rat sarcoma viral oncogene homolog

CTD Direct Evidence: marker/mechanism

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

CTD Direct Evidence: marker/mechanism

NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635

G

transformation related protein 53

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

Penis Agenesis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

steroid 5 alpha-reductase 2

ClinVar Annotator: match by term: Micropenis

PMID:10898110 PMID:12843198 PMID:14594182 PMID:15064320 PMID:19342739 More...

NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911

G

WAP four-disulfide core domain 17

ClinVar Annotator: match by term: Micropenis

PMID:11297579 PMID:25741868

NCBI chr11:83,594,882...83,597,095
Ensembl chr11:83,594,817...83,597,094

Peyronie's disease

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

histone deacetylase 2

RGD

NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885

G

transforming growth factor, beta 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502

phimosis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

integrin alpha 3

ClinVar Annotator: match by term: Phimosis

NCBI chr11:94,935,301...94,967,637
Ensembl chr11:94,935,300...94,967,627

priapism

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

B cell leukemia/lymphoma 2

protein:increased expression:erectile tissue (rat)

RGD

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

coagulation factor XIII, A1 subunit

susceptibility

associated with sickle cell anemia;DNA:SNPs::multiple(human)

RGD

NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220

G

transformed mouse 3T3 cell double minute 2

protein:increased expression:corpus cavernosum

RGD

NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663

prostate adenocarcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adiponectin, C1Q and collagen domain containing

susceptibility

DNA:SNPs, haplotypes:5' utr, introns, exon:multiple

RGD

NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778

G

adiponectin receptor 1

susceptibility

DNA:SNPs, haplotype:intron, exon: (rs12733285, rs7539452) (human)

RGD

NCBI chr 1:134,343,116...134,361,089
Ensembl chr 1:134,343,116...134,361,089

G

thymoma viral proto-oncogene 1

treatment

ClinVar Annotator: match by term: Adenocarcinoma of prostate

PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 More...

NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318

G

thymoma viral proto-oncogene 2

treatment

RGD

NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251

G

thymoma viral proto-oncogene 3

treatment

RGD

NCBI chr 1:176,847,642...177,091,688
Ensembl chr 1:176,847,639...177,085,769

G

androgen receptor

treatment

RGD

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

bridging integrator 1

RGD

NCBI chr18:32,509,671...32,568,793
Ensembl chr18:32,510,283...32,568,790

G

baculoviral IAP repeat-containing 6

ameliorates

mRNA:increased expression:prostate gland (human)

NCBI chr17:74,835,247...75,010,351
Ensembl chr17:74,835,290...75,010,351

G

baculoviral IAP repeat-containing 7

exacerbates

mRNALincreased expression:prostate gland (human)

NCBI chr 2:180,570,402...180,575,803
Ensembl chr 2:180,570,816...180,575,803

G

Braf transforming gene

ClinVar Annotator: match by term: Adenocarcinoma of prostate | ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:2493360 PMID:12068308 PMID:12198537 PMID:12460918 PMID:12460919 More...

NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397

G

calcium/calmodulin-dependent protein kinase II inhibitor 1

treatment

RGD

NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434

G

cyclin B1

severity

RGD

NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078

G

cyclin E2

RGD

NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779

G

CD9 antigen

disease_progression

DNA, mRNA:deletion, point mutation, decreased expression:prostate gland

RGD

NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754

G

cyclin dependent kinase inhibitor 2A

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:25741868 PMID:26619011 PMID:28492532

NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890

G

chromodomain helicase DNA binding protein 4

mRNA:decreased expression:prostate gland (human)

NCBI chr 6:125,073,144...125,107,554
Ensembl chr 6:125,072,944...125,107,554

G

conserved helix-loop-helix ubiquitous kinase

treatment

RGD

NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919

G

clusterin

treatment

RGD

NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996

G

CCR4-NOT transcription complex, subunit 9

ClinVar Annotator: match by term: Prostate adenocarcinoma

NCBI chr 1:74,545,192...74,570,001
Ensembl chr 1:74,545,217...74,570,001

G

cAMP responsive element binding protein 3-like 4

RGD

PMID:17270658 PMID:11830526

RGD:13504714, RGD:13504715

NCBI chr 3:90,144,805...90,161,387
Ensembl chr 3:90,144,807...90,150,819

G

catenin beta 1

ClinVar Annotator: match by term: Adenocarcinoma of prostate | ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 More...

NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573

G

DNA methyltransferase 1

mRNA,protein:increased expression:prostate gland:

RGD

NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184

G

DNA methyltransferase 3A

mRNA:increased expression:prostate gland:

RGD

NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443

G

DNA methyltransferase 3B

mRNA,protein:increased expression:prostate gland:

RGD

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

erb-b2 receptor tyrosine kinase 2

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:23220880 PMID:26619011

NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542

G

fibroblast growth factor 2

disease_progression

RGD

NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257

G

fibroblast growth factor receptor 1

RGD

PMID:23576558 PMID:18068632

RGD:13504748, RGD:2298702

NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734

G

growth factor receptor bound protein 2

RGD

NCBI chr11:115,534,871...115,599,423
Ensembl chr11:115,534,871...115,599,423

G

Harvey rat sarcoma virus oncogene

ClinVar Annotator: match by term: Adenocarcinoma of prostate | ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:1904555 PMID:3510078 PMID:11150980 PMID:16155195 PMID:16170316 More...

NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918

G

isocitrate dehydrogenase 1 (NADP+), soluble

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 More...

NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659

G

insulin-like growth factor I receptor

treatment
disease_progression

RGD

PMID:26452103 PMID:8692980 PMID:25442907 PMID:25862373

RGD:13504753, RGD:13504771, RGD:13504768, RGD:13504767

NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416

G

inhibitor of kappaB kinase beta

treatment

RGD

NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605

G

integrin linked kinase

disease_progression

protein:increased expression:tumor: high-grade tumors versus adjacent BHP (P<0.001), BHP from cancer-free patients (P<0.002), or low-grade tumors (P=0.003), also associated with proliferative index (P=0.001), but inversely related to 5-year survival (p=0.004) (human)

RGD

NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132

G

insulin receptor

treatment

RGD

NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617

G

jun proto-oncogene

disease_progression

RGD

NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459

G

kinase insert domain protein receptor

protein:increased expression:prostate gland

RGD

PMID:17491265 PMID:20808233

RGD:2291925, RGD:5684541

NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118

G

leucine rich repeat containing 56

ClinVar Annotator: match by term: Adenocarcinoma of prostate

PMID:1904555 PMID:3510078 PMID:11150980 PMID:16155195 PMID:16170316 More...

NCBI chr 7:140,774,024...140,789,968
Ensembl chr 7:140,774,070...140,789,968

G

mitogen-activated protein kinase kinase 1

disease_progression

metastasis
ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:23444215 PMID:25157968 PMID:26619011 PMID:12688676

NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913

G

mitogen-activated protein kinase 1

treatment

RGD

PMID:28492138 PMID:22139534

RGD:13504818, RGD:13504820

NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317

G

mediator complex subunit 12

ClinVar Annotator: match by term: Prostate adenocarcinoma

NCBI chr X:100,317,697...100,342,540
Ensembl chr X:100,317,636...100,341,071

G

myelocytomatosis oncogene

human gene in mouse model

RGD

PMID:14522256 PMID:20195545

RGD:7207413, RGD:7207781

NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223

G

nuclear receptor coactivator 2

ameliorates

human cells in mouse model

RGD

NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307

G

nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha

severity

protein:increased serine phosphorylation

RGD

PMID:15712212 PMID:15073126

RGD:2298768, RGD:13506768

NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432

G

peptidylglycine alpha-amidating monooxygenase

mRNA:increased expression:prostate gland (human)

RGD

NCBI chr 1:97,748,816...98,023,578
Ensembl chr 1:97,722,839...98,023,371

G

platelet derived growth factor, alpha

protein:increased expression:prostate

RGD

NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125

G

platelet derived growth factor receptor, alpha polypeptide

protein:increased expression:prostate

RGD

NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876

G

3-phosphoinositide dependent protein kinase 1

treatment

RGD

NCBI chr17:24,292,654...24,370,957
Ensembl chr17:24,292,654...24,369,898

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

ClinVar Annotator: match by term: Adenocarcinoma of prostate | ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 More...

NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta

treatment

RGD

NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674

G

protein phosphatase 2, regulatory subunit A, alpha

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:25741868 PMID:26168268 PMID:26619011 PMID:28492532 PMID:31687265 More...

NCBI chr17:21,165,716...21,186,167
Ensembl chr17:21,165,573...21,186,178

G

protein kinase C, theta

mRNA:increased expression:prostate

RGD

NCBI chr 2:11,176,922...11,306,033
Ensembl chr 2:11,176,919...11,306,033

G

phosphatase and tensin homolog

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:1945792 PMID:9467011 PMID:9915974 PMID:10866302 PMID:11051241 More...

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

v-raf-leukemia viral oncogene 1

treatment

RGD

NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596

G

v-rel reticuloendotheliosis viral oncogene homolog A (avian)

disease_progression

protein:increased expression:prostate gland

RGD

PMID:15712212 PMID:15073126

RGD:2298768, RGD:13506768

NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158

G

SMAD family member 4

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:6604412 PMID:12116240 PMID:15031030 PMID:26619011

NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851

G

speckle-type BTB/POZ protein

ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:23265383 PMID:26619011

NCBI chr11:95,304,909...95,384,236
Ensembl chr11:95,304,906...95,384,232

G

signal transducer and activator of transcription 1

disease_progression

protein:increased activity:prostate

RGD

NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024

G

telomerase reverse transcriptase

treatment

RGD

NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962

G

transmembrane protease, serine 2

disease_progression

protein:increased expression, altered localization:prostate gland

RGD

NCBI chr16:97,365,882...97,460,741
Ensembl chr16:97,365,882...97,412,395

G

transformation related protein 53

ClinVar Annotator: match by term: Adenocarcinoma of prostate | ClinVar Annotator: match by term: Prostate adenocarcinoma

PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1591732 More...

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

exportin 1

ClinVar Annotator: match by term: Prostate adenocarcinoma

NCBI chr11:23,205,768...23,248,250
Ensembl chr11:23,206,055...23,248,249

prostate calculus

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

lactotransferrin

RGD

NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835

prostate cancer

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP-binding cassette, sub-family A member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:24,570,997...24,629,178
Ensembl chr17:24,570,924...24,629,175

G

ATP-binding cassette, sub-family C member 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631

G

ATP-binding cassette, sub-family E member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:80,410,071...80,438,369
Ensembl chr 8:80,410,091...80,438,369

G

ATP-binding cassette, sub-family F member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr16:20,367,309...20,380,357
Ensembl chr16:20,367,327...20,380,129

G

ATP binding cassette subfamily G member 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:44,184,485...44,199,953
Ensembl chr 9:44,184,485...44,199,912

G

ankyrin repeat and BTB domain containing 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:85,220,835...85,496,156
Ensembl chr10:85,222,678...85,496,156

G

acid phosphatase 3

disease_progression

OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959

PMID:16024648 PMID:17991541

RGD:2301055, RGD:2301054

NCBI chr 9:104,165,439...104,214,921
Ensembl chr 9:104,165,450...104,214,947

G

acrosomal vesicle protein 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:36,604,550...36,610,139
Ensembl chr 9:36,604,516...36,610,139

G

acyl-CoA synthetase long-chain family member 3

disease_progression
treatment

RGD

PMID:27270436 PMID:27270436

RGD:13831303, RGD:13831303

NCBI chr 1:78,635,600...78,685,462
Ensembl chr 1:78,635,542...78,685,460

G

ADAM metallopeptidase with thrombospondin type 1 motif 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:89,821,700...90,031,521
Ensembl chr 5:89,824,946...90,031,193

G

adenosine deaminase, tRNA-specific 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:112,685,552...112,718,938
Ensembl chr 8:112,693,540...112,718,934

G

adhesion regulating molecule 1 26S proteasome ubiquitin receptor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:179,813,381...179,818,076
Ensembl chr 2:179,813,278...179,818,079

G

adenylosuccinate lyase

severity

protein:increased activity:tumor (human)

RGD

NCBI chr15:80,832,691...80,855,148
Ensembl chr15:80,832,691...80,855,147

G

alpha fetoprotein

protein:increased expression:serum

RGD

NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766

G

ArfGAP with GTPase domain, ankyrin repeat and PH domain 2

protein:increased expression:prostate

RGD

NCBI chr10:126,911,154...126,929,039
Ensembl chr10:126,911,153...126,929,038

G

ATP/GTP binding protein-like 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:110,254,823...111,521,521
Ensembl chr 4:110,254,858...111,521,521

G

advanced glycosylation end product-specific receptor

mRNA:increased expression:prostate gland (human)

RGD

NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910

G

1-acylglycerol-3-phosphate O-acyltransferase 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:26,483,069...26,494,429
Ensembl chr 2:26,483,069...26,494,429

G

aryl-hydrocarbon receptor repressor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:74,359,237...74,440,450
Ensembl chr13:74,359,237...74,440,450

G

apoptosis-inducing factor, mitochondrion-associated 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440

G

A kinase anchor protein 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:88,721,618...88,755,426
Ensembl chr11:88,721,618...88,755,412

G

aldo-keto reductase family 1, member C18

disease_progression

protein:increased expression:epithelium:
ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:24571686

NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653

G

thymoma viral proto-oncogene 1

severity

DNA:SNPs:5' utr, intron: (rs1130214, rs2494738) (human)

RGD

NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318

G

thymoma viral proto-oncogene 2

DNA:SNP: :rs7254617 (human)

RGD

NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251

G

thymoma viral proto-oncogene 3

severity

DNA:SNP: :rs2125230 (human)

RGD

NCBI chr 1:176,847,642...177,091,688
Ensembl chr 1:176,847,639...177,085,769

G

aldhehyde dehydrogenase family 5, subfamily A1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:25,091,562...25,121,740
Ensembl chr13:25,091,562...25,121,644

G

aldehyde dehydrogenase 9, subfamily A1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:167,177,560...167,196,100
Ensembl chr 1:167,177,560...167,196,101

G

arachidonate 12-lipoxygenase

disease_progression

mRNA:increased expression:prostate gland

RGD

NCBI chr11:70,132,283...70,146,206
Ensembl chr11:70,132,283...70,146,179

G

S-adenosylmethionine decarboxylase 1

protein:increased expression:prostate

RGD

NCBI chr10:40,163,454...40,178,184
Ensembl chr10:40,163,454...40,178,184

G

angiogenin, ribonuclease, RNase A family, 5

RGD

PMID:11948474 PMID:19276260

RGD:2325707, RGD:2325697

NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466

G

ankyrin repeat domain 12

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:66,272,698...66,386,242
Ensembl chr17:66,272,693...66,384,084

G

anoctamin 9

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:140,681,125...140,697,719
Ensembl chr 7:140,681,125...140,697,719

G

annexin A7

protein:decreased expression:prostate gland

RGD

NCBI chr14:20,505,344...20,530,009
Ensembl chr14:20,505,328...20,530,201

G

adaptor-related protein complex 3, beta 1 subunit

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr13:94,492,332...94,702,838
Ensembl chr13:94,495,468...94,702,825

G

APC, WNT signaling pathway regulator

disease_progression

OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959

NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605

G

androgen receptor

treatment
no_association

mRNA:decreased expression:prostate gland
ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer

ClinVar
OMIM
RGD

PMID:1307250 PMID:1631125 PMID:1779964 PMID:2594783 PMID:7671849 More...

RGD:2293865, RGD:10043311, RGD:10043311, RGD:1578687, RGD:1578686

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:38,105,676...38,132,583
Ensembl chr18:38,105,681...38,132,022

G

Rho GTPase activating protein 20

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:51,676,651...51,765,158
Ensembl chr 9:51,676,637...51,765,156

G

Rho guanine nucleotide exchange factor 15

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:68,819,726...68,847,760
Ensembl chr11:68,833,981...68,848,306

G

Rho guanine nucleotide exchange factor 25

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:127,018,390...127,025,952
Ensembl chr10:127,018,394...127,025,952

G

Rho guanine nucleotide exchange factor 40

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:52,222,158...52,243,704
Ensembl chr14:52,222,176...52,243,708

G

armadillo repeat containing 12

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:28,749,835...28,757,949
Ensembl chr17:28,749,780...28,758,084

G

cyclic AMP-regulated phosphoprotein, 21

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:111,894,159...112,065,356
Ensembl chr 9:111,894,159...112,065,006

G

acid-sensing ion channel 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:80,770,989...81,859,222
Ensembl chr11:80,770,995...81,859,283

G

aspartic peptidase, retroviral-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:86,605,216...86,606,692
Ensembl chr 6:86,605,146...86,606,692

G

activating transcription factor 3

treatment
disease_progression

RGD

PMID:26944919 PMID:26522727 PMID:26522727

RGD:13506816, RGD:13506817, RGD:13506817

NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236

G

autophagy related 13

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:91,504,957...91,540,947
Ensembl chr 2:91,504,963...91,540,921

G

atlastin GTPase 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:7,471,178...7,515,974
Ensembl chr19:7,471,405...7,517,039

G

ataxia telangiectasia mutated

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23807571 PMID:25614872 PMID:25741868 PMID:28492532

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

ATPase, Na+/K+ transporting, alpha 1 polypeptide

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000

G

ATPase, Ca++ transporting, plasma membrane 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:133,630,416...133,728,755
Ensembl chr 1:133,627,195...133,728,779

G

ATPase, H+ transporting, lysosomal V0 subunit A1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:100,899,262...100,954,545
Ensembl chr11:100,900,278...100,954,545

G

alpha-2-glycoprotein 1, zinc

protein:increased expression:serum

RGD

NCBI chr 5:137,979,783...137,988,495
Ensembl chr 5:137,979,782...137,988,495

G

UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:67,395,528...67,953,226
Ensembl chr 2:67,396,215...67,953,033

G

BRISC and BRCA1 A complex member 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:31,855,394...32,242,083
Ensembl chr 5:31,855,028...32,242,306

G

BCL2-associated athanogene 1

DNA, protein:amplification, increased expression:prostate gland

RGD

NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294

G

BCL2-associated X protein

RGD

PMID:17575222 PMID:18444130

RGD:1643354, RGD:2292907

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

B cell leukemia/lymphoma 2

disease_progression

RGD

PMID:17850375 PMID:16984224 PMID:18084610

RGD:2293017, RGD:2292512, RGD:2293015

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

BEN domain containing 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:111,271,993...111,317,495
Ensembl chr 4:111,272,203...111,317,495

G

bone gamma carboxyglutamate protein

RGD

NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771

G

BRD4 interacting chromatin remodeling complex associated protein like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:47,109,046...47,201,329
Ensembl chr17:47,109,046...47,169,408

G

BCL2-interacting killer

RGD

NCBI chr15:83,410,992...83,428,836
Ensembl chr15:83,411,063...83,428,835

G

baculoviral IAP repeat-containing 5

severity

mRNA:increased expression:prostate gland

RGD

PMID:18336887 PMID:17804712

RGD:2293091, RGD:2293100

NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569

G

bridge-like lipid transfer protein family member 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:78,152,476...78,181,451
Ensembl chr11:78,152,578...78,181,449

G

bone morphogenetic protein 2

susceptibility
disease_progression

DNA:amplification:prostate gland

RGD

PMID:17656261 PMID:15042598

RGD:2289030, RGD:2299981

NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805

G

bone morphogenetic protein 6

protein:increased expression:prostate

RGD

NCBI chr13:38,529,098...38,684,283
Ensembl chr13:38,529,083...38,684,278

G

bone morphogenetic protein 7

susceptibility

DNA:amplification:prostate gland
protein:decreased expression:prostate gland

RGD

PMID:17656261 PMID:15861517

RGD:2289030, RGD:2289031

NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114

G

BCL2 interacting protein 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:29,114,248...29,134,310
Ensembl chr17:29,115,366...29,134,298

G

breast cancer 1, early onset

no_association
severity

mutations in Brca1 and Brca2 do not contribute to prostate cancer in Jewish men
ClinVar Annotator: match by term: Malignant tumor of prostate
mRNA, protein:splice variant
DNA:deletions: :185_186del,1294_1333del,3875_3878del

PMID:12491487 PMID:15235020 PMID:15447980 PMID:16267036 PMID:17924331 More...

RGD:734657, RGD:126925963, RGD:2289042

NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781

G

breast cancer 2, early onset

disease_progression
susceptibility

DNA:mutation
ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer
protein:decreased expression:prostate gland

OMIM
ClinVar
RGD

PMID:1 PMID:251866 PMID:278235 PMID:2200631 PMID:8524414 More...

RGD:2289042, RGD:2289050

NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794

G

BRF2, RNA polymerase III transcription initiation factor 50kDa subunit

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:27,613,367...27,618,743
Ensembl chr 8:27,613,392...27,618,708

G

BTB domain containing 16

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:130,375,799...130,427,631
Ensembl chr 7:130,375,799...130,427,629

G

C2 calcium dependent domain containing 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:59,036,275...59,134,283
Ensembl chr 1:59,036,275...59,134,059

G

complement component 3a receptor 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120

G

calcineurin binding protein 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:75,481,944...75,600,194
Ensembl chr10:75,481,946...75,600,175

G

calcium channel, voltage-dependent, L type, alpha 1D subunit

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:29,761,898...30,213,113
Ensembl chr14:29,761,896...30,213,412

G

cell adhesion molecule 1

DNA:hypermethylation:promoter

RGD

NCBI chr 9:47,441,468...47,773,578
Ensembl chr 9:47,441,471...47,769,413

G

cell adhesion molecule 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:173,161,825...173,195,214
Ensembl chr 1:173,160,825...173,195,261

G

Ca2+-dependent secretion activator

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:9,646,424...10,097,203
Ensembl chr14:9,646,684...10,097,200

G

calcium/calmodulin-dependent protein kinase II inhibitor 1

disease_progression

mRNA, protein:decreased expression:prostate gland

RGD

PMID:31762801 PMID:25003983

RGD:18337271, RGD:18337280

NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434

G

cullin associated and neddylation disassociated 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:119,034,717...119,075,960
Ensembl chr10:119,035,160...119,075,960

G

calpain 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:142,585,232...142,610,408
Ensembl chr X:142,585,227...142,610,410

G

calcium/calmodulin dependent serine protein kinase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:13,383,319...13,713,020
Ensembl chr X:13,383,319...13,717,606

G

caspase 1

protein:decreased expression:prostate gland

RGD

NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290

G

caspase 3

RGD

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

calcium-sensing receptor

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr16:36,310,947...36,382,605
Ensembl chr16:36,314,058...36,382,503

G

caveolin 1, caveolae protein

disease_progression

protein:increased expression:serum
DNA:hypermethylation:promoter

RGD

PMID:14506154 PMID:15948133 PMID:11170154

RGD:2289109, RGD:2289104, RGD:2289112

NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451

G

chromobox 1

protein:increased expression:prostate:

RGD

NCBI chr11:96,679,506...96,699,808
Ensembl chr11:96,679,953...96,699,466

G

chromobox 3

protein:increased expression:prostate:

RGD

NCBI chr 6:51,447,596...51,460,684
Ensembl chr 6:51,447,340...51,460,684

G

chromobox 5

protein:increased expression:prostate:

RGD

NCBI chr15:103,099,973...103,148,337
Ensembl chr15:103,099,971...103,148,243

G

chromobox 7

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320

G

chibby family member 1, beta catenin antagonist

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:79,543,437...79,551,861
Ensembl chr15:79,543,400...79,551,861

G

coiled-coil domain containing 171

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:83,443,649...83,784,380
Ensembl chr 4:83,443,782...83,782,907

G

cyclin A1

disease_progression

human gene, mouse model

RGD

NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922

G

cyclin B1

RGD

NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078

G

cyclin D1

RGD

NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662

G

cyclin D2

disease_progression

DNA, mRNA:hyperymethylation, decreased expression:promoter, prostate gland

RGD

PMID:17016690 PMID:16322291

RGD:2289151, RGD:151665170

NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156

G

cyclin D3

disease_progression

RGD

NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616

G

CD2 antigen

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:101,183,224...101,195,255
Ensembl chr 3:101,183,215...101,195,255

G

CD244 molecule A

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:171,386,761...171,412,884
Ensembl chr 1:171,386,761...171,437,314

G

CD2-associated protein

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:43,059,857...43,187,593
Ensembl chr17:43,103,842...43,187,556

G

CD44 antigen

disease_progression

DNA:hypermethylation:prostate gland

RGD

NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010

G

CD55 molecule, decay accelerating factor for complement

RGD

PMID:18288643 PMID:16533428

RGD:2326167, RGD:2326168

NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481

G

CD82 antigen

disease_progression

protein:decreased expression:prostate gland

RGD

NCBI chr 2:93,249,447...93,293,295
Ensembl chr 2:93,249,456...93,293,485

G

cell division cycle 25A

RGD

NCBI chr 9:109,704,545...109,722,963
Ensembl chr 9:109,704,647...109,722,963

G

cell division cycle 25B

protein:increased expression:prostate gland

RGD

NCBI chr 2:131,028,356...131,040,431
Ensembl chr 2:131,028,869...131,040,417

G

cell division cycle 25C

mRNA, protein:alternative form, increased expression, increased activity:prostate gland

RGD

PMID:16000564 PMID:17460776 PMID:12896904 PMID:16140946

RGD:2776427, RGD:2756028, RGD:4105453, RGD:2774210

NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586

G

cadherin 1

susceptibility
disease_progression

DNA:polymorphism:promoter:-160C>A (human)
ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer | ClinVar Annotator: match by term: Prostate cancer, susceptibility to
protein:decreased expression:prostate gland

OMIM
ClinVar
RGD

PMID:1722187 PMID:2403327 PMID:2449335 PMID:8075649 PMID:9537325 More...

RGD:2289493, RGD:2289479, RGD:2289487

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cadherin 13

disease_progression

DNA:hypermethylation:promoter

RGD

NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660

G

cadherin 3

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr 8:107,237,484...107,283,543
Ensembl chr 8:107,237,523...107,283,929

G

cyclin dependent kinase 13

mRNA,protein:increased expression:prostate:

RGD

NCBI chr13:17,885,309...17,979,960
Ensembl chr13:17,884,900...17,979,682

G

cyclin dependent kinase 2

RGD

NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900

G

cyclin dependent kinase 4

RGD

NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789

G

cyclin dependent kinase inhibitor 1A

RGD

NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701

G

cyclin dependent kinase inhibitor 2A

disease_progression

DNA:hypermethylation:promoter
protein:increased expression:prostate gland

RGD

PMID:16483154 PMID:16799475

RGD:2289685, RGD:2289684

NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890

G

CDKN2A interacting protein

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:48,162,379...48,166,966
Ensembl chr 8:48,162,379...48,166,967

G

cyclin dependent kinase inhibitor 2B

disease_progression

protein:increased expression:prostate gland

RGD

NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276

G

ceramide synthase 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:66,382,864...66,473,440
Ensembl chr 7:66,393,252...66,473,439

G

cilia and flagella associated protein 43

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:47,723,706...47,825,893
Ensembl chr19:47,725,296...47,907,726

G

cilia and flagella associated protein 65

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:74,941,230...74,974,785
Ensembl chr 1:74,941,230...74,974,758

G

ChaC, cation transport regulator 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:119,181,723...119,184,807
Ensembl chr 2:119,181,710...119,184,862

G

chromatin assembly factor 1, subunit B

disease_progression

protein:increased expression:prostate:
ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:19309489

NCBI chr16:93,680,801...93,703,003
Ensembl chr16:93,680,789...93,703,003

G

chromodomain helicase DNA binding protein 1

DNA:deletions: :

RGD

NCBI chr17:15,925,229...15,992,874
Ensembl chr17:15,925,229...15,992,872

G

chromodomain helicase DNA binding protein 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:73,076,400...73,191,494
Ensembl chr 7:73,076,386...73,191,578

G

checkpoint kinase 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361

G

checkpoint kinase 2

susceptibility

DNA:mutations: :multiple
ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer | ClinVar Annotator: match by term: Prostate cancer, susceptibility to

ClinVar
OMIM
RGD

PMID:3313277 PMID:9536098 PMID:10617473 PMID:11053450 PMID:11298456 More...

RGD:2289707, RGD:734756

NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011

G

chromogranin A

susceptibility

DNA:missense mutation:cds:p.E264D (human)

RGD

NCBI chr12:102,521,200...102,531,286
Ensembl chr12:102,521,228...102,531,287

G

chromogranin B

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:132,623,562...132,636,999
Ensembl chr 2:132,623,198...132,636,999

G

cysteine-rich hydrophobic domain 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:102,400,009...102,452,698
Ensembl chr X:102,400,082...102,439,698

G

conserved helix-loop-helix ubiquitous kinase

protein:increased serine phosphorylation:prostate gland

RGD

NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919

G

cytoskeleton associated protein 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:91,357,092...91,451,024
Ensembl chr 2:91,357,107...91,451,009

G

CLPTM1-like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:73,752,121...73,768,758
Ensembl chr13:73,752,125...73,768,724

G

cyclic nucleotide gated channel alpha 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:72,761,039...72,800,095
Ensembl chr 5:72,761,039...72,801,618

G

ciliary neurotrophic factor receptor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:41,657,498...41,697,091
Ensembl chr 4:41,657,498...41,697,089

G

component of oligomeric golgi complex 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:113,540,004...113,560,157
Ensembl chr11:113,539,995...113,557,880

G

collagen, type I, alpha 1

ClinVar Annotator: match by term: Prostate cancer

PMID:17211858 PMID:23265383 PMID:25741868 PMID:28492532

NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868

G

collagen, type XXIV, alpha 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:144,998,233...145,257,768
Ensembl chr 3:144,998,233...145,257,766

G

collagen, type V, alpha 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526

G

catechol-O-methyltransferase

no_association
susceptibility
disease_progression

DNA:polymorphism: :p.V158M
DNA:polymorphism:cds

RGD

PMID:17507624 PMID:16492910 PMID:16126332

RGD:2289719, RGD:2289718, RGD:2289720

NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602

G

COP9 signalosome subunit 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:138,159,364...138,162,246
Ensembl chr 5:138,159,333...138,162,908

G

corin, serine peptidase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:72,457,291...72,661,884
Ensembl chr 5:72,457,368...72,661,816

G

carboxypeptidase A6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:10,366,016...10,790,277
Ensembl chr 1:10,394,945...10,790,170

G

cleavage and polyadenylation specific factor 7

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:10,502,594...10,525,099
Ensembl chr19:10,502,630...10,525,017

G

CREB regulated transcription coactivator 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:80,236,375...80,339,443
Ensembl chr 7:80,236,375...80,338,625

G

cone-rod homeobox

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:15,599,872...15,613,880
Ensembl chr 7:15,599,872...15,613,893

G

CUB and Sushi multiple domains 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:127,880,310...128,461,459
Ensembl chr 4:127,881,650...128,461,449

G

catenin alpha 1

disease_progression

protein:decreased expression:prostate gland

RGD

PMID:17639504 PMID:16334164

RGD:2289791, RGD:2289793

NCBI chr18:35,251,955...35,387,829
Ensembl chr18:35,251,912...35,387,832

G

catenin beta 1

ClinVar Annotator: match by term: Malignant tumor of prostate
OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959

ClinVar
MouseDO
RGD

PMID:9927029 PMID:23265383 PMID:25157968 PMID:26619011 PMID:27067790

NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573

G

cathepsin E

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:131,566,052...131,603,245
Ensembl chr 1:131,566,044...131,603,243

G

cortactin binding protein 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:18,366,470...18,515,216
Ensembl chr 6:18,366,477...18,514,842

G

C-X-C motif chemokine ligand 12

ameliorates

human cells in mouse model

RGD

NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328

G

C-X-C motif chemokine receptor 4

ameliorates

human cells in mouse model

RGD

NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030

G

cytochrome P450, family 17, subfamily a, polypeptide 1

RGD

NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611

G

cytochrome P450, family 1, subfamily a, polypeptide 1

RGD

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

cysteinyl leukotriene receptor 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:105,617,952...105,647,329
Ensembl chr X:105,617,952...105,647,285

G

RIKEN cDNA D630003M21 gene

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:158,024,453...158,071,837
Ensembl chr 2:158,024,453...158,071,142

G

disabled 2 interacting protein

treatment

human cells in mouse model

RGD

NCBI chr 2:35,448,285...35,621,006
Ensembl chr 2:35,448,278...35,621,006

G

Fas death domain-associated protein

disease_progression

RGD

NCBI chr17:34,128,379...34,134,564
Ensembl chr17:34,128,388...34,134,564

G

dachsous cadherin related 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:83,032,589...83,270,336
Ensembl chr 3:83,035,255...83,264,516

G

DExD box helicase 50

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:62,451,571...62,487,260
Ensembl chr10:62,451,674...62,486,997

G

DExD/H box helicase 60

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:62,381,155...62,491,278
Ensembl chr 8:62,381,121...62,491,278

G

DEAF1, transcription factor

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr 7:140,877,089...140,918,758
Ensembl chr 7:140,877,093...140,907,603

G

diacylglycerol O-acyltransferase 2-like 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:99,568,444...99,589,714
Ensembl chr X:99,568,444...99,589,750

G

dihydrodiol dehydrogenase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:45,122,380...45,138,312
Ensembl chr 7:45,120,411...45,138,229

G

DExH-box helicase 29

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:113,063,976...113,105,968
Ensembl chr13:113,063,988...113,105,966

G

DIS3 like exosome 3'-5' exoribonuclease

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:64,214,038...64,248,707
Ensembl chr 9:64,214,038...64,248,570

G

dihydrolipoamide S-acetyltransferase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:50,545,933...50,571,080
Ensembl chr 9:50,545,933...50,571,080

G

delta like canonical Notch ligand 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:15,587,616...15,597,275
Ensembl chr17:15,587,616...15,597,134

G

dynein, axonemal, heavy chain 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:119,520,555...119,694,520
Ensembl chr 7:119,521,894...119,694,503

G

dynein, axonemal, heavy chain 8

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:30,845,909...31,094,736
Ensembl chr17:30,843,328...31,096,339

G

dynein, axonemal, heavy chain 9

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:65,722,150...66,059,379
Ensembl chr11:65,722,108...66,059,377

G

DnaJ heat shock protein family (Hsp40) member C3

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:25466870 PMID:28940199

NCBI chr14:119,175,371...119,219,114
Ensembl chr14:119,175,388...119,219,109

G

DnaJ heat shock protein family (Hsp40) member C6

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:22563501 PMID:23211418 PMID:26528954 PMID:28492532

NCBI chr 4:101,353,751...101,499,996
Ensembl chr 4:101,353,828...101,499,996

G

DNA methyltransferase 1

disease_progression

protein:increased expression:nucleus:

RGD

NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184

G

dedicator of cyto-kinesis 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:34,176,815...34,674,732
Ensembl chr11:34,176,815...34,674,719

G

dedicator of cytokinesis 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:67,989,377...68,171,021
Ensembl chr14:67,989,584...68,170,891

G

diphthamine biosynethesis 7

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:24,852,183...24,862,198
Ensembl chr 2:24,852,412...24,862,175

G

developmental pluripotency associated 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr16:48,104,098...48,114,655
Ensembl chr16:48,104,096...48,114,600

G

dihydropyrimidine dehydrogenase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573

G

DS cell adhesion molecule like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:45,338,735...45,665,011
Ensembl chr 9:45,337,926...45,665,010

G

dual specificity phosphatase 1

disease_progression

RGD

NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102

G

dymeclin

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:75,151,772...75,420,037
Ensembl chr18:75,151,852...75,420,035

G

E2F transcription factor 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812

G

E2F transcription factor 3

disease_progression

RGD

PMID:25017995 PMID:15184867 PMID:17701752

RGD:13504717, RGD:13504730, RGD:13504729

NCBI chr13:30,090,558...30,171,172
Ensembl chr13:30,090,558...30,170,046

G

E2F transcription factor 5

mRNA,protein:increased expression:prostate:

RGD

NCBI chr 3:14,638,370...14,671,369
Ensembl chr 3:14,643,701...14,671,369

G

ELL associated factor 2

protein:decreased expression:prostate gland

RGD

NCBI chr16:36,613,246...36,695,275
Ensembl chr16:36,613,246...36,695,365

G

eukaryotic translation elongation factor 2

protein:increased expression:prostate (human)

RGD

NCBI chr10:81,012,465...81,018,343
Ensembl chr10:81,012,465...81,018,332

G

EF-hand calcium binding domain 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:83,750,913...83,959,226
Ensembl chr15:83,750,913...83,949,580

G

epidermal growth factor receptor

RGD

NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158

G

eukaryotic translation initiation factor 3, subunit H

disease_progression

DNA:amplification
mRNA:increased expression:prostate gland

RGD

PMID:11733359 PMID:10362802

RGD:2289901, RGD:2289902

NCBI chr15:51,649,956...51,728,901
Ensembl chr15:51,649,954...51,728,919

G

eukaryotic translation initiation factor 4 gamma, 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:137,719,090...137,934,397
Ensembl chr 4:137,720,333...137,935,819

G

elastin microfibril interfacer 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:31,070,729...31,078,623
Ensembl chr 5:31,070,746...31,078,621

G

endoglin

severity

protein:increased expression:tumor, vasculature (human)

RGD

NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681

G

enolase 2, gamma neuronal

RGD

NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636

G

ecto-NOX disulfide-thiol exchanger 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:77,393,790...77,959,203
Ensembl chr14:77,394,203...77,959,200

G

ectonucleotide pyrophosphatase/phosphodiesterase 7

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:118,879,007...118,884,047
Ensembl chr11:118,879,014...118,884,047

G

ectonucleoside triphosphate diphosphohydrolase 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:120,368,884...120,397,393
Ensembl chr 9:120,368,884...120,397,393

G

endosomal transmembrane epsin interactor 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:23,950,114...24,008,800
Ensembl chr19:23,950,114...24,008,383

G

E1A binding protein p300

disease_progression

RGD

NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278

G

Eph receptor B1

susceptibility

DNA:SNPs,haplptype:multiple

RGD

NCBI chr 9:101,799,327...102,231,892
Ensembl chr 9:101,799,327...102,231,892

G

epithelial stromal interaction 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:78,141,679...78,240,096
Ensembl chr14:78,141,679...78,240,097

G

erb-b2 receptor tyrosine kinase 2

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:16771730

NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542

G

erb-b2 receptor tyrosine kinase 3

disease_progression

protein:altered localization:nucleus
ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:17532856

NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521

G

erb-b2 receptor tyrosine kinase 4

protein:increased expression:prostate gland

RGD

NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218

G

Erbb2 interacting protein

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:103,955,294...104,057,094
Ensembl chr13:103,955,295...104,057,022

G

excision repair cross-complementing rodent repair deficiency, complementation group 2

susceptibility

DNA:missense mutation:cds:p.D312N (human)
DNA:polymorphism:exon:p.R156R(human)

RGD

PMID:17695467 PMID:24649009

RGD:5688739, RGD:8657136

NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619

G

estrogen receptor 1 (alpha)

susceptibility
severity
disease_progression

DNA:repeat
DNA:hypermethylation:promoter
mRNA:increased expression:prostate gland

RGD

PMID:18006911 PMID:17922863 PMID:17908481

RGD:2290020, RGD:2290022, RGD:2290023

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

estrogen receptor 2 (beta)

susceptibility

DNA:snps, haplotype:multiple (human)

RGD

NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033

G

exocyst complex component 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:30,968,421...31,162,082
Ensembl chr13:30,968,416...30,979,209
Ensembl chr13:30,968,416...30,979,209

G

EYA transcriptional coactivator and phosphatase 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:14,239,177...14,381,259
Ensembl chr 1:14,239,178...14,380,459

G

enhancer of zeste 2 polycomb repressive complex 2 subunit

severity

protein:increased expression:prostate gland (human)

RGD

NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275

G

coagulation factor II

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759

G

coagulation factor V

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846

G

fatty acid binding protein 5, epidermal

mRNA:increased expression:prostate (human)

RGD

NCBI chr 3:10,077,645...10,081,670
Ensembl chr 3:10,077,608...10,081,667

G

family with sequence similarity 13, member C

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:70,274,981...70,394,566
Ensembl chr10:70,276,311...70,394,566

G

family with sequence similarity 83, member C

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:155,671,103...155,676,772
Ensembl chr 2:155,669,468...155,676,774

G

Fanconi anemia, complementation group A

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:10094191 PMID:24728327 PMID:25741868 PMID:26181256 PMID:28492532 More...

NCBI chr 8:123,993,033...124,045,390
Ensembl chr 8:123,995,039...124,045,315

G

Fas cell surface death receptor

severity
disease_progression

DNA:polymorphism

RGD

PMID:18237448 PMID:17667965

RGD:2289639, RGD:2290050

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

failed axon connections homolog

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:21,930,906...22,001,461
Ensembl chr 4:21,931,329...21,996,839

G

F-box DNA helicase 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:11,747,384...11,782,396
Ensembl chr 2:11,747,384...11,782,393

G

fibrillin 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:58,141,689...58,343,200
Ensembl chr18:58,141,695...58,343,559

G

F-box and leucine-rich repeat protein 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:43,901,958...43,939,529
Ensembl chr 5:43,901,957...43,978,980

G

FYVE, RhoGEF and PH domain containing 1

protein:increased expression:prostate gland (human)

RGD

NCBI chr X:149,829,141...149,872,682
Ensembl chr X:149,829,146...149,872,517

G

FYVE, RhoGEF and PH domain containing 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:29,579,878...29,598,509
Ensembl chr17:29,579,888...29,598,635

G

fibroblast growth factor 7

RGD

NCBI chr 2:125,876,578...125,933,105
Ensembl chr 2:125,876,578...125,933,105

G

fibroblast growth factor receptor 1

disease_progression

RGD

NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734

G

fibroblast growth factor receptor 2

no_association
disease_progression

RGD

PMID:9285567 PMID:11069376 PMID:12111699

RGD:2289086, RGD:2289845, RGD:2289728

NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079

G

fibroblast growth factor receptor 4

disease_progression

DNA:SNP:exon 9: 288G>A, p.G288R (human)

RGD

NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572

G

FHF complex subunit HOOK interacting protein 1B

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:105,020,418...105,049,349
Ensembl chr 7:105,020,418...105,049,261

G

fragile histidine triad gene

RGD

PMID:11839671 PMID:15705877 PMID:17548701

RGD:2289896, RGD:2289878, RGD:2289869

NCBI chr14:11,307,718...12,919,681
Ensembl chr14:11,307,738...12,919,681

G

FMS-like tyrosine kinase 3

RGD

NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299

G

forkhead box O1

disease_progression

mRNA:decreased expression:tumor:lower in high versus low Gleason score tumors, also lower in tumor vs adjacent normal tissue (p<0.05 compared to at least one housekeeping gene) (human)

RGD

NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642

G

forkhead box O3

mRNA:decreased expression:tumor:lower in tumor vs adjacent normal tissue (p<0.05 compared to at least one housekeeping gene) (human)

RGD

NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751

G

formyl peptide receptor 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:18,096,733...18,104,201
Ensembl chr17:18,096,733...18,104,202

G

Fras1 related extracellular matrix protein 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:53,421,359...53,566,014
Ensembl chr 3:53,421,359...53,564,776

G

gamma-aminobutyric acid type A receptor subunit beta 2

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:25741868 PMID:28492532

NCBI chr11:42,310,342...42,523,418
Ensembl chr11:42,310,584...42,519,855

G

gamma-aminobutyric acid type A receptor subunit gamma 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:70,906,512...70,999,960
Ensembl chr 5:70,908,390...70,999,960

G

glyceraldehyde-3-phosphate dehydrogenase, spermatogenic

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:30,429,204...30,443,106
Ensembl chr 7:30,429,200...30,443,106

G

growth differentiation factor 10

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:33,645,544...33,658,471
Ensembl chr14:33,645,544...33,659,940

G

GEN1, Holliday junction 5' flap endonuclease

ClinVar Annotator: match by term: GEN1-related prostate cancer

PMID:25741868 PMID:28492532

NCBI chr12:11,288,929...11,316,030
Ensembl chr12:11,288,921...11,315,802

G

guided entry of tail-anchored proteins factor 3, ATPase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:85,744,558...85,751,916
Ensembl chr 8:85,744,560...85,751,910

G

glial cell line derived neurotrophic factor family receptor alpha 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:34,822,951...34,853,440
Ensembl chr18:34,822,951...34,853,440

G

GLI-Kruppel family member GLI1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843

G

predicted gene 15283

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:73,981,498...73,999,213
Ensembl chr12:73,889,813...73,996,588

G

predicted gene, 36566

ClinVar Annotator: match by term: Prostate cancer

PMID:25741868 PMID:27535533

NCBI chr19:32,731,847...32,734,812

G

guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:3,989,082...3,997,441
Ensembl chr 6:3,993,792...3,997,436

G

glyceronephosphate O-acyltransferase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:125,589,772...125,616,796
Ensembl chr 8:125,589,772...125,616,796

G

golgi membrane protein 1

protein,mRNA:increased expression:prostate

RGD

NCBI chr13:59,782,810...59,823,598
Ensembl chr13:59,782,440...59,823,625

G

gephyrin

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:78,264,099...78,731,546
Ensembl chr12:78,273,153...78,731,546

G

G protein-coupled receptor 26

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:131,567,891...131,587,362
Ensembl chr 7:131,568,189...131,596,134

G

G protein-coupled receptor 55

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:85,860,927...85,924,781
Ensembl chr 1:85,866,039...85,888,729

G

G protein-coupled receptor 82

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:13,512,373...13,533,669
Ensembl chr X:13,527,602...13,533,672

G

growth factor receptor bound protein 2

disease_progression
treatment

DNA:amplification, mutation

RGD

PMID:28930697 PMID:17372910

RGD:13504750, RGD:13504751

NCBI chr11:115,534,871...115,599,423
Ensembl chr11:115,534,871...115,599,423

G

glutamate receptor, ionotropic, delta 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:34,541,751...35,305,344
Ensembl chr14:34,542,065...35,305,336

G

glutamate receptor, ionotropic, NMDA1 (zeta 1)

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199

G

glutamate receptor, metabotropic 8

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:27,275,120...28,135,094
Ensembl chr 6:27,275,118...28,135,177

G

gastrin releasing peptide

protein:increased expression:serum (human)

RGD

NCBI chr18:66,005,826...66,019,670
Ensembl chr18:66,005,891...66,019,667

G

glutamate-rich WD repeat containing 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:45,474,647...45,480,218
Ensembl chr 7:45,474,647...45,480,368

G

glutathione S-transferase, mu 1

RGD

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

glutathione S-transferase, pi 1

susceptibility

DNA:polymorphism:exon:p.I105V (human)

RGD

PMID:17067754 PMID:9111193

RGD:4142515, RGD:6906883

NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985

G

glutathione S-transferase, theta 1

susceptibility

DNA:polymorphism

RGD

NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418

G

glucuronidase, beta

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:130,011,278...130,031,890
Ensembl chr 5:130,017,852...130,031,890

G

histocompatibility 2, class II antigen E beta

susceptibility

RGD

NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648

G

hemolytic complement

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450

G

heme binding protein 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:18,415,871...18,421,824
Ensembl chr10:18,415,246...18,421,824

G

HEPACAM family member 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:3,457,202...3,498,319
Ensembl chr 6:3,457,096...3,498,298

G

hedgehog interacting protein-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:108,272,100...108,294,559
Ensembl chr12:108,272,529...108,297,128

G

hypoxia inducible factor 1, alpha subunit

DNA, protein:polymorphism, increased expression:exon, prostate gland:1772C>T (human)
ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:19106642

NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304

G

homeodomain interacting protein kinase 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:27,222,686...27,230,605
Ensembl chr 7:27,222,692...27,230,600

G

histone cell cycle regulator

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr16:18,695,500...18,789,059
Ensembl chr16:18,695,787...18,789,059

G

hepatic leukemia factor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:90,227,361...90,281,745
Ensembl chr11:90,227,362...90,281,721

G

hemicentin 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:150,438,251...150,869,568
Ensembl chr 1:150,438,275...150,869,186

G

heterogeneous nuclear ribonucleoprotein K

protein:increased expression:prostate gland (human)

RGD

NCBI chr13:58,538,946...58,551,157
Ensembl chr13:58,538,956...58,551,157

G

homeobox B13

mRNA:increased expression:prostate gland

RGD

NCBI chr11:96,085,142...96,087,436
Ensembl chr11:96,085,142...96,088,273

G

HPS3, biogenesis of lysosomal organelles complex 2 subunit 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:20,050,109...20,089,478
Ensembl chr 3:20,050,109...20,089,479

G

5-hydroxytryptamine (serotonin) receptor 2C

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:145,745,509...145,980,273
Ensembl chr X:145,745,509...145,980,273

G

5-hydroxytryptamine (serotonin) receptor 5A

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:28,046,836...28,059,403
Ensembl chr 5:28,047,147...28,060,086

G

HtrA serine peptidase 2

mRNA, protein:increased expression:prostate (human)

RGD

NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254

G

inhibitor of Bruton agammaglobulinemia tyrosine kinase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:85,569,412...85,632,756
Ensembl chr 9:85,569,413...85,631,387

G

intercellular adhesion molecule 1

RGD

NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113

G

interferon induced with helicase C domain 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:62,426,137...62,476,599
Ensembl chr 2:62,426,142...62,476,599

G

intraflagellar transport 43

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:86,129,335...86,209,233
Ensembl chr12:86,129,315...86,209,233

G

insulin-like growth factor I receptor

disease_progression

RGD

NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416

G

insulin-like growth factor 2 receptor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551

G

insulin-like growth factor binding protein 3

severity
no_association

RGD

PMID:17668637 PMID:15006930 PMID:17724372

RGD:2290015, RGD:2290012, RGD:2290008

NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923

G

inhibitor of kappaB kinase beta

protein:increased serine phosphorylation:prostate gland

RGD

NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605

G

interleukin 16

DNA:SNP:exon:rs4072111 (human)

RGD

NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934

G

interleukin 33

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118

G

integrin linked kinase

disease_progression

protein:decreased expression:tumor:significantly lower in benign prostatic hyperplasia then any prostate cancer (p<0.01), gradient of expression from BPH to poorly differentiated C+D stage neoplasms (human)
mRNA:decreased expression:tumor:lower in high versus low Gleason score tumors (p<0.05 compared to at least one housekeeping gene) (human)

RGD

PMID:15704679 PMID:18336616

RGD:2301731, RGD:2301729

NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132

G

interphotoreceptor matrix proteoglycan 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr16:56,019,447...56,094,119
Ensembl chr16:56,024,676...56,094,119

G

inhibitor of growth family, member 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:125,016,811...125,026,228
Ensembl chr 6:125,016,723...125,026,228

G

inhibin alpha

RGD

NCBI chr 1:75,483,872...75,487,010
Ensembl chr 1:75,483,721...75,487,010

G

indolethylamine N-methyltransferase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:55,147,612...55,151,975
Ensembl chr 6:55,147,611...55,152,028

G

insulin II

disease_progression

RGD

NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118

G

integrator complex subunit 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:90,298,691...90,340,800
Ensembl chr 3:90,298,695...90,340,929

G

integrator complex subunit 8

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:11,199,158...11,254,264
Ensembl chr 4:11,199,158...11,254,258

G

immunity-related GTPase family, Q

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:24,230,073...24,238,025
Ensembl chr 7:24,230,114...24,238,025

G

integrin, alpha D

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:127,773,105...127,822,988
Ensembl chr 7:127,753,548...127,822,988

G

integrin beta 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987

G

inter-alpha-trypsin inhibitor, heavy chain 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:10,158,354...10,261,340
Ensembl chr 2:10,158,382...10,261,340

G

inositol 1,4,5-triphosphate receptor interacting protein-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:126,980,689...126,985,377
Ensembl chr 2:126,980,692...126,985,362

G

Janus kinase 1

severity

DNA:frameshift mutations

RGD

NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479

G

junction plakoglobin

severity

RGD

PMID:15781623 PMID:10206308

RGD:2291864, RGD:2291876

NCBI chr11:100,259,682...100,288,639
Ensembl chr11:100,259,784...100,288,589

G

K(lysine) acetyltransferase 7

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:95,162,683...95,201,030
Ensembl chr11:95,165,085...95,201,072

G

katanin p60 subunit A-like 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:77,063,725...77,135,007
Ensembl chr18:77,064,844...77,135,004

G

potassium voltage-gated channel, subfamily F, member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:17,222,101...17,226,551
Ensembl chr12:17,222,101...17,226,889

G

potassium inwardly-rectifying channel, subfamily J, member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:32,283,714...32,310,493
Ensembl chr 9:32,283,789...32,310,493

G

potassium inwardly-rectifying channel, subfamily J, member 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:79,364,427...79,396,712
Ensembl chr15:79,367,915...79,389,442

G

potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:89,427,471...89,579,801
Ensembl chr 3:89,427,471...89,582,439

G

potassium voltage-gated channel, subfamily Q, member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:65,858,223...66,158,485
Ensembl chr15:65,858,236...66,158,491

G

potassium voltage-gated channel, subfamily Q, member 5

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr 1:21,468,623...22,032,874
Ensembl chr 1:21,468,627...22,032,166

G

lysine (K)-specific demethylase 3A

mRNA:increased expression:prostate (human)
mRNA:increased expression:prostate gland (human)

RGD

PMID:22120715 PMID:20127736

RGD:9586733, RGD:9587486

NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974

G

lysine (K)-specific demethylase 4A

mRNA:increased expression:prostate (human)

RGD

NCBI chr 4:117,994,154...118,037,216
Ensembl chr 4:117,994,154...118,037,240

G

lysine (K)-specific demethylase 4B

mRNA:increased expression:prostate (human)

RGD

NCBI chr17:56,632,975...56,710,774
Ensembl chr17:56,633,062...56,709,870

G

lysine (K)-specific demethylase 4C

severity

mRNA:increased expression:prostate gland (human)

RGD

NCBI chr 4:74,160,734...74,324,101
Ensembl chr 4:74,160,734...74,324,097

G

lysine demethylase 5A

mRNA:decreased expression:prostate gland (human)

RGD

NCBI chr 6:120,341,060...120,421,535
Ensembl chr 6:120,341,085...120,421,535

G

lysine demethylase 5B

severity

mRNA:increased expression:prostate gland (human)

RGD

NCBI chr 1:134,487,916...134,560,621
Ensembl chr 1:134,487,909...134,563,023

G

lysine (K)-specific demethylase 6A

mRNA:decreased expression:prostate gland (human)
ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:24200674

NCBI chr X:18,027,101...18,147,061
Ensembl chr X:18,028,814...18,146,175

G

kinase insert domain protein receptor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118

G

kinesin family member 12

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:63,076,185...63,090,382
Ensembl chr 4:63,083,867...63,090,368

G

kinesin family member 16B

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:142,459,399...142,743,535
Ensembl chr 2:142,459,394...142,743,451

G

kinesin family member 5A

DNA:mutations:multiple (human)
ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532 PMID:23265383

NCBI chr10:127,061,564...127,102,217
Ensembl chr10:127,061,565...127,099,217

G

Kruppel-like transcription factor 6

DNA:loss of heterozygosity, missense mutations:multiple

OMIM
RGD

NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393

G

kelch-like 20

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:160,915,945...160,959,078
Ensembl chr 1:160,915,945...160,959,081

G

kallikrein related-peptidase 10

susceptibility

DNA:SNP:exon:p.A50S (human)

RGD

NCBI chr 7:43,430,478...43,434,834
Ensembl chr 7:43,430,459...43,434,834

G

kallikrein related-peptidase 13

protein:decreased expression:prostate

RGD

NCBI chr 7:43,361,991...43,377,288
Ensembl chr 7:43,361,991...43,376,958

G

kallikrein related-peptidase 4 (prostase, enamel matrix, prostate)

protein:increased expression:prostate gland

RGD

PMID:12370833 PMID:17545602

RGD:2314857, RGD:2314854

NCBI chr 7:43,530,584...43,535,228
Ensembl chr 7:43,530,584...43,535,228

G

kallikrein related-peptidase 6

protein:decreased expression:prostate

RGD

NCBI chr 7:43,473,967...43,481,219
Ensembl chr 7:43,473,923...43,481,454

G

lysine (K)-specific methyltransferase 2A

mRNA:decreased expression:prostate gland (human)

RGD

NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594

G

lysine (K)-specific methyltransferase 2B

mRNA:decreased expression:prostate gland (human)

RGD

NCBI chr 7:30,268,280...30,288,371
Ensembl chr 7:30,268,283...30,288,151

G

lysine (K)-specific methyltransferase 2C

mRNA:decreased expression:prostate gland (human)

RGD

NCBI chr 5:25,476,793...25,703,853
Ensembl chr 5:25,476,796...25,703,781

G

lysine (K)-specific methyltransferase 2D

mRNA:decreased expression:prostate gland (human)

RGD

NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085

G

lysine (K)-specific methyltransferase 2E

mRNA:decreased expression:prostate gland (human)

RGD

NCBI chr 5:23,638,034...23,709,233
Ensembl chr 5:23,639,439...23,709,233

G

lysine methyltransferase 5A

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:124,577,980...124,600,371
Ensembl chr 5:124,577,993...124,600,371

G

kinetochore associated 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:123,887,755...123,959,656
Ensembl chr 5:123,887,779...123,959,656

G

keratinocyte expressed, proline-rich

ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer

NCBI chr 3:92,730,381...92,734,554
Ensembl chr 3:92,730,381...92,734,554

G

Kirsten rat sarcoma viral oncogene homolog

OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

keratin 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:101,753,861...101,759,221
Ensembl chr15:101,753,861...101,759,229

G

keratin 33A

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:99,902,025...99,907,038
Ensembl chr11:99,902,021...99,907,038

G

keratin 9

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:100,077,607...100,084,072
Ensembl chr11:100,077,607...100,084,072

G

laminin, alpha 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:179,818,166...179,867,652
Ensembl chr 2:179,818,166...179,867,652

G

La ribonucleoprotein 1B

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:40,904,198...40,994,642
Ensembl chr 3:40,904,263...40,994,669

G

ligand dependent nuclear receptor corepressor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:41,471,121...41,584,600
Ensembl chr19:41,471,076...41,574,975

G

lymphoid enhancer binding factor 1

associated with prostate cancer

RGD

NCBI chr 3:130,903,972...131,018,006
Ensembl chr 3:130,904,120...131,018,005

G

ligase IV, DNA, ATP-dependent

treatment

RGD

NCBI chr 8:10,020,020...10,027,680
Ensembl chr 8:10,019,049...10,027,686

G

lectin, mannose-binding 1 like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:57,514,080...57,528,057
Ensembl chr 9:57,514,368...57,528,057

G

leishmanolysin-like (metallopeptidase M8 family)

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr16:32,881,974...32,948,065
Ensembl chr16:32,882,891...32,948,065

G

Sox9 promoter region

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:112,671,077...112,673,365

G

lon peptidase 2, peroxisomal

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:87,350,672...87,443,264
Ensembl chr 8:87,350,672...87,450,501

G

low density lipoprotein receptor-related protein 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:127,374,026...127,457,158
Ensembl chr10:127,374,030...127,457,017

G

low density lipoprotein-related protein 1B

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:40,485,302...42,543,747
Ensembl chr 2:40,485,258...42,543,636

G

low density lipoprotein receptor-related protein 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:134,423,439...134,543,876
Ensembl chr 6:134,423,439...134,543,928

G

low density lipoprotein receptor-related protein associated protein 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:35,248,834...35,263,043
Ensembl chr 5:35,248,845...35,263,110

G

leucine rich repeat containing 37

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:103,425,403...103,512,309
Ensembl chr11:103,425,403...103,511,966

G

microtubule-actin crosslinking factor 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:123,243,386...123,581,594
Ensembl chr 4:123,243,426...123,581,331

G

MAD1 mitotic arrest deficient 1-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:11423979 PMID:25741868

NCBI chr 5:139,994,444...140,307,346
Ensembl chr 5:139,994,444...140,307,307

G

membrane associated guanylate kinase, WW and PDZ domain containing 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:19,431,787...20,909,790
Ensembl chr 5:19,432,034...20,909,790

G

MAM domain containing 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:23,279,973...23,425,855
Ensembl chr19:23,279,973...23,425,806

G

mastermind like transcriptional coactivator 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:50,146,461...50,183,163
Ensembl chr11:50,146,461...50,183,138

G

mastermind-like domain containing 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:70,093,642...70,199,662
Ensembl chr X:70,093,846...70,199,662

G

mitogen-activated protein kinase kinase 5

RGD

NCBI chr 9:63,071,050...63,288,964
Ensembl chr 9:63,071,050...63,285,184

G

mitogen-activated protein kinase kinase 7

mRNA:splice variant:exon 2: (human)

RGD

NCBI chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897

G

mitogen-activated protein kinase kinase kinase 7

RGD

NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467

G

mitogen-activated protein kinase 10

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:103,056,413...103,359,200
Ensembl chr 5:103,055,814...103,359,200

G

mitogen-activated protein kinase 7

RGD

NCBI chr11:61,379,638...61,385,101
Ensembl chr11:61,379,638...61,385,232

G

microtubule-associated protein tau

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916

G

mutated in colorectal cancers

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:44,558,127...44,945,573
Ensembl chr18:44,558,127...44,945,249

G

magnesium-dependent phosphatase 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:55,895,346...55,897,908
Ensembl chr14:55,895,336...55,897,965

G

mediator complex subunit 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:98,042,980...98,084,121
Ensembl chr11:98,042,980...98,084,119

G

microRNA 126a

RNA:decreased expression:prostate gland

RGD

NCBI chr 2:26,481,369...26,481,441
Ensembl chr 2:26,481,369...26,481,441

G

microRNA 152

disease_progression

miRNA:decreased expression:serum

RGD

NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291

G

microRNA 155

severity

miRNA:increased expression:prostate gland

RGD

NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092

G

microRNA 20a

RGD

NCBI chr14:115,281,589...115,281,695
Ensembl chr14:115,281,589...115,281,695

G

microRNA 615

ameliorates

RNA:decreased expression:prostate gland

RGD

PMID:29471894 PMID:29471894

RGD:151665098, RGD:151665098

NCBI chr15:102,923,342...102,923,433
Ensembl chr15:102,923,342...102,923,433

G

matrix metallopeptidase 13

disease_progression

RGD

NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331

G

matrix metallopeptidase 15

disease_progression

RGD

NCBI chr 8:96,078,924...96,100,921
Ensembl chr 8:96,078,896...96,101,708

G

matrix metallopeptidase 2

disease_progression

protein:increased expression:prostate gland

RGD

NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048

G

matrix metallopeptidase 7

RGD

NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,586

G

mitochondrial ribosomal protein L46

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:78,425,089...78,432,837
Ensembl chr 7:78,424,984...78,433,279

G

mutS homolog 2

disease_progression

RGD

NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141

G

mutS homolog 6

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:25741868 PMID:28492532

NCBI chr17:88,282,478...88,298,320
Ensembl chr17:88,282,490...88,298,320

G

beta-microseminoprotein

OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959

NCBI chr14:31,863,980...31,880,284
Ensembl chr14:31,863,980...31,880,327

G

macrophage scavenger receptor 1

susceptibility

DNA:SNPs
ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:12244320 PMID:12958598 PMID:21791690 PMID:24082139 PMID:25333069 More...

NCBI chr 8:39,996,284...40,095,790
Ensembl chr 8:40,034,726...40,095,714

G

Mdm2, transformed 3T3 cell double minute p53 binding protein

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:55,420,800...55,489,819
Ensembl chr15:55,420,804...55,489,819

G

methylenetetrahydrofolate reductase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008

G

mitochondrial nucleoid associated protein 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:113,574,490...113,590,201
Ensembl chr11:113,575,238...113,585,473

G

mechanistic target of rapamycin kinase

treatment

RGD

NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140

G

mucin 1, transmembrane

severity

RGD

NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688

G

mucin 17, cell surface associated

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:137,163,772...137,202,809
Ensembl chr 5:137,163,770...137,202,830

G

mucin 6, gastric

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:141,212,404...141,241,659
Ensembl chr 7:141,213,373...141,241,641

G

MX dynamin-like GTPase 1

susceptibility

DNA:SNP:promoter:-g.88G>T (rs2071430) (human)

RGD

NCBI chr16:97,248,235...97,264,106
Ensembl chr16:97,248,235...97,264,107

G

MAX interactor 1, dimerization protein

ClinVar Annotator: match by term: Malignant tumor of prostate

OMIM
ClinVar
RGD

PMID:7773287 PMID:7773287

NCBI chr19:53,298,509...53,361,724
Ensembl chr19:53,298,949...53,364,241

G

myelocytomatosis oncogene

susceptibility
severity

DNA:snp:intron:IVS1-355T>A rs3891248 (human)
protein:increased expression:prostate gland (human)

RGD

PMID:18483343 PMID:20140016

RGD:7207432, RGD:7240541

NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223

G

MYC binding protein 2, E3 ubiquitin protein ligase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:103,350,847...103,584,276
Ensembl chr14:103,350,847...103,584,250

G

myosin, heavy polypeptide 3, skeletal muscle, embryonic

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:25741868 PMID:28492532 PMID:31030430

NCBI chr11:66,969,101...66,993,117
Ensembl chr11:66,969,126...66,993,112

G

myosin, heavy polypeptide 8, skeletal muscle, perinatal

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:67,167,950...67,199,460
Ensembl chr11:67,167,950...67,199,460

G

myosin heavy chain gene antisense RNA

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:67,115,022...67,128,107
Ensembl chr11:67,102,082...67,128,399

G

myosin, light polypeptide kinase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790

G

myosin XVI

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:10,203,911...10,684,742
Ensembl chr 8:10,203,911...10,684,742

G

myosin XVIIIA

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:77,654,066...77,756,806
Ensembl chr11:77,654,072...77,756,806

G

myosin IA

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:127,539,306...127,556,809
Ensembl chr10:127,541,039...127,556,809

G

myosin VI

protein:increased expression:prostate gland epithelium, perinuclear region of cytoplasm

RGD

NCBI chr 9:80,072,262...80,219,011
Ensembl chr 9:80,072,313...80,219,011

G

myocardin

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:65,064,434...65,160,821
Ensembl chr11:65,067,387...65,160,815

G

myotilin

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:44,467,126...44,488,795
Ensembl chr18:44,467,141...44,488,791

G

myelin regulatory factor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:10,185,635...10,218,134
Ensembl chr19:10,185,636...10,218,112

G

N-ethylmaleimide sensitive fusion protein attachment protein beta

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:148,535,905...148,574,396
Ensembl chr 2:148,535,905...148,574,387

G

N-acetyl transferase 1

susceptibility

DNA:polymorphism

RGD

NCBI chr 8:67,943,620...67,945,183
Ensembl chr 8:67,933,573...67,944,756

G

N-acetyltransferase 2 (arylamine N-acetyltransferase)

susceptibility

DNA:polymorphism

RGD

NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236

G

nibrin

susceptibility

DNA:deletion, loss of heterozygosity
ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer

PMID:23265383 PMID:23555315 PMID:25741868 PMID:26467025 PMID:26976419 More...

NCBI chr 4:15,955,388...15,992,589
Ensembl chr 4:15,957,925...15,992,589

G

nuclear receptor coactivator 1

disease_progression

RGD

NCBI chr12:4,297,362...4,569,452
Ensembl chr12:4,297,362...4,527,182

G

nuclear receptor coactivator 2

mRNA:increased expression:prostate (human)

RGD

NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307

G

nuclear receptor coactivator 3

mRNA:increased expression:prostate (human)

RGD

NCBI chr 2:165,834,557...165,915,162
Ensembl chr 2:165,834,556...165,915,162

G

nuclear receptor coactivator 4

severity

protein:increased expression:prostate gland
mRNA:decreased expression:prostate gland

RGD

PMID:15166229 PMID:12368219

RGD:2293534, RGD:2293535

NCBI chr14:31,881,884...31,901,210
Ensembl chr14:31,881,822...31,901,812

G

NECAP endocytosis associated 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:140,793,823...140,805,672
Ensembl chr 4:140,793,823...140,805,668

G

NIMA (never in mitosis gene a)-related expressed kinase 9

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:85,346,288...85,386,136
Ensembl chr12:85,346,288...85,386,136

G

negative elongation factor complex member C/D, Th1l

disease_progression

RGD

NCBI chr 2:174,257,623...174,269,298
Ensembl chr 2:174,257,597...174,269,295

G

NEL-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:49,625,098...50,513,037
Ensembl chr 7:49,624,612...50,516,356

G

neuropilin (NRP) and tolloid (TLL)-like 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:86,363,347...86,428,011
Ensembl chr 8:86,363,217...86,427,553

G

nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105

treatment
susceptibility

DNA:SNPs, haplotype: :multiple
DNA:indel:promoter

RGD

PMID:28797847 PMID:26068031 PMID:26788504

RGD:13506729, RGD:11054182, RGD:11554936

NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308

G

nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha

susceptibility
disease_progression
no_association

DNA:SNPs:promoter:-826C>T, -881A>G (human)
ClinVar Annotator: match by term: Malignant tumor of prostate
protein:increased serine phosphorylation
DNA:SNPs: :rs2233406, rs3138053 (human)
protein:decreased expression, increased phosphorylation
DNA:polymorphism:3' UTR

PMID:26068031 PMID:23093296 PMID:26834482 PMID:28041912 PMID:26068031

RGD:11054182, RGD:13506767, RGD:13506766, RGD:13506765, RGD:11054182

NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432

G

NHS actin remodeling regulator

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr X:160,616,286...160,942,437
Ensembl chr X:160,616,292...160,942,726

G

NK3 homeobox 1

OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959

NCBI chr14:69,428,141...69,432,107
Ensembl chr14:69,428,087...69,432,111

G

NLR family, pyrin domain containing 1A

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr11:70,982,023...71,035,780
Ensembl chr11:70,983,062...71,035,530

G

NMD3 ribosome export adaptor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:69,629,354...69,656,380
Ensembl chr 3:69,629,318...69,663,706

G

nitric oxide synthase 3, endothelial cell

disease_progression

DNA:polymorphism:exon:p.E298D (human)

RGD

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

notch 3

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:7732783 PMID:15364702 PMID:16328531 PMID:23265383 PMID:25033846 More...

NCBI chr17:32,339,794...32,385,869
Ensembl chr17:32,339,794...32,385,826

G

nuclear receptor subfamily 3, group C, member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474

G

neuroblastoma ras oncogene

disease_progression

RGD

NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230

G

netrin 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:93,476,911...93,581,834
Ensembl chr10:93,476,543...93,583,069

G

NACHT and WD repeat domain containing 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:73,372,865...73,443,508
Ensembl chr 8:73,373,339...73,444,504

G

8-oxoguanine DNA-glycosylase 1

susceptibility

DNA:missense mutation:cds:p.S326C (human)
DNA:missense mutation:exon:p.S326C (1245C>G) (rs1052133) (human)

RGD

PMID:24649009 PMID:19914098

RGD:8657136, RGD:8657378

NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029

G

oncoprotein induced transcript 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:59,258,782...59,277,601
Ensembl chr10:59,258,780...59,277,600

G

Obg-like ATPase 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:72,923,145...73,044,791
Ensembl chr 2:72,923,145...73,049,268

G

olfactomedin-like 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:103,642,710...103,645,317
Ensembl chr 3:103,629,538...103,645,317

G

olfactory receptor family 1 subfamily S member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:13,757,912...13,758,978
Ensembl chr19:13,755,242...13,760,284

G

olfactory receptor family 2 subfamily T member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:8,140,697...8,141,650
Ensembl chr14:8,137,972...8,146,935

G

olfactory receptor family 2 subfamily Z member 9

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:72,853,606...72,854,550
Ensembl chr 8:72,837,021...72,856,928

G

olfactory receptor family 4 subfamily C member 12B

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:89,646,672...89,647,604
Ensembl chr 2:89,642,395...89,648,204

G

olfactory receptor family 5 subfamily AC member 16

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr16:59,021,867...59,022,787
Ensembl chr16:59,020,715...59,023,896

G

olfactory receptor family 6 subfamily K member 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:173,986,288...173,987,333
Ensembl chr 1:173,983,199...173,989,761

G

olfactory receptor family 8 subfamily K member 40

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:86,584,139...86,585,080
Ensembl chr 2:86,583,068...86,589,337

G

oxidase assembly 1-like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:54,598,298...54,607,130
Ensembl chr14:54,598,291...54,607,130

G

p21 (RAC1) activated kinase 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:28,258,244...28,297,609
Ensembl chr 7:28,258,244...28,297,610

G

paralemmin A kinase anchor protein

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:57,434,475...57,896,984
Ensembl chr 4:57,717,657...57,896,984
Ensembl chr 4:57,717,657...57,896,984
Ensembl chr 4:57,717,657...57,896,984

G

par-3 family cell polarity regulator

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:127,790,131...128,338,767
Ensembl chr 8:127,790,643...128,338,767

G

protocadherin alpha 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,063,338...37,320,710
Ensembl chr18:37,063,237...37,320,714

G

protocadherin alpha 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,072,258...37,320,714
Ensembl chr18:37,072,258...37,320,710

G

protocadherin alpha 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,079,141...37,320,716
Ensembl chr18:37,079,158...37,320,710

G

protocadherin alpha 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,085,742...37,320,710
Ensembl chr18:37,085,701...37,320,714

G

protocadherin alpha 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,093,329...37,320,716
Ensembl chr18:37,093,493...37,320,710

G

protocadherin alpha 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,100,678...37,321,950
Ensembl chr18:37,100,684...37,320,710

G

protocadherin alpha 7

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,106,864...37,320,716
Ensembl chr18:37,106,855...37,320,710

G

protocadherin alpha 8

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,125,520...37,320,710
Ensembl chr18:37,125,424...37,320,710

G

protocadherin alpha 9

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,130,933...37,320,710
Ensembl chr18:37,130,933...37,320,710

G

protocadherin beta 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:37,397,897...37,400,507
Ensembl chr18:37,397,991...37,400,578

G

pecanex 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:81,906,688...82,047,698
Ensembl chr12:81,906,797...82,047,698

G

phosphodiesterase 1C

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:56,046,783...56,629,590
Ensembl chr 6:56,046,789...56,629,472

G

phosphodiesterase 3A, cGMP inhibited

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:141,194,995...141,452,588
Ensembl chr 6:141,194,995...141,453,174

G

phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:108,536,239...108,579,609
Ensembl chr 5:108,536,257...108,580,263

G

phosphodiesterase 7B

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:20,272,798...20,600,824
Ensembl chr10:20,273,750...20,600,824

G

platelet derived growth factor receptor, beta polypeptide

RGD

NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133

G

pyruvate dehydrogenase kinase, isoenzyme 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309

G

pyruvate dehydrogenase phosphatase catalytic subunit 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:105,318,104...105,325,658
Ensembl chr 8:105,318,083...105,325,658

G

3-phosphoinositide dependent protein kinase 1

treatment

RGD

NCBI chr17:24,292,654...24,370,957
Ensembl chr17:24,292,654...24,369,898

G

phosphatidylethanolamine binding protein 1

RGD

NCBI chr 5:117,420,716...117,425,629
Ensembl chr 5:117,420,719...117,425,690

G

pyroglutamyl-peptidase I

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:71,099,086...71,113,096
Ensembl chr 8:71,099,085...71,113,038

G

PHD finger protein 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:48,955,226...49,024,361
Ensembl chr13:48,955,226...49,024,595

G

PHD finger protein 8

mRNA:increased expression:prostate (human)

RGD

NCBI chr X:150,303,621...150,416,855
Ensembl chr X:150,303,668...150,416,855

G

PH domain and leucine rich repeat protein phosphatase 1

disease_progression

mRNA:decreased expression:tumor:lower in high versus low Gleason score tumors (p<0.05 compared to at least one housekeeping gene) (human)

RGD

NCBI chr 1:106,099,599...106,321,975
Ensembl chr 1:106,099,482...106,321,980

G

phosphatidylinositol glycan anchor biosynthesis, class H

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:79,127,443...79,136,478
Ensembl chr12:79,127,438...79,136,425

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:15016963 PMID:15254419 PMID:15520168 PMID:15647370 PMID:15805248 More...

NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta

treatment
disease_progression

RGD

PMID:20103642 PMID:18372911

RGD:13506809, RGD:13506810

NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658

G

phosphoinositide-3-kinase regulatory subunit 1

disease_progression

mRNA:decreased expression:tumor:lower in high versus low Gleason score tumors (p<0.05 compared to at least one housekeeping gene) (human)
ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:18336616

NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725

G

phosphoinositide-3-kinase regulatory subunit 2

RGD

NCBI chr 8:71,220,820...71,229,356
Ensembl chr 8:71,220,820...71,229,357

G

paired-like homeodomain transcription factor 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:128,993,527...129,013,243
Ensembl chr 3:128,993,527...129,013,240

G

polycystic kidney disease 2-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:44,136,076...44,235,355
Ensembl chr19:44,136,076...44,180,881

G

polycystic kidney and hepatic disease 1

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr 1:20,128,003...20,688,306
Ensembl chr 1:20,128,003...20,688,288

G

plasminogen activator, urokinase

severity

protein:increased expression:serum (human)

RGD

NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453

G

phospholipase B1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:32,390,035...32,521,700
Ensembl chr 5:32,390,052...32,523,864

G

phospholipase C, beta 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:135,500,523...135,856,522
Ensembl chr 2:135,500,931...135,856,513

G

pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:45,175,754...45,203,653
Ensembl chr 7:45,175,754...45,203,653

G

pleckstrin homology domain containing, family G (with RhoGef domain) member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:3,690,206...3,917,303
Ensembl chr10:3,690,364...3,917,303

G

prostate transmembrane protein, androgen induced 1

disease_progression

RGD

NCBI chr 2:173,066,251...173,118,329
Ensembl chr 2:173,066,251...173,118,326

G

PMS1 homolog2, mismatch repair system component

disease_progression

RGD

NCBI chr 5:143,846,379...143,922,538
Ensembl chr 5:143,846,782...143,870,786
Ensembl chr 5:143,846,782...143,870,786

G

pancreatic lipase related protein 1

RGD

NCBI chr19:58,717,319...58,732,601
Ensembl chr19:58,717,319...58,732,601

G

podocan

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:107,871,990...107,889,544
Ensembl chr 4:107,871,988...107,889,534

G

polymerase (DNA directed), kappa

ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer

PMID:25741868 PMID:26046662

NCBI chr13:96,617,195...96,679,087
Ensembl chr13:96,617,198...96,679,087

G

DNA polymerase N

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:34,164,523...34,326,870
Ensembl chr 5:34,164,523...34,326,792

G

paraoxonase 1

protein:increased activity:serum (human)

RGD

NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946

G

diphosphoinositol pentakisphosphate kinase 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:97,633,768...97,698,133
Ensembl chr 1:97,633,773...97,698,136

G

protein phosphatase 1, regulatory subunit 3C

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:36,709,131...36,714,004
Ensembl chr19:36,709,131...36,714,053

G

protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform

mRNA:decreased expression:tumor:lower in tumor vs adjacent normal tissue (p<0.05 compared to at least one housekeeping gene) (human)
ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605

G

protein phosphatase 2, regulatory subunit B', gamma

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:110,413,532...110,549,509
Ensembl chr12:110,413,554...110,549,496

G

protein phosphatase 6, regulatory subunit 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:89,095,654...89,171,218
Ensembl chr15:89,095,756...89,171,213

G

peroxisome proliferative activated receptor, gamma, coactivator-related 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:46,044,955...46,061,348
Ensembl chr19:46,033,325...46,061,354

G

proline-rich protein BstNI subfamily 1B

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:132,288,553...132,291,706
Ensembl chr 6:132,288,553...132,291,720

G

phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1

protein:increased expression:prostate, lymph node

RGD

NCBI chr 2:166,408,265...166,555,752
Ensembl chr 2:166,408,262...166,555,752

G

phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:11,063,496...11,373,907
Ensembl chr 1:11,063,689...11,373,905

G

proline rich protein HaeIII subfamily 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:132,546,805...132,549,364
Ensembl chr 6:132,546,772...132,549,904

G

protein kinase D1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:50,388,009...50,696,075
Ensembl chr12:50,388,014...50,695,881

G

peripherin 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:47,221,404...47,235,859
Ensembl chr17:47,221,385...47,235,859

G

serine protease 22

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:24,212,508...24,219,696
Ensembl chr17:24,212,508...24,217,074

G

protease (prosome, macropain) 26S subunit, ATPase 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:100,076,461...100,089,623
Ensembl chr12:100,076,413...100,089,664

G

phosphatase and tensin homolog

disease_progression

ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer
OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959
mRNA:decreased expression:tumor:lower in high versus low Gleason score tumors (p<0.05 compared to at least one housekeeping gene) (human)
DNA:deletion

ClinVar
OMIM
MouseDO
RGD

PMID:9259288 PMID:9399897 PMID:9467011 PMID:9856571 PMID:10232405 More...

RGD:2292512, RGD:2301729, RGD:2292502

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

prostaglandin-endoperoxide synthase 2

susceptibility

DNA:SNP:promoter:-1195G>A (human)

RGD

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

PTK2 protein tyrosine kinase 2

protein:increased expression:prostate gland

RGD

NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129

G

PTK2 protein tyrosine kinase 2 beta

severity

protein:decreased expression:prostate gland

RGD

NCBI chr14:66,390,706...66,518,549
Ensembl chr14:66,390,706...66,518,501

G

protein tyrosine phosphatase, non-receptor type 21

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:98,643,000...98,703,664
Ensembl chr12:98,643,000...98,703,664

G

protein tyrosine phosphatase, non-receptor type 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:57,190,841...57,339,036
Ensembl chr 4:57,190,841...57,301,837

G

protein tyrosine phosphatase receptor type D

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:75,859,474...78,132,282
Ensembl chr 4:75,859,475...78,130,198

G

protein tyrosine phosphatase receptor type N polypeptide 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:116,449,316...117,241,787
Ensembl chr12:116,449,340...117,240,469

G

pyrroline-5-carboxylate reductase 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:75,788,319...75,793,369
Ensembl chr15:75,788,326...75,793,409

G

RAB11 family interacting protein 4 (class II)

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:79,481,847...79,588,842
Ensembl chr11:79,482,038...79,588,849

G

RAB33A, member RAS oncogene family

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:47,602,540...47,619,112
Ensembl chr X:47,608,162...47,619,109

G

Rac family small GTPase 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:78,443,369...78,456,983
Ensembl chr15:78,443,367...78,456,983

G

RAD50 double strand break repair protein

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:26467025 PMID:28492532 PMID:33339169

NCBI chr11:53,540,346...53,598,146
Ensembl chr11:53,540,346...53,598,146

G

v-raf-leukemia viral oncogene 1

disease_progression

RGD

NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596

G

Rap guanine nucleotide exchange factor (GEF)-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:98,727,611...98,744,519
Ensembl chr11:98,727,611...98,744,523

G

Ras association (RalGDS/AF-6) and pleckstrin homology domains 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:60,509,997...60,606,233
Ensembl chr 1:60,521,451...60,606,263

G

RAS protein activator like 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:156,962,759...157,240,170
Ensembl chr 1:156,962,752...157,240,165

G

Ras association (RalGDS/AF-6) domain family member 1

disease_progression

DNA:hypermethylation:promoter

RGD

NCBI chr 9:107,428,752...107,439,460
Ensembl chr 9:107,428,754...107,439,466

G

RB transcriptional corepressor 1

DNA:loss of heterozygosity

RGD

NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262

G

RB-associated KRAB zinc finger

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:143,157,941...143,166,530
Ensembl chr 5:143,157,941...143,166,530

G

regulator of chromosome condensation 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:140,427,308...140,450,531
Ensembl chr 4:140,427,852...140,450,531

G

RERG/RAS-like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:139,470,180...139,478,907
Ensembl chr 6:139,469,971...139,478,974

G

Rho-related BTB domain containing 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:70,022,439...70,062,296
Ensembl chr14:70,022,439...70,043,085

G

RIPOR family member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:167,822,081...167,892,809
Ensembl chr 2:167,822,084...167,852,538

G

ring finger protein, LIM domain interacting

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:103,000,770...103,024,886
Ensembl chr X:103,000,769...103,024,890

G

ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)

ClinVar Annotator: match by term: Prostate cancer | ClinVar Annotator: match by term: Prostate cancer, susceptibility to

PMID:11799394 PMID:12415269 PMID:16609730 PMID:25741868 PMID:28492532 More...

RGD:1599614, RGD:2291998

NCBI chr 1:153,625,089...153,644,441
Ensembl chr 1:153,625,172...153,639,967

G

ribosomal protein L10-like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:66,330,153...66,331,175
Ensembl chr12:66,330,153...66,331,175

G

ribosomal protein S6 kinase polypeptide 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:190,505,076...190,645,207
Ensembl chr 1:190,432,399...190,643,967

G

RNA pseudouridylate synthase domain containing 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:25,943,758...25,950,438
Ensembl chr17:25,946,644...25,950,438

G

regulator of telomere elongation helicase 1

susceptibility

DNA:SNP:cds:rs2297441|rs3208008 (human)

RGD

NCBI chr 2:180,961,504...180,998,409
Ensembl chr 2:180,961,532...180,998,409

G

RUN and cysteine rich domain containing beclin 1 interacting protein like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr14:75,253,467...75,289,977
Ensembl chr14:75,253,467...75,289,972

G

RUN domain containing 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:101,315,910...101,326,492
Ensembl chr11:101,315,911...101,326,499

G

S100 calcium binding protein A3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:90,467,571...90,510,922
Ensembl chr 3:90,491,966...90,510,009

G

scaffold attachment factor B2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:56,867,971...56,891,673
Ensembl chr17:56,867,965...56,891,585

G

strawberry notch 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:124,506,765...124,564,059
Ensembl chr 5:124,506,765...124,564,064

G

sodium channel, nonvoltage-gated 1 alpha

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:125,286,657...125,321,906
Ensembl chr 6:125,297,622...125,321,906

G

secernin 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:54,451,813...54,543,332
Ensembl chr 6:54,478,158...54,543,474

G

signal peptide, CUB domain, EGF-like 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:28,361,074...28,393,825
Ensembl chr17:28,361,115...28,393,828

G

sidekick cell adhesion molecule 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:141,227,252...142,201,377
Ensembl chr 5:141,227,245...142,201,341

G

serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 13

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:106,908,714...106,928,925
Ensembl chr 1:106,908,714...106,928,925

G

serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:106,973,317...106,980,033
Ensembl chr 1:106,973,317...106,980,033

G

SET domain containing 5

severity

RGD

NCBI chr 6:113,054,326...113,130,393
Ensembl chr 6:113,054,326...113,130,396

G

SET domain, bifurcated 1

mRNA, protein:increased expression:prostate gland (human)

RGD

NCBI chr 3:95,230,836...95,264,513
Ensembl chr 3:95,230,836...95,264,513

G

seizure related 6 homolog like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:112,567,020...112,726,401
Ensembl chr 5:112,567,017...112,725,051

G

splicing factor 3b, subunit 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:111,537,123...111,573,578
Ensembl chr 8:111,536,871...111,573,419

G

serum/glucocorticoid regulated kinase 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:9,868,355...9,972,795
Ensembl chr 1:9,868,332...9,971,070

G

small G protein signaling modulator 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:74,740,088...74,787,929
Ensembl chr11:74,740,087...74,787,886

G

Shc SH2-domain binding protein 1-like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:153,300,846...153,328,320
Ensembl chr 1:153,300,908...153,328,320

G

sirtuin 1

disease_progression

RGD

NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483

G

sucrase isomaltase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:72,795,890...72,875,196
Ensembl chr 3:72,795,890...72,875,196

G

SKI3 subunit of superkiller complex

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:76,246,837...76,338,437
Ensembl chr13:76,246,853...76,338,435

G

SKI-like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:31,149,259...31,176,741
Ensembl chr 3:31,149,207...31,176,726

G

S-phase kinase-associated protein 2

disease_progression

RGD

NCBI chr15:9,112,070...9,155,512
Ensembl chr15:9,112,073...9,155,512

G

solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:25741868 PMID:28492532

NCBI chr 2:165,247,215...165,315,117
Ensembl chr 2:165,246,948...165,315,150

G

solute carrier family 16 (monocarboxylic acid transporters), member 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr X:102,741,020...102,865,594
Ensembl chr X:102,741,020...102,865,589

G

solute carrier family 25 (mitochondrial carrier, glutamate), member 22

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:141,009,662...141,017,787
Ensembl chr 7:141,009,657...141,017,805

G

solute carrier family 25, member 32

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:38,954,625...38,976,213
Ensembl chr15:38,954,626...38,976,111

G

solute carrier family 25, member 47

ClinVar Annotator: match by term: Prostate cancer

NCBI chr12:108,815,740...108,822,741
Ensembl chr12:108,801,972...108,822,741

G

solute carrier family 30 (zinc transporter), member 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:134,070,357...134,081,795
Ensembl chr 4:134,070,492...134,081,795

G

solute carrier family 34 (sodium phosphate), member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:55,547,435...55,562,508
Ensembl chr13:55,546,000...55,563,405

G

solute carrier family 35, member C1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:92,283,109...92,290,863
Ensembl chr 2:92,283,109...92,290,883

G

solute carrier family 35, member G1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:38,384,428...38,394,055
Ensembl chr19:38,384,428...38,394,058

G

solute carrier family 46, member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:147,812,707...147,831,670
Ensembl chr 5:147,815,247...147,831,625

G

solute carrier family 5 (sodium/glucose cotransporter), member 2

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:25741868

NCBI chr 7:127,864,855...127,871,602
Ensembl chr 7:127,864,829...127,871,602

G

solute carrier family 5 (choline transporter), member 7

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:54,580,618...54,606,071
Ensembl chr17:54,580,618...54,606,062

G

solute carrier family 6 (neurotransmitter transporter, glycine), member 9

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr 4:117,692,240...117,726,502
Ensembl chr 4:117,691,703...117,732,395

G

solute carrier family 8 (sodium/calcium exchanger), member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:81,244,686...81,380,506
Ensembl chr12:81,244,689...81,379,954

G

solute carrier organic anion transporter family, member 1b2

disease_progression

mRNA,protein:increased expression:prostate (human)

RGD

NCBI chr 6:141,575,178...141,632,372
Ensembl chr 6:141,575,244...141,632,372

G

SMAD family member 3

disease_progression

RGD

NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276

G

SMAD family member 9

protein:altered localization

RGD

NCBI chr 3:54,662,873...54,709,162
Ensembl chr 3:54,663,003...54,708,678

G

SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2

disease_progression

NCBI chr19:26,582,578...26,755,721
Ensembl chr19:26,582,450...26,755,722

G

SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4

no_association
disease_progression

human gene: absence of somatic mutations in the samples used

PMID:17075831 PMID:12684665

RGD:2302527, RGD:2302528

NCBI chr 9:21,527,377...21,615,526
Ensembl chr 9:21,527,465...21,615,526

G

SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:128,294,823...128,326,460
Ensembl chr10:128,295,117...128,326,351

G

single-strand selective monofunctional uracil DNA glycosylase

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:103,061,717...103,077,360
Ensembl chr15:103,061,717...103,075,519

G

small nuclear ribonucleoprotein E

severity

mRNA:increased expression:prostate gland (human)

RGD

NCBI chr 1:133,531,609...133,538,018
Ensembl chr 1:133,531,609...133,538,029

G

suppressor of cytokine signaling 1

DNA:hypermethylation

RGD

NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400

G

sorbin and SH3 domain containing 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:40,280,484...40,502,399
Ensembl chr19:40,283,197...40,502,223

G

sortilin-related VPS10 domain containing receptor 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:50,131,733...50,668,030
Ensembl chr19:50,131,737...50,667,084

G

SOS Ras/Rac guanine nucleotide exchange factor 1

RGD

NCBI chr17:80,701,181...80,787,882
Ensembl chr17:80,701,180...80,787,882

G

SRY (sex determining region Y)-box 9

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586

G

spermatogenesis associated 18

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:73,808,723...73,836,927
Ensembl chr 5:73,808,722...73,836,855

G

sperm antigen with calponin homology and coiled-coil domains 1-like

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr10:75,047,872...75,148,234
Ensembl chr10:75,047,905...75,148,577

G

serine peptidase inhibitor, Kazal type 1

severity

protein:increased expression:prostate gland, serum

RGD

NCBI chr18:43,861,134...43,870,302
Ensembl chr18:43,861,147...43,870,622

G

speckle-type BTB/POZ protein

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:25741868 PMID:26619011

NCBI chr11:95,304,909...95,384,236
Ensembl chr11:95,304,906...95,384,232

G

Rous sarcoma oncogene

disease_progression

protein:increased tyrosine phosphorylation:prostate gland, membrane

RGD

NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782

G

steroid 5 alpha-reductase 1

disease_progression

protein:increased expression:prostate gland

RGD

PMID:17720776 PMID:16818707 PMID:16818707

RGD:2302521, RGD:2302523, RGD:2302523

NCBI chr13:69,721,568...69,759,611
Ensembl chr13:69,721,568...69,759,561

G

steroid 5 alpha-reductase 2

susceptibility

DNA:missense mutation:cds:p.A49T (human)
mRNA:decreased expression:prostate gland

RGD

PMID:10501358 PMID:12949937

RGD:4891929, RGD:2302560

NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911

G

sterol regulatory element binding factor 2

disease_progression

PMID:15026365 PMID:15026365

RGD:1581413, RGD:1581413

NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580

G

single-stranded DNA binding protein 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:91,608,449...91,854,299
Ensembl chr13:91,608,402...91,851,548

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:13,659,745...13,798,659
Ensembl chr 2:13,655,832...13,798,875

G

signal transducer and activator of transcription 3

treatment

RGD

NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366

G

signal transducer and activator of transcription 5A

disease_progression

DNA:CNV: :prostate (human)

RGD

NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995

G

signal transducer and activator of transcription 6

disease_progression

RGD

NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826

G

syntaxin 8

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:67,857,237...68,097,974
Ensembl chr11:67,857,019...68,097,974

G

syntaxin binding protein 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:32,677,619...32,737,249
Ensembl chr 2:32,677,614...32,737,257

G

SUFU negative regulator of hedgehog signaling

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr19:46,385,335...46,477,243
Ensembl chr19:46,385,335...46,477,243

G

sulfotransferase family 1A, phenol-preferring, member 1

RGD

NCBI chr 7:126,272,042...126,289,615
Ensembl chr 7:126,272,037...126,275,604

G

sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1

severity
no_association

DNA:SNP:intron: (rs2547238) (human)
DNA:missense mutations:cds:p.A63P (187G>C), p.A261T (781G>A) (human)

RGD

PMID:22542949 PMID:16617014

RGD:6893648, RGD:6893649

NCBI chr 7:13,530,171...13,571,335
Ensembl chr 7:13,530,171...13,571,334

G

synaptic vesicle glycoprotein 2b

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:74,764,642...74,959,143
Ensembl chr 7:74,764,642...74,959,010

G

synaptonemal complex protein 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:177,987,088...178,051,580
Ensembl chr 2:177,987,086...178,049,478

G

synaptogyrin 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:79,975,537...80,003,702
Ensembl chr15:79,975,535...80,003,702

G

TAO kinase 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:117,258,180...117,413,283
Ensembl chr 5:117,258,194...117,413,284

G

taste receptor, type 2, member 115

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 6:132,714,017...132,714,949
Ensembl chr 6:132,713,966...132,714,998

G

transcription factor 3

severity

RGD

NCBI chr10:80,245,375...80,269,814
Ensembl chr10:80,245,348...80,269,481

G

transcription factor 7, T cell specific

severity

RGD

NCBI chr11:52,137,347...52,174,211
Ensembl chr11:52,143,198...52,174,158

G

transcription factor 7 like 2, T cell specific, HMG box

disease_progression

DNA:SNPs: :rs7094463, rs10749127, rs11196224 (human)
DNA:SNP: :rs7903146 (human)

RGD

PMID:25678841 PMID:24961829

RGD:13506821, RGD:13506825

NCBI chr19:55,730,227...55,922,091
Ensembl chr19:55,730,252...55,922,086

G

telomerase RNA component

DNA:amplification:prostate gland

RGD

NCBI chr 3:96,321,753...96,322,149
Ensembl chr 3:96,321,753...96,322,149

G

telomerase reverse transcriptase

mRNA:increased expression:plasma

RGD

NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962

G

testis expressed gene 14 intercellular bridge forming factor

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:87,295,839...87,446,649
Ensembl chr11:87,295,891...87,446,649

G

trefoil factor 1

disease_progression

protein:increased expression:plasma
mRNA:increased expression:prostate gland

RGD

PMID:16467092 PMID:10458410

RGD:2291999, RGD:2298571

NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251

G

trefoil factor 2 (spasmolytic protein 1)

disease_progression

protein:increased expression:plasma

RGD

NCBI chr17:31,360,036...31,363,256
Ensembl chr17:31,360,023...31,363,256

G

trefoil factor 3, intestinal

disease_progression

protein:increased expression:plasma

RGD

NCBI chr17:31,344,280...31,348,585
Ensembl chr17:31,344,280...31,348,620

G

transferrin receptor

protein:increased expression:serum

RGD

NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612

G

thyroglobulin

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr15:66,542,606...66,722,570
Ensembl chr15:66,542,602...66,722,570

G

transforming growth factor, beta 1

protein:increased expression:prostate gland

RGD

NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502

G

transforming growth factor, beta receptor II

OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959

NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428

G

transforming growth factor, beta receptor III

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:107,254,433...107,437,495
Ensembl chr 5:107,254,436...107,437,495

G

thrombospondin 1

mRNA:decreased expression:prostate gland

RGD

NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614

G

thrombospondin 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:89,122,470...89,134,148
Ensembl chr 3:89,122,487...89,134,144

G

thyroid hormone receptor beta

DNA:loss of heterozygosity (human)

RGD

NCBI chr14:4,429,599...4,810,538
Ensembl chr14:4,431,611...4,809,435

G

tissue inhibitor of metalloproteinase 2

disease_progression

DNA, protein:hypermethylation, decreased expression:promoter, prostate gland
protein:increased expression:prostate gland

RGD

PMID:17325663 PMID:18329693

RGD:2290397, RGD:2290389

NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566

G

tissue inhibitor of metalloproteinase 3

disease_progression

mRNA:decreased expression:prostate gland

RGD

NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370

G

toll-like receptor 2

susceptibility

DNA:deletion:promoter:−196_−174del (human)

RGD

NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074

G

transmembrane and coiled-coil domains 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:116,709,174...116,722,987
Ensembl chr 2:116,709,172...116,722,975

G

transmembrane protein with EGF-like and two follistatin-like domains 2

disease_progression

DNA:hypermethylation

RGD

PMID:16458425 PMID:15299075 PMID:16500022

RGD:2290486, RGD:2290490, RGD:2290485

NCBI chr 1:50,951,946...51,226,429
Ensembl chr 1:50,939,806...51,226,429

G

transmembrane protein 183A

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:134,273,834...134,289,765
Ensembl chr 1:134,273,835...134,289,717

G

transmembrane protein 230

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 2:132,081,412...132,089,708
Ensembl chr 2:132,081,412...132,089,727

G

transmembrane protein 94

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:115,656,245...115,689,859
Ensembl chr11:115,656,259...115,690,192

G

tumor necrosis factor

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

tumor necrosis factor receptor superfamily, member 8

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734

G

topoisomerase (DNA) II alpha

RGD

NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015

G

topoisomerase I binding, arginine/serine-rich

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:40,259,606...40,269,841
Ensembl chr 4:40,259,601...40,269,850

G

transferrin

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643

G

tripartite motif-containing 28

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:12,758,079...12,764,959
Ensembl chr 7:12,733,041...12,764,962

G

tripartite motif-containing 34A

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:103,893,657...103,911,446
Ensembl chr 7:103,893,664...103,911,441

G

tripartite motif-containing 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:103,912,593...103,937,448
Ensembl chr 7:103,912,593...103,937,301

G

tripartite motif family-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:43,582,843...43,633,531
Ensembl chr 8:43,582,844...43,594,523

G

thyroid hormone receptor interactor 12

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:84,698,910...84,818,285
Ensembl chr 1:84,698,910...84,818,237

G

transformation related protein 53

disease_progression

DNA:mutations:exon
ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar Annotator: match by term: Prostate cancer

PMID:1467311 PMID:1565144 PMID:2750177 PMID:7887414 PMID:7969167 More...

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

transformation related protein 63

ClinVar Annotator: match by term: Prostate cancer

PMID:23265383 PMID:28492532

NCBI chr16:25,502,513...25,710,842
Ensembl chr16:25,502,513...25,710,852

G

transformation related protein 73

mRNA:alternative forms

RGD

NCBI chr 4:154,140,706...154,224,332
Ensembl chr 4:154,140,706...154,224,665

G

transient receptor potential cation channel, subfamily C, member 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:95,587,125...95,632,438
Ensembl chr 9:95,587,135...95,632,428

G

transient receptor potential cation channel, subfamily C, member 4

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:54,063,441...54,225,892
Ensembl chr 3:54,063,456...54,225,892

G

transient receptor potential cation channel, subfamily M, member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr19:22,114,789...22,972,774
Ensembl chr19:22,116,410...22,972,774

G

transformation/transcription domain-associated protein

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:144,704,547...144,796,588
Ensembl chr 5:144,704,542...144,796,588

G

tumor susceptibility gene 101

mRNA:alternative forms:cds:multiple

RGD

NCBI chr 7:46,538,693...46,569,716
Ensembl chr 7:46,538,697...46,569,717

G

teashirt zinc finger family member 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:36,397,543...36,472,978
Ensembl chr 7:36,397,543...36,472,978

G

translin-associated factor X (Tsnax) interacting protein 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:106,554,343...106,571,310
Ensembl chr 8:106,554,363...106,571,312

G

tetraspanin 5

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:138,447,609...138,610,194
Ensembl chr 3:138,447,956...138,613,666

G

tubulin, beta 3 class III

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754

G

unc-51 like kinase 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:61,666,424...61,750,754
Ensembl chr11:61,666,475...61,745,899

G

uromodulin-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr17:31,173,614...31,229,684
Ensembl chr17:31,173,614...31,229,684

G

unc-79 homolog

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr12:102,913,642...103,150,487
Ensembl chr12:102,915,118...103,150,324

G

URB2 ribosome biogenesis 2 homolog (S. cerevisiae)

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 8:124,748,236...124,775,244
Ensembl chr 8:124,748,247...124,775,244

G

upstream transcription factor 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:30,645,421...30,656,288
Ensembl chr 7:30,644,673...30,656,228

G

usherin

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 1:187,995,035...188,697,694
Ensembl chr 1:187,994,220...188,697,238

G

ubiquitin specific peptidase 28

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:48,896,577...48,953,817
Ensembl chr 9:48,896,675...48,953,817

G

ubiquitin specific peptidase 48

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 4:137,321,079...137,385,842
Ensembl chr 4:137,321,066...137,385,848

G

UV radiation resistance associated gene

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:98,535,949...98,790,373
Ensembl chr 7:98,534,228...98,790,348

G

versican

ClinVar Annotator: match by term: Malignant tumor of prostate

PMID:23265383 PMID:28492532

NCBI chr13:89,803,429...89,891,146
Ensembl chr13:89,803,431...89,890,628

G

voltage-dependent anion channel 1

DNA:SNP: :rs7250897 (human)

RGD

NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224

G

vitamin D (1,25-dihydroxyvitamin D3) receptor

susceptibility

DNA:SNP: :rs11574143 (human)

RGD

NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511

G

vascular endothelial growth factor A

RGD

NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295

G

vitamin K epoxide reductase complex, subunit 1-like 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:129,970,950...130,015,533
Ensembl chr 5:129,970,811...130,015,533

G

WD repeat and FYVE domain containing 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:101,980,819...102,220,081
Ensembl chr 5:101,980,822...102,217,787

G

WD repeat domain 49

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:75,181,235...75,389,472
Ensembl chr 3:75,182,295...75,389,463

G

WAP four-disulfide core domain 1

disease_progression

protein:decreased expression, increased expression:connective tissue, epithelium
mRNA:decreased expression:prostate gland

RGD

PMID:15305341 PMID:15305342

RGD:2291860, RGD:2291859

NCBI chr 8:120,393,104...120,414,759
Ensembl chr 8:120,393,104...120,414,961

G

Wnt inhibitory factor 1

mRNA, protein:decreased expression:prostate gland

RGD

NCBI chr10:120,869,909...120,936,547
Ensembl chr10:120,869,865...120,936,555

G

wingless-type MMTV integration site family, member 2

mRNA:decreased expression:prostate gland

RGD

NCBI chr 6:17,988,939...18,032,771
Ensembl chr 6:17,988,939...18,030,584

G

X-linked inhibitor of apoptosis

disease_progression

protein:increased expression:prostate gland

RGD

PMID:17947468 PMID:19415464

RGD:2315852, RGD:2315849

NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533

G

X-ray repair complementing defective repair in Chinese hamster cells 1

susceptibility

DNA:polymorphism: :p.R399Q

RGD

NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865

G

YTH domain containing 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr18:44,961,521...45,022,782
Ensembl chr18:44,960,813...45,022,791

G

zinc finger, DHHC domain containing 8

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr16:18,038,612...18,056,471
Ensembl chr16:18,038,617...18,053,000

G

zinc finger homeobox 3

susceptibility

DNA:deletion (human)
DNA, mRNA:mutations, decreased expression: :multiple, prostate gland (human)

OMIM
RGD

PMID:16637072 PMID:15750593

RGD:2315694, RGD:2315695

NCBI chr 8:109,005,975...109,688,272
Ensembl chr 8:108,669,276...109,688,262

G

zinc finger protein 184 (Kruppel-like)

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr13:22,129,223...22,144,961
Ensembl chr13:22,129,264...22,144,949

G

zinc finger protein 287

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:62,583,270...62,622,749
Ensembl chr11:62,591,182...62,622,731

G

zinc finger protein 39

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr11:58,778,979...58,795,051
Ensembl chr11:58,778,979...58,795,051

G

zinc finger protein 553

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:126,832,233...126,837,369
Ensembl chr 7:126,832,233...126,837,351

G

zinc finger protein 560

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 9:20,256,432...20,296,479
Ensembl chr 9:20,256,432...20,296,473

G

zinc finger protein 773

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:7,133,677...7,139,754
Ensembl chr 7:7,130,072...7,139,754

G

zinc finger with KRAB and SCAN domains 1

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 5:138,083,312...138,106,084
Ensembl chr 5:138,083,346...138,106,084

G

zinc finger matrin type 3

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 3:32,388,941...32,419,814
Ensembl chr 3:32,388,941...32,420,163

G

zinc finger and SCAN domain containing 2

ClinVar Annotator: match by term: Malignant tumor of prostate

NCBI chr 7:80,510,485...80,539,740
Ensembl chr 7:80,510,668...80,526,285

Prostate Cancer, Hereditary, 1

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Braf transforming gene

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

PMID:12068308 PMID:12460918 PMID:12460919 PMID:14679157 PMID:15035987 More...

NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397

G

homeobox B13

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

PMID:9536098 PMID:17576681 PMID:25741868 PMID:26467025 PMID:28492532

NCBI chr11:96,085,142...96,087,436
Ensembl chr11:96,085,142...96,088,273

G

Harvey rat sarcoma virus oncogene

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918

G

Kirsten rat sarcoma viral oncogene homolog

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

PMID:17056636 PMID:17468812 PMID:17704260 PMID:18386799 PMID:20949621 More...

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

leucine rich repeat containing 56

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

NCBI chr 7:140,774,024...140,789,968
Ensembl chr 7:140,774,070...140,789,968

G

neuroblastoma ras oncogene

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230

G

phosphatase and tensin homolog

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

PMID:9467011 PMID:9600246 PMID:10051160 PMID:12786840 PMID:16773562 More...

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

PMID:11799394 PMID:12415269 PMID:16609730 PMID:25741868 PMID:28492532

NCBI chr 1:153,625,089...153,644,441
Ensembl chr 1:153,625,172...153,639,967

G

transformation related protein 53

ClinVar Annotator: match by term: Prostate cancer, hereditary, 1

PMID:12826609 PMID:20522432 PMID:25741868 PMID:27545002 PMID:28492532 More...

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

Prostate Cancer, Hereditary, 12

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

EH domain binding protein 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Prostate cancer, hereditary, 12

OMIM
CTD
ClinVar

NCBI chr11:21,955,825...22,237,086
Ensembl chr11:21,955,828...22,292,292

Prostate Cancer, Hereditary, 13

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

beta-microseminoprotein

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Prostate cancer, hereditary, 13

OMIM
CTD
ClinVar

PMID:18264096 PMID:18264097 PMID:19153072 PMID:19383797 PMID:19644707

NCBI chr14:31,863,980...31,880,284
Ensembl chr14:31,863,980...31,880,327

Prostate Cancer, Hereditary, 2

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

elaC ribonuclease Z 2

ClinVar Annotator: match by term: Prostate cancer, hereditary, 2

PMID:10986046 PMID:11175785 PMID:11254448 PMID:11507049 PMID:12515253 More...

NCBI chr11:64,869,856...64,892,906
Ensembl chr11:64,869,864...64,892,895

Prostate Cancer, Hereditary, 9

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

homeobox B13

ClinVar Annotator: match by term: Prostate cancer, hereditary, 9
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:8756292 PMID:15964834 PMID:17138648 PMID:22236224 PMID:22714738 More...

NCBI chr11:96,085,142...96,087,436
Ensembl chr11:96,085,142...96,088,273

Prostate Cancer, Somatic

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

androgen receptor

ClinVar Annotator: match by term: Prostate cancer, somatic

PMID:1631125 PMID:1779964 PMID:6541981 PMID:7723794 PMID:7795646 More...

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

checkpoint kinase 2

ClinVar Annotator: match by term: Prostate cancer, somatic

PMID:12533788 PMID:16835864 PMID:16941491 PMID:18058223 PMID:18996005 More...

NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011

G

Kruppel-like transcription factor 6

ClinVar Annotator: match by term: Prostate cancer, somatic

NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393

G

MAD1 mitotic arrest deficient 1-like 1

ClinVar Annotator: match by term: Prostate cancer, somatic

PMID:11423979 PMID:25741868

NCBI chr 5:139,994,444...140,307,346
Ensembl chr 5:139,994,444...140,307,307

G

phosphatase and tensin homolog

ClinVar Annotator: match by term: Prostate cancer, somatic

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

zinc finger homeobox 3

ClinVar Annotator: match by term: Prostate cancer, somatic

NCBI chr 8:109,005,975...109,688,272
Ensembl chr 8:108,669,276...109,688,262

Prostate Cancer/Brain Cancer Susceptibility

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Eph receptor B2

susceptibility

ClinVar Annotator: match by term: Prostate cancer/brain cancer susceptibility
CTD Direct Evidence: marker/mechanism

ClinVar
OMIM
CTD

PMID:15300251 PMID:16155194 PMID:25741868 PMID:28492532

NCBI chr 4:136,374,850...136,563,637
Ensembl chr 4:136,374,850...136,563,299

prostate carcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

thymoma viral proto-oncogene 2

treatment

RGD

NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251

G

angiopoietin 1

protein:increased expression:prostate gland

RGD

NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373

G

activating transcription factor 4

treatment

RGD

NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742

G

alpha-2-glycoprotein 1, zinc

exacerbates

RGD

NCBI chr 5:137,979,783...137,988,495
Ensembl chr 5:137,979,782...137,988,495

G

BCL2-associated agonist of cell death

protein:increased expression:prostate gland

RGD

NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267

G

BCL2-associated X protein

disease_progression

protein:increased expression:prostate gland epithelium

RGD

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

BCL2-like 1

RGD

NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648

G

BCL2 like 14

mRNA:decreased expression:prostate gland

RGD

NCBI chr 6:134,373,292...134,415,687
Ensembl chr 6:134,373,281...134,415,699

G

bone morphogenetic protein 2

disease_progression

protein:increased expression:prostate gland

RGD

NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805

G

bone morphogenetic protein 4

disease_progression

protein:increased expression:prostate

RGD

NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126

G

caspase 6

mRNA:increased expression:prostate gland

NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752

G

cyclin dependent kinase 13

ameliorates

RGD

NCBI chr13:17,885,309...17,979,960
Ensembl chr13:17,884,900...17,979,682

G

glycoprotein hormones, alpha subunit

mRNA:increased expression:prostate gland

RGD

NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370

G

chitinase 3 like 1

severity

protein:increased secretion:serum (human)

RGD

NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919

G

v-crk avian sarcoma virus CT10 oncogene homolog-like

protein:decreased tyrosine phosphorylation:prostate gland

RGD

NCBI chr16:17,269,849...17,305,304
Ensembl chr16:17,269,851...17,305,298

G

E2F transcription factor 5

ameliorates

RGD

NCBI chr 3:14,638,370...14,671,369
Ensembl chr 3:14,643,701...14,671,369

G

eukaryotic translation initiation factor 3, subunit H

DNA:amplification

RGD

NCBI chr15:51,649,956...51,728,901
Ensembl chr15:51,649,954...51,728,919

G

growth hormone releasing hormone

mRNA:increased expression:prostate

RGD

NCBI chr 2:157,171,416...157,190,645
Ensembl chr 2:157,171,417...157,189,426

G

histone deacetylase 2

disease_progression

protein:increased expression:prostate gland

RGD

NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885

G

histone deacetylase 3

protein:increased expression:prostate gland

RGD

NCBI chr18:38,070,024...38,088,073
Ensembl chr18:38,068,897...38,088,069

G

hydroxymethylbilane synthase

mRNA:decreased expression:tumor:in matched malignant and non-malignant sample pairs (p = 0.009) (human)

RGD

NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525

G

insulin-like growth factor I receptor

RGD

NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416

G

inhibin alpha

RGD

NCBI chr 1:75,483,872...75,487,010
Ensembl chr 1:75,483,721...75,487,010

G

jun proto-oncogene

RGD

NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459

G

met proto-oncogene

disease_progression

protein:increased expression:primary tumor, metastatic carcinoma (human)

RGD

NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979

G

matrix Gla protein

RGD

NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821

G

antigen identified by monoclonal antibody Ki 67

RGD

NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090

G

matrix metallopeptidase 7

RGD

NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,586

G

NME/NM23 nucleoside diphosphate kinase 1

RGD

NCBI chr11:93,849,751...93,859,341
Ensembl chr11:93,847,805...93,859,347

G

platelet derived growth factor, B polypeptide

RGD

NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178

G

platelet-derived growth factor, D polypeptide

disease_progression

RGD

NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850

G

polo like kinase 1

mRNA, protein:increased expression:prostate gland

RGD

NCBI chr 7:121,758,658...121,769,107
Ensembl chr 7:121,758,662...121,769,096

G

protein kinase C, alpha

RGD

NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754

G

seryl-tRNA synthetase 1

mRNA:decreased expression:prostate gland (human)

RGD

NCBI chr 3:108,332,180...108,352,575
Ensembl chr 3:108,332,181...108,352,525

G

S-phase kinase-associated protein 2

RGD

NCBI chr15:9,112,070...9,155,512
Ensembl chr15:9,112,073...9,155,512

G

serine protease inhibitor, Kunitz type 1

disease_progression

protein:decreased expression:prostate gland (human)

RGD

NCBI chr 2:119,067,841...119,079,995
Ensembl chr 2:119,067,843...119,080,008

G

secreted phosphoprotein 1

RGD

NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916

G

signal transducer and activator of transcription 3

protein:increased activity:prostate gland

RGD

PMID:11987152 PMID:18210874

RGD:2298538, RGD:2291910

NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366

G

signal transducer and activator of transcription 6

RGD

NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826

G

transmembrane BAX inhibitor motif containing 6

mRNA:increased expression:prostate gland

RGD

NCBI chr15:99,290,828...99,307,930
Ensembl chr15:99,290,763...99,307,930

G

transformation related protein 73

disease_progression

mRNA, protein:increased expression:prostate gland

RGD

NCBI chr 4:154,140,706...154,224,332
Ensembl chr 4:154,140,706...154,224,665

prostate carcinoma in situ

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-methylacyl-CoA racemase

disease_progression

RGD

NCBI chr15:10,981,875...10,995,693
Ensembl chr15:10,981,842...10,996,712

G

angiogenin, ribonuclease, RNase A family, 5

RGD

NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466

G

apurinic/apyrimidinic endonuclease 1

protein:increased expression, altered localization:prostate, cytoplasm

RGD

NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596

G

androgen receptor

CTD Direct Evidence: marker/mechanism

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

amphiregulin

protein:increased expression:prostate gland

RGD

NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291

G

ataxia telangiectasia mutated

protein:increased serine phosphorylation:prostate gland

RGD

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

aurora kinase A

protein:increased expression:prostate gland

RGD

PMID:16707419 PMID:15754349

RGD:2293877, RGD:2293883

NCBI chr 2:172,198,116...172,212,825
Ensembl chr 2:172,198,110...172,212,455

G

aurora kinase B

RGD

NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490

G

BTG anti-proliferation factor 2

protein:decreased expression:prostate gland

RGD

NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858

G

coactivator-associated arginine methyltransferase 1

protein:increased expression:prostate gland

RGD

NCBI chr 9:21,458,163...21,500,763
Ensembl chr 9:21,458,190...21,503,919

G

cyclin D1

mRNA, protein:decreased expression:prostate gland

RGD

NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662

G

cyclin E1

mRNA, protein:increased expression:prostate gland

RGD

NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959

G

cadherin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cyclin dependent kinase inhibitor 1B

CTD Direct Evidence: therapeutic

CTD
RGD

PMID:20932324 PMID:18691549

NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476

G

cAMP responsive element binding protein 3-like 4

severity

RGD

NCBI chr 3:90,144,805...90,161,387
Ensembl chr 3:90,144,807...90,150,819

G

colony stimulating factor 1 receptor

protein:increased expression:prostate gland

RGD

NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221

G

cytochrome P450, family 19, subfamily a, polypeptide 1

RGD

NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394

G

DNA methyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184

G

estrogen receptor 1 (alpha)

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16220300 PMID:22025007

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

estrogen receptor 2 (beta)

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16220300 PMID:22025007

NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033

G

fibroblast growth factor 6

protein:increased expression:prostate gland

RGD

NCBI chr 6:126,992,505...127,001,681
Ensembl chr 6:126,992,549...127,005,150

G

fibroblast growth factor 8

RGD

NCBI chr19:45,724,930...45,731,380
Ensembl chr19:45,725,237...45,731,354

G

fibroblast growth factor receptor 1

RGD

NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734

G

fibroblast growth factor receptor 2

RGD

NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079

G

FMS-like tyrosine kinase 1

protein:decreased expression:prostate gland

RGD

NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821

G

frizzled class receptor 4

protein:increased expression:prostate gland

RGD

NCBI chr 7:89,053,574...89,062,341
Ensembl chr 7:89,053,563...89,062,342

G

glutathione S-transferase, pi 1

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:22581815 PMID:24312188

NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985

G

histone deacetylase 1

protein:increased expression:prostate gland

RGD

NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506

G

insulin-like growth factor 1

protein:increased expression:prostate gland

RGD

NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904

G

Kirsten rat sarcoma viral oncogene homolog

RGD

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

lymphoid enhancer binding factor 1

RGD

NCBI chr 3:130,903,972...131,018,006
Ensembl chr 3:130,904,120...131,018,005

G

low density lipoprotein receptor-related protein 1

protein:increased expression:prostate gland

RGD

NCBI chr10:127,374,026...127,457,158
Ensembl chr10:127,374,030...127,457,017

G

mitogen-activated protein kinase kinase 4

disease_progression

RGD

NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123

G

mitogen-activated protein kinase kinase 6

disease_progression

RGD

NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348

G

mitogen-activated protein kinase kinase 7

disease_progression

RGD

NCBI chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897

G

metallothionein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196

G

myelocytomatosis oncogene

RGD

NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223

G

prohibitin 1

mRNA, protein:increased expression:prostate gland

RGD

NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599

G

proviral integration site 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:29,709,759...29,715,085
Ensembl chr17:29,709,727...29,715,086

G

serine protease 8 (prostasin)

disease_progression

mRNA, protein:increased expression:prostate gland

RGD

NCBI chr 7:127,524,889...127,529,266
Ensembl chr 7:127,524,888...127,529,276

G

phosphatase and tensin homolog

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:19081794 PMID:22581815 PMID:18268330

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

prostaglandin-endoperoxide synthase 2

protein:altered localization

RGD

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

v-rel reticuloendotheliosis viral oncogene homolog A (avian)

protein:increased expression:prostate gland

RGD

PMID:15570007 PMID:16278667

RGD:2298769, RGD:2298767

NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158

G

retinoid X receptor alpha

protein:decreased expression:prostate

RGD

NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969

G

solute carrier family 30 (zinc transporter), member 4

protein:decreased expression:prostate gland

RGD

NCBI chr 2:122,523,153...122,544,583
Ensembl chr 2:122,523,153...122,544,583

G

SMAD family member 4

protein:increased expression:prostate gland

RGD

NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851

G

suppression of tumorigenicity 14 (colon carcinoma)

protein:increased expression:prostate gland

RGD

NCBI chr 9:30,999,886...31,043,138
Ensembl chr 9:31,000,698...31,043,149

G

serine/threonine kinase 11

RGD

NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516

G

tissue inhibitor of metalloproteinase 4

RGD

NCBI chr 6:115,221,405...115,229,166
Ensembl chr 6:115,218,853...115,229,166

G

topoisomerase (DNA) II beta

CTD Direct Evidence: marker/mechanism

NCBI chr14:6,038,976...6,104,585
Ensembl chr14:6,034,301...6,104,584

G

transformation related protein 63

protein:decreased expression:prostate gland
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:22581815 PMID:17189982 PMID:17982114

RGD:2315434, RGD:2315433

NCBI chr16:25,502,513...25,710,842
Ensembl chr16:25,502,513...25,710,852

prostate disease

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

oxytocin

CTD Direct Evidence: marker/mechanism

NCBI chr 2:130,416,432...130,418,974
Ensembl chr 2:130,418,093...130,418,974

prostate small cell carcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

breast cancer 2, early onset

ClinVar Annotator: match by term: Metastatic Prostate Small Cell Carcinoma

PMID:10660329 PMID:11597388 PMID:11802209 PMID:15024741 PMID:15689453 More...

NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794

prostatic hypertrophy

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

androgen receptor

treatment

RGD

PMID:22430536 PMID:24872436

RGD:10043335, RGD:10045676

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

activating transcription factor 4

RGD

NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742

G

BCL2-associated agonist of cell death

protein:increased expression:prostate gland

RGD

NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267

G

caspase 1

protein:decreased expression:prostate gland

RGD

NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290

G

caspase 6

RGD

NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752

G

cyclin B1

RGD

NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078

G

cyclin dependent kinase 4

protein:decreased expression:prostate gland

RGD

NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789

G

cystic fibrosis transmembrane conductance regulator

protein:decreased expression:prostate gland

RGD

NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767

G

clusterin

mRNA, protein:increased expression:prostate gland

RGD

NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996

G

estrogen receptor 1 (alpha)

treatment

RGD

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

estrogen receptor 2 (beta)

treatment

RGD

NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033

G

Fas associated via death domain

treatment

RGD

NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200

G

fibroblast growth factor 7

no_association

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:14999240 PMID:11482780 PMID:9000125 PMID:9285567

RGD:2289085, RGD:2301094, RGD:2289086

NCBI chr 2:125,876,578...125,933,105
Ensembl chr 2:125,876,578...125,933,105

G

fibroblast growth factor 8

RGD

NCBI chr19:45,724,930...45,731,380
Ensembl chr19:45,725,237...45,731,354

G

growth hormone releasing hormone

treatment

RGD

PMID:22341819 PMID:21321192

RGD:10401238, RGD:10401264

NCBI chr 2:157,171,416...157,190,645
Ensembl chr 2:157,171,417...157,189,426

G

gonadotropin releasing hormone 1

treatment

RGD

NCBI chr14:67,982,717...67,986,889
Ensembl chr14:67,982,630...67,986,888

G

glutathione S-transferase, pi 1

treatment

RGD

NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985

G

insulin-like growth factor I receptor

mRNA: increased expression: prostate

RGD

NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416

G

interleukin 13

mRNA:increased expression:prostate gland

RGD

NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529

G

interleukin 3

mRNA: increased expression: prostate

RGD

NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103

G

interleukin 5

treatment

RGD

NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933

G

kinase insert domain protein receptor

RGD

NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118

G

myelocytomatosis oncogene

treatment

RGD

NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223

G

NME/NM23 nucleoside diphosphate kinase 2

RGD

NCBI chr11:93,840,640...93,847,082
Ensembl chr11:93,840,640...93,847,085

G

platelet derived growth factor, B polypeptide

RGD

NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178

G

platelet-derived growth factor, D polypeptide

disease_progression

RGD

NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850

G

prolactin

CTD Direct Evidence: marker/mechanism

NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188

G

phosphatase and tensin homolog

RGD

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

prostaglandin-endoperoxide synthase 2

protein:increased expression:prostate gland

RGD

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

v-rel reticuloendotheliosis viral oncogene homolog A (avian)

protein:increased expression:prostate gland

RGD

NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158

G

steroid 5 alpha-reductase 1

severity

DNA:SNPs:cds

RGD

NCBI chr13:69,721,568...69,759,611
Ensembl chr13:69,721,568...69,759,561

G

steroid 5 alpha-reductase 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911

G

transmembrane protease, serine 2

protein:increased expression:prostate gland

RGD

NCBI chr16:97,365,882...97,460,741
Ensembl chr16:97,365,882...97,412,395

G

transformation related protein 73

mRNA:alternative forms

RGD

NCBI chr 4:154,140,706...154,224,332
Ensembl chr 4:154,140,706...154,224,665

Prostatic Neoplasms

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

achalasia, adrenocortical insufficiency, alacrimia

CTD Direct Evidence: marker/mechanism

NCBI chr15:102,246,682...102,259,194
Ensembl chr15:102,246,687...102,259,206

G

ATP-binding cassette, sub-family C member 4

CTD Direct Evidence: marker/mechanism

NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631

G

ATP binding cassette subfamily G member 5

CTD Direct Evidence: marker/mechanism

NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439

G

ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991

G

active BCR-related gene

CTD Direct Evidence: marker/mechanism

NCBI chr11:76,307,560...76,468,515
Ensembl chr11:76,307,560...76,514,384

G

angiotensin I converting enzyme

CTD Direct Evidence: marker/mechanism

NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790

G

acetylcholinesterase

CTD Direct Evidence: marker/mechanism

NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728

G

acid phosphatase 3

RGD

NCBI chr 9:104,165,439...104,214,921
Ensembl chr 9:104,165,450...104,214,947

G

proacrosin binding protein

CTD Direct Evidence: marker/mechanism

NCBI chr 6:125,026,890...125,040,228
Ensembl chr 6:125,026,652...125,040,230

G

acyl-CoA synthetase long-chain family member 4

CTD Direct Evidence: marker/mechanism

NCBI chr X:141,100,989...141,173,792
Ensembl chr X:141,100,989...141,173,531

G

acyl-CoA synthetase medium-chain family member 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:119,360,106...119,384,119
Ensembl chr 7:119,360,146...119,386,736

G

activin receptor IIA

RGD

NCBI chr 2:48,704,121...48,793,276
Ensembl chr 2:48,704,121...48,793,281

G

ADAM metallopeptidase domain 26A

CTD Direct Evidence: marker/mechanism

NCBI chr 8:44,021,310...44,029,744
Ensembl chr 8:44,021,315...44,029,744

G

a disintegrin and metallopeptidase domain 28

CTD Direct Evidence: marker/mechanism

NCBI chr14:68,842,447...68,893,338
Ensembl chr14:68,843,476...68,893,291

G

ADAM metallopeptidase domain 9

CTD Direct Evidence: marker/mechanism

NCBI chr 8:25,439,627...25,507,138
Ensembl chr 8:25,439,627...25,506,943

G

ADAM metallopeptidase with thrombospondin type 1 motif 8

CTD Direct Evidence: marker/mechanism

NCBI chr 9:30,853,858...30,875,134
Ensembl chr 9:30,853,858...30,875,134

G

acireductone dioxygenase 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:28,725,206...28,732,174
Ensembl chr12:28,725,230...28,732,174

G

adrenergic receptor, beta 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030

G

anterior gradient 2

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:25237833

NCBI chr12:36,042,924...36,054,080
Ensembl chr12:36,042,906...36,054,086

G

S-adenosylhomocysteine hydrolase-like 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:29,768,378...29,912,309
Ensembl chr 6:29,768,010...29,912,309

G

aryl-hydrocarbon receptor

CTD Direct Evidence: marker/mechanism

NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037

G

A kinase anchor protein 13

CTD Direct Evidence: marker/mechanism

NCBI chr 7:75,105,271...75,404,357
Ensembl chr 7:75,105,282...75,404,357

G

aldo-keto reductase family 1, member C18

CTD Direct Evidence: marker/mechanism

PMID:17507624 PMID:18306354

NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653

G

thymoma viral proto-oncogene 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Prostate neoplasm

PMID:15682402 PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 More...

NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318

G

thymoma viral proto-oncogene 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251

G

aminolevulinate, delta-, dehydratase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155

G

aldehyde dehydrogenase family 1, subfamily A2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:71,123,071...71,203,525
Ensembl chr 9:71,123,071...71,203,525

G

arachidonate 12-lipoxygenase, 12R type

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,047,898...69,060,617
Ensembl chr11:69,047,815...69,060,618

G

arachidonate 5-lipoxygenase

CTD Direct Evidence: marker/mechanism

NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139

G

arachidonate lipoxygenase 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,016,243...69,039,941
Ensembl chr11:69,016,722...69,039,941

G

alpha-methylacyl-CoA racemase

mRNA, protein:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17173048 PMID:22919386 PMID:24763052 PMID:20003233

NCBI chr15:10,981,875...10,995,693
Ensembl chr15:10,981,842...10,996,712

G

anthrax toxin receptor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 5:98,032,547...98,178,876
Ensembl chr 5:98,030,642...98,178,902

G

annexin A1

CTD Direct Evidence: marker/mechanism

NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308

G

annexin A3

CTD Direct Evidence: marker/mechanism

NCBI chr 5:96,941,257...96,993,825
Ensembl chr 5:96,941,198...96,993,825

G

annexin A4

CTD Direct Evidence: marker/mechanism

NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566

G

amine oxidase, copper-containing 1

RGD

NCBI chr 6:48,872,189...48,886,122
Ensembl chr 6:48,849,830...48,886,122

G

aldehyde oxidase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:58,068,963...58,145,569
Ensembl chr 1:58,069,090...58,145,572

G

APC, WNT signaling pathway regulator

CTD Direct Evidence: marker/mechanism

PMID:17363566 PMID:29610475

NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605

G

apurinic/apyrimidinic endonuclease 1

susceptibility

CTD Direct Evidence: marker/mechanism
protein:increased expression, altered localization:prostate, cytoplasm

CTD
RGD

PMID:16406883 PMID:29541389 PMID:16406883 PMID:11309329

RGD:2315665, RGD:2315666

NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596

G

adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:83,435,897...83,484,741
Ensembl chr10:83,435,897...83,484,602

G

androgen receptor

onset

ClinVar Annotator: match by term: Prostate neoplasm
CTD Direct Evidence: marker/mechanism|therapeutic

ClinVar
CTD
RGD

PMID:11742035 PMID:12237244 PMID:15389811 PMID:15790600 PMID:16266977 More...

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

amphiregulin

protein:increased expression:prostate gland

RGD

NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291

G

arginase type II

CTD Direct Evidence: marker/mechanism

NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075

G

Rho guanine nucleotide exchange factor 5

CTD Direct Evidence: marker/mechanism

NCBI chr 6:43,242,578...43,266,250
Ensembl chr 6:43,242,516...43,266,254

G

AT-rich interaction domain 1A

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chr 4:133,406,319...133,484,682
Ensembl chr 4:133,406,319...133,484,080

G

AT-rich interaction domain 2

CTD Direct Evidence: marker/mechanism

NCBI chr15:96,185,403...96,303,344
Ensembl chr15:96,185,399...96,302,873

G

AT-rich interaction domain 4A

CTD Direct Evidence: marker/mechanism

NCBI chr12:71,061,314...71,146,125
Ensembl chr12:71,062,764...71,145,366

G

ADP-ribosylation factor-like 6 interacting protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:117,718,113...117,728,848
Ensembl chr 7:117,718,114...117,728,885

G

ASH1 like histone lysine methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 3:88,857,721...88,986,682
Ensembl chr 3:88,857,929...88,986,682

G

ankyrin repeat, SAM and basic leucine zipper domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:18,050,963...18,109,060
Ensembl chr 6:18,050,963...18,109,060

G

ATPase family, AAA domain containing 3A

CTD Direct Evidence: marker/mechanism

NCBI chr 4:155,825,097...155,845,579
Ensembl chr 4:155,825,098...155,845,550

G

activating transcription factor 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236

G

ataxia telangiectasia mutated

protein:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17502119 PMID:25415046 PMID:26098866 PMID:29610475 PMID:14983937

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

ATPase, Cu++ transporting, beta polypeptide

CTD Direct Evidence: marker/mechanism

NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321

G

ataxia telangiectasia and Rad3 related

CTD Direct Evidence: marker/mechanism

NCBI chr 9:95,739,655...95,834,813
Ensembl chr 9:95,739,650...95,833,834

G

aurora kinase A

CTD Direct Evidence: marker/mechanism
protein:increased expression:prostate gland

CTD
RGD

PMID:17898866 PMID:16707419 PMID:15754349

RGD:2293877, RGD:2293883

NCBI chr 2:172,198,116...172,212,825
Ensembl chr 2:172,198,110...172,212,455

G

aurora kinase B

RGD

NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490

G

alpha-2-glycoprotein 1, zinc

CTD Direct Evidence: marker/mechanism

NCBI chr 5:137,979,783...137,988,495
Ensembl chr 5:137,979,782...137,988,495

G

beta-2 microglobulin

CTD Direct Evidence: marker/mechanism

NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564

G

UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4

CTD Direct Evidence: marker/mechanism

NCBI chr16:38,562,600...38,589,416
Ensembl chr16:38,562,626...38,589,411

G

BCL2-associated agonist of cell death

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17542986 PMID:19593445 PMID:17607361

NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267

G

Brca1 associated protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:30,973,358...30,981,887
Ensembl chr14:30,973,407...30,981,901

G

BCL2-associated X protein

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17542986 PMID:18317887

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

bromodomain adjacent to zinc finger domain, 2A

CTD Direct Evidence: marker/mechanism

NCBI chr10:127,927,453...127,965,172
Ensembl chr10:127,927,446...127,965,172

G

breast cancer anti-estrogen resistance 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:112,437,106...112,470,481
Ensembl chr 8:112,437,106...112,470,441

G

brain enriched myelin associated protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:170,188,911...170,270,292
Ensembl chr 2:170,188,911...170,269,765

G

B cell leukemia/lymphoma 2

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16733517 PMID:18317887

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

bone gamma carboxyglutamate protein

CTD Direct Evidence: marker/mechanism

NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771

G

baculoviral IAP repeat-containing 5

CTD Direct Evidence: marker/mechanism

NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569

G

bone morphogenetic protein 7

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:19283074

NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114

G

bone morphogenetic protein receptor, type 1B

CTD Direct Evidence: marker/mechanism

NCBI chr 3:141,540,230...141,875,335
Ensembl chr 3:141,542,897...141,875,186

G

BCL2/adenovirus E1B interacting protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248

G

Braf transforming gene

CTD Direct Evidence: marker/mechanism

PMID:25735316 PMID:29610475

NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397

G

breast cancer 1, early onset

CTD Direct Evidence: marker/mechanism

NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781

G

breast cancer 2, early onset

CTD Direct Evidence: marker/mechanism

NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794

G

bromodomain containing 4

CTD Direct Evidence: marker/mechanism

NCBI chr17:32,415,246...32,503,717
Ensembl chr17:32,415,248...32,503,696

G

bromodomain and PHD finger containing, 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:113,283,824...113,301,823
Ensembl chr 6:113,284,098...113,301,821

G

basigin

RGD

NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803

G

BTG anti-proliferation factor 2

protein:decreased expression:prostate gland

RGD

NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858

G

calcitonin/calcitonin-related polypeptide, alpha

CTD Direct Evidence: marker/mechanism

NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592

G

calreticulin

CTD Direct Evidence: marker/mechanism

NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563

G

calcium/calmodulin-dependent protein kinase kinase 2, beta

CTD Direct Evidence: marker/mechanism

NCBI chr 5:122,856,064...122,918,295
Ensembl chr 5:122,869,233...122,917,472

G

calpain, small subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:29,886,359...29,898,308
Ensembl chr 7:29,886,361...29,898,236

G

coactivator-associated arginine methyltransferase 1

protein:increased expression:prostate gland

RGD

NCBI chr 9:21,458,163...21,500,763
Ensembl chr 9:21,458,190...21,503,919

G

caspase 3

RGD

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

caspase 6

mRNA:increased expression:prostate gland

RGD

NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752

G

caspase 9

CTD Direct Evidence: marker/mechanism

NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287

G

castor zinc finger 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:148,888,823...149,039,350
Ensembl chr 4:148,888,886...149,039,346

G

caveolin 1, caveolae protein

disease_progression

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:15948133 PMID:22159333 PMID:11751529 PMID:17786030

RGD:2289111, RGD:2289102

NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451

G

caveolin 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:17,281,184...17,289,129
Ensembl chr 6:17,281,184...17,289,114

G

carbonyl reductase 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393

G

chromobox 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:96,679,506...96,699,808
Ensembl chr11:96,679,953...96,699,466

G

coiled-coil alpha-helical rod protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,827,914...35,841,912
Ensembl chr17:35,827,997...35,841,912

G

cyclin A2

severity

protein:increased expression:prostate gland

RGD

NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299

G

cyclin D1

disease_progression

mRNA, protein:decreased expression:prostate gland
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17606477 PMID:14968434

NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662

G

cyclin D2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156

G

cyclin H

CTD Direct Evidence: marker/mechanism

NCBI chr13:85,337,504...85,361,850
Ensembl chr13:85,337,527...85,371,588

G

CD276 antigen

CTD Direct Evidence: marker/mechanism

NCBI chr 9:58,431,581...58,463,437
Ensembl chr 9:58,431,581...58,462,720

G

CD9 antigen

CTD Direct Evidence: marker/mechanism

NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754

G

cell division cycle 27

CTD Direct Evidence: marker/mechanism

NCBI chr11:104,393,350...104,441,371
Ensembl chr11:104,393,571...104,441,446

G

cadherin 1

CTD Direct Evidence: marker/mechanism

PMID:16813949 PMID:22581815 PMID:29295717 PMID:29610475

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cadherin 12

CTD Direct Evidence: marker/mechanism

NCBI chr15:20,448,967...21,598,668
Ensembl chr15:20,449,351...21,589,619

G

cadherin 13

CTD Direct Evidence: marker/mechanism

PMID:17288544 PMID:18264096

NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660

G

cyclin dependent kinase 1

RGD

PMID:17575168 PMID:17460776

RGD:2711357, RGD:2756028

NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768

G

cyclin dependent kinase 12

CTD Direct Evidence: marker/mechanism

NCBI chr11:98,093,259...98,171,941
Ensembl chr11:98,093,885...98,169,330

G

cyclin dependent kinase 2 associated protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:4,146,204...4,149,019
Ensembl chr19:4,147,182...4,149,019

G

cyclin dependent kinase inhibitor 1A

CTD Direct Evidence: marker/mechanism

PMID:12727815 PMID:15598783

NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701

G

cyclin dependent kinase inhibitor 1B

severity

protein:decreased expression:prostate gland
CTD Direct Evidence: marker/mechanism|therapeutic

CTD
RGD

PMID:12727815 PMID:20932324 PMID:29610475 PMID:18415709 PMID:18006855

RGD:2293591, RGD:2293596

NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476

G

cyclin dependent kinase inhibitor 2A

DNA, mRNA, protein:hypermethylation, increased expression:exon, prostate

RGD

NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890

G

CUGBP, Elav-like family member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:6,544,505...7,401,345
Ensembl chr 2:6,544,505...7,514,374

G

centromere protein F

CTD Direct Evidence: marker/mechanism

NCBI chr 1:189,372,803...189,420,302
Ensembl chr 1:189,372,803...189,420,283

G

chromodomain helicase DNA binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:15,925,229...15,992,874
Ensembl chr17:15,925,229...15,992,872

G

chromodomain helicase DNA binding protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,234,099...69,260,325
Ensembl chr11:69,234,099...69,260,232

G

chromodomain helicase DNA binding protein 6

CTD Direct Evidence: marker/mechanism

NCBI chr 2:160,788,898...160,951,006
Ensembl chr 2:160,788,898...160,950,995

G

chromodomain helicase DNA binding protein 7

CTD Direct Evidence: marker/mechanism

NCBI chr 4:8,690,345...8,868,449
Ensembl chr 4:8,690,406...8,867,659

G

checkpoint kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011

G

carbohydrate sulfotransferase 14

CTD Direct Evidence: marker/mechanism

NCBI chr 2:118,756,978...118,759,066
Ensembl chr 2:118,756,977...118,759,066

G

conserved helix-loop-helix ubiquitous kinase

protein:increased expression:prostate gland

RGD

NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919

G

CDKN1A interacting zinc finger protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:32,252,724...32,268,311
Ensembl chr 2:32,242,339...32,270,982

G

claudin 3

CTD Direct Evidence: marker/mechanism

NCBI chr 5:135,015,068...135,016,330
Ensembl chr 5:135,015,068...135,016,326

G

claudin 7

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,855,605...69,858,712
Ensembl chr11:69,855,605...69,858,711

G

claudin 9

CTD Direct Evidence: marker/mechanism

NCBI chr17:23,901,558...23,903,000
Ensembl chr17:23,901,558...23,903,000

G

chloride intracellular channel 4

CTD Direct Evidence: marker/mechanism

NCBI chr 4:134,941,280...135,000,071
Ensembl chr 4:134,941,280...135,000,125

G

CLPTM1-like

CTD Direct Evidence: marker/mechanism

NCBI chr13:73,752,121...73,768,758
Ensembl chr13:73,752,125...73,768,724

G

clusterin

CTD Direct Evidence: marker/mechanism

NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996

G

calponin 3, acidic

CTD Direct Evidence: marker/mechanism

NCBI chr 3:121,220,190...121,251,854
Ensembl chr 3:121,220,146...121,251,856

G

CCR4-NOT transcription complex, subunit 3

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chr 7:3,646,717...3,664,108
Ensembl chr 7:3,648,267...3,664,108

G

collagen, type XV, alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:47,207,744...47,313,165
Ensembl chr 4:47,208,161...47,313,167

G

collagen, type V, alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526

G

collagen, type V, alpha 3

CTD Direct Evidence: marker/mechanism

NCBI chr 9:20,681,353...20,726,363
Ensembl chr 9:20,681,346...20,726,363

G

catechol-O-methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602

G

copine III

CTD Direct Evidence: marker/mechanism

NCBI chr 4:19,519,252...19,570,108
Ensembl chr 4:19,519,254...19,570,108

G

cAMP responsive element binding protein 3-like 4

CTD Direct Evidence: marker/mechanism

NCBI chr 3:90,144,805...90,161,387
Ensembl chr 3:90,144,807...90,150,819

G

CREB binding protein

CTD Direct Evidence: marker/mechanism

PMID:15378487 PMID:25735316

NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861

G

cellular repressor of E1A-stimulated genes 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:165,591,327...165,602,878
Ensembl chr 1:165,591,315...165,602,877

G

crystallin, alpha B

CTD Direct Evidence: marker/mechanism

NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936

G

crystallin, lambda 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:57,512,491...57,635,940
Ensembl chr14:57,512,450...57,635,986

G

colony stimulating factor 1 receptor

protein:increased expression:prostate gland

RGD

NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221

G

cysteine and glycine-rich protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:135,614,650...135,679,970
Ensembl chr 1:135,647,799...135,679,970

G

cystatin E/M

CTD Direct Evidence: marker/mechanism

NCBI chr19:5,394,733...5,399,602
Ensembl chr19:5,394,733...5,399,602

G

C-terminal binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:132,588,727...132,726,048
Ensembl chr 7:132,589,292...132,726,083

G

cytotoxic T-lymphocyte-associated protein 4

RGD

NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991

G

catenin beta 1

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17363566 PMID:29610475 PMID:17638904

NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573

G

cathepsin B

CTD Direct Evidence: marker/mechanism

NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372

G

cathepsin D

CTD Direct Evidence: marker/mechanism

NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775

G

cullin 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:80,242,640...80,318,426
Ensembl chr 1:80,242,640...80,318,197

G

C-X3-C motif chemokine ligand 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055

G

C-X-C motif chemokine ligand 12

CTD Direct Evidence: marker/mechanism

NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328

G

C-X-C motif chemokine ligand 15

CTD Direct Evidence: marker/mechanism

PMID:16606632 PMID:17606477

NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926

G

cytochrome P450, family 11, subfamily b, polypeptide 2

CTD Direct Evidence: marker/mechanism

NCBI chr15:74,722,467...74,728,080
Ensembl chr15:74,722,859...74,728,167

G

cytochrome P450, family 17, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

PMID:15538743 PMID:16424004 PMID:16859836 PMID:16998812 PMID:17592021

NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611

G

cytochrome P450, family 19, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

PMID:16424004 PMID:17704407

NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394

G

cytochrome P450, family 1, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

PMID:11275366 PMID:17919073

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

cytochrome P450, family 1, subfamily b, polypeptide 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490

G

cytochrome P450, family 2, subfamily a, polypeptide 5

CTD Direct Evidence: marker/mechanism

NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973

G

cytochrome P450, family 2, subfamily c, polypeptide 38

CTD Direct Evidence: marker/mechanism

NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519

G

cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene

CTD Direct Evidence: marker/mechanism

NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733

G

cytochrome P450, family 2, subfamily d, polypeptide 22

CTD Direct Evidence: marker/mechanism

NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461

G

cytochrome P450, family 2, subfamily e, polypeptide 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900

G

cytochrome P450, family 3, subfamily a, polypeptide 13

CTD Direct Evidence: marker/mechanism

NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881

G

cytochrome P450, family 7, subfamily b, polypeptide 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:18,126,108...18,298,054
Ensembl chr 3:18,126,114...18,297,502

G

disabled 2 interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chr 2:35,448,285...35,621,006
Ensembl chr 2:35,448,278...35,621,006

G

dystroglycan 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:108,082,060...108,141,176
Ensembl chr 9:108,081,833...108,141,157

G

DDB1 and CUL4 associated factor 6

CTD Direct Evidence: marker/mechanism

NCBI chr 1:165,157,069...165,288,475
Ensembl chr 1:165,156,267...165,288,044

G

dicarbonyl L-xylulose reductase

CTD Direct Evidence: marker/mechanism

NCBI chr11:120,615,372...120,618,110
Ensembl chr11:120,616,225...120,618,107

G

discoidin domain receptor family, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513

G

defensin beta 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:22,266,571...22,285,201
Ensembl chr 8:22,266,615...22,285,201

G

delta 4-desaturase, sphingolipid 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:182,103,529...182,110,366
Ensembl chr 1:182,103,337...182,110,369

G

dihydrodiol dehydrogenase

CTD Direct Evidence: marker/mechanism

NCBI chr 7:45,122,380...45,138,312
Ensembl chr 7:45,120,411...45,138,229

G

DExH-box helicase 30

CTD Direct Evidence: marker/mechanism

NCBI chr 9:109,913,387...109,946,728
Ensembl chr 9:109,913,388...109,946,898

G

diablo, IAP-binding mitochondrial protein

CTD Direct Evidence: therapeutic

NCBI chr 5:123,649,393...123,664,825
Ensembl chr 5:123,647,828...123,662,239

G

DnaJ heat shock protein family (Hsp40) member C10

CTD Direct Evidence: marker/mechanism

NCBI chr 2:80,145,790...80,184,399
Ensembl chr 2:80,145,810...80,184,387

G

DnaJ heat shock protein family (Hsp40) member C3

CTD Direct Evidence: marker/mechanism

NCBI chr14:119,175,371...119,219,114
Ensembl chr14:119,175,388...119,219,109

G

deoxyribonuclease 1-like 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:24,659,054...24,662,075
Ensembl chr17:24,659,055...24,662,079

G

DNA methyltransferase 1

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:22581815 PMID:24038143 PMID:20584988

RGD:9588628, RGD:9588671

NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184

G

DNA methyltransferase 3B

CTD Direct Evidence: marker/mechanism

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

DOT1 like histone lysine methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr10:80,590,935...80,631,295
Ensembl chr10:80,591,040...80,631,295

G

ELL associated factor 2

CTD Direct Evidence: marker/mechanism

NCBI chr16:36,613,246...36,695,275
Ensembl chr16:36,613,246...36,695,365

G

epidermal growth factor-containing fibulin-like extracellular matrix protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:5,523,974...5,532,548
Ensembl chr19:5,523,982...5,532,545

G

epidermal growth factor

CTD Direct Evidence: marker/mechanism

NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965

G

epidermal growth factor receptor

CTD Direct Evidence: marker/mechanism|therapeutic
ClinVar Annotator: match by term: Prostate neoplasm

PMID:15302576 PMID:17136230 PMID:17914592 PMID:23485129 PMID:25157968

NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158

G

early growth response 1

CTD Direct Evidence: marker/mechanism

NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037

G

EH domain binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:21,955,825...22,237,086
Ensembl chr11:21,955,828...22,292,292

G

ets homologous factor

CTD Direct Evidence: marker/mechanism

NCBI chr 2:103,093,776...103,133,620
Ensembl chr 2:103,093,778...103,133,623

G

enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase

CTD Direct Evidence: marker/mechanism

NCBI chr16:21,580,035...21,606,589
Ensembl chr16:21,580,037...21,606,557

G

etoposide induced 2.4 mRNA

CTD Direct Evidence: marker/mechanism

NCBI chr 9:36,690,449...36,708,630
Ensembl chr 9:36,690,455...36,708,689

G

eukaryotic translation initiation factor 2-alpha kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002

G

eukaryotic translation initiation factor 3, subunit A

CTD Direct Evidence: marker/mechanism

NCBI chr19:60,749,554...60,779,131
Ensembl chr19:60,749,555...60,779,096

G

eukaryotic translation initiation factor 3, subunit H

CTD Direct Evidence: marker/mechanism

NCBI chr15:51,649,956...51,728,901
Ensembl chr15:51,649,954...51,728,919

G

elaC ribonuclease Z 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:64,869,856...64,892,906
Ensembl chr11:64,869,864...64,892,895

G

epithelial membrane protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:135,339,548...135,360,171
Ensembl chr 6:135,339,543...135,360,171

G

epithelial membrane protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:45,567,447...45,570,850
Ensembl chr 7:45,567,447...45,570,828

G

ectonucleotide pyrophosphatase/phosphodiesterase 5

CTD Direct Evidence: marker/mechanism

NCBI chr17:44,389,693...44,397,458
Ensembl chr17:44,389,704...44,397,458

G

epithelial cell adhesion molecule

CTD Direct Evidence: marker/mechanism

NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557

G

epoxide hydrolase 1, microsomal

CTD Direct Evidence: marker/mechanism

PMID:17919073 PMID:21716162 PMID:24763052

NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469

G

EPS8-like 3

CTD Direct Evidence: marker/mechanism

NCBI chr 3:107,781,177...107,800,216
Ensembl chr 3:107,784,545...107,800,216

G

erb-b2 receptor tyrosine kinase 2

CTD Direct Evidence: marker/mechanism

PMID:11222871 PMID:16984552 PMID:17363613

NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542

G

erb-b2 receptor tyrosine kinase 3

CTD Direct Evidence: marker/mechanism

NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521

G

excision repair cross-complementing rodent repair deficiency, complementation group 1

disease_progression

RGD

NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449

G

excision repair cross-complementing rodent repair deficiency, complementation group 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619

G

Ets2 repressor factor

CTD Direct Evidence: marker/mechanism

NCBI chr 7:24,941,985...24,950,522
Ensembl chr 7:24,941,986...24,950,186

G

ETS transcription factor

CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:18798265 PMID:19396168 PMID:25735316 PMID:27223260 More...

NCBI chr16:95,160,028...95,387,452
Ensembl chr16:95,160,028...95,387,452

G

endoplasmic reticulum protein 29

CTD Direct Evidence: marker/mechanism

NCBI chr 5:121,582,816...121,590,537
Ensembl chr 5:121,566,653...121,590,569

G

endoplasmic reticulum protein 44

CTD Direct Evidence: marker/mechanism

NCBI chr 4:48,190,711...48,279,635
Ensembl chr 4:48,193,323...48,279,558

G

estrogen receptor 1 (alpha)

CTD Direct Evidence: marker/mechanism

PMID:16220300 PMID:17176215

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

estrogen receptor 2 (beta)

disease_progression

mRNA:decreased expression:prostate gland
CTD Direct Evidence: marker/mechanism|therapeutic

CTD
RGD

PMID:15046698 PMID:16220300 PMID:16921512 PMID:17132221 PMID:17639508 More...

NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033

G

ets variant 1

CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:17671502 PMID:27783944

NCBI chr12:38,829,655...38,920,484
Ensembl chr12:38,829,379...38,920,483

G

ets variant 3

CTD Direct Evidence: marker/mechanism

NCBI chr 3:87,432,891...87,447,463
Ensembl chr 3:87,432,714...87,447,463

G

ets variant 4

CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:27783944

NCBI chr11:101,660,573...101,677,963
Ensembl chr11:101,660,568...101,676,197

G

ets variant 5

CTD Direct Evidence: marker/mechanism

NCBI chr16:22,200,063...22,258,320
Ensembl chr16:22,200,059...22,258,469

G

Ewing sarcoma breakpoint region 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:5,019,687...5,049,314
Ensembl chr11:5,019,689...5,049,266

G

enhancer of zeste 2 polycomb repressive complex 2 subunit

CTD Direct Evidence: marker/mechanism

PMID:17003774 PMID:17173048 PMID:21903722

NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275

G

ezrin

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:17566973 PMID:24763052

NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183

G

Fas associated factor family member 2

CTD Direct Evidence: marker/mechanism

NCBI chr13:54,769,597...54,811,876
Ensembl chr13:54,769,597...54,811,876

G

Fas cell surface death receptor

RGD

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

Fas ligand

CTD Direct Evidence: therapeutic

NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064

G

fibulin 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736

G

fibulin 5

CTD Direct Evidence: marker/mechanism

NCBI chr12:101,712,820...101,785,541
Ensembl chr12:101,712,824...101,785,314

G

F-box protein 44

CTD Direct Evidence: marker/mechanism

NCBI chr 4:148,237,256...148,244,663
Ensembl chr 4:148,237,257...148,244,939

G

fibroblast growth factor 10

CTD Direct Evidence: marker/mechanism

NCBI chr13:118,851,199...118,928,651
Ensembl chr13:118,806,327...118,928,651

G

fibroblast growth factor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257

G

fibroblast growth factor 6

RGD

NCBI chr 6:126,992,505...127,001,681
Ensembl chr 6:126,992,549...127,005,150

G

fibroblast growth factor 8

disease_progression

RGD

PMID:11406643 PMID:10343609 PMID:12778074

RGD:2289340, RGD:2289343, RGD:2289338

NCBI chr19:45,724,930...45,731,380
Ensembl chr19:45,725,237...45,731,354

G

fibroblast growth factor receptor 4

CTD Direct Evidence: marker/mechanism

NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572

G

fragile histidine triad gene

CTD Direct Evidence: marker/mechanism

NCBI chr14:11,307,718...12,919,681
Ensembl chr14:11,307,738...12,919,681

G

FMS-like tyrosine kinase 1

RGD

PMID:12824880 PMID:10475375

RGD:2289963, RGD:2289936

NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821

G

FMS-like tyrosine kinase 3

RGD

NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299

G

folate hydrolase 1

CTD Direct Evidence: marker/mechanism

PMID:18247401 PMID:21923190

NCBI chr 7:86,365,733...86,425,171
Ensembl chr 7:86,368,185...86,425,151

G

forkhead box A1

CTD Direct Evidence: marker/mechanism

PMID:22610119 PMID:26457646 PMID:29295717 PMID:29610475 PMID:32690948

NCBI chr12:57,585,750...57,594,815
Ensembl chr12:57,587,414...57,593,702

G

forkhead box A3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:18,747,208...18,757,464
Ensembl chr 7:18,747,209...18,757,463

G

forkhead box C1

CTD Direct Evidence: marker/mechanism

NCBI chr13:31,990,629...31,994,618
Ensembl chr13:31,990,616...31,996,459

G

forkhead box O1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642

G

forkhead box P4

CTD Direct Evidence: marker/mechanism

NCBI chr17:48,178,058...48,235,401
Ensembl chr17:48,178,058...48,235,570

G

frizzled class receptor 4

protein:increased expression:prostate gland

RGD

NCBI chr 7:89,053,574...89,062,341
Ensembl chr 7:89,053,563...89,062,342

G

growth arrest and DNA-damage-inducible 45 alpha

CTD Direct Evidence: marker/mechanism

NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441

G

polypeptide N-acetylgalactosaminyltransferase 3

CTD Direct Evidence: marker/mechanism

NCBI chr 2:65,913,110...65,955,217
Ensembl chr 2:65,913,110...65,955,338

G

glucosaminyl (N-acetyl) transferase 1, core 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:17,303,505...17,350,208
Ensembl chr19:17,303,505...17,350,208

G

growth differentiation factor 15

CTD Direct Evidence: marker/mechanism

PMID:16775185 PMID:23996089

NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106

G

gamma-glutamyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034

G

growth hormone receptor

CTD Direct Evidence: marker/mechanism

NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974

G

growth hormone releasing hormone receptor

disease_progression

DNA:transition:cds:p.D60G (mouse)

RGD

NCBI chr 6:55,353,204...55,365,515
Ensembl chr 6:55,353,280...55,365,515

G

gap junction protein, alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609

G

G protein subunit gamma 5

CTD Direct Evidence: marker/mechanism

NCBI chr 3:146,205,591...146,211,298
Ensembl chr 3:146,205,562...146,211,327

G

glycine N-methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr17:47,036,590...47,040,091
Ensembl chr17:47,036,590...47,040,094

G

golgin A4

CTD Direct Evidence: marker/mechanism

NCBI chr 9:118,335,280...118,411,587
Ensembl chr 9:118,335,335...118,411,587

G

glutathione peroxidase 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203

G

growth factor receptor bound protein 7

CTD Direct Evidence: marker/mechanism

NCBI chr11:98,337,660...98,346,199
Ensembl chr11:98,337,220...98,346,199

G

gene regulated by estrogen in breast cancer protein

CTD Direct Evidence: marker/mechanism

NCBI chr12:16,720,616...16,851,395
Ensembl chr12:16,720,616...16,850,887

G

glyoxylate reductase/hydroxypyruvate reductase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:44,981,394...44,990,734
Ensembl chr 4:44,981,395...44,990,734

G

gastrin releasing peptide receptor

CTD Direct Evidence: marker/mechanism

NCBI chr X:162,296,900...162,332,732
Ensembl chr X:162,296,900...162,332,673

G

glycogen synthase kinase 3 beta

CTD Direct Evidence: marker/mechanism

PMID:16421604 PMID:25246272

NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446

G

glutathione S-transferase, C-terminal domain containing

CTD Direct Evidence: marker/mechanism

NCBI chr 3:132,687,511...132,797,800
Ensembl chr 3:132,687,513...132,797,794

G

glutathione S-transferase kappa 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381

G

glutathione S-transferase, mu 1

CTD Direct Evidence: marker/mechanism

PMID:11275366 PMID:18304461 PMID:22564066

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

glutathione S-transferase, mu 5

CTD Direct Evidence: marker/mechanism

NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002

G

glutathione S-transferase omega 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:47,843,412...47,853,229
Ensembl chr19:47,843,409...47,853,229

G

glutathione S-transferase, pi 1

CTD Direct Evidence: marker/mechanism

PMID:11196146 PMID:15538743 PMID:17173048 PMID:19223546 PMID:22581815

NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985

G

glutathione S-transferase, theta 1

CTD Direct Evidence: marker/mechanism

PMID:11275366 PMID:16998812 PMID:17507624 PMID:22564066

NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418

G

glutathione S-transferase, theta 3

CTD Direct Evidence: marker/mechanism

NCBI chr10:75,609,951...75,617,256
Ensembl chr10:75,609,949...75,617,248

G

guanylyl cyclase domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:75,342,648...75,353,806
Ensembl chr10:75,186,945...75,353,806

G

H2B clustered histone 8

CTD Direct Evidence: marker/mechanism

NCBI chr13:23,755,574...23,756,037
Ensembl chr13:23,755,570...23,756,187

G

H4 clustered histone 12

CTD Direct Evidence: marker/mechanism

NCBI chr13:21,934,315...21,934,723
Ensembl chr13:21,934,364...21,934,675

G

hydroxyacid oxidase 1, liver

CTD Direct Evidence: marker/mechanism

NCBI chr 2:134,339,281...134,396,272
Ensembl chr 2:134,339,281...134,396,288

G

hemoglobin Z, beta-like embryonic chain

CTD Direct Evidence: marker/mechanism

NCBI chr 7:103,490,845...103,492,369
Ensembl chr 7:103,490,844...103,492,371

G

histone deacetylase 1

protein:increased expression:prostate gland

RGD

PMID:18212746 PMID:15042618

RGD:2306214, RGD:2306219

NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506

G

histone deacetylase 6

CTD Direct Evidence: marker/mechanism

NCBI chr X:7,796,355...7,814,284
Ensembl chr X:7,796,359...7,814,128

G

homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:95,113,057...95,121,999
Ensembl chr 8:95,113,066...95,122,005

G

hypoxia inducible factor 1, alpha subunit

CTD Direct Evidence: marker/mechanism

NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304

G

high mobility group box 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033

G

high-mobility group nucleosome binding domain 5

CTD Direct Evidence: marker/mechanism

NCBI chr X:108,048,143...108,056,986
Ensembl chr X:108,048,140...108,057,010

G

heme oxygenase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217

G

HNF1 homeobox B

CTD Direct Evidence: marker/mechanism

PMID:18264096 PMID:18758462

NCBI chr11:83,741,035...83,796,743
Ensembl chr11:83,740,889...83,796,645

G

heterogeneous nuclear ribonucleoprotein H1

CTD Direct Evidence: marker/mechanism

NCBI chr11:50,266,084...50,277,355
Ensembl chr11:50,267,817...50,277,355

G

heterogeneous nuclear ribonucleoprotein K

disease_progression

protein:increased expression:prostate gland (mouse)

RGD

NCBI chr13:58,538,946...58,551,157
Ensembl chr13:58,538,956...58,551,157

G

homeobox B13

CTD Direct Evidence: marker/mechanism

PMID:23104005 PMID:24239177 PMID:24390282 PMID:26457646 PMID:32690948 More...

NCBI chr11:96,085,142...96,087,436
Ensembl chr11:96,085,142...96,088,273

G

homeobox B9

CTD Direct Evidence: marker/mechanism

NCBI chr11:96,162,156...96,167,421
Ensembl chr11:96,162,283...96,167,421

G

homeobox D3

CTD Direct Evidence: marker/mechanism

NCBI chr 2:74,542,337...74,578,615
Ensembl chr 2:74,542,271...74,578,786

G

hydroxyprostaglandin dehydrogenase 15 (NAD)

CTD Direct Evidence: marker/mechanism

NCBI chr 8:56,747,587...56,774,081
Ensembl chr 8:56,747,620...56,774,078

G

hepsin

CTD Direct Evidence: marker/mechanism

PMID:15583422 PMID:16783571

NCBI chr 7:30,798,150...30,814,751
Ensembl chr 7:30,798,150...30,814,715

G

Harvey rat sarcoma virus oncogene

CTD Direct Evidence: marker/mechanism

NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918

G

hydroxysteroid (17-beta) dehydrogenase 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:100,968,792...100,972,014
Ensembl chr11:100,969,237...100,971,353

G

hydroxysteroid (17-beta) dehydrogenase 3

CTD Direct Evidence: marker/mechanism

NCBI chr13:64,206,088...64,237,076
Ensembl chr13:64,206,080...64,237,044

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110

G

heat shock protein 90 alpha (cytosolic), class B member 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197

G

heat shock protein 90, beta (Grp94), member 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373

G

heat shock protein 1A

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132

G

intercellular adhesion molecule 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113

G

inhibitor of DNA binding 3

CTD Direct Evidence: marker/mechanism

NCBI chr 4:135,871,133...135,872,703
Ensembl chr 4:135,870,808...135,873,066

G

isocitrate dehydrogenase 1 (NADP+), soluble

CTD Direct Evidence: marker/mechanism

NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659

G

insulin-like growth factor 1

protein:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16465378 PMID:19208208 PMID:24586243 PMID:19171036

NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904

G

insulin-like growth factor 2 receptor

CTD Direct Evidence: marker/mechanism

NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551

G

insulin-like growth factor binding protein 3

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:15318950 PMID:16000583 PMID:24586243

NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923

G

insulin-like growth factor binding protein 6

CTD Direct Evidence: therapeutic

NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946

G

insulin-like growth factor binding protein 7

CTD Direct Evidence: therapeutic

NCBI chr 5:77,497,092...77,555,892
Ensembl chr 5:77,497,087...77,555,888

G

immunoglobulin superfamily, member 5

CTD Direct Evidence: marker/mechanism

NCBI chr16:96,162,676...96,266,772
Ensembl chr16:96,162,868...96,223,321

G

interleukin 10

CTD Direct Evidence: marker/mechanism

PMID:16284379 PMID:17999153 PMID:18174250

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

interleukin 16

CTD Direct Evidence: marker/mechanism

NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934

G

interleukin 17 receptor C

CTD Direct Evidence: marker/mechanism

NCBI chr 6:113,448,416...113,460,124
Ensembl chr 6:113,448,388...113,460,101

G

interleukin 17 receptor D

CTD Direct Evidence: marker/mechanism

NCBI chr14:26,760,990...26,829,243
Ensembl chr14:26,760,898...26,829,243

G

interleukin 18

CTD Direct Evidence: marker/mechanism

NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140

G

interleukin 1 receptor antagonist

CTD Direct Evidence: marker/mechanism

PMID:16106254 PMID:16284379

NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506

G

interleukin 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108

G

interleukin 24

CTD Direct Evidence: therapeutic

PMID:14678967 PMID:21671747

NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191

G

interleukin 27

CTD Direct Evidence: therapeutic

PMID:21801027 PMID:24028178

NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113

G

interleukin 6

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:15672864 PMID:17196171 PMID:19011039 PMID:19240160 PMID:25970160

NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979

G

interleukin 6 signal transducer

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620

G

insulin II

CTD Direct Evidence: marker/mechanism

NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118

G

insulin receptor

RGD

NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617

G

integrator complex subunit 4

CTD Direct Evidence: marker/mechanism

NCBI chr 7:97,130,158...97,190,605
Ensembl chr 7:97,130,163...97,190,602

G

interleukin-1 receptor-associated kinase 4

CTD Direct Evidence: marker/mechanism

NCBI chr15:94,441,495...94,466,198
Ensembl chr15:94,441,524...94,479,696

G

insulin receptor substrate 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137

G

integrin beta 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302

G

inositol 1,4,5-trisphosphate receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070

G

intersectin 1 (SH3 domain protein 1A)

CTD Direct Evidence: marker/mechanism

NCBI chr16:91,526,198...91,717,479
Ensembl chr16:91,526,169...91,717,485

G

intersectin 2

CTD Direct Evidence: marker/mechanism

NCBI chr12:4,642,792...4,763,952
Ensembl chr12:4,642,638...4,763,962

G

influenza virus NS1A binding protein

CTD Direct Evidence: marker/mechanism

NCBI chr 1:151,220,237...151,240,196
Ensembl chr 1:151,220,228...151,240,173

G

jade family PHD finger 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:51,704,278...51,749,835
Ensembl chr11:51,704,282...51,748,480

G

Janus kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479

G

Janus kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480

G

JAZF zinc finger 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:52,745,050...53,045,613
Ensembl chr 6:52,745,782...53,045,616

G

jumonji domain containing 6

CTD Direct Evidence: marker/mechanism

NCBI chr11:116,728,258...116,734,593
Ensembl chr11:116,728,258...116,734,275

G

jun proto-oncogene

disease_progression

Jun interacts with androgen receptor and ETV1 to mediate invasion

PMID:17634427 PMID:17634427

RGD:2290478, RGD:2290478

NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459

G

junction plakoglobin

CTD Direct Evidence: marker/mechanism

NCBI chr11:100,259,682...100,288,639
Ensembl chr11:100,259,784...100,288,589

G

K(lysine) acetyltransferase 5

protein:increased expression:pancreas, nucleus (human)

RGD

NCBI chr19:5,653,042...5,661,584
Ensembl chr19:5,653,042...5,660,265

G

K(lysine) acetyltransferase 6A

CTD Direct Evidence: marker/mechanism

NCBI chr 8:23,349,458...23,433,275
Ensembl chr 8:23,349,551...23,433,275

G

KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:45,522,264...45,533,150
Ensembl chr 7:45,522,196...45,533,156

G

lysine (K)-specific demethylase 6A

CTD Direct Evidence: marker/mechanism

NCBI chr X:18,027,101...18,147,061
Ensembl chr X:18,028,814...18,146,175

G

kelch-like ECH-associated protein 1

CTD Direct Evidence: marker/mechanism

PMID:24763052 PMID:29610475

NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657

G

Kruppel-like transcription factor 15

CTD Direct Evidence: marker/mechanism

NCBI chr 6:90,437,785...90,468,785
Ensembl chr 6:90,439,558...90,452,220

G

Kruppel-like transcription factor 6

CTD Direct Evidence: marker/mechanism

NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393

G

kallikrein related-peptidase 5

CTD Direct Evidence: marker/mechanism

NCBI chr 7:43,483,581...43,500,605
Ensembl chr 7:43,491,395...43,500,605

G

lysine (K)-specific methyltransferase 2A

CTD Direct Evidence: marker/mechanism

NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594

G

lysine (K)-specific methyltransferase 2C

CTD Direct Evidence: marker/mechanism

NCBI chr 5:25,476,793...25,703,853
Ensembl chr 5:25,476,796...25,703,781

G

lysine (K)-specific methyltransferase 2D

CTD Direct Evidence: marker/mechanism

NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085

G

Kirsten rat sarcoma viral oncogene homolog

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:29610475 PMID:19117991

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

laminin, beta 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:108,357,080...108,367,729
Ensembl chr 9:108,356,935...108,367,729

G

laminin, gamma 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:153,094,668...153,208,532
Ensembl chr 1:153,094,668...153,208,532

G

lipid droplet associated hydrolase

CTD Direct Evidence: marker/mechanism

NCBI chr12:8,258,095...8,350,811
Ensembl chr12:8,258,107...8,335,759

G

lactate dehydrogenase B

CTD Direct Evidence: marker/mechanism

NCBI chr 6:142,435,975...142,453,683
Ensembl chr 6:142,435,975...142,453,683

G

leptin

CTD Direct Evidence: marker/mechanism

NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876

G

LIF receptor alpha

CTD Direct Evidence: marker/mechanism

NCBI chr15:7,120,091...7,226,970
Ensembl chr15:7,120,095...7,226,970

G

LPS-induced TN factor

CTD Direct Evidence: marker/mechanism

NCBI chr16:10,777,137...10,810,985
Ensembl chr16:10,777,139...10,884,021

G

lemur tyrosine kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 5:144,037,179...144,125,026
Ensembl chr 5:144,037,254...144,125,022

G

lysophosphatidic acid receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:58,435,252...58,554,601
Ensembl chr 4:58,435,255...58,553,898

G

lipoprotein lipase

CTD Direct Evidence: marker/mechanism

NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100

G

low density lipoprotein-related protein 1B

CTD Direct Evidence: marker/mechanism

NCBI chr 2:40,485,302...42,543,747
Ensembl chr 2:40,485,258...42,543,636

G

low density lipoprotein receptor-related protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:69,254,679...69,416,373
Ensembl chr 2:69,254,684...69,416,409

G

leucine zipper, putative tumor suppressor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:69,585,311...69,636,901
Ensembl chr 8:69,585,321...69,636,877

G

mannose-6-phosphate receptor, cation dependent

CTD Direct Evidence: marker/mechanism

NCBI chr 6:122,285,679...122,294,639
Ensembl chr 6:122,285,679...122,294,639

G

macrophage immunometabolism regulator

CTD Direct Evidence: marker/mechanism

NCBI chr 1:97,571,627...97,589,743
Ensembl chr 1:97,534,043...97,589,799

G

MAD1 mitotic arrest deficient 1-like 1

CTD Direct Evidence: marker/mechanism

CTD
RGD

NCBI chr 5:139,994,444...140,307,346
Ensembl chr 5:139,994,444...140,307,307

G

mesencephalic astrocyte-derived neurotrophic factor

susceptibility

RGD

NCBI chr 9:106,765,952...106,769,137
Ensembl chr 9:106,715,511...106,769,178

G

mitogen-activated protein kinase kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913

G

mitogen-activated protein kinase kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809

G

mitogen-activated protein kinase kinase 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:60,822,880...60,843,637
Ensembl chr11:60,822,859...60,843,637

G

mitogen-activated protein kinase kinase 4

disease_progression

expression inhibits metastatic colonization of secondary sites by cancer cells in the AT6.1 model system
protein:increased expression:tumor:increased in high-grade prostatic intraepithelial neoplasias and tumor tissues (p<0.0001)

RGD

PMID:16322247 PMID:17577251 PMID:11306453

RGD:2293337, RGD:2293334, RGD:2293333

NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123

G

mitogen-activated protein kinase kinase 5

CTD Direct Evidence: marker/mechanism

NCBI chr 9:63,071,050...63,288,964
Ensembl chr 9:63,071,050...63,285,184

G

mitogen-activated protein kinase kinase 6

no_association

protein:increased expression:tumor:increased in high-grade prostatic intraepithelial neoplasias and tumor tissues (p<0.0001)
CTD Direct Evidence: marker/mechanism
expression of human gene has no effect on metastatic colonization of secondary sites by cancer cells in the AT6.1 model system

CTD
RGD

PMID:32512071 PMID:17577251 PMID:16322247

RGD:2293334, RGD:2293337

NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348

G

mitogen-activated protein kinase kinase 7

disease_progression

expression inhibits metastatic colonization of secondary sites by cancer cells in the AT6.1 model system
protein:increased expression:tumor:increased in high-grade prostatic intraepithelial neoplasias and tumor tissues (p<0.0001)

RGD

PMID:16322247 PMID:17577251

RGD:2293337, RGD:2293334

NCBI chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897

G

mitogen-activated protein kinase kinase kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chr13:111,882,962...111,954,803
Ensembl chr13:111,882,962...111,945,527

G

mitogen-activated protein kinase kinase kinase 7

no_association

based one the lack of correlation to loss of heterozygosity (LOH) in humans
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17199135 PMID:12967473

NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467

G

mitogen-activated protein kinase 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991

G

mitogen-activated protein kinase 9

CTD Direct Evidence: marker/mechanism

NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248

G

matrilin 4

CTD Direct Evidence: marker/mechanism

NCBI chr 2:164,231,313...164,247,080
Ensembl chr 2:164,231,313...164,247,080

G

methyl-CpG binding domain protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr18:74,400,676...74,415,808
Ensembl chr18:74,400,676...74,415,803

G

methyl-CpG binding domain protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:70,701,298...70,761,769
Ensembl chr18:70,701,260...70,759,202

G

membrane-bound transcription factor peptidase, site 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:120,234,890...120,285,603
Ensembl chr 8:120,234,895...120,285,474

G

melanocortin 2 receptor

CTD Direct Evidence: marker/mechanism

NCBI chr18:68,539,970...68,562,391
Ensembl chr18:68,539,978...68,562,391

G

transformed mouse 3T3 cell double minute 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663

G

mediator complex subunit 12

CTD Direct Evidence: marker/mechanism

PMID:22610119 PMID:29610475

NCBI chr X:100,317,697...100,342,540
Ensembl chr X:100,317,636...100,341,071

G

met proto-oncogene

CTD Direct Evidence: marker/mechanism

NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979

G

MAX gene associated

CTD Direct Evidence: marker/mechanism

NCBI chr 2:119,702,974...119,800,610
Ensembl chr 2:119,727,709...119,800,062

G

macrophage migration inhibitory factor (glycosylation-inhibiting factor)

CTD Direct Evidence: marker/mechanism

NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074

G

microRNA 106a

CTD Direct Evidence: marker/mechanism

NCBI chr X:51,831,380...51,831,444
Ensembl chr X:51,831,380...51,831,444

G

microRNA 21a

CTD Direct Evidence: marker/mechanism

NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984

G

mutL homolog 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:111,057,296...111,100,854
Ensembl chr 9:111,057,296...111,100,859

G

membrane metallo endopeptidase

CTD Direct Evidence: marker/mechanism

NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451

G

matrix metallopeptidase 13

CTD Direct Evidence: marker/mechanism

NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331

G

matrix metallopeptidase 9

CTD Direct Evidence: marker/mechanism

NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770

G

myeloperoxidase

CTD Direct Evidence: marker/mechanism

NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239

G

MRE11A homolog A, double strand break repair nuclease

CTD Direct Evidence: marker/mechanism

NCBI chr 9:14,695,971...14,748,421
Ensembl chr 9:14,695,950...14,748,419

G

mutS homolog 3

CTD Direct Evidence: marker/mechanism

NCBI chr13:92,348,387...92,491,515
Ensembl chr13:92,348,380...92,491,511

G

beta-microseminoprotein

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:18264096 PMID:18264097

NCBI chr14:31,863,980...31,880,284
Ensembl chr14:31,863,980...31,880,327

G

macrophage scavenger receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:39,996,284...40,095,790
Ensembl chr 8:40,034,726...40,095,714

G

metallothionein 2

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:16574721 PMID:17914565

NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196

G

methylthioadenosine phosphorylase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:89,055,607...89,099,327
Ensembl chr 4:89,055,359...89,099,318

G

methylenetetrahydrofolate reductase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008

G

mechanistic target of rapamycin kinase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140

G

mucin 4

CTD Direct Evidence: marker/mechanism

NCBI chr16:32,555,089...32,602,786
Ensembl chr16:32,555,015...32,602,754

G

MAX interactor 1, dimerization protein

CTD Direct Evidence: marker/mechanism

NCBI chr19:53,298,509...53,361,724
Ensembl chr19:53,298,949...53,364,241

G

MYB binding protein (P160) 1a

CTD Direct Evidence: marker/mechanism

NCBI chr11:72,332,153...72,342,596
Ensembl chr11:72,332,181...72,342,594

G

myelocytomatosis oncogene

CTD Direct Evidence: marker/mechanism

PMID:17173048 PMID:23704919 PMID:29295717 PMID:32512071

NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223

G

v-myc avian myelocytomatosis viral oncogene lung carcinoma derived

CTD Direct Evidence: marker/mechanism

NCBI chr 4:122,889,414...122,896,278
Ensembl chr 4:122,889,445...122,896,278

G

myosin, heavy polypeptide 14

CTD Direct Evidence: marker/mechanism

NCBI chr 7:44,255,227...44,320,296
Ensembl chr 7:44,255,227...44,320,267

G

N-acetylglucosamine kinase

CTD Direct Evidence: marker/mechanism

NCBI chr 6:83,770,810...83,779,538
Ensembl chr 6:83,771,964...83,781,000

G

alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB)

CTD Direct Evidence: marker/mechanism

NCBI chr11:100,960,918...100,968,483
Ensembl chr11:100,960,838...100,968,498

G

N-acetyl transferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:67,943,620...67,945,183
Ensembl chr 8:67,933,573...67,944,756

G

N-acetyltransferase 2 (arylamine N-acetyltransferase)

CTD Direct Evidence: marker/mechanism

PMID:12618593 PMID:12622714 PMID:15717312 PMID:16083506

NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236

G

nibrin

CTD Direct Evidence: marker/mechanism

PMID:14973119 PMID:25415046

NCBI chr 4:15,955,388...15,992,589
Ensembl chr 4:15,957,925...15,992,589

G

nuclear receptor coactivator 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:4,297,362...4,569,452
Ensembl chr12:4,297,362...4,527,182

G

nuclear receptor coactivator 2

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:12237244 PMID:23759327

NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307

G

nuclear receptor coactivator 3

CTD Direct Evidence: marker/mechanism

PMID:11927493 PMID:12237244

NCBI chr 2:165,834,557...165,915,162
Ensembl chr 2:165,834,556...165,915,162

G

nuclear receptor coactivator 7

CTD Direct Evidence: marker/mechanism

NCBI chr10:30,521,578...30,683,401
Ensembl chr10:30,504,995...30,679,322

G

nuclear receptor co-repressor 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:62,207,132...62,348,200
Ensembl chr11:62,207,252...62,349,367

G

nuclear receptor co-repressor 2

RGD

NCBI chr 5:125,094,217...125,256,302
Ensembl chr 5:125,094,217...125,256,283

G

N-myc downstream regulated gene 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489

G

N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:20,773,798...20,784,638
Ensembl chr14:20,773,798...20,784,630

G

N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4

CTD Direct Evidence: marker/mechanism

NCBI chr 3:125,197,678...125,522,550
Ensembl chr 3:125,197,725...125,522,548

G

nuclear paraspeckle assembly transcript 1 (non-protein coding)

CTD Direct Evidence: marker/mechanism

NCBI chr19:5,874,736...5,895,508
Ensembl chr19:5,874,736...5,895,898

G

nectin cell adhesion molecule 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:19,450,569...19,483,498
Ensembl chr 7:19,450,569...19,484,408

G

neural precursor cell expressed, developmentally down-regulated 4

RGD

NCBI chr 9:72,569,613...72,657,133
Ensembl chr 9:72,569,628...72,657,134

G

nuclear factor, erythroid derived 2, like 2

CTD Direct Evidence: marker/mechanism

PMID:20124447 PMID:23441843

NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985

G

nuclear factor I/C

CTD Direct Evidence: marker/mechanism

NCBI chr10:81,232,025...81,267,753
Ensembl chr10:81,232,020...81,291,469

G

nerve growth factor receptor (TNFR superfamily, member 16)

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:17409433 PMID:18056468

NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561

G

NIPA-like domain containing 3

CTD Direct Evidence: marker/mechanism

NCBI chr 4:135,173,454...135,222,283
Ensembl chr 4:135,172,731...135,222,349

G

NK3 homeobox 1

CTD Direct Evidence: marker/mechanism

PMID:16817226 PMID:17173048 PMID:17202838 PMID:22610119 PMID:32690948

NCBI chr14:69,428,141...69,432,107
Ensembl chr14:69,428,087...69,432,111

G

nucleolar protein 8

CTD Direct Evidence: marker/mechanism

NCBI chr13:49,806,554...49,832,492
Ensembl chr13:49,806,554...49,832,492

G

nitric oxide synthase 3, endothelial cell

CTD Direct Evidence: marker/mechanism

PMID:12429631 PMID:12445681 PMID:16458450

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

NADPH oxidase 3

CTD Direct Evidence: marker/mechanism

NCBI chr17:3,685,515...3,746,536
Ensembl chr17:3,685,515...3,746,536

G

natriuretic peptide type A

CTD Direct Evidence: therapeutic

NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536

G

natriuretic peptide receptor 3

CTD Direct Evidence: marker/mechanism

NCBI chr15:11,839,982...11,907,287
Ensembl chr15:11,839,982...11,907,373

G

NAD(P)H dehydrogenase, quinone 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838

G

nuclear receptor subfamily 3, group C, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474

G

neuropilin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844

G

nucleobindin 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:116,103,579...116,139,823
Ensembl chr 7:116,103,604...116,139,819

G

8-oxoguanine DNA-glycosylase 1

CTD Direct Evidence: marker/mechanism

PMID:11956079 PMID:14634453

NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029

G

olfactomedin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:28,083,105...28,120,748
Ensembl chr 2:28,083,004...28,120,748

G

one cut domain, family member 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:64,473,098...64,531,559
Ensembl chr18:64,473,091...64,534,058

G

prolyl 4-hydroxylase, beta polypeptide

CTD Direct Evidence: marker/mechanism

NCBI chr11:120,451,124...120,464,079
Ensembl chr11:120,451,124...120,464,079

G

p21 (RAC1) activated kinase 6

CTD Direct Evidence: marker/mechanism

NCBI chr 2:118,493,531...118,528,501
Ensembl chr 2:118,493,784...118,528,501

G

partner and localizer of BRCA2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:121,706,485...121,732,203
Ensembl chr 7:121,706,485...121,732,208

G

progestin and adipoQ receptor family member IV

CTD Direct Evidence: marker/mechanism

NCBI chr17:23,955,160...23,959,873
Ensembl chr17:23,955,160...23,959,841

G

par-3 family cell polarity regulator

CTD Direct Evidence: marker/mechanism

NCBI chr 8:127,790,131...128,338,767
Ensembl chr 8:127,790,643...128,338,767

G

poly (ADP-ribose) polymerase family, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819

G

PATJ, crumbs cell polarity complex component

CTD Direct Evidence: marker/mechanism

NCBI chr 4:98,283,803...98,607,840
Ensembl chr 4:98,284,022...98,607,840

G

PRKC, apoptosis, WT1, regulator

CTD Direct Evidence: marker/mechanism

NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101

G

paired box 6

CTD Direct Evidence: marker/mechanism

NCBI chr 2:105,499,241...105,528,755
Ensembl chr 2:105,499,245...105,527,709

G

probasin

CTD Direct Evidence: marker/mechanism

NCBI chr X:76,881,504...76,897,132
Ensembl chr X:76,881,507...76,897,229

G

protocadherin 8

CTD Direct Evidence: marker/mechanism

NCBI chr14:80,004,224...80,008,752
Ensembl chr14:80,004,215...80,008,752

G

phosphodiesterase 4D, cAMP specific

CTD Direct Evidence: marker/mechanism

PMID:16740699 PMID:29662167

NCBI chr13:108,790,711...110,092,503
Ensembl chr13:108,586,482...110,089,995

G

pyruvate dehydrogenase E1 alpha 1

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:29335542

NCBI chr X:158,905,215...158,921,426
Ensembl chr X:158,905,205...158,921,409

G

protein disulfide isomerase associated 3

CTD Direct Evidence: marker/mechanism

NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168

G

pyruvate dehydrogenase phosphatase catalytic subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:11,958,183...11,966,450
Ensembl chr 4:11,958,184...11,966,452

G

PDS5 cohesin associated factor A

CTD Direct Evidence: marker/mechanism

NCBI chr 5:65,763,062...65,855,579
Ensembl chr 5:65,763,064...65,855,616

G

PDZ domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:96,736,772...96,778,242
Ensembl chr 3:96,736,600...96,778,242

G

PDZK1 interacting protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:114,945,905...114,951,091
Ensembl chr 4:114,945,905...114,951,096

G

preproenkephalin

CTD Direct Evidence: marker/mechanism

NCBI chr 4:4,133,536...4,138,815
Ensembl chr 4:4,133,531...4,138,819

G

phosphoglycerate mutase 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:5,751,637...5,753,796
Ensembl chr11:5,751,640...5,753,733

G

progesterone receptor membrane component 1

CTD Direct Evidence: marker/mechanism

NCBI chr X:35,861,846...35,869,732
Ensembl chr X:35,861,859...35,869,732

G

prohibitin 1

mRNA, protein:increased expression:prostate gland

RGD

NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599

G

3-phosphoglycerate dehydrogenase

CTD Direct Evidence: marker/mechanism

NCBI chr 3:98,220,487...98,247,285
Ensembl chr 3:98,220,486...98,247,306

G

phosphatidylinositol glycan anchor biosynthesis, class P

CTD Direct Evidence: marker/mechanism

NCBI chr16:94,159,622...94,171,874
Ensembl chr16:94,159,622...94,172,701

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17013881 PMID:29610475 PMID:23759327

NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta

CTD Direct Evidence: marker/mechanism

NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta

CTD Direct Evidence: marker/mechanism

NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028

G

phosphoinositide-3-kinase regulatory subunit 1

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167 PMID:33129824

NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725

G

phosphoinositide-3-kinase regulatory subunit 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:71,220,820...71,229,356
Ensembl chr 8:71,220,820...71,229,357

G

paired-like homeodomain transcription factor 3

CTD Direct Evidence: marker/mechanism

NCBI chr19:46,123,720...46,136,764
Ensembl chr19:46,124,124...46,136,765

G

plakophilin 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:140,658,202...140,670,424
Ensembl chr 7:140,658,131...140,670,423

G

plasminogen activator, urokinase

CTD Direct Evidence: marker/mechanism

PMID:11454671 PMID:16430655 PMID:17192053

NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453

G

plasminogen activator, urokinase receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393

G

pleckstrin 2

CTD Direct Evidence: marker/mechanism

NCBI chr12:78,935,465...78,955,166
Ensembl chr12:78,935,465...78,953,738

G

promyelocytic leukemia

CTD Direct Evidence: marker/mechanism

NCBI chr 9:58,125,359...58,157,077
Ensembl chr 9:58,125,359...58,157,069

G

PMS1 homolog 1, mismatch repair system component

CTD Direct Evidence: marker/mechanism

NCBI chr 1:53,225,794...53,336,190
Ensembl chr 1:53,228,346...53,336,177

G

podocalyxin-like

CTD Direct Evidence: marker/mechanism

NCBI chr 6:31,496,428...31,540,872
Ensembl chr 6:31,496,423...31,540,916

G

polymerase (DNA directed), kappa

CTD Direct Evidence: marker/mechanism

NCBI chr13:96,617,195...96,679,087
Ensembl chr13:96,617,198...96,679,087

G

paraoxonase 1

CTD Direct Evidence: marker/mechanism

PMID:12783936 PMID:15538743 PMID:21716162

NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946

G

peroxisome proliferator activated receptor alpha

CTD Direct Evidence: marker/mechanism

NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020

G

PTPRF interacting protein, binding protein 2 (liprin beta 2)

CTD Direct Evidence: marker/mechanism

NCBI chr 7:107,192,608...107,347,790
Ensembl chr 7:107,194,414...107,347,790

G

periplakin

CTD Direct Evidence: marker/mechanism

NCBI chr16:4,904,155...4,950,345
Ensembl chr16:4,904,155...4,950,285

G

protein phosphatase 2, regulatory subunit B, alpha

CTD Direct Evidence: marker/mechanism

NCBI chr14:67,251,505...67,309,920
Ensembl chr14:67,251,505...67,309,893

G

protein phosphatase 3, catalytic subunit, alpha isoform

CTD Direct Evidence: marker/mechanism

NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488

G

peroxiredoxin 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:85,696,251...85,701,440
Ensembl chr 8:85,696,216...85,701,463

G

protein kinase, cAMP dependent, catalytic, beta

CTD Direct Evidence: marker/mechanism

NCBI chr 3:146,435,334...146,518,691
Ensembl chr 3:146,435,329...146,518,745

G

protein kinase C, zeta

CTD Direct Evidence: marker/mechanism

NCBI chr 4:155,344,579...155,445,856
Ensembl chr 4:155,344,586...155,445,818

G

protein kinase, DNA activated, catalytic polypeptide

CTD Direct Evidence: marker/mechanism

PMID:17196815 PMID:25415046

NCBI chr16:15,455,698...15,660,103
Ensembl chr16:15,455,730...15,660,099

G

prion protein

CTD Direct Evidence: marker/mechanism

NCBI chr 2:131,751,848...131,780,356
Ensembl chr 2:131,751,848...131,780,349

G

paired related homeobox 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:163,072,688...163,142,714
Ensembl chr 1:163,072,688...163,141,279

G

serine protease 2

protein:increased expression:serum

RGD

NCBI chr 6:41,498,710...41,502,013
Ensembl chr 6:41,498,721...41,502,013

G

serine protease 8 (prostasin)

disease_progression

mRNA:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism
mRNA:increased expression:blood

CTD
RGD

PMID:16541421 PMID:12518323 PMID:11173941

RGD:2292484, RGD:2292487

NCBI chr 7:127,524,889...127,529,266
Ensembl chr 7:127,524,888...127,529,276

G

prostate stem cell antigen

CTD Direct Evidence: marker/mechanism

NCBI chr15:74,586,688...74,588,914
Ensembl chr15:74,586,688...74,588,918

G

proteasome (prosome, macropain) 26S subunit, ATPase 3, interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chr11:100,981,238...100,986,261
Ensembl chr11:100,982,649...100,986,262

G

phosphatase and tensin homolog

disease_progression

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:9371490 PMID:16421604 PMID:17173048 PMID:19081794 PMID:19396168 More...

RGD:2326139, RGD:1302553, RGD:8693397, RGD:2290476, RGD:2292497, RGD:2292510

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

prostaglandin-endoperoxide synthase 2

severity

protein:altered localization
CTD Direct Evidence: marker/mechanism
DNA:hypermethylation

CTD
RGD

PMID:10753955 PMID:14754878 PMID:15126378 PMID:16506214 PMID:17609663 More...

RGD:2300123, RGD:2300193

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

parathyroid hormone-like peptide

CTD Direct Evidence: marker/mechanism

NCBI chr 6:147,153,607...147,165,511
Ensembl chr 6:147,153,599...147,165,681

G

protein tyrosine phosphatase receptor type C

CTD Direct Evidence: marker/mechanism

NCBI chr 1:137,990,601...138,103,491
Ensembl chr 1:137,990,599...138,103,446

G

protein tyrosine phosphatase receptor type K

CTD Direct Evidence: marker/mechanism

NCBI chr10:27,950,406...28,473,393
Ensembl chr10:27,950,816...28,473,393

G

peptidyl-tRNA hydrolase 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:86,574,900...86,583,283
Ensembl chr11:86,574,811...86,583,283

G

poliovirus receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 7:19,637,503...19,655,068
Ensembl chr 7:19,637,503...19,655,085

G

glutaminyl-tRNA synthetase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:108,385,204...108,393,140
Ensembl chr 9:108,384,905...108,393,140

G

RAB4B, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr 7:26,867,858...26,878,308
Ensembl chr 7:26,867,849...26,878,321

G

RAD23 homolog B, nucleotide excision repair protein

CTD Direct Evidence: marker/mechanism

NCBI chr 4:55,350,042...55,392,237
Ensembl chr 4:55,350,043...55,392,237

G

v-raf-leukemia viral oncogene 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596

G

recombination activating 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:101,468,597...101,479,877
Ensembl chr 2:101,468,627...101,479,846

G

ralA binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:66,155,410...66,192,750
Ensembl chr17:66,155,413...66,192,793

G

RAS, dexamethasone-induced 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:59,854,007...59,855,770
Ensembl chr11:59,854,007...59,855,770

G

Ras association (RalGDS/AF-6) domain family member 1

RGD

NCBI chr 9:107,428,752...107,439,460
Ensembl chr 9:107,428,754...107,439,466

G

RB transcriptional corepressor 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262

G

REC8 meiotic recombination protein

CTD Direct Evidence: marker/mechanism

NCBI chr14:55,855,459...55,862,852
Ensembl chr14:55,855,494...55,862,852

G

v-rel reticuloendotheliosis viral oncogene homolog A (avian)

disease_progression

protein:altered localization, increased expression:nucleus, prostate gland

RGD

NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158

G

riboflavin kinase

CTD Direct Evidence: marker/mechanism

NCBI chr19:17,371,407...17,378,713
Ensembl chr19:17,371,407...17,378,713

G

regulatory factor X, 6

CTD Direct Evidence: marker/mechanism

NCBI chr10:51,553,856...51,606,525
Ensembl chr10:51,553,852...51,606,528

G

repulsive guidance molecule family member B

CTD Direct Evidence: marker/mechanism

NCBI chr17:16,024,923...16,051,508
Ensembl chr17:16,023,450...16,051,301

G

ring finger protein, LIM domain interacting

CTD Direct Evidence: marker/mechanism

NCBI chr X:103,000,770...103,024,886
Ensembl chr X:103,000,769...103,024,890

G

ribonuclease, RNase A family 4

CTD Direct Evidence: marker/mechanism

NCBI chr14:51,328,534...51,343,608
Ensembl chr14:51,328,534...51,343,608

G

ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)

CTD Direct Evidence: marker/mechanism

PMID:16114055 PMID:17020975 PMID:27318894

NCBI chr 1:153,625,089...153,644,441
Ensembl chr 1:153,625,172...153,639,967

G

ring finger protein 130

CTD Direct Evidence: marker/mechanism

NCBI chr11:49,916,158...50,016,546
Ensembl chr11:49,916,173...50,016,546

G

ring finger protein 31

CTD Direct Evidence: marker/mechanism

NCBI chr14:55,829,199...55,841,131
Ensembl chr14:55,829,165...55,841,150

G

ring finger protein 43

CTD Direct Evidence: marker/mechanism

NCBI chr11:87,553,913...87,626,365
Ensembl chr11:87,553,548...87,626,365

G

roundabout guidance receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:71,824,406...72,844,379
Ensembl chr16:72,105,194...72,842,983

G

roundabout guidance receptor 2

CTD Direct Evidence: marker/mechanism

NCBI chr16:73,688,725...75,244,331
Ensembl chr16:73,688,727...74,208,713

G

ribosomal protein L10

CTD Direct Evidence: marker/mechanism

NCBI chr X:73,314,463...73,316,741
Ensembl chr X:73,314,418...73,316,741

G

ribosomal protein L11

CTD Direct Evidence: marker/mechanism

NCBI chr 4:135,776,665...135,780,704
Ensembl chr 4:135,755,576...135,780,739

G

ribosomal protein L12

CTD Direct Evidence: marker/mechanism

NCBI chr 2:32,851,724...32,854,057
Ensembl chr 2:32,851,571...32,855,357

G

ribophorin II

CTD Direct Evidence: marker/mechanism

NCBI chr 2:157,121,018...157,168,238
Ensembl chr 2:157,120,937...157,168,239

G

regulation of nuclear pre-mRNA domain containing 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:95,667,183...95,727,034
Ensembl chr 3:95,667,653...95,726,175

G

ribosomal protein S19

CTD Direct Evidence: marker/mechanism

NCBI chr 7:24,584,013...24,589,236
Ensembl chr 7:24,583,796...24,589,231

G

related RAS viral (r-ras) oncogene

CTD Direct Evidence: marker/mechanism

NCBI chr 7:44,665,686...44,671,070
Ensembl chr 7:44,667,385...44,671,071

G

runt related transcription factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037

G

retinoid X receptor alpha

protein:decreased expression:prostate
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:15318950 PMID:15318950

NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969

G

spermine binding protein

CTD Direct Evidence: marker/mechanism

NCBI chr17:24,141,525...24,164,577
Ensembl chr17:24,160,646...24,164,581

G

stromal cell-derived factor 2-like 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:16,948,002...16,950,247
Ensembl chr16:16,948,002...16,950,247

G

selenoprotein P

CTD Direct Evidence: marker/mechanism

NCBI chr15:3,300,249...3,309,992
Ensembl chr15:3,298,029...3,309,990

G

selenoprotein S

CTD Direct Evidence: marker/mechanism

NCBI chr 7:65,729,397...65,739,153
Ensembl chr 7:65,729,397...65,739,153

G

SUMO/sentrin specific peptidase 6

CTD Direct Evidence: marker/mechanism

NCBI chr 9:79,973,862...80,052,064
Ensembl chr 9:79,974,185...80,052,235

G

serine incorporator 3

CTD Direct Evidence: marker/mechanism

NCBI chr 2:163,466,577...163,487,767
Ensembl chr 2:163,465,192...163,487,051

G

serine (or cysteine) peptidase inhibitor, clade A, member 3B

CTD Direct Evidence: marker/mechanism

NCBI chr12:104,094,245...104,105,805
Ensembl chr12:104,094,255...104,105,804

G

serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 10

CTD Direct Evidence: marker/mechanism

NCBI chr 1:107,456,724...107,488,469
Ensembl chr 1:107,456,757...107,477,001

G

serine (or cysteine) peptidase inhibitor, clade E, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122

G

serine (or cysteine) peptidase inhibitor, clade F, member 1

treatment

human gene in a rat model
CTD Direct Evidence: therapeutic

CTD
RGD

PMID:21671747 PMID:20360944

NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527

G

sestrin 3

CTD Direct Evidence: marker/mechanism

NCBI chr 9:14,187,597...14,237,430
Ensembl chr 9:14,186,363...14,244,397

G

SET domain containing 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:110,361,368...110,447,703
Ensembl chr 9:110,361,665...110,447,701

G

SET domain, bifurcated 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:95,230,836...95,264,513
Ensembl chr 3:95,230,836...95,264,513

G

splicing factor 3b, subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:55,024,328...55,066,660
Ensembl chr 1:55,024,328...55,066,640

G

sex hormone binding globulin

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731

G

SIL1 nucleotide exchange factor

CTD Direct Evidence: marker/mechanism

NCBI chr18:35,399,449...35,632,443
Ensembl chr18:35,399,449...35,632,833

G

sirtuin 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483

G

solute carrier family 12, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:58,011,505...58,079,893
Ensembl chr18:58,011,750...58,079,893

G

solute carrier family 22 (organic cation transporter), member 3

CTD Direct Evidence: marker/mechanism

NCBI chr17:12,638,859...12,726,591
Ensembl chr17:12,637,847...12,726,591

G

solute carrier family 26, member 4

CTD Direct Evidence: marker/mechanism

NCBI chr12:31,569,813...31,610,054
Ensembl chr12:31,569,826...31,609,968

G

solute carrier family 30 (zinc transporter), member 4

disease_progression

protein:decreased expression:prostate gland

RGD

NCBI chr 2:122,523,153...122,544,583
Ensembl chr 2:122,523,153...122,544,583

G

solute carrier family 31, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:62,278,821...62,310,006
Ensembl chr 4:62,278,964...62,310,006

G

solute carrier family 39 (zinc transporter), member 1

CTD Direct Evidence: marker/mechanism

PMID:16700911 PMID:19208208

NCBI chr 3:90,155,512...90,160,923
Ensembl chr 3:90,155,479...90,160,919

G

solute carrier family 4 (anion exchanger), member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 5:24,628,834...24,645,945
Ensembl chr 5:24,628,835...24,645,948

G

solute carrier family 5 (sodium iodide symporter), member 5

CTD Direct Evidence: therapeutic

PMID:12489024 PMID:14633711

NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401

G

solute carrier family 6 (neurotransmitter transporter), member 20B

CTD Direct Evidence: marker/mechanism

NCBI chr 9:123,422,888...123,461,603
Ensembl chr 9:123,419,865...123,461,630

G

solute carrier family 7 (cationic amino acid transporter, y+ system), member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:148,264,220...148,336,714
Ensembl chr 5:148,264,220...148,336,714

G

SMAD family member 4

disease_progression

RGD

NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851

G

SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr X:46,898,247...46,981,490
Ensembl chr X:46,898,245...46,981,851

G

SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4

RGD

NCBI chr 9:21,527,377...21,615,526
Ensembl chr 9:21,527,465...21,615,526

G

SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:65,019,577...65,093,045
Ensembl chr 6:65,019,567...65,093,045

G

superoxide dismutase 2, mitochondrial

CTD Direct Evidence: marker/mechanism|therapeutic

CTD
RGD

PMID:12592389 PMID:17465268 PMID:17646272 PMID:18829485 PMID:19074884 More...

NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950

G

SRY (sex determining region Y)-box 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610

G

trans-acting transcription factor 5

CTD Direct Evidence: marker/mechanism

NCBI chr 2:70,305,267...70,308,070
Ensembl chr 2:70,305,267...70,308,073

G

spermatogenesis associated 18

CTD Direct Evidence: marker/mechanism

NCBI chr 5:73,808,723...73,836,927
Ensembl chr 5:73,808,722...73,836,855

G

spen family transcription repressor

CTD Direct Evidence: marker/mechanism

NCBI chr 4:141,195,199...141,265,955
Ensembl chr 4:141,195,201...141,265,908

G

serine peptidase inhibitor, Kazal type 1

CTD Direct Evidence: marker/mechanism

NCBI chr18:43,861,134...43,870,302
Ensembl chr18:43,861,147...43,870,622

G

serine peptidase inhibitor, Kazal type 5

CTD Direct Evidence: marker/mechanism

NCBI chr18:44,092,612...44,155,554
Ensembl chr18:44,096,302...44,155,568

G

sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1

CTD Direct Evidence: marker/mechanism

NCBI chr13:57,569,008...58,056,194
Ensembl chr13:57,569,008...58,056,146

G

spondin 2, extracellular matrix protein

CTD Direct Evidence: marker/mechanism

NCBI chr 5:33,370,862...33,375,596
Ensembl chr 5:33,355,528...33,375,799

G

speckle-type BTB/POZ protein

CTD Direct Evidence: marker/mechanism

PMID:22610119 PMID:29295717 PMID:29610475

NCBI chr11:95,304,909...95,384,236
Ensembl chr11:95,304,906...95,384,232

G

secreted phosphoprotein 1

RGD

NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916

G

steroid 5 alpha-reductase 1

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:18500220 PMID:20564326 PMID:17707058

NCBI chr13:69,721,568...69,759,611
Ensembl chr13:69,721,568...69,759,561

G

steroid 5 alpha-reductase 2

CTD Direct Evidence: marker/mechanism

PMID:16998812 PMID:17136762 PMID:17823934 PMID:18306354 PMID:18500220 More...

NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911

G

single-stranded DNA binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr13:91,608,449...91,854,299
Ensembl chr13:91,608,402...91,851,548

G

signal sequence receptor, beta

CTD Direct Evidence: marker/mechanism

NCBI chr 3:88,486,915...88,495,727
Ensembl chr 3:88,483,183...88,495,726

G

SSX member B15

CTD Direct Evidence: marker/mechanism

NCBI chr X:8,379,782...8,392,965
Ensembl chr X:8,380,291...8,391,193

G

suppression of tumorigenicity 14 (colon carcinoma)

protein:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17013881 PMID:18813126

NCBI chr 9:30,999,886...31,043,138
Ensembl chr 9:31,000,698...31,043,149

G

stabilin 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:86,677,058...86,843,902
Ensembl chr10:86,677,062...86,843,889

G

StAR related lipid transfer domain containing 10

CTD Direct Evidence: marker/mechanism

NCBI chr 7:100,966,293...100,995,833
Ensembl chr 7:100,966,293...100,995,833

G

StAR related lipid transfer domain containing 3

CTD Direct Evidence: marker/mechanism

PMID:17013881 PMID:17592021

NCBI chr11:98,249,245...98,271,938
Ensembl chr11:98,249,194...98,271,938

G

signal transducer and activator of transcription 3

protein:increased expression:prostate gland
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:14975756 PMID:16427044 PMID:25970160 PMID:18317887

NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366

G

signal transducer and activator of transcription 5B

RGD

NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550

G

STEAP family member 4

CTD Direct Evidence: marker/mechanism

NCBI chr 5:8,010,472...8,032,213
Ensembl chr 5:8,010,457...8,032,213

G

stathmin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:134,195,631...134,201,154
Ensembl chr 4:134,195,631...134,201,154

G

syntaxin 4A (placental)

CTD Direct Evidence: marker/mechanism

NCBI chr 7:127,439,832...127,450,160
Ensembl chr 7:127,423,466...127,448,191

G

sulfotransferase family 1A, phenol-preferring, member 1

RGD

NCBI chr 7:126,272,042...126,289,615
Ensembl chr 7:126,272,037...126,275,604

G

sulfotransferase family 1E, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453

G

sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:13,530,171...13,571,335
Ensembl chr 7:13,530,171...13,571,334

G

sulfotransferase family, cytosolic, 2B, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:45,379,405...45,409,096
Ensembl chr 7:45,379,407...45,434,093

G

surfeit gene 4

CTD Direct Evidence: marker/mechanism

NCBI chr 2:26,810,052...26,823,801
Ensembl chr 2:26,810,052...26,823,940

G

transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)

CTD Direct Evidence: marker/mechanism

NCBI chr17:34,406,530...34,416,199
Ensembl chr17:34,406,527...34,416,199

G

TBC1 domain family, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 4:46,604,390...46,650,396
Ensembl chr 4:46,604,390...46,650,209

G

transducin (beta)-like 1X-linked receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:22,130,756...22,270,758
Ensembl chr 3:22,130,816...22,270,758

G

T-box 3

CTD Direct Evidence: marker/mechanism

NCBI chr 5:119,808,600...119,822,789
Ensembl chr 5:119,808,734...119,822,789

G

thromboxane A synthase 1, platelet

CTD Direct Evidence: marker/mechanism

NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519

G

transcription elongation factor A (SII)-like 7

CTD Direct Evidence: marker/mechanism

NCBI chr X:135,124,790...135,126,849
Ensembl chr X:135,115,528...135,126,849

G

transcobalamin 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:3,867,077...3,882,078
Ensembl chr11:3,867,192...3,882,159

G

t-complex protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:13,135,216...13,143,954
Ensembl chr17:13,134,588...13,143,954

G

telomerase RNA component

CTD Direct Evidence: therapeutic

NCBI chr 3:96,321,753...96,322,149
Ensembl chr 3:96,321,753...96,322,149

G

telomerase reverse transcriptase

CTD Direct Evidence: marker/mechanism

PMID:19151717 PMID:21743467

NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962

G

tet methylcytosine dioxygenase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:133,169,438...133,250,882
Ensembl chr 3:133,169,440...133,250,900

G

transforming growth factor alpha

CTD Direct Evidence: therapeutic

NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701

G

transforming growth factor, beta 1

CTD Direct Evidence: marker/mechanism

PMID:15159307 PMID:18082198

NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502

G

transforming growth factor, beta receptor II

CTD Direct Evidence: marker/mechanism

NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428

G

thymocyte nuclear protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:26,910,950...26,918,632
Ensembl chr 9:26,911,006...26,918,632

G

tissue inhibitor of metalloproteinase 4

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17013881 PMID:16940965

NCBI chr 6:115,221,405...115,229,166
Ensembl chr 6:115,218,853...115,229,166

G

toll-interleukin 1 receptor (TIR) domain-containing adaptor protein

CTD Direct Evidence: marker/mechanism

NCBI chr 9:35,095,687...35,111,587
Ensembl chr 9:35,095,847...35,111,587

G

tight junction protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr10:81,109,022...81,127,415
Ensembl chr10:81,109,041...81,127,415

G

toll-like receptor 4

CTD Direct Evidence: marker/mechanism

NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521

G

toll-like receptor 5

CTD Direct Evidence: marker/mechanism

NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010

G

toll-like receptor 6

CTD Direct Evidence: marker/mechanism

NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440

G

transmembrane protein with EGF-like and two follistatin-like domains 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:50,951,946...51,226,429
Ensembl chr 1:50,939,806...51,226,429

G

TATA element modulatory factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:97,128,911...97,156,107
Ensembl chr 6:97,129,958...97,156,083

G

tropomodulin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:46,038,940...46,116,032
Ensembl chr 4:46,038,935...46,116,032

G

thymosin, beta 4, X chromosome

CTD Direct Evidence: marker/mechanism

NCBI chr X:165,990,089...165,996,475
Ensembl chr X:165,990,089...165,992,311

G

tumor necrosis factor receptor superfamily, member 10b

CTD Direct Evidence: marker/mechanism

NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860

G

tumor necrosis factor receptor superfamily, member 11a, NFKB activator

protein:increased expression:prostate gland

RGD

NCBI chr 1:105,708,443...105,777,172
Ensembl chr 1:105,708,443...105,775,709

G

tumor necrosis factor receptor superfamily, member 21

CTD Direct Evidence: marker/mechanism

NCBI chr17:43,327,446...43,400,079
Ensembl chr17:43,327,446...43,400,080

G

tumor necrosis factor (ligand) superfamily, member 10

CTD Direct Evidence: therapeutic

PMID:16368536 PMID:17636462 PMID:17718901 PMID:21209944

NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576

G

target of myb1-like 1 (chicken)

CTD Direct Evidence: marker/mechanism

NCBI chr11:90,536,516...90,579,105
Ensembl chr11:90,534,291...90,579,192

G

topoisomerase (DNA) II alpha

CTD Direct Evidence: marker/mechanism

NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015

G

trophoblast glycoprotein

CTD Direct Evidence: marker/mechanism

NCBI chr 9:85,724,433...85,729,110
Ensembl chr 9:85,724,433...85,729,093

G

tumor protein D52

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:17875733 PMID:27415467

NCBI chr 3:8,991,590...9,069,824
Ensembl chr 3:8,990,653...9,069,783

G

tumor protein D52-like 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:31,208,369...31,321,989
Ensembl chr10:31,208,372...31,321,954

G

tripeptidyl peptidase I

CTD Direct Evidence: marker/mechanism

NCBI chr 7:105,394,018...105,401,489
Ensembl chr 7:105,394,018...105,401,442

G

tumor protein, translationally-controlled 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:76,082,771...76,085,743
Ensembl chr14:76,082,533...76,085,965

G

TNF receptor-associated factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:34,831,762...34,851,784
Ensembl chr 2:34,831,762...34,851,784

G

transformation related protein 53

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16434975 PMID:17202838 PMID:20875869 PMID:21946351 PMID:25735316 More...

RGD:1331525, RGD:8693397

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

transformation related protein 63

protein:decreased expression:prostate gland
CTD Direct Evidence: marker/mechanism
mRNA:decreased expression:prostate gland

CTD
RGD

PMID:22581815 PMID:17189982 PMID:17982114

RGD:2315434, RGD:2315433

NCBI chr16:25,502,513...25,710,842
Ensembl chr16:25,502,513...25,710,852

G

transient receptor potential cation channel, subfamily M, member 4

CTD Direct Evidence: marker/mechanism

NCBI chr 7:44,952,579...44,983,495
Ensembl chr 7:44,952,056...44,983,204

G

testis specific protein-Y encoded, pseudogene

DNA:deletion (human)

RGD

NCBI chr  Y:1,055,764...1,058,868
Ensembl chr  Y:1,055,764...1,058,868
Ensembl chr  Y:1,055,764...1,058,868

G

thiosulfate sulfurtransferase, mitochondrial

CTD Direct Evidence: marker/mechanism

NCBI chr15:78,283,756...78,290,065
Ensembl chr15:78,283,756...78,290,107

G

tetratricopeptide repeat domain 9C

CTD Direct Evidence: marker/mechanism

NCBI chr19:8,786,430...8,797,270
Ensembl chr19:8,786,439...8,796,697

G

thioredoxin domain containing 5

CTD Direct Evidence: marker/mechanism

NCBI chr13:38,684,242...38,712,800
Ensembl chr13:38,684,055...38,712,800

G

thioredoxin reductase 2

CTD Direct Evidence: marker/mechanism

NCBI chr16:18,245,167...18,297,823
Ensembl chr16:18,245,134...18,297,823

G

thymidylate synthase

CTD Direct Evidence: marker/mechanism

NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615

G

U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:31,866,055...31,878,122
Ensembl chr17:31,866,055...31,877,866

G

uridine-cytidine kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:167,050,464...167,112,657
Ensembl chr 1:167,050,452...167,112,889

G

uncoupling protein 3 (mitochondrial, proton carrier)

CTD Direct Evidence: marker/mechanism

NCBI chr 7:100,122,198...100,135,639
Ensembl chr 7:100,122,197...100,135,639

G

UDP glucuronosyltransferase 2 family, polypeptide B1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389

G

uridine monophosphate synthetase

CTD Direct Evidence: marker/mechanism

PMID:15999119 PMID:19082440

NCBI chr16:33,775,152...33,787,408
Ensembl chr16:33,775,152...33,787,408

G

unc-13 homolog D

CTD Direct Evidence: marker/mechanism

NCBI chr11:115,952,921...115,969,321
Ensembl chr11:115,952,921...115,968,787

G

USO1 vesicle docking factor

CTD Direct Evidence: marker/mechanism

NCBI chr 5:92,285,770...92,350,659
Ensembl chr 5:92,285,797...92,350,657

G

ubiquitin specific peptidase 28

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chr 9:48,896,577...48,953,817
Ensembl chr 9:48,896,675...48,953,817

G

ubiquitin specific peptidase 7

CTD Direct Evidence: marker/mechanism

NCBI chr16:8,506,586...8,574,931
Ensembl chr16:8,507,459...8,610,172

G

ubiquitously expressed prefoldin like chaperone

CTD Direct Evidence: marker/mechanism

NCBI chr X:20,818,162...20,828,259
Ensembl chr X:20,807,961...20,828,256

G

vav 3 oncogene

CTD Direct Evidence: marker/mechanism

NCBI chr 3:109,247,757...109,593,010
Ensembl chr 3:109,247,969...109,593,014

G

valosin containing protein

CTD Direct Evidence: marker/mechanism

NCBI chr 4:42,979,964...43,000,507
Ensembl chr 4:42,979,963...43,000,507

G

vitamin D (1,25-dihydroxyvitamin D3) receptor

CTD Direct Evidence: marker/mechanism

NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511

G

vascular endothelial growth factor A

CTD Direct Evidence: marker/mechanism

PMID:12893367 PMID:16606632 PMID:16908180 PMID:20052738

NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295

G

vimentin

CTD Direct Evidence: marker/mechanism

PMID:17566973 PMID:24763052

NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637

G

vasoactive intestinal polypeptide

CTD Direct Evidence: marker/mechanism

NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617

G

VPS52 GARP complex subunit

CTD Direct Evidence: marker/mechanism

NCBI chr17:34,174,753...34,186,012
Ensembl chr17:34,174,786...34,186,009

G

WW domain containing adaptor with coiled-coil

CTD Direct Evidence: marker/mechanism

NCBI chr18:7,868,614...7,929,028
Ensembl chr18:7,868,832...7,929,028

G

WASP family, member 3

CTD Direct Evidence: marker/mechanism

NCBI chr 5:146,317,411...146,410,425
Ensembl chr 5:146,321,795...146,410,425

G

wingless-type MMTV integration site family, member 10B

CTD Direct Evidence: marker/mechanism

NCBI chr15:98,668,593...98,676,093
Ensembl chr15:98,668,593...98,676,031

G

wingless-type MMTV integration site family, member 11

disease_progression

RGD

NCBI chr 7:98,484,293...98,503,954
Ensembl chr 7:98,484,319...98,504,402

G

wingless-type MMTV integration site family, member 4

CTD Direct Evidence: marker/mechanism

NCBI chr 4:137,004,946...137,026,812
Ensembl chr 4:137,004,800...137,027,037

G

WW domain containing E3 ubiquitin protein ligase 1

RGD

NCBI chr 4:19,608,296...19,709,004
Ensembl chr 4:19,608,303...19,708,993

G

X-linked inhibitor of apoptosis

severity

RGD

NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533

G

exportin 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:23,205,768...23,248,250
Ensembl chr11:23,206,055...23,248,249

G

X-ray repair complementing defective repair in Chinese hamster cells 1

CTD Direct Evidence: marker/mechanism

PMID:16406883 PMID:17196815 PMID:17486273

NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865

G

zinc finger and BTB domain containing 16

CTD Direct Evidence: marker/mechanism

NCBI chr 9:48,563,097...48,747,525
Ensembl chr 9:48,565,597...48,747,522

G

zinc finger and BTB domain containing 20

CTD Direct Evidence: marker/mechanism

NCBI chr16:42,728,008...43,462,981
Ensembl chr16:42,696,244...43,462,965

G

zinc finger and BTB domain containing 7a

CTD Direct Evidence: therapeutic

NCBI chr10:80,971,113...80,988,056
Ensembl chr10:80,971,054...80,988,829

G

zinc finger, AN1-type domain 5

CTD Direct Evidence: marker/mechanism

NCBI chr19:21,249,150...21,264,204
Ensembl chr19:21,249,642...21,264,204

G

zinc finger homeobox 3

CTD Direct Evidence: marker/mechanism

PMID:16637072 PMID:17013881 PMID:29610475

NCBI chr 8:109,005,975...109,688,272
Ensembl chr 8:108,669,276...109,688,262

G

zinc finger protein 292

CTD Direct Evidence: marker/mechanism

PMID:29610475 PMID:29662167

NCBI chr 4:34,803,110...34,882,982
Ensembl chr 4:34,803,113...34,882,960

G

zinc finger protein 36, C3H type-like 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:84,491,352...84,495,375
Ensembl chr17:84,491,359...84,495,375

G

zinc finger protein of the cerebellum 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:122,712,796...122,717,740
Ensembl chr14:122,712,847...122,717,264

G

zinc finger, MYM-type 3

CTD Direct Evidence: marker/mechanism

PMID:24763052 PMID:29610475 PMID:29662167

NCBI chr X:100,447,990...100,464,986
Ensembl chr X:100,447,990...100,464,455

prostatitis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BMP and activin membrane-bound inhibitor

associated with prostatic hypertrophy;mRNA,protein:decreased expression:prostate:

RGD

NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404

G

C-C motif chemokine ligand 11

mRNA:increased expression:prostate gland dorsolateral lobe

RGD

NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781

G

C-X-C motif chemokine ligand 1

treatment

RGD

NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974

G

C-X-C motif chemokine ligand 5

RGD

NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483

G

cytochrome P450, family 19, subfamily a, polypeptide 1

RGD

NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394

G

DNA methyltransferase 3A

mRNA,protein:increased expression:prostate gland ventral lobe:

RGD

NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443

G

DNA methyltransferase 3B

mRNA,protein:increased expression:prostate gland ventral lobe:

RGD

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

interleukin 10

protein:increased expression:prostate gland, serum
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:12050565 PMID:19213347

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

interleukin 1 receptor antagonist

mRNA:increased expression:prostate gland (mouse)

RGD

NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506

G

NAD(P)H dehydrogenase, quinone 1

treatment

RGD

NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838

G

prostaglandin-endoperoxide synthase 2

RGD

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

SMAD family member 4

RGD

NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851

Pseudovaginal Perineoscrotal Hypospadias

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cytochrome P450, family 1, subfamily b, polypeptide 1

ClinVar Annotator: match by term: 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency

PMID:9097971 PMID:9497261 PMID:11403040 PMID:12036985 PMID:19234632 More...

NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490

G

steroid 5 alpha-reductase 2

ClinVar Annotator: match by term: 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | ClinVar Annotator: match by term: Familial incomplete male pseudohermaphroditism, type 2
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:431680 PMID:755047 PMID:835597 PMID:1147889 PMID:1406794 More...

NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911

G

xanthine dehydrogenase

ClinVar Annotator: match by term: 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency

PMID:18384427 PMID:28492532

NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191

scalp-ear-nipple syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

potassium channel tetramerisation domain containing 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Scalp-ear-nipple syndrome

OMIM
CTD
ClinVar

PMID:1799422 PMID:8042668 PMID:9383029 PMID:10517259 PMID:16411189 More...

NCBI chr18:15,101,742...15,284,503
Ensembl chr18:15,101,742...15,284,503

Sensorineural Deafness and Male Infertility

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cation channel, sperm associated 2

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Deafness-infertility syndrome

PMID:19344877 PMID:24033266 PMID:25741868

NCBI chr 2:121,222,109...121,245,082
Ensembl chr 2:121,223,112...121,244,273

G

creatine kinase, mitochondrial 1, ubiquitous

ClinVar Annotator: match by term: Deafness-infertility syndrome

NCBI chr 2:121,188,257...121,194,218
Ensembl chr 2:121,188,195...121,194,218

G

protein disulfide isomerase associated 3

ClinVar Annotator: match by term: Deafness-infertility syndrome

NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168

G

diphosphoinositol pentakisphosphate kinase 1

ClinVar Annotator: match by term: Deafness-infertility syndrome

NCBI chr 2:121,141,038...121,186,138
Ensembl chr 2:121,141,042...121,185,877

G

stereocilin

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Deafness-infertility syndrome

PMID:18414213 PMID:21078986 PMID:22147502 PMID:24033266 PMID:25157971 More...

NCBI chr 2:121,193,729...121,211,851
Ensembl chr 2:121,194,209...121,217,649

Sertoli cell-only syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

DNA meiotic recombinase 1

OMIM:305700 | OMIM:400042

NCBI chr15:79,445,698...79,489,362
Ensembl chr15:79,445,698...79,489,310

G

heterogeneous nuclear ribonucleoprotein L

protein:decreased expression:testis (human)

RGD

NCBI chr 7:28,507,971...28,521,693
Ensembl chr 7:28,507,966...28,521,691

G

nuclear protein transcription regulator 1

OMIM:305700 | OMIM:400042

NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033

sexual dysfunction

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

D-aspartate oxidase

CTD Direct Evidence: marker/mechanism

NCBI chr10:40,505,933...40,557,847
Ensembl chr10:40,506,007...40,557,843

G

prolactin

CTD Direct Evidence: marker/mechanism

PMID:10084644 PMID:15677431

NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188

G

prostaglandin E receptor 1 (subtype EP1)

CTD Direct Evidence: therapeutic

NCBI chr 8:84,393,171...84,399,385
Ensembl chr 8:84,393,307...84,399,382

G

prostaglandin E receptor 2 (subtype EP2)

CTD Direct Evidence: therapeutic

NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277

G

prostaglandin E receptor 4 (subtype EP4)

CTD Direct Evidence: therapeutic

NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668

Skeletal Defects, Genital Hypoplasia, And Mental Retardation

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

zinc finger and BTB domain containing 16

ClinVar Annotator: match by term: Skeletal defects, genital hypoplasia, and mental retardation

PMID:11891687 PMID:18611983

NCBI chr 9:48,563,097...48,747,525
Ensembl chr 9:48,565,597...48,747,522

spermatic cord torsion

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

caspase 3

RGD

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

glutathione peroxidase 3

treatment

RGD

NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203

spermatocytoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Spermatocytic seminoma

PMID:7773297 PMID:8599935 PMID:8754806 PMID:9207791 PMID:9677066 More...

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

Harvey rat sarcoma virus oncogene

ClinVar Annotator: match by term: Spermatocytic seminoma

PMID:12727991 PMID:19855393 PMID:25157968 PMID:31775759

NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918

G

leucine rich repeat containing 56

ClinVar Annotator: match by term: Spermatocytic seminoma

PMID:12727991 PMID:19855393 PMID:25157968 PMID:31775759

NCBI chr 7:140,774,024...140,789,968
Ensembl chr 7:140,774,070...140,789,968

spermatogenic failure

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aurora kinase C

ClinVar Annotator: match by term: Spermatogenic Failure

NCBI chr 7:6,998,346...7,006,090
Ensembl chr 7:6,998,299...7,006,090

G

coiled-coil domain containing 34

NCBI chr 2:109,847,816...110,006,007
Ensembl chr 2:109,848,162...110,003,705

G

dynein, axonemal, heavy chain 10

NCBI chr 5:124,802,149...124,911,372
Ensembl chr 5:124,802,149...124,911,372

G

NLR family, pyrin domain containing 14

ClinVar Annotator: match by term: Spermatogenic Failure

PMID:16931801 PMID:20981092 PMID:22344438 PMID:24033266 PMID:25741868

NCBI chr 7:106,712,662...106,797,310
Ensembl chr 7:106,766,197...106,797,309

G

regulator of DNA class I crossover intermediates 1

ClinVar Annotator: match by term: Spermatogenic Failure

NCBI chr15:91,083,654...91,146,291
Ensembl chr15:91,083,697...91,145,097

G

spermatogenesis and oogenesis specific basic helix-loop-helix 1

ClinVar Annotator: match by term: Spermatogenic Failure

PMID:20506135 PMID:28492532 PMID:28718531

NCBI chr 2:25,733,007...25,737,347
Ensembl chr 2:25,733,007...25,737,260

G

spermatogenesis associated 16

ClinVar Annotator: match by term: Spermatogenic Failure

NCBI chr 3:26,691,769...27,037,398
Ensembl chr 3:26,691,769...27,037,361

G

synaptonemal complex protein 3

ClinVar Annotator: match by term: Spermatogenic Failure

NCBI chr10:88,295,449...88,309,098
Ensembl chr10:88,295,431...88,309,098

spermatogenic failure 1

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ankyrin 2, brain

ClinVar Annotator: match by term: Oligosynaptic infertility

PMID:228900 PMID:258150

NCBI chr 3:126,715,256...127,293,996
Ensembl chr 3:126,715,261...127,292,999

G

ankyrin repeat domain 36

ClinVar Annotator: match by term: Oligosynaptic infertility

NCBI chr11:5,519,680...5,639,617
Ensembl chr11:5,519,684...5,639,337

G

dynein, axonemal, heavy chain 1

ClinVar Annotator: match by term: Oligosynaptic infertility

PMID:25741868 PMID:28492532

NCBI chr14:30,982,332...31,045,926
Ensembl chr14:30,982,332...31,045,853

G

nuclear receptor subfamily 5, group A, member 1

ClinVar Annotator: match by term: Oligosynaptic infertility

PMID:9536098 PMID:10369247 PMID:11038323 PMID:12907682 PMID:16199547 More...

NCBI chr 2:38,582,668...38,604,554
Ensembl chr 2:38,582,668...38,604,554

G

pyruvate dehydrogenase E1 alpha 2

ClinVar Annotator: match by term: Oligosynaptic infertility

PMID:29581481 PMID:35172124

NCBI chr 3:140,915,765...140,918,116
Ensembl chr 3:140,915,765...140,918,116

G

synaptonemal complex protein 2

ClinVar Annotator: match by term: OLIGOCHIASMATIC INFERTILITY | ClinVar Annotator: match by term: Oligosynaptic infertility

PMID:25741868 PMID:31866047

NCBI chr 2:177,987,088...178,051,580
Ensembl chr 2:177,987,086...178,049,478

G

testis expressed gene 15 meiosis and synapsis associated

ClinVar Annotator: match by term: Oligosynaptic infertility

NCBI chr 8:34,006,712...34,082,531
Ensembl chr 8:34,006,766...34,075,610

spermatogenic failure 10

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

septin 12

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 10

OMIM
CTD
ClinVar

PMID:22275165 PMID:22479503

NCBI chr16:4,804,722...4,815,716
Ensembl chr16:4,804,722...4,815,716

spermatogenic failure 11

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

kelch-like 10

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 11

OMIM
CTD
ClinVar

PMID:17047026 PMID:25741868 PMID:28492532

NCBI chr11:100,331,954...100,347,853
Ensembl chr11:100,332,743...100,347,848

spermatogenic failure 12

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

nanos C2HC-type zinc finger 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:60,744,425...60,748,352
Ensembl chr19:60,744,425...60,748,352

spermatogenic failure 13

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

TATA-box binding protein associated factor 4b

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 13

OMIM
CTD
ClinVar

NCBI chr18:14,916,302...15,035,160
Ensembl chr18:14,916,302...15,033,416

spermatogenic failure 14

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

zinc finger, MYND-type containing 15

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 14

OMIM
CTD
ClinVar

NCBI chr11:70,350,259...70,357,028
Ensembl chr11:70,350,259...70,357,028

spermatogenic failure 15

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

synaptonemal complex central element protein 1

ClinVar Annotator: match by term: Spermatogenic failure 15
CTD Direct Evidence: marker/mechanism

ClinVar
CTD
OMIM

NCBI chr 7:140,357,142...140,367,767
Ensembl chr 7:140,357,142...140,367,765

spermatogenic failure 16

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Sad1 and UNC84 domain containing 5

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 16

OMIM
CTD
ClinVar

PMID:25741868 PMID:27640305 PMID:28492532 PMID:29331481

NCBI chr 2:153,698,108...153,713,281
Ensembl chr 2:153,698,108...153,713,004

spermatogenic failure 17

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma

ClinVar Annotator: match by term: Spermatogenic failure 17

PMID:25741868 PMID:26721930 PMID:31463947 PMID:36593593 PMID:37004249

NCBI chr 6:139,591,070...139,915,010
Ensembl chr 6:139,564,219...139,915,010

G

phospholipase C, zeta 1

ClinVar Annotator: match by term: Spermatogenic failure 17
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:25741868 PMID:26721930 PMID:31463947 PMID:36593593 PMID:37004249

NCBI chr 6:139,933,118...139,987,188
Ensembl chr 6:139,935,399...139,987,183

spermatogenic failure 18

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 251

ClinVar Annotator: match by term: Spermatogenic failure 18

NCBI chr 5:123,390,196...123,465,547
Ensembl chr 5:123,390,165...123,465,547

G

dynein, axonemal, heavy chain 1

ClinVar Annotator: match by term: Spermatogenic failure 18

PMID:9536098 PMID:16199547 PMID:17576681 PMID:24033266 PMID:24360805 More...

NCBI chr14:30,982,332...31,045,926
Ensembl chr14:30,982,332...31,045,853

G

dynein, axonemal, heavy chain 3

ClinVar Annotator: match by term: Spermatogenic failure 18

NCBI chr 7:119,520,555...119,694,520
Ensembl chr 7:119,521,894...119,694,503

G

proteasome (prosome, macropain) 26S subunit, non-ATPase, 12

ClinVar Annotator: match by term: Spermatogenic failure 18

NCBI chr11:107,370,354...107,388,862
Ensembl chr11:107,370,310...107,395,188

spermatogenic failure 19

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 43

OMIM:617592
ClinVar Annotator: match by term: Spermatogenic failure 19

MouseDO
ClinVar
OMIM

PMID:25741868 PMID:28552195 PMID:29277146 PMID:29449551

NCBI chr19:47,723,706...47,825,893
Ensembl chr19:47,725,296...47,907,726

spermatogenic failure 2

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

mutS homolog 4

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 2

OMIM
CTD
ClinVar

PMID:25741868 PMID:33437391 PMID:33448284 PMID:34755185 PMID:35090489

NCBI chr 3:153,562,783...153,611,495
Ensembl chr 3:153,562,786...153,611,775

spermatogenic failure 20

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 44

OMIM:617593
ClinVar Annotator: match by term: Spermatogenic failure 20

MouseDO
ClinVar
OMIM

PMID:25741868 PMID:25741916 PMID:28552195 PMID:29277146 PMID:29449551

NCBI chr16:44,215,103...44,303,057
Ensembl chr16:44,215,159...44,302,791

G

spindle and centriole associated protein 1

ClinVar Annotator: match by term: Spermatogenic failure 20

PMID:25741868 PMID:25741916 PMID:28552195 PMID:29277146 PMID:29449551

NCBI chr16:44,167,761...44,208,857
Ensembl chr16:44,167,484...44,208,860

spermatogenic failure 21

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

bromodomain, testis-specific

ClinVar Annotator: match by term: Spermatogenic failure 21

NCBI chr 5:107,478,982...107,534,927
Ensembl chr 5:107,479,025...107,534,924

spermatogenic failure 22

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

fumarylacetoacetate hydrolase domain containing 1

ClinVar Annotator: match by term: Spermatogenic failure 22

NCBI chr17:25,067,866...25,069,276
Ensembl chr17:25,067,866...25,069,338

G

meiosis specific with OB domains

ClinVar Annotator: match by term: Spermatogenic failure 22

PMID:28206990 PMID:28492532 PMID:30838384 PMID:34392356 PMID:35991565 More...

NCBI chr17:25,023,275...25,058,762
Ensembl chr17:25,023,263...25,058,762

spermatogenic failure 23

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

testis expressed gene 14 intercellular bridge forming factor

ClinVar Annotator: match by term: Spermatogenic failure 23

PMID:25741868 PMID:28206990 PMID:28492532 PMID:29790874 PMID:31479588

NCBI chr11:87,295,839...87,446,649
Ensembl chr11:87,295,891...87,446,649

spermatogenic failure 24

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 69

ClinVar Annotator: match by term: Spermatogenic failure 24
OMIM:617959

OMIM
ClinVar
MouseDO

PMID:25741868 PMID:29606301 PMID:30415212

NCBI chr 5:5,629,284...5,714,232
Ensembl chr 5:5,629,278...5,714,239

spermatogenic failure 25

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

testis expressed gene 15 meiosis and synapsis associated

ClinVar Annotator: match by term: Spermatogenic failure 25

PMID:25741868 PMID:26199321 PMID:28355598 PMID:28492532

NCBI chr 8:34,006,712...34,082,531
Ensembl chr 8:34,006,766...34,075,610

spermatogenic failure 26

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

testis specific 10

ClinVar Annotator: match by term: Spermatogenic failure 26

NCBI chr 1:37,793,651...37,905,507
Ensembl chr 1:37,793,857...37,905,510

spermatogenic failure 27

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adenylate kinase 7

ClinVar Annotator: match by term: Spermatogenic failure 27

PMID:25741868 PMID:28492532 PMID:29365104

NCBI chr12:105,670,115...105,748,706
Ensembl chr12:105,672,235...105,748,706

spermatogenic failure 28

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Fanconi anemia, complementation group M

ClinVar Annotator: match by term: Spermatogenic failure 28

PMID:2867840 PMID:9536098 PMID:17289582 PMID:17576681 PMID:18174376 More...

NCBI chr12:65,120,884...65,178,616
Ensembl chr12:65,122,377...65,178,832

spermatogenic failure 29

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

serine peptidase inhibitor, Kazal type 2

ClinVar Annotator: match by term: Spermatogenic failure 29

PMID:25741868 PMID:28554943

NCBI chr 5:77,352,953...77,364,106
Ensembl chr 5:77,352,954...77,359,318

spermatogenic failure 3

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 4930447C04 gene

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr12:72,926,967...72,964,742
Ensembl chr12:72,927,883...72,987,548

G

adenosine deaminase domain containing 2

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr 8:120,339,449...120,343,665
Ensembl chr 8:120,339,486...120,343,663

G

androgen receptor

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:28492532 PMID:36572623

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

DEAD box helicase 3, Y-linked

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr Y:1,260,715...1,286,630
Ensembl chr Y:1,260,771...1,286,629

G

doublesex and mab-3 related transcription factor 1

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:24934491 PMID:25741868 PMID:28492532 PMID:31479588

NCBI chr19:25,483,070...25,581,692
Ensembl chr19:25,482,982...25,581,693

G

DNA methyltransferase 3B

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:10647011 PMID:11102980 PMID:11919202 PMID:15580563 PMID:25741868 More...

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

forkhead box P3

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:24258212 PMID:25741868 PMID:28492532

NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484

G

kelch-like 10

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:28492532 PMID:31479588

NCBI chr11:100,331,954...100,347,853
Ensembl chr11:100,332,743...100,347,848

G

meiosis 1 associated protein

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:32673564

NCBI chr 6:82,923,889...83,007,290
Ensembl chr 6:82,923,883...83,007,290

G

minichromosome maintenance 9 homologous recombination repair factor

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25480036 PMID:25741868 PMID:31042289

NCBI chr10:53,412,411...53,507,251
Ensembl chr10:53,412,411...53,506,535

G

MON1 homolog B, secretory traffciking associated

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:28492532 PMID:31479588

NCBI chr 8:114,362,218...114,371,824
Ensembl chr 8:114,362,219...114,371,811

G

Mov10 like RISC complex RNA helicase 1

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:35476666

NCBI chr15:88,867,094...88,939,355
Ensembl chr15:88,867,112...88,939,355

G

mutS homolog 4

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:33448284 PMID:34755185

NCBI chr 3:153,562,783...153,611,495
Ensembl chr 3:153,562,786...153,611,775

G

mutS homolog 5

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:34755185

NCBI chr17:35,247,581...35,267,842
Ensembl chr17:35,247,581...35,265,721

G

neuronal PAS domain protein 2

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr 1:39,233,013...39,402,321
Ensembl chr 1:39,232,812...39,402,317

G

nuclear receptor subfamily 5, group A, member 1

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:18414213 PMID:20887963 PMID:25741868 PMID:25989977 PMID:28492532 More...

NCBI chr 2:38,582,668...38,604,554
Ensembl chr 2:38,582,668...38,604,554

G

poly(A)-specific ribonuclease (PARN)-like domain containing 1

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr17:13,107,610...13,129,489
Ensembl chr17:13,107,616...13,129,117

G

RAD21-like (S. pombe)

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr 2:151,486,286...151,512,542
Ensembl chr 2:151,487,324...151,510,453

G

REC8 meiotic recombination protein

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:31479588

NCBI chr14:55,855,459...55,862,852
Ensembl chr14:55,855,494...55,862,852

G

ring finger protein 212

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr 5:108,875,971...108,922,933
Ensembl chr 5:108,877,156...108,922,848

G

solute carrier family 26, member 8

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 3

OMIM
CTD
ClinVar

PMID:23582645 PMID:25741868 PMID:28492532 PMID:34923715

NCBI chr17:28,856,757...28,910,242
Ensembl chr17:28,856,757...28,909,207

G

SPO11 initiator of meiotic double stranded breaks

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr 2:172,819,172...172,835,369
Ensembl chr 2:172,819,493...172,835,369

G

serine and arginine-rich splicing factor 6

susceptibility

DNA:snp:intron:g.IVS2+305T>C (rs6103330) (human)

RGD

NCBI chr 2:162,773,428...162,779,041
Ensembl chr 2:162,773,448...162,779,041

G

STAG3 cohesin complex component

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:31682730 PMID:35176428

NCBI chr 5:138,270,757...138,310,659
Ensembl chr 5:138,278,502...138,310,655

G

synaptonemal complex central element protein 1 like

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:28492532 PMID:31479588

NCBI chr 8:114,369,845...114,382,165
Ensembl chr 8:114,369,845...114,382,165

G

synaptonemal complex protein 2

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:31866047

NCBI chr 2:177,987,088...178,051,580
Ensembl chr 2:177,987,086...178,049,478

G

telomere repeat binding bouquet formation protein 1

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:33211200

NCBI chr 8:105,173,350...105,236,692
Ensembl chr 8:105,173,351...105,236,542

G

telomere repeat binding bouquet formation protein 2

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr 2:122,016,753...122,036,874
Ensembl chr 2:122,016,753...122,036,878

G

testis expressed gene 11

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25970010 PMID:28132688

NCBI chr X:99,882,254...100,103,245
Ensembl chr X:99,882,254...100,103,273

G

testis expressed gene 14 intercellular bridge forming factor

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:28492532 PMID:31479588

NCBI chr11:87,295,839...87,446,649
Ensembl chr11:87,295,891...87,446,649

G

testis expressed gene 15 meiosis and synapsis associated

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:28492532 PMID:31479588

NCBI chr 8:34,006,712...34,082,531
Ensembl chr 8:34,006,766...34,075,610

G

tripartite motif-containing 71

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr 9:114,340,336...114,393,437
Ensembl chr 9:114,336,201...114,393,437

G

zinc finger, MYND-type containing 15

ClinVar Annotator: match by term: Non-obstructive azoospermia

NCBI chr11:70,350,259...70,357,028
Ensembl chr11:70,350,259...70,357,028

G

zinc finger SWIM-type containing 7

ClinVar Annotator: match by term: Non-obstructive azoospermia

PMID:25741868 PMID:32719396 PMID:33713115

NCBI chr11:62,158,050...62,172,221
Ensembl chr11:62,158,050...62,172,201

spermatogenic failure 30

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

tudor domain containing 9

ClinVar Annotator: match by term: Spermatogenic failure 30

NCBI chr12:111,937,922...112,035,288
Ensembl chr12:111,937,993...112,035,288

spermatogenic failure 31

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cytochrome b-245, alpha polypeptide

ClinVar Annotator: match by term: CYBA DEFICIENCY

PMID:3368442 PMID:9445163 PMID:10440830 PMID:10910929 PMID:19388116 More...

NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669

G

polyamine modulated factor 1 binding protein 1

ClinVar Annotator: match by term: Spermatogenic failure 31
OMIM:618112

OMIM
ClinVar
MouseDO

PMID:25741868 PMID:30032984 PMID:30298696

NCBI chr 8:110,104,447...110,269,274
Ensembl chr 8:110,220,659...110,269,272

spermatogenic failure 32

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

spermatogenesis and oogenesis specific basic helix-loop-helix 1

ClinVar Annotator: match by term: Spermatogenic failure 32

PMID:20506135 PMID:28492532 PMID:28718531

NCBI chr 2:25,733,007...25,737,347
Ensembl chr 2:25,733,007...25,737,260

spermatogenic failure 33

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

coiled-coil domain containing 146

ClinVar Annotator: match by term: Male infertility due to sperm motility disorder | ClinVar Annotator: match by term: Male infertility with spermatogenesis disorder due to single gene mutation

NCBI chr 5:21,496,749...21,629,675
Ensembl chr 5:21,497,959...21,629,675

G

cilia and flagella associated protein 251

ClinVar Annotator: match by term: Spermatogenic failure 33

PMID:30122540 PMID:30122541

NCBI chr 5:123,390,196...123,465,547
Ensembl chr 5:123,390,165...123,465,547

G

dynein, axonemal, heavy chain 1

ClinVar Annotator: match by term: Non-syndromic male infertility due to sperm motility disorder

NCBI chr14:30,982,332...31,045,926
Ensembl chr14:30,982,332...31,045,853

spermatogenic failure 34

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

fibrous sheath-interacting protein 2

ClinVar Annotator: match by term: Spermatogenic failure 34

PMID:25741868 PMID:30137358 PMID:35654582

NCBI chr 2:82,773,978...82,839,281
Ensembl chr 2:82,773,978...82,839,281

spermatogenic failure 35

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

glutamine rich 2

ClinVar Annotator: match by term: Spermatogenic failure 35

PMID:25741868 PMID:31110204 PMID:31292949

NCBI chr11:116,332,149...116,357,092
Ensembl chr11:116,332,151...116,357,067

spermatogenic failure 36

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

family with sequence similarity 177 member A2

ClinVar Annotator: match by term: Spermatogenic failure 36

PMID:8849014 PMID:30893644 PMID:34714774 PMID:34750818

NCBI chr12:55,246,377...55,263,953
Ensembl chr12:55,246,377...55,263,953

G

protein phosphatase 2, regulatory subunit B'', gamma

ClinVar Annotator: match by term: Spermatogenic failure 36

PMID:8849014 PMID:25741868 PMID:30893644 PMID:34714774 PMID:34750818

NCBI chr12:55,327,594...55,350,024
Ensembl chr12:55,325,776...55,349,783

G

protein only RNase P catalytic subunit

ClinVar Annotator: match by term: Spermatogenic failure 36

NCBI chr12:55,349,422...55,429,276
Ensembl chr12:55,346,362...55,429,318

spermatogenic failure 37

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

tetratricopeptide repeat domain 21A

ClinVar Annotator: match by term: Spermatogenic failure 37

NCBI chr 9:119,766,656...119,798,496
Ensembl chr 9:119,766,672...119,796,859

spermatogenic failure 38

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

armadillo repeat containing 2

ClinVar Annotator: match by term: Spermatogenic failure 38

NCBI chr10:41,784,284...41,894,383
Ensembl chr10:41,790,986...41,894,438

G

cilia and flagella associated protein 91

ClinVar Annotator: match by term: Male infertility with teratozoospermia due to single gene mutation

NCBI chr16:38,118,116...38,162,222
Ensembl chr16:38,118,116...38,162,505

spermatogenic failure 39

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dynein, axonemal, heavy chain 17

ClinVar Annotator: match by term: Spermatogenic failure 39
OMIM:618643

OMIM
ClinVar
MouseDO

PMID:25741868 PMID:31178125 PMID:31658987 PMID:33070343

NCBI chr11:117,912,549...118,021,684
Ensembl chr11:117,912,549...118,021,460

spermatogenic failure 4

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

choline phosphotransferase 1

ClinVar Annotator: match by term: Spermatogenic failure 4

NCBI chr10:88,305,376...88,339,855
Ensembl chr10:88,288,607...88,339,935

G

HFM1, ATP-dependent DNA helicase homolog

ClinVar Annotator: match by term: Spermatogenic failure 4

NCBI chr 5:106,988,059...107,074,427
Ensembl chr 5:106,988,058...107,074,187

G

meiosis 1 associated protein

ClinVar Annotator: match by term: Spermatogenesis maturation arrest

NCBI chr 6:82,923,889...83,007,290
Ensembl chr 6:82,923,883...83,007,290

G

ribosomal protein L10-like

ClinVar Annotator: match by term: Spermatogenesis maturation arrest

NCBI chr12:66,330,153...66,331,175
Ensembl chr12:66,330,153...66,331,175

G

synaptonemal complex protein 2

ClinVar Annotator: match by term: Early spermatogenesis maturation arrest

PMID:25741868 PMID:31866047

NCBI chr 2:177,987,088...178,051,580
Ensembl chr 2:177,987,086...178,049,478

G

synaptonemal complex protein 3

ClinVar Annotator: match by term: Spermatogenic failure 4
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:14643120 PMID:19110213 PMID:25741868 PMID:28492532 PMID:28801929 More...

NCBI chr10:88,295,449...88,309,098
Ensembl chr10:88,295,431...88,309,098

spermatogenic failure 40

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 65

ClinVar Annotator: match by term: Spermatogenic failure 40
OMIM:618664

OMIM
ClinVar
MouseDO

PMID:25741868 PMID:28552195 PMID:31413122 PMID:31501240 PMID:31571197

NCBI chr 1:74,941,230...74,974,785
Ensembl chr 1:74,941,230...74,974,758

spermatogenic failure 41

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 70

ClinVar Annotator: match by term: Spermatogenic failure 41

NCBI chr14:20,444,258...20,502,332
Ensembl chr14:20,444,261...20,502,294

spermatogenic failure 42

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

tetratricopeptide repeat domain 29

ClinVar Annotator: match by term: Spermatogenic failure 42

PMID:31735292 PMID:31735294

NCBI chr 8:78,939,911...79,120,955
Ensembl chr 8:78,939,926...79,120,955

spermatogenic failure 43

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

sperm flagellar 2

ClinVar Annotator: match by term: Spermatogenic failure 43

PMID:24033266 PMID:25741868 PMID:28492532 PMID:31048344 PMID:31151990 More...

NCBI chr15:9,578,279...9,748,954
Ensembl chr15:9,578,279...9,748,954

spermatogenic failure 44

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

centrosomal protein 112

ClinVar Annotator: match by term: Spermatogenic failure 44

NCBI chr11:108,316,041...108,751,441
Ensembl chr11:108,316,018...108,751,441

spermatogenic failure 45

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dynein, axonemal, heavy chain 2

ClinVar Annotator: match by term: Spermatogenic failure 45

PMID:25741868 PMID:30811583

NCBI chr11:69,311,635...69,439,934
Ensembl chr11:69,311,635...69,439,936

spermatogenic failure 46

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dynein, axonemal, heavy chain 8

ClinVar Annotator: match by term: DNAH8-related condition | ClinVar Annotator: match by term: Spermatogenic failure 46
OMIM:619095

OMIM
ClinVar
MouseDO

PMID:16199547 PMID:24033266 PMID:24307375 PMID:25741868 PMID:25741916 More...

NCBI chr17:30,845,909...31,094,736
Ensembl chr17:30,843,328...31,096,339

spermatogenic failure 47

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

DAZ interacting protein 1

OMIM:619102
ClinVar Annotator: match by term: Spermatogenic failure 47

OMIM
MouseDO
ClinVar

NCBI chr14:119,112,927...119,162,947
Ensembl chr14:119,112,932...119,162,872

spermatogenic failure 48

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

meiosis 1 associated protein

ClinVar Annotator: match by term: Spermatogenic failure 48

PMID:25741868 PMID:32017041 PMID:32673564

NCBI chr 6:82,923,889...83,007,290
Ensembl chr 6:82,923,883...83,007,290

spermatogenic failure 49

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 58

ClinVar Annotator: match by term: Spermatogenic failure 49

PMID:25741868 PMID:32791035

NCBI chr19:47,926,151...48,023,818
Ensembl chr19:47,926,114...48,023,826

spermatogenic failure 5

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aurora kinase C

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Infertility associated with multi-tailed spermatozoa and excessive DNA | ClinVar Annotator: match by term: Male infertility with spermatogenesis disorder

OMIM
CTD
ClinVar

PMID:17435757 PMID:19147683 PMID:21733974 PMID:22888167 PMID:24033266 More...

NCBI chr 7:6,998,346...7,006,090
Ensembl chr 7:6,998,299...7,006,090

spermatogenic failure 50

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

X-ray repair complementing defective repair in Chinese hamster cells 2

ClinVar Annotator: match by term: SPERMATOGENIC FAILURE 50

PMID:28492532 PMID:30042186 PMID:30489636 PMID:33194656

NCBI chr 5:25,894,812...25,910,795
Ensembl chr 5:25,894,810...25,910,823

spermatogenic failure 51

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 91

ClinVar Annotator: match by term: Spermatogenic failure 51

PMID:25741868 PMID:32161152

NCBI chr16:38,118,116...38,162,222
Ensembl chr16:38,118,116...38,162,505

spermatogenic failure 52

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 4930447C04 gene

ClinVar Annotator: match by term: Spermatogenic failure 52

NCBI chr12:72,926,967...72,964,742
Ensembl chr12:72,927,883...72,987,548

spermatogenic failure 53

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

actin-like 9

ClinVar Annotator: match by term: Spermatogenic failure 53

NCBI chr17:33,651,873...33,653,242
Ensembl chr17:33,651,870...33,653,242

spermatogenic failure 54

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ciliogenesis associated TTC17 interacting protein

ClinVar Annotator: match by term: Spermatogenic failure 54

NCBI chr 1:74,401,272...74,408,482
Ensembl chr 1:74,401,267...74,408,480

spermatogenic failure 55

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

sperm associated antigen 17

ClinVar Annotator: match by term: Spermatogenic failure 55

NCBI chr 3:99,792,653...100,050,638
Ensembl chr 3:99,792,722...100,050,638

spermatogenic failure 56

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 1700129C05 gene

ClinVar Annotator: match by term: Spermatogenic failure 56

PMID:25741868 PMID:34237282

NCBI chr14:59,370,484...59,380,379
Ensembl chr14:59,370,489...59,380,342

G

dynein, axonemal, heavy chain 10

ClinVar Annotator: match by term: Spermatogenic failure 56

PMID:25741868 PMID:34237282

NCBI chr 5:124,802,149...124,911,372
Ensembl chr 5:124,802,149...124,911,372

spermatogenic failure 57

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

poly(A)-specific ribonuclease (PARN)-like domain containing 1

ClinVar Annotator: match by term: Spermatogenic failure 57

PMID:25741868 PMID:34347949 PMID:35476664

NCBI chr17:13,107,610...13,129,489
Ensembl chr17:13,107,616...13,129,117

G

SPOC domain containing 1

ClinVar Annotator: match by term: Male infertility with azoospermia or oligozoospermia due to single gene mutation

PMID:25741868 PMID:38359823

NCBI chr 4:129,822,560...129,850,908
Ensembl chr 4:129,823,042...129,850,908

spermatogenic failure 58

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

intraflagellar transport 74

ClinVar Annotator: match by term: Spermatogenic failure 58

PMID:25741868 PMID:28492532 PMID:33689014

NCBI chr 4:94,491,503...94,581,470
Ensembl chr 4:94,502,728...94,581,466

spermatogenic failure 59

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

telomere repeat binding bouquet formation protein 2

ClinVar Annotator: match by term: Spermatogenic failure 59

NCBI chr 2:122,016,753...122,036,874
Ensembl chr 2:122,016,753...122,036,878

spermatogenic failure 6

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

spermatogenesis associated 16

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Globozoospermia | ClinVar Annotator: match by term: Spermatogenic failure 6

OMIM
CTD
ClinVar

PMID:17847006 PMID:24265589 PMID:25741868 PMID:28492532 PMID:29065458

NCBI chr 3:26,691,769...27,037,398
Ensembl chr 3:26,691,769...27,037,361

spermatogenic failure 60

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

telomere repeat binding bouquet formation protein 1

ClinVar Annotator: match by term: Spermatogenic failure 60

PMID:25741868 PMID:32741963 PMID:33211200

NCBI chr 8:105,173,350...105,236,692
Ensembl chr 8:105,173,351...105,236,542

spermatogenic failure 61

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

STAG3 cohesin complex component

ClinVar Annotator: match by term: Spermatogenic failure 61

PMID:25741868 PMID:31125047 PMID:31682730

NCBI chr 5:138,270,757...138,310,659
Ensembl chr 5:138,278,502...138,310,655

spermatogenic failure 62

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ring finger protein 212

ClinVar Annotator: match by term: Spermatogenic failure 62

NCBI chr 5:108,875,971...108,922,933
Ensembl chr 5:108,877,156...108,922,848

spermatogenic failure 63

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ribosomal protein L10-like

ClinVar Annotator: match by term: Spermatogenic failure 63

NCBI chr12:66,330,153...66,331,175
Ensembl chr12:66,330,153...66,331,175

spermatogenic failure 64

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

F-box protein 43

ClinVar Annotator: match by term: Spermatogenic failure 64

PMID:30878252 PMID:34052850 PMID:34595750

NCBI chr15:36,150,206...36,170,086
Ensembl chr15:36,150,206...36,165,030

spermatogenic failure 65

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dynein heavy chain domain 1

ClinVar Annotator: match by term: DNHD1-related condition | ClinVar Annotator: match by term: Spermatogenic failure 65

PMID:16199547 PMID:25741868 PMID:28492532 PMID:33279834 PMID:34932939

NCBI chr 7:105,299,983...105,371,007
Ensembl chr 7:105,300,034...105,371,006

Spermatogenic Failure 66

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

zona pellucida binding protein

ClinVar Annotator: match by term: Spermatogenic failure 66

PMID:25741868 PMID:31985809

NCBI chr11:11,229,624...11,414,222
Ensembl chr11:11,229,626...11,412,408

Spermatogenic Failure 67

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

coiled-coil domain containing 62

ClinVar Annotator: match by term: Spermatogenic failure 67

NCBI chr 5:124,068,683...124,107,958
Ensembl chr 5:124,065,481...124,107,958

Spermatogenic Failure 68

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C2 calcium dependent domain containing 6

ClinVar Annotator: match by term: Spermatogenic failure 68

NCBI chr 1:59,036,275...59,134,283
Ensembl chr 1:59,036,275...59,134,059

Spermatogenic Failure 69

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

gametogenetin

ClinVar Annotator: match by term: Spermatogenic failure 69

PMID:31985809 PMID:33108537

NCBI chr 7:28,869,635...28,873,363
Ensembl chr 7:28,869,635...28,873,401

spermatogenic failure 7

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cation channel, sperm associated 1

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 7

OMIM
CTD
ClinVar

PMID:19344877 PMID:20301780 PMID:21255775 PMID:24442342 PMID:25741868 More...

NCBI chr19:5,385,643...5,394,309
Ensembl chr19:5,385,769...5,394,308

G

cation channel, sperm associated 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:121,222,109...121,245,082
Ensembl chr 2:121,223,112...121,244,273

G

stereocilin

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: MALE INFERTILITY, NONSYNDROMIC, AUTOSOMAL RECESSIVE | ClinVar Annotator: match by term: SPERMATOGENIC FAILURE 7

PMID:21078986 PMID:22147502 PMID:24033266 PMID:25157971 PMID:25741868 More...

NCBI chr 2:121,193,729...121,211,851
Ensembl chr 2:121,194,209...121,217,649

Spermatogenic Failure 70

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

pyruvate dehydrogenase E1 alpha 2

ClinVar Annotator: match by term: Spermatogenic failure 70

PMID:29581481 PMID:35172124

NCBI chr 3:140,915,765...140,918,116
Ensembl chr 3:140,915,765...140,918,116

Spermatogenic Failure 71

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

zinc finger SWIM-type containing 7

ClinVar Annotator: match by term: Spermatogenic failure 71

PMID:25741868 PMID:32719396 PMID:33713115

NCBI chr11:62,158,050...62,172,221
Ensembl chr11:62,158,050...62,172,201

Spermatogenic Failure 72

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

WD repeat domain 19

ClinVar Annotator: match by term: Spermatogenic failure 72

PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532 PMID:32323121 More...

NCBI chr 5:65,357,039...65,417,758
Ensembl chr 5:65,357,039...65,417,758

Spermatogenic Failure 73

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Mov10 like RISC complex RNA helicase 1

ClinVar Annotator: match by term: Spermatogenic failure 73

PMID:25741868 PMID:35476666

NCBI chr15:88,867,094...88,939,355
Ensembl chr15:88,867,112...88,939,355

Spermatogenic Failure 74

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

mutS homolog 5

ClinVar Annotator: match by term: Spermatogenic failure 74

PMID:25741868 PMID:34755185

NCBI chr17:35,247,581...35,267,842
Ensembl chr17:35,247,581...35,265,721

Spermatogenic Failure 75

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

shortage in chiasmata 1

ClinVar Annotator: match by term: Spermatogenic failure 75

PMID:32741963 PMID:32900840 PMID:35485979

NCBI chr 4:59,041,984...59,138,983
Ensembl chr 4:59,043,753...59,138,983

Spermatogenic Failure 76

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

coiled-coil domain containing 34

ClinVar Annotator: match by term: Spermatogenic failure 76

NCBI chr 2:109,847,816...110,006,007
Ensembl chr 2:109,848,162...110,003,705

Spermatogenic Failure 77

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

FK506 binding protein 6

ClinVar Annotator: match by term: Spermatogenic failure 77

PMID:25741868 PMID:36150389

NCBI chr 5:135,320,558...135,380,662
Ensembl chr 5:135,320,558...135,378,898

Spermatogenic Failure 78

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

IQ motif containing N

ClinVar Annotator: match by term: Spermatogenic failure 78

PMID:25741868 PMID:36321563

NCBI chr 8:71,154,661...71,170,299
Ensembl chr 8:71,156,106...71,170,299

Spermatogenic Failure 79

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

potassium channel, subfamily U, member 1

ClinVar Annotator: match by term: Spermatogenic failure 79

PMID:34980136 PMID:35551387

NCBI chr 8:26,338,656...26,427,971
Ensembl chr 8:26,339,651...26,427,967

spermatogenic failure 8

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

nuclear receptor subfamily 5, group A, member 1

ClinVar Annotator: match by term: Spermatogenic failure 8
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:20887963 PMID:25741868 PMID:25989977 PMID:28492532 PMID:35690514 More...

NCBI chr 2:38,582,668...38,604,554
Ensembl chr 2:38,582,668...38,604,554

Spermatogenic Failure 80

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dynein regulatory complex subunit 1

ClinVar Annotator: match by term: DRC1-related condition | ClinVar Annotator: match by term: Spermatogenic failure 80

PMID:23354437 PMID:25741868 PMID:28492532 PMID:31960620 PMID:34169321

NCBI chr 5:30,486,328...30,524,039
Ensembl chr 5:30,486,386...30,524,039

Spermatogenic Failure 81

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

tektin 3

ClinVar Annotator: match by term: Spermatogenic failure 81

NCBI chr11:62,952,485...62,985,786
Ensembl chr11:62,952,480...62,985,790

Spermatogenic Failure 82

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

A kinase anchor protein 3

ClinVar Annotator: match by term: Spermatogenic failure 82

NCBI chr 6:126,830,061...126,851,271
Ensembl chr 6:126,830,061...126,851,271

Spermatogenic Failure 83

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dynein, axonemal, light intermediate polypeptide 1

ClinVar Annotator: match by term: Spermatogenic failure 83

NCBI chr 4:124,949,131...124,959,443
Ensembl chr 4:124,949,131...124,959,496

Spermatogenic Failure 84

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 61

ClinVar Annotator: match by term: Spermatogenic failure 84

PMID:34792097 PMID:35174165 PMID:35387802

NCBI chr 2:145,776,677...146,056,955
Ensembl chr 2:145,776,704...146,056,959

Spermatogenic Failure 85

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

sperm acrosome associated 1

ClinVar Annotator: match by term: Spermatogenic failure 85

NCBI chr 4:34,024,872...34,050,067
Ensembl chr 4:34,024,874...34,050,191

Spermatogenic Failure 86

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

actin-like 7a

ClinVar Annotator: match by term: Spermatogenic failure 86

PMID:32923619 PMID:34727571 PMID:36593593 PMID:37004249

NCBI chr 4:56,743,422...56,744,925
Ensembl chr 4:56,743,413...56,744,925

Spermatogenic Failure 87

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acrosin prepropeptide

ClinVar Annotator: match by term: Spermatogenic failure 87

NCBI chr15:89,452,549...89,458,790
Ensembl chr15:89,452,529...89,458,788

Spermatogenic Failure 88

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

KASH domain containing 5

ClinVar Annotator: match by term: Spermatogenic failure 88

PMID:25741905 PMID:29790874 PMID:35587281 PMID:35674372 PMID:36864840

NCBI chr 7:44,833,043...44,854,344
Ensembl chr 7:44,833,048...44,854,316

Spermatogenic Failure 89

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adenylate kinase 9

ClinVar Annotator: match by term: Spermatogenic failure 89

NCBI chr10:41,179,433...41,309,565
Ensembl chr10:41,179,976...41,310,530

spermatogenic failure 9

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dpy-19 like 2

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Spermatogenic failure 9

OMIM
CTD
ClinVar

PMID:15533374 PMID:21397063 PMID:21397064 PMID:22627659 PMID:22653751 More...

NCBI chr 9:24,468,343...24,607,752
Ensembl chr 9:24,468,343...24,607,589

Spermatogenic Failure 90

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

armadillo repeat containing 12

ClinVar Annotator: match by term: Spermatogenic failure 90

NCBI chr17:28,749,835...28,757,949
Ensembl chr17:28,749,780...28,758,084

syphilis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-C motif chemokine receptor 5

RGD

NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736

G

forkhead box P3

treatment

RGD

NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484

G

neurofilament, light polypeptide

associated with age;protein:increased expression:CSF (human)

RGD

NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544

G

triggering receptor expressed on myeloid cells 2

associated with age;protein:increased expression:CSF (human)

RGD

NCBI chr17:48,653,429...48,659,304
Ensembl chr17:48,653,429...48,661,175

Teratozoospermia

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

autophagy related 5

CTD Direct Evidence: marker/mechanism

NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287

G

family with sequence similarity 83, member F

ClinVar Annotator: match by term: Teratozoospermia

NCBI chr15:80,555,829...80,584,626
Ensembl chr15:80,556,048...80,584,626

G

nectin cell adhesion molecule 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:19,450,569...19,483,498
Ensembl chr 7:19,450,569...19,484,408

G

nectin cell adhesion molecule 3

CTD Direct Evidence: marker/mechanism

NCBI chr16:46,208,028...46,318,898
Ensembl chr16:46,208,069...46,318,888

G

nitric oxide synthase 3, endothelial cell

CTD Direct Evidence: marker/mechanism

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

YTH domain containing 2

CTD Direct Evidence: therapeutic

NCBI chr18:44,961,521...45,022,782
Ensembl chr18:44,960,813...45,022,791

Testicular Anomalies with or without Congenital Heart Disease

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

GATA binding protein 4

ClinVar Annotator: match by term: Testicular anomalies with or without congenital heart disease
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:9536098 PMID:15863664 PMID:17576681 PMID:17643447 PMID:18672102 More...

NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141

testicular cancer

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

B cell leukemia/lymphoma 10

ClinVar Annotator: match by term: Malignant tumor of testis

NCBI chr 3:145,630,017...145,640,121
Ensembl chr 3:145,628,559...145,640,111

G

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Cancer of the testes

PMID:1908846 PMID:7649548 PMID:7670477 PMID:7702086 PMID:7773297 More...

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

glutathione S-transferase, pi 1

RGD

NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985

G

KIT proto-oncogene receptor tyrosine kinase

ClinVar Annotator: match by term: Cancer of the testes | ClinVar Annotator: match by term: Malignant tumor of testis

PMID:25741868 PMID:28492532 PMID:28724667 PMID:31350202

NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382

G

solute carrier organic anion transporter family, member 1b2

mRNA:decreased expression:testis (human)

RGD

NCBI chr 6:141,575,178...141,632,372
Ensembl chr 6:141,575,244...141,632,372

G

serine/threonine kinase 11

ClinVar Annotator: match by term: Cancer of the testes | ClinVar Annotator: match by term: Malignant tumor of testis

PMID:9605748 PMID:9887330 PMID:25741868 PMID:26467025 PMID:28135145 More...

NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516

testicular disease

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Fas ligand

CTD Direct Evidence: marker/mechanism

NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064

G

immunoglobulin superfamily, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr X:48,871,413...48,886,798
Ensembl chr X:48,871,413...48,886,626

G

protein phosphatase 3, catalytic subunit, alpha isoform

treatment

CTD Direct Evidence: marker/mechanism
associated with Cadmium Poisoning

CTD
RGD

PMID:17785681 PMID:17785681

NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488

G

TSC22 domain family, member 3

CTD Direct Evidence: marker/mechanism

NCBI chr X:139,440,277...139,501,257
Ensembl chr X:139,440,277...139,501,408

testicular germ cell cancer

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Germ cell tumor of testis

PMID:7647778 PMID:8723106 PMID:8841188 PMID:9042914 PMID:9107244 More...

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

KIT proto-oncogene receptor tyrosine kinase

ClinVar Annotator: match by term: Germ cell tumor of testis

PMID:7530509 PMID:9438854 PMID:10362788 PMID:11276010 PMID:15790786 More...

NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382

G

serine/threonine kinase 11

ClinVar Annotator: match by term: Germ cell tumor of testis

PMID:25741868 PMID:26467025 PMID:28492532

NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516

Testicular Germ Cell Tumor

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

arachidonate 12-lipoxygenase, 12R type

CTD Direct Evidence: marker/mechanism

NCBI chr11:69,047,898...69,060,617
Ensembl chr11:69,047,815...69,060,618

G

arachidonate 5-lipoxygenase

CTD Direct Evidence: marker/mechanism

NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139

G

B cell leukemia/lymphoma 10

ClinVar Annotator: match by term: Male germ cell tumor, somatic
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:9989495 PMID:10380920 PMID:10408400 PMID:25365219 PMID:28492532 More...

NCBI chr 3:145,630,017...145,640,121
Ensembl chr 3:145,628,559...145,640,111

G

baculoviral IAP repeat-containing 2

exacerbates

mRNA:increased expression:testis (human)

NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065

G

baculoviral IAP repeat-containing 3

exacerbates

mRNA:increased expression:testis (human)

NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187

G

baculoviral IAP repeat-containing 5

exacerbates

mRNA:increased expression:testis (human)

NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569

G

baculoviral IAP repeat-containing 6

disease_progression

mRNA:decreased expression:testis (human)

NCBI chr17:74,835,247...75,010,351
Ensembl chr17:74,835,290...75,010,351

G

deleted in azoospermia-like

CTD Direct Evidence: marker/mechanism

NCBI chr17:50,586,422...50,600,627
Ensembl chr17:50,586,423...50,600,664

G

eukaryotic translation initiation factor 2 subunit 2 beta

RGD

NCBI chr 2:154,713,330...154,734,826
Ensembl chr 2:154,713,330...154,734,855

G

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Testicular germ cell tumor
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:7647778 PMID:8723106 PMID:8841188 PMID:9042914 PMID:9107244 More...

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

hematopoietic prostaglandin D synthase

CTD Direct Evidence: marker/mechanism

NCBI chr 6:65,094,019...65,121,960
Ensembl chr 6:65,094,277...65,121,892

G

KIT proto-oncogene receptor tyrosine kinase

ClinVar Annotator: match by term: Germ cell tumor of testis | ClinVar Annotator: match by term: Testicular germ cell tumor
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:7530509 PMID:9438854 PMID:10362788 PMID:11276010 PMID:15790786 More...

NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382

G

MAD1 mitotic arrest deficient 1-like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:139,994,444...140,307,346
Ensembl chr 5:139,994,444...140,307,307

G

matrix metallopeptidase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048

G

NLR family, apoptosis inhibitory protein 2

exacerbates

mRNA:increased expression:testis (human)

NCBI chr13:100,280,571...100,338,630
Ensembl chr13:100,280,571...100,338,600

G

paired-like homeodomain transcription factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr13:55,972,857...55,984,002
Ensembl chr13:55,972,864...55,984,005

G

PR domain containing 14

CTD Direct Evidence: marker/mechanism

NCBI chr 1:13,183,649...13,197,467
Ensembl chr 1:13,183,681...13,197,387

G

ring finger and WD repeat domain 3

CTD Direct Evidence: marker/mechanism

NCBI chr 8:111,997,576...112,026,854
Ensembl chr 8:111,997,576...112,026,854

G

spalt like transcription factor 4

protein:increased expression:testis (human)

RGD

NCBI chr 2:168,590,252...168,609,121
Ensembl chr 2:168,590,252...168,609,863

G

serine/threonine kinase 11

ClinVar Annotator: match by term: Germ cell tumor of testis | ClinVar Annotator: match by term: Testicular germ cell tumor
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:25741868 PMID:26467025 PMID:28492532

NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516

Testicular Injury

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cytochrome P450, family 2, subfamily e, polypeptide 1

treatment

RGD

NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900

G

Fas cell surface death receptor

mRNA:increased expression:testis (rat)

RGD

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

FTO alpha-ketoglutarate dependent dioxygenase

mRNA:decreased expression:testis

RGD

NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067

G

glucose-6-phosphate dehydrogenase X-linked

treatment

RGD

NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800

G

glutathione reductase

treatment

RGD

NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191

testicular lymphoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

myeloid differentiation primary response gene 88

associated with diffuse large B-cell lymphoma;DNA:missense mutation:CDS:p.L265P (human)

RGD

NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477

Testicular Neoplasms

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

arachidonate 12-lipoxygenase

protein:increased expression:testis

RGD

NCBI chr11:70,132,283...70,146,206
Ensembl chr11:70,132,283...70,146,179

G

activating transcription factor 7 interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chr 6:136,495,787...136,587,848
Ensembl chr 6:136,483,165...136,587,860

G

Brca1 associated protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:30,973,358...30,981,887
Ensembl chr14:30,973,407...30,981,901

G

cyclin A1

mRNA:decreased expression:testis (human)

RGD

NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922

G

cyclin D2

mRNA:increased expression:testis

RGD

NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156

G

cyclin dependent kinase inhibitor 1B

protein:decreased expression:testis

RGD

NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476

G

doublesex and mab-3 related transcription factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:25,483,070...25,581,692
Ensembl chr19:25,482,982...25,581,693

G

excision repair cross-complementing rodent repair deficiency, complementation group 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449

G

excision repair cross-complementing rodent repair deficiency, complementation group 4

CTD Direct Evidence: marker/mechanism

NCBI chr16:12,927,600...12,969,873
Ensembl chr16:12,927,548...12,968,481

G

fibroblast growth factor 9

CTD Direct Evidence: marker/mechanism

NCBI chr14:58,308,543...58,350,311
Ensembl chr14:58,308,004...58,350,177

G

glutathione S-transferase, mu 1

DNA:deletion

RGD

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

kit ligand

CTD Direct Evidence: marker/mechanism

PMID:19483681 PMID:19483682

NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278

G

kallikrein related-peptidase 10

mRNA, protein:decreased expression:testis

RGD

NCBI chr 7:43,430,478...43,434,834
Ensembl chr 7:43,430,459...43,434,834

G

O-6-methylguanine-DNA methyltransferase

DNA:hypermethylation:promoter (human)

RGD

NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995

G

proliferating cell nuclear antigen

disease_progression

RGD

NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234

G

phospholipase A and acyltransferase 3

RGD

NCBI chr19:7,534,824...7,565,914
Ensembl chr19:7,534,824...7,565,910

G

ring finger protein 4

mRNA:decreased expression:testes (human)

RGD

NCBI chr 5:34,493,594...34,510,789
Ensembl chr 5:34,493,633...34,512,973

G

SMAD family member 1

RGD

NCBI chr 8:80,065,024...80,126,057
Ensembl chr 8:80,065,024...80,126,147

G

SMAD family member 5

RGD

NCBI chr13:56,850,804...56,890,191
Ensembl chr13:56,850,823...56,890,190

Testis Reperfusion Injury

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

apoptotic peptidase activating factor 1

treatment

RGD

NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632

G

BCL2-associated X protein

RGD

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

B cell leukemia/lymphoma 2

RGD

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

caspase 3

RGD

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

caspase 9

RGD

NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287

G

hypoxia inducible factor 1, alpha subunit

protein:increased expression:testes (rat)

RGD

NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304

G

heme oxygenase 1

treatment

RGD

NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217

G

mitogen-activated protein kinase 1

treatment

RGD

NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317

G

mitogen-activated protein kinase 3

treatment

RGD

NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991

G

nitric oxide synthase 3, endothelial cell

protein:increased expression:testis

RGD

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

ubiquitin carboxyl-terminal esterase L5

mRNA, protein:decreased expression:testis

RGD

NCBI chr 1:143,652,993...143,683,204
Ensembl chr 1:143,653,010...143,683,204

G

xanthine dehydrogenase

treatment

RGD

NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191

trachoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

C-X-C motif chemokine ligand 15

susceptibility

DNA:SNP:promoter:g.-251A>T (rs4073) (human)

RGD

NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926

G

histocompatibility 2, M region locus 2

DNA:polymorphism:cds:HLA-B*14 (human, Tanzanian)

NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443

G

histocompatibility 2, Q region locus 4

DNA:polymorphisms:cds:HLA-B*14 (human, Tanzanian)

RGD

NCBI chr17:35,598,593...35,603,650
Ensembl chr17:35,598,593...35,604,266

G

interleukin 10

no_association
severity

protein:increased expression:tear
DNA:SNP:promoter:−1082G>A (human)
DNA:SNP:promoter:−819T>C, −592A>C (human)
DNA:SNP, haplotype:promoter:−1082G>A (human)
DNA:haplotype: :

RGD

PMID:18628987 PMID:11023480 PMID:11023480 PMID:15789056 PMID:17947295

RGD:7365037, RGD:7365085, RGD:7365085, RGD:7365072, RGD:7365053

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

interleukin 17A

mRNA:increased expression:conjunctiva (human)

RGD

NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720

G

tumor necrosis factor

DNA:SNP, haplotypes:promoter:−308G>A (human)

RGD

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

Trachomatous Trichiasis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

collagen, type I, alpha 1

mRNA:decreased expression:tarsal conjunctiva (human)

RGD

NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868

tuberculoid leprosy

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)

susceptibility

DNA:polymorphism: :

RGD

NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295

G

vitamin D (1,25-dihydroxyvitamin D3) receptor

GAD

NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511

varicocele

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

caspase 3

protein:increased expression:testis

RGD

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

caspase 9

protein:increased expression:testis

RGD

NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287

G

Fas cell surface death receptor

protein:decreased expression:Leydig cell, spermatid

RGD

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

hypoxia inducible factor 1, alpha subunit

protein:increased expression:epididymus (rat)

RGD

NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304

G

heme oxygenase 1

severity

RGD

NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217

G

heat shock protein 1 (chaperonin)

mRNA:increased expression:spermatid

RGD

NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402

G

interleukin 1 alpha

protein:increased expression:testis

RGD

NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892

G

interleukin 1 beta

protein:increased expression:testis

RGD

NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059

G

programmed cell death 10

protein:increased expression:testis (rat)

RGD

NCBI chr 3:75,423,797...75,464,159
Ensembl chr 3:75,423,797...75,464,163

vasculogenic impotence

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

angiopoietin 2

associated with Hypercholesterolemia; mRNA, protein:decreased expression:cavernous body of penis (rat)

RGD

NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578

G

apolipoprotein D

mRNA:increased expression:penis erectile tissue

RGD

NCBI chr16:31,115,010...31,133,626
Ensembl chr16:31,115,010...31,133,626

G

phosphodiesterase 5A, cGMP-specific

RGD

NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023

G

transforming growth factor, beta receptor II

protein:increased expression:penis erectile tissue

RGD

NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428

Visceral Heterotaxy 10, Autosomal

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 52

ClinVar Annotator: match by term: Heterotaxy, visceral, 10, autosomal, with male infertility

PMID:25469542 PMID:25741868 PMID:33139725

NCBI chr11:67,815,632...67,856,494
Ensembl chr11:67,815,632...67,856,477

Visceral Heterotaxy 11, Autosomal

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 45

ClinVar Annotator: match by term: Heterotaxy, visceral, 11, autosomal, with male infertility

NCBI chr 1:172,348,697...172,373,437
Ensembl chr 1:172,348,368...172,373,437

Visceral Heterotaxy 9, Autosomal

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

meiosis-specific nuclear structural protein 1

ClinVar Annotator: match by term: Heterotaxy, visceral, 9, autosomal, with male infertility | ClinVar Annotator: match by term: MNS1-related condition

PMID:25741868 PMID:28492532 PMID:30148830 PMID:31534215

NCBI chr 9:72,345,276...72,366,036
Ensembl chr 9:72,345,293...72,369,307

G

testis expressed gene 9

ClinVar Annotator: match by term: Heterotaxy, visceral, 9, autosomal, with male infertility | ClinVar Annotator: match by term: MNS1-related condition

PMID:25741868 PMID:28492532 PMID:30148830 PMID:31534215

NCBI chr 9:72,365,337...72,418,226
Ensembl chr 9:72,357,676...72,399,494

X-linked congenital bilateral absence of vas deferens

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adhesion G protein-coupled receptor G2

ClinVar Annotator: match by term: Vas deferens, congenital bilateral aplasia of, X-linked

PMID:25741868 PMID:27476656

NCBI chr X:159,173,315...159,281,072
Ensembl chr X:159,173,686...159,281,066

X-linked spermatogenic failure 2

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

testis expressed gene 11

ClinVar Annotator: match by term: MALE INFERTILITY FROM DEFECT IN MEIOSIS | ClinVar Annotator: match by term: Spermatogenic failure, X-linked, 2
CTD Direct Evidence: marker/mechanism

OMIM
ClinVar
CTD

PMID:25741868 PMID:25970010 PMID:28492532

NCBI chr X:99,882,254...100,103,245
Ensembl chr X:99,882,254...100,103,273

X-linked spermatogenic failure 3

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cilia and flagella associated protein 47

ClinVar Annotator: match by term: Spermatogenic failure, X-linked, 3

PMID:25741868 PMID:33472045

NCBI chr X:78,310,164...78,560,957
Ensembl chr X:78,310,165...78,560,891

X-Linked Spermatogenic Failure 5

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

SSX member B5

ClinVar Annotator: match by term: Spermatogenic failure, X-linked, 5

PMID:25741868 PMID:36796361

NCBI chr X:8,669,930...8,676,348
Ensembl chr X:8,669,930...8,675,625

X-Linked Spermatogenic Failure 6

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ubiquitin specific peptidase 26

ClinVar Annotator: match by term: Spermatogenic failure, X-linked, 6

NCBI chr X:50,841,544...50,890,110
Ensembl chr X:50,842,836...50,890,110

X-Linked Spermatogenic Failure 7

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cancer/testis antigen 55

ClinVar Annotator: match by term: Spermatogenic failure, X-linked, 7

NCBI chr X:52,726,622...52,740,532
Ensembl chr X:52,718,510...52,740,410

Y-linked spermatogenic failure 2

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cystic fibrosis transmembrane conductance regulator

ClinVar Annotator: match by term: Spermatogenic failure, Y-linked, 2

PMID:1380943 PMID:1712898 PMID:1723032 PMID:1998343 PMID:11186891 More...

NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767

G

DEAD box helicase 3, Y-linked

CTD Direct Evidence: marker/mechanism

NCBI chr Y:1,260,715...1,286,630
Ensembl chr Y:1,260,771...1,286,629

G

predicted gene 15013

CTD Direct Evidence: marker/mechanism

NCBI chr X:138,614,346...138,615,254
Ensembl chr X:138,614,430...138,615,230

G

lysine demethylase 5D

CTD Direct Evidence: marker/mechanism

NCBI chr Y:897,566...946,316
Ensembl chr Y:897,788...956,786

G

ubiquitin specific peptidase 9, Y chromosome

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hypospermatogenesis, nonobstructive, Y-linked | ClinVar Annotator: match by term: Spermatogenic failure, Y-linked, 2

OMIM
CTD
ClinVar

PMID:9384609 PMID:10402373 PMID:10507722 PMID:10767340 PMID:19246359 More...

NCBI chr Y:1,298,961...1,459,782
Ensembl chr Y:1,298,961...1,459,782

Young Syndrome

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

phosphoglycerate kinase 1

ClinVar Annotator: match by term: Male infertility due to obstructive azoospermia

NCBI chr X:105,230,706...105,247,305
Ensembl chr X:105,230,706...105,247,305

ZIEGLER-HUANG SYNDROME

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 30 (zinc transporter), member 7

ClinVar Annotator: match by term: Ziegler-Huang syndrome

PMID:25741868 PMID:36821639

NCBI chr 3:115,732,622...115,801,079
Ensembl chr 3:115,732,622...115,801,055

Term paths to the root

Path 1
Term	Annotations
disease	18301
disease of anatomical entity	15631
reproductive system disease	2973
male reproductive system disease	1954
Fibrous Sheath Dysplasia	2
Fournier Gangrene	0
Hemospermia	0
Male Genital Neoplasms +	1334
Penis Agenesis	2
Reproductive Tract Infections	0
Sexually Transmitted Diseases +	237
Tuberculosis, Male Genital	0
chylocele of tunica vaginalis	0
epididymis disease +	3
hydrocele +	1
infertility +	339
inhibited male orgasm	0
male genital organ stricture	0
male genital organ vascular disease	0
male infertility +	263
penile disease +	132
prostate disease +	1321
sexual dysfunction +	49
spermatic cord torsion	2
spermatocele	0
testicular disease +	170
varicocele	9
vesiculitis +	0
Path 2
Term	Annotations
disease	18301
disease of anatomical entity	15631
Urogenital Diseases	4894
reproductive system disease	2973
male reproductive system disease	1954
Fibrous Sheath Dysplasia	2
Fournier Gangrene	0
Hemospermia	0
Male Genital Neoplasms +	1334
Penis Agenesis	2
Reproductive Tract Infections	0
Sexually Transmitted Diseases +	237
Tuberculosis, Male Genital	0
chylocele of tunica vaginalis	0
epididymis disease +	3
hydrocele +	1
infertility +	339
inhibited male orgasm	0
male genital organ stricture	0
male genital organ vascular disease	0
male infertility +	263
penile disease +	132
prostate disease +	1321
sexual dysfunction +	49
spermatic cord torsion	2
spermatocele	0
testicular disease +	170
varicocele	9
vesiculitis +	0

paths to the root